date generated: 2022-10-13

Background

Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch

Input profiles

Here is the first few lines of the input profile.

##                      hyp         hip         amy        pag          ni
## 0610009B22Rik -1.1049767 -0.23239644  0.19606842  0.5780015 -0.23492611
## 0610009E02Rik  0.6328195 -1.02165121  2.50381380  0.4394343 -0.09139988
## 0610009L18Rik -1.8903112 -0.01240851  0.71226654  1.4508124 -1.43010001
## 0610010K14Rik  0.5240337 -0.07303716 -0.06247159  2.1194691 -0.78295210
## 0610012G03Rik -0.2555955  0.88341789 -0.08438765  2.6585547 -0.10566247
## 0610030E20Rik  0.7313254  0.32408607 -0.30737084 -1.5015909 -0.39636314
Here are some metrics about the input data profile:
Profile metrics
Profile metrics
num_genes_in_profile 15984
duplicated_genes_present 0
num_profile_genes_in_sets 8078
num_profile_genes_not_in_sets 7906

Here is a plot of the input profiles. Note the dynamic ranges.

Here is the contour plot of the profile including all detected genes.

Input genesets

Here are some metrics about the gene sets used: GMT file of genesets: mouse_msigdb_reactome_2022-02-16.gmt
Gene sets metrics
Gene sets metrics
num_genesets 1604
num_genesets_excluded 452
num_genesets_included 1152
Genes by sector
hyp hip amy pag ni Count
1 -1 -1 -1 -1 -1 1186
2 1 -1 -1 -1 -1 505
3 -1 1 -1 -1 -1 367
4 1 1 -1 -1 -1 224
5 -1 -1 1 -1 -1 417
6 1 -1 1 -1 -1 503
7 -1 1 1 -1 -1 217
8 1 1 1 -1 -1 310
9 -1 -1 -1 0 -1 1
10 -1 -1 -1 1 -1 650
11 1 -1 -1 1 -1 228
12 -1 1 -1 1 -1 704
13 1 1 -1 1 -1 238
14 -1 -1 0 1 -1 1
15 -1 -1 1 1 -1 523
16 1 -1 1 1 -1 319
17 -1 0 1 1 -1 1
18 -1 1 1 1 -1 640
19 1 1 1 1 -1 465
20 1 -1 -1 -1 0 1
21 -1 -1 -1 -1 1 833
22 1 -1 -1 -1 1 686
23 -1 1 -1 -1 1 388
24 0 1 -1 -1 1 1
25 1 1 -1 -1 1 407
26 -1 -1 1 -1 1 357
27 1 -1 1 -1 1 1054
28 -1 1 1 -1 1 240
29 1 1 1 -1 1 721
30 -1 -1 -1 1 1 363
31 1 -1 -1 1 1 244
32 -1 1 -1 1 1 512
33 1 1 -1 1 1 451
34 -1 -1 1 1 1 299
35 1 -1 1 1 1 449
36 -1 1 1 1 1 476
37 1 1 1 1 1 1003
Number of significant gene sets (FDR<0.05)= 456

Gene sets by sector


Gene sets by sector
s.hyp s.hip s.amy s.pag s.ni Count
1 -1 -1 -1 -1 -1 33
2 1 -1 -1 -1 -1 3
3 -1 1 -1 -1 -1 1
4 1 1 -1 -1 -1 5
5 -1 -1 1 -1 -1 8
6 1 -1 1 -1 -1 5
7 -1 1 1 -1 -1 2
8 1 1 1 -1 -1 1
9 -1 -1 -1 1 -1 36
10 -1 1 -1 1 -1 58
11 1 1 -1 1 -1 1
12 -1 -1 1 1 -1 28
13 1 -1 1 1 -1 2
14 -1 1 1 1 -1 56
15 -1 -1 -1 -1 1 18
16 1 -1 -1 -1 1 17
17 -1 1 -1 -1 1 3
18 1 1 -1 -1 1 5
19 -1 -1 1 -1 1 13
20 1 -1 1 -1 1 81
21 -1 1 1 -1 1 1
22 1 1 1 -1 1 16
23 -1 -1 -1 1 1 7
24 1 -1 -1 1 1 1
25 -1 1 -1 1 1 7
26 1 1 -1 1 1 9
27 -1 -1 1 1 1 12
28 -1 1 1 1 1 11
29 1 1 1 1 1 16

Interactive enrichment scatterplot

All sets with FDR<0.05. Try hovering over the points.

Top N sets irrespective of FDR. Try hovering over the points.

A heatmap of S values for top results


A plot of effect size versus significance


Significance is the -log2(p.adjustMANOVA) and effect size is the s.dist which is the hypotenuse of the s scores.

Results table

Top N= 50 gene sets
set setSize pMANOVA p.adjustMANOVA s.dist s.hyp s.hip s.amy s.pag s.ni p.hyp p.hip p.amy p.pag p.ni
EUKARYOTIC TRANSLATION ELONGATION 87 4.25e-70 2.45e-67 1.230 -0.5120 0.1370 -0.20400 0.85700 -0.67800 1.54e-16 2.73e-02 1.02e-03 1.20e-43 7.01e-28
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY 94 8.77e-65 2.53e-62 1.140 -0.4870 0.0738 -0.21100 0.76200 -0.66000 3.28e-16 2.17e-01 4.01e-04 1.89e-37 1.80e-28
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE 106 6.08e-69 2.33e-66 1.100 -0.4810 0.0605 -0.20600 0.75500 -0.61100 1.13e-17 2.82e-01 2.43e-04 2.89e-41 1.58e-27
ATTENUATION PHASE 23 8.18e-10 1.33e-08 1.090 -0.5550 -0.4740 -0.39000 -0.38200 -0.59400 4.09e-06 8.30e-05 1.20e-03 1.53e-03 8.16e-07
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES 10 4.53e-04 2.25e-03 1.080 -0.5160 -0.6620 -0.50300 -0.17100 -0.41400 4.70e-03 2.89e-04 5.89e-03 3.50e-01 2.34e-02
EUKARYOTIC TRANSLATION INITIATION 114 4.37e-62 8.39e-60 1.010 -0.4260 0.1060 -0.13500 0.74400 -0.50100 3.80e-15 5.03e-02 1.28e-02 5.38e-43 2.36e-20
SELENOAMINO ACID METABOLISM 107 6.38e-57 8.17e-55 1.010 -0.4230 0.1280 -0.15800 0.71700 -0.52500 4.10e-14 2.27e-02 4.68e-03 1.01e-37 5.83e-21
NONSENSE MEDIATED DECAY NMD 109 1.23e-54 1.29e-52 0.972 -0.3850 0.0938 -0.12000 0.66900 -0.57200 3.96e-12 9.08e-02 3.07e-02 1.36e-33 5.59e-25
COMPLEX I BIOGENESIS 56 3.98e-28 2.29e-26 0.971 -0.5040 0.0518 -0.06440 0.72200 -0.40200 6.85e-11 5.02e-01 4.05e-01 8.79e-21 1.90e-07
HSF1 ACTIVATION 25 1.20e-07 1.38e-06 0.942 -0.5870 -0.3990 -0.41800 -0.18600 -0.41700 3.83e-07 5.47e-04 2.93e-04 1.07e-01 3.06e-04
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S 59 6.17e-25 3.23e-23 0.908 -0.4480 0.0815 -0.11300 0.65900 -0.41200 2.57e-09 2.79e-01 1.34e-01 2.03e-18 4.51e-08
MITOCHONDRIAL TRANSLATION 93 8.92e-39 5.71e-37 0.893 -0.3170 0.2560 -0.03590 0.74800 -0.26700 1.24e-07 2.01e-05 5.50e-01 9.42e-36 8.92e-06
RESPIRATORY ELECTRON TRANSPORT 102 1.10e-43 9.74e-42 0.882 -0.4400 0.0842 -0.05910 0.69700 -0.29800 1.70e-14 1.42e-01 3.02e-01 3.70e-34 2.11e-07
ADENYLATE CYCLASE ACTIVATING PATHWAY 10 1.18e-03 4.97e-03 0.875 0.3020 -0.2610 0.17700 -0.73600 0.18000 9.83e-02 1.53e-01 3.32e-01 5.54e-05 3.23e-01
MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS 13 2.23e-04 1.18e-03 0.867 -0.3980 0.2210 -0.16100 0.63100 -0.34900 1.29e-02 1.69e-01 3.14e-01 8.26e-05 2.95e-02
REGULATION OF EXPRESSION OF SLITS AND ROBOS 159 1.64e-62 3.77e-60 0.866 -0.4130 0.0693 -0.07520 0.59300 -0.46600 2.84e-19 1.32e-01 1.02e-01 3.09e-38 3.43e-24
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING 18 1.68e-07 1.89e-06 0.857 -0.3070 -0.0183 -0.12900 0.74400 -0.26500 2.42e-02 8.93e-01 3.45e-01 4.54e-08 5.15e-02
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS 125 1.57e-49 1.51e-47 0.841 -0.3890 0.0804 -0.06970 0.68700 -0.27000 5.65e-14 1.21e-01 1.79e-01 3.01e-40 1.81e-07
SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS 11 1.16e-03 4.95e-03 0.826 -0.4420 0.1650 0.19900 0.53700 -0.36400 1.12e-02 3.42e-01 2.54e-01 2.05e-03 3.68e-02
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO 10 1.07e-03 4.64e-03 0.818 0.2330 -0.1030 0.56700 -0.49000 0.20800 2.02e-01 5.72e-01 1.91e-03 7.29e-03 2.56e-01
FORMATION OF FIBRIN CLOT CLOTTING CASCADE 18 8.81e-07 8.38e-06 0.811 0.1690 0.6310 -0.29300 0.29700 0.23900 2.14e-01 3.56e-06 3.12e-02 2.91e-02 7.93e-02
SIGNALING BY HIPPO 20 7.87e-07 7.75e-06 0.806 -0.4010 -0.0681 -0.41800 -0.54300 0.12000 1.90e-03 5.98e-01 1.20e-03 2.62e-05 3.51e-01
RHOBTB2 GTPASE CYCLE 23 3.79e-05 2.44e-04 0.796 -0.4220 -0.3850 -0.23600 -0.23800 -0.44200 4.66e-04 1.39e-03 4.98e-02 4.84e-02 2.45e-04
CAMK IV MEDIATED PHOSPHORYLATION OF CREB 10 8.28e-03 2.51e-02 0.781 0.3490 -0.2550 0.49600 -0.14000 0.39800 5.63e-02 1.63e-01 6.62e-03 4.44e-01 2.95e-02
CRISTAE FORMATION 31 1.60e-10 2.79e-09 0.781 -0.2750 0.0520 -0.07630 0.69000 -0.22200 8.11e-03 6.17e-01 4.62e-01 2.84e-11 3.23e-02
TRANSLATION 286 8.05e-94 9.27e-91 0.780 -0.3350 0.1410 -0.07790 0.61800 -0.29800 1.99e-22 4.36e-05 2.38e-02 1.27e-72 4.67e-18
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY 17 1.83e-04 9.97e-04 0.779 0.1190 -0.4290 -0.16300 -0.57800 -0.22100 3.96e-01 2.22e-03 2.44e-01 3.72e-05 1.15e-01
ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K 11 5.54e-03 1.81e-02 0.777 0.1510 -0.6350 -0.08550 -0.40200 0.09190 3.85e-01 2.64e-04 6.24e-01 2.09e-02 5.98e-01
INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION 12 1.69e-04 9.28e-04 0.775 0.0314 0.5990 -0.42900 0.16500 0.16900 8.51e-01 3.25e-04 1.00e-02 3.22e-01 3.12e-01
UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION 21 1.63e-05 1.14e-04 0.769 0.4370 -0.2780 0.40600 -0.29300 0.26900 5.23e-04 2.77e-02 1.28e-03 2.03e-02 3.29e-02
REDUCTION OF CYTOSOLIC CA LEVELS 11 1.31e-02 3.62e-02 0.763 0.4460 -0.1730 0.27200 -0.31900 0.42200 1.05e-02 3.19e-01 1.19e-01 6.74e-02 1.53e-02
TRAF6 MEDIATED IRF7 ACTIVATION 15 3.31e-03 1.18e-02 0.756 -0.1760 -0.4480 -0.38500 -0.43500 0.04760 2.38e-01 2.64e-03 9.89e-03 3.54e-03 7.50e-01
TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS 17 4.81e-04 2.38e-03 0.747 0.4410 -0.1000 0.55400 -0.11200 0.18500 1.66e-03 4.75e-01 7.59e-05 4.22e-01 1.86e-01
LONG TERM POTENTIATION 23 1.26e-05 8.91e-05 0.743 0.4420 -0.2890 0.32500 -0.32800 0.24600 2.44e-04 1.65e-02 7.00e-03 6.50e-03 4.10e-02
INFLUENZA INFECTION 145 1.16e-41 8.32e-40 0.742 -0.3580 -0.0182 -0.10800 0.48100 -0.42300 9.47e-14 7.05e-01 2.55e-02 1.38e-23 1.44e-18
SYNAPTIC ADHESION LIKE MOLECULES 21 7.75e-06 5.95e-05 0.742 0.3280 -0.1230 0.52000 -0.37100 0.14300 9.20e-03 3.30e-01 3.74e-05 3.26e-03 2.55e-01
CELLULAR RESPONSE TO STARVATION 145 3.07e-43 2.35e-41 0.741 -0.3040 0.0548 -0.06220 0.57100 -0.35100 2.59e-10 2.56e-01 1.97e-01 1.47e-32 3.19e-13
PKA MEDIATED PHOSPHORYLATION OF CREB 19 5.46e-05 3.33e-04 0.740 -0.0309 -0.3860 0.05160 -0.61200 0.14500 8.16e-01 3.58e-03 6.97e-01 3.84e-06 2.74e-01
RRNA PROCESSING 194 2.68e-56 3.08e-54 0.731 -0.2900 0.0620 -0.00171 0.54400 -0.38800 3.49e-12 1.37e-01 9.67e-01 4.44e-39 1.21e-20
BIOTIN TRANSPORT AND METABOLISM 11 7.31e-03 2.26e-02 0.730 0.1110 0.5500 0.33800 -0.00956 0.32300 5.24e-01 1.57e-03 5.25e-02 9.56e-01 6.40e-02
CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE 11 1.13e-02 3.21e-02 0.724 -0.3190 -0.4050 -0.15100 -0.46600 0.13600 6.72e-02 2.02e-02 3.87e-01 7.40e-03 4.34e-01
NEGATIVE REGULATION OF NOTCH4 SIGNALING 54 4.60e-16 1.89e-14 0.724 -0.3820 0.0500 0.08490 0.58200 -0.17000 1.18e-06 5.25e-01 2.81e-01 1.31e-13 3.05e-02
PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING 11 9.16e-03 2.75e-02 0.721 0.3950 -0.2320 0.40200 -0.38600 0.02240 2.34e-02 1.83e-01 2.11e-02 2.67e-02 8.98e-01
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING 26 1.69e-06 1.53e-05 0.719 -0.4880 -0.1340 -0.05830 0.37000 -0.34800 1.65e-05 2.37e-01 6.07e-01 1.10e-03 2.11e-03
TRAF3 DEPENDENT IRF ACTIVATION PATHWAY 13 1.96e-02 4.96e-02 0.716 -0.2110 -0.4010 -0.34700 -0.43300 0.00433 1.89e-01 1.23e-02 3.04e-02 6.84e-03 9.78e-01
ADENYLATE CYCLASE INHIBITORY PATHWAY 13 2.99e-03 1.09e-02 0.714 0.0959 -0.2210 0.02000 -0.66200 0.11300 5.49e-01 1.67e-01 9.01e-01 3.53e-05 4.80e-01
MITOCHONDRIAL PROTEIN IMPORT 63 2.86e-17 1.27e-15 0.712 -0.2390 0.1760 0.04490 0.64300 -0.06040 1.03e-03 1.60e-02 5.38e-01 9.77e-19 4.07e-01
MUCOPOLYSACCHARIDOSES 11 6.18e-03 1.95e-02 0.711 0.2360 0.4280 0.43800 -0.19200 0.19200 1.75e-01 1.39e-02 1.19e-02 2.69e-01 2.70e-01
NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION 21 6.46e-05 3.87e-04 0.707 0.3520 -0.3500 0.34300 -0.24300 0.27700 5.26e-03 5.56e-03 6.54e-03 5.37e-02 2.81e-02
ATF6 ATF6 ALPHA ACTIVATES CHAPERONES 12 4.70e-02 9.94e-02 0.704 -0.3330 -0.4040 -0.38800 -0.13700 -0.22700 4.58e-02 1.54e-02 1.99e-02 4.11e-01 1.73e-01


Results (complete table)


Click HERE to show results for all gene sets

Complete results
set setSize pMANOVA p.adjustMANOVA s.dist s.hyp s.hip s.amy s.pag s.ni p.hyp p.hip p.amy p.pag p.ni
EUKARYOTIC TRANSLATION ELONGATION 87 4.25e-70 2.45e-67 1.2300 -0.512000 0.137000 -0.204000 8.57e-01 -6.78e-01 1.54e-16 2.73e-02 1.02e-03 1.20e-43 7.01e-28
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY 94 8.77e-65 2.53e-62 1.1400 -0.487000 0.073800 -0.211000 7.62e-01 -6.60e-01 3.28e-16 2.17e-01 4.01e-04 1.89e-37 1.80e-28
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE 106 6.08e-69 2.33e-66 1.1000 -0.481000 0.060500 -0.206000 7.55e-01 -6.11e-01 1.13e-17 2.82e-01 2.43e-04 2.89e-41 1.58e-27
ATTENUATION PHASE 23 8.18e-10 1.33e-08 1.0900 -0.555000 -0.474000 -0.390000 -3.82e-01 -5.94e-01 4.09e-06 8.30e-05 1.20e-03 1.53e-03 8.16e-07
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES 10 4.53e-04 2.25e-03 1.0800 -0.516000 -0.662000 -0.503000 -1.71e-01 -4.14e-01 4.70e-03 2.89e-04 5.89e-03 3.50e-01 2.34e-02
EUKARYOTIC TRANSLATION INITIATION 114 4.37e-62 8.39e-60 1.0100 -0.426000 0.106000 -0.135000 7.44e-01 -5.01e-01 3.80e-15 5.03e-02 1.28e-02 5.38e-43 2.36e-20
SELENOAMINO ACID METABOLISM 107 6.38e-57 8.17e-55 1.0100 -0.423000 0.128000 -0.158000 7.17e-01 -5.25e-01 4.10e-14 2.27e-02 4.68e-03 1.01e-37 5.83e-21
NONSENSE MEDIATED DECAY NMD 109 1.23e-54 1.29e-52 0.9720 -0.385000 0.093800 -0.120000 6.69e-01 -5.72e-01 3.96e-12 9.08e-02 3.07e-02 1.36e-33 5.59e-25
COMPLEX I BIOGENESIS 56 3.98e-28 2.29e-26 0.9710 -0.504000 0.051800 -0.064400 7.22e-01 -4.02e-01 6.85e-11 5.02e-01 4.05e-01 8.79e-21 1.90e-07
HSF1 ACTIVATION 25 1.20e-07 1.38e-06 0.9420 -0.587000 -0.399000 -0.418000 -1.86e-01 -4.17e-01 3.83e-07 5.47e-04 2.93e-04 1.07e-01 3.06e-04
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S 59 6.17e-25 3.23e-23 0.9080 -0.448000 0.081500 -0.113000 6.59e-01 -4.12e-01 2.57e-09 2.79e-01 1.34e-01 2.03e-18 4.51e-08
MITOCHONDRIAL TRANSLATION 93 8.92e-39 5.71e-37 0.8930 -0.317000 0.256000 -0.035900 7.48e-01 -2.67e-01 1.24e-07 2.01e-05 5.50e-01 9.42e-36 8.92e-06
RESPIRATORY ELECTRON TRANSPORT 102 1.10e-43 9.74e-42 0.8820 -0.440000 0.084200 -0.059100 6.97e-01 -2.98e-01 1.70e-14 1.42e-01 3.02e-01 3.70e-34 2.11e-07
ADENYLATE CYCLASE ACTIVATING PATHWAY 10 1.18e-03 4.97e-03 0.8750 0.302000 -0.261000 0.177000 -7.36e-01 1.80e-01 9.83e-02 1.53e-01 3.32e-01 5.54e-05 3.23e-01
MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS 13 2.23e-04 1.18e-03 0.8670 -0.398000 0.221000 -0.161000 6.31e-01 -3.49e-01 1.29e-02 1.69e-01 3.14e-01 8.26e-05 2.95e-02
REGULATION OF EXPRESSION OF SLITS AND ROBOS 159 1.64e-62 3.77e-60 0.8660 -0.413000 0.069300 -0.075200 5.93e-01 -4.66e-01 2.84e-19 1.32e-01 1.02e-01 3.09e-38 3.43e-24
FORMATION OF ATP BY CHEMIOSMOTIC COUPLING 18 1.68e-07 1.89e-06 0.8570 -0.307000 -0.018300 -0.129000 7.44e-01 -2.65e-01 2.42e-02 8.93e-01 3.45e-01 4.54e-08 5.15e-02
RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS 125 1.57e-49 1.51e-47 0.8410 -0.389000 0.080400 -0.069700 6.87e-01 -2.70e-01 5.65e-14 1.21e-01 1.79e-01 3.01e-40 1.81e-07
SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS 11 1.16e-03 4.95e-03 0.8260 -0.442000 0.165000 0.199000 5.37e-01 -3.64e-01 1.12e-02 3.42e-01 2.54e-01 2.05e-03 3.68e-02
REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO 10 1.07e-03 4.64e-03 0.8180 0.233000 -0.103000 0.567000 -4.90e-01 2.08e-01 2.02e-01 5.72e-01 1.91e-03 7.29e-03 2.56e-01
FORMATION OF FIBRIN CLOT CLOTTING CASCADE 18 8.81e-07 8.38e-06 0.8110 0.169000 0.631000 -0.293000 2.97e-01 2.39e-01 2.14e-01 3.56e-06 3.12e-02 2.91e-02 7.93e-02
SIGNALING BY HIPPO 20 7.87e-07 7.75e-06 0.8060 -0.401000 -0.068100 -0.418000 -5.43e-01 1.20e-01 1.90e-03 5.98e-01 1.20e-03 2.62e-05 3.51e-01
RHOBTB2 GTPASE CYCLE 23 3.79e-05 2.44e-04 0.7960 -0.422000 -0.385000 -0.236000 -2.38e-01 -4.42e-01 4.66e-04 1.39e-03 4.98e-02 4.84e-02 2.45e-04
CAMK IV MEDIATED PHOSPHORYLATION OF CREB 10 8.28e-03 2.51e-02 0.7810 0.349000 -0.255000 0.496000 -1.40e-01 3.98e-01 5.63e-02 1.63e-01 6.62e-03 4.44e-01 2.95e-02
CRISTAE FORMATION 31 1.60e-10 2.79e-09 0.7810 -0.275000 0.052000 -0.076300 6.90e-01 -2.22e-01 8.11e-03 6.17e-01 4.62e-01 2.84e-11 3.23e-02
TRANSLATION 286 8.05e-94 9.27e-91 0.7800 -0.335000 0.141000 -0.077900 6.18e-01 -2.98e-01 1.99e-22 4.36e-05 2.38e-02 1.27e-72 4.67e-18
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY 17 1.83e-04 9.97e-04 0.7790 0.119000 -0.429000 -0.163000 -5.78e-01 -2.21e-01 3.96e-01 2.22e-03 2.44e-01 3.72e-05 1.15e-01
ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K 11 5.54e-03 1.81e-02 0.7770 0.151000 -0.635000 -0.085500 -4.02e-01 9.19e-02 3.85e-01 2.64e-04 6.24e-01 2.09e-02 5.98e-01
INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION 12 1.69e-04 9.28e-04 0.7750 0.031400 0.599000 -0.429000 1.65e-01 1.69e-01 8.51e-01 3.25e-04 1.00e-02 3.22e-01 3.12e-01
UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION 21 1.63e-05 1.14e-04 0.7690 0.437000 -0.278000 0.406000 -2.93e-01 2.69e-01 5.23e-04 2.77e-02 1.28e-03 2.03e-02 3.29e-02
REDUCTION OF CYTOSOLIC CA LEVELS 11 1.31e-02 3.62e-02 0.7630 0.446000 -0.173000 0.272000 -3.19e-01 4.22e-01 1.05e-02 3.19e-01 1.19e-01 6.74e-02 1.53e-02
TRAF6 MEDIATED IRF7 ACTIVATION 15 3.31e-03 1.18e-02 0.7560 -0.176000 -0.448000 -0.385000 -4.35e-01 4.76e-02 2.38e-01 2.64e-03 9.89e-03 3.54e-03 7.50e-01
TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS 17 4.81e-04 2.38e-03 0.7470 0.441000 -0.100000 0.554000 -1.12e-01 1.85e-01 1.66e-03 4.75e-01 7.59e-05 4.22e-01 1.86e-01
LONG TERM POTENTIATION 23 1.26e-05 8.91e-05 0.7430 0.442000 -0.289000 0.325000 -3.28e-01 2.46e-01 2.44e-04 1.65e-02 7.00e-03 6.50e-03 4.10e-02
INFLUENZA INFECTION 145 1.16e-41 8.32e-40 0.7420 -0.358000 -0.018200 -0.108000 4.81e-01 -4.23e-01 9.47e-14 7.05e-01 2.55e-02 1.38e-23 1.44e-18
SYNAPTIC ADHESION LIKE MOLECULES 21 7.75e-06 5.95e-05 0.7420 0.328000 -0.123000 0.520000 -3.71e-01 1.43e-01 9.20e-03 3.30e-01 3.74e-05 3.26e-03 2.55e-01
CELLULAR RESPONSE TO STARVATION 145 3.07e-43 2.35e-41 0.7410 -0.304000 0.054800 -0.062200 5.71e-01 -3.51e-01 2.59e-10 2.56e-01 1.97e-01 1.47e-32 3.19e-13
PKA MEDIATED PHOSPHORYLATION OF CREB 19 5.46e-05 3.33e-04 0.7400 -0.030900 -0.386000 0.051600 -6.12e-01 1.45e-01 8.16e-01 3.58e-03 6.97e-01 3.84e-06 2.74e-01
RRNA PROCESSING 194 2.68e-56 3.08e-54 0.7310 -0.290000 0.062000 -0.001710 5.44e-01 -3.88e-01 3.49e-12 1.37e-01 9.67e-01 4.44e-39 1.21e-20
BIOTIN TRANSPORT AND METABOLISM 11 7.31e-03 2.26e-02 0.7300 0.111000 0.550000 0.338000 -9.56e-03 3.23e-01 5.24e-01 1.57e-03 5.25e-02 9.56e-01 6.40e-02
CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE 11 1.13e-02 3.21e-02 0.7240 -0.319000 -0.405000 -0.151000 -4.66e-01 1.36e-01 6.72e-02 2.02e-02 3.87e-01 7.40e-03 4.34e-01
NEGATIVE REGULATION OF NOTCH4 SIGNALING 54 4.60e-16 1.89e-14 0.7240 -0.382000 0.050000 0.084900 5.82e-01 -1.70e-01 1.18e-06 5.25e-01 2.81e-01 1.31e-13 3.05e-02
PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING 11 9.16e-03 2.75e-02 0.7210 0.395000 -0.232000 0.402000 -3.86e-01 2.24e-02 2.34e-02 1.83e-01 2.11e-02 2.67e-02 8.98e-01
COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING 26 1.69e-06 1.53e-05 0.7190 -0.488000 -0.134000 -0.058300 3.70e-01 -3.48e-01 1.65e-05 2.37e-01 6.07e-01 1.10e-03 2.11e-03
TRAF3 DEPENDENT IRF ACTIVATION PATHWAY 13 1.96e-02 4.96e-02 0.7160 -0.211000 -0.401000 -0.347000 -4.33e-01 4.33e-03 1.89e-01 1.23e-02 3.04e-02 6.84e-03 9.78e-01
ADENYLATE CYCLASE INHIBITORY PATHWAY 13 2.99e-03 1.09e-02 0.7140 0.095900 -0.221000 0.020000 -6.62e-01 1.13e-01 5.49e-01 1.67e-01 9.01e-01 3.53e-05 4.80e-01
MITOCHONDRIAL PROTEIN IMPORT 63 2.86e-17 1.27e-15 0.7120 -0.239000 0.176000 0.044900 6.43e-01 -6.04e-02 1.03e-03 1.60e-02 5.38e-01 9.77e-19 4.07e-01
MUCOPOLYSACCHARIDOSES 11 6.18e-03 1.95e-02 0.7110 0.236000 0.428000 0.438000 -1.92e-01 1.92e-01 1.75e-01 1.39e-02 1.19e-02 2.69e-01 2.70e-01
NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION 21 6.46e-05 3.87e-04 0.7070 0.352000 -0.350000 0.343000 -2.43e-01 2.77e-01 5.26e-03 5.56e-03 6.54e-03 5.37e-02 2.81e-02
ATF6 ATF6 ALPHA ACTIVATES CHAPERONES 12 4.70e-02 9.94e-02 0.7040 -0.333000 -0.404000 -0.388000 -1.37e-01 -2.27e-01 4.58e-02 1.54e-02 1.99e-02 4.11e-01 1.73e-01
PURINE CATABOLISM 16 4.23e-03 1.43e-02 0.7030 -0.042100 0.455000 0.167000 4.89e-01 1.36e-01 7.71e-01 1.64e-03 2.47e-01 7.02e-04 3.46e-01
CGMP EFFECTS 15 4.25e-03 1.43e-02 0.7020 0.466000 -0.089800 0.494000 -5.66e-02 1.39e-01 1.77e-03 5.47e-01 9.16e-04 7.04e-01 3.50e-01
RNA POLYMERASE III CHAIN ELONGATION 18 7.51e-04 3.46e-03 0.7010 0.024600 0.279000 0.178000 6.02e-01 1.38e-01 8.56e-01 4.02e-02 1.90e-01 9.79e-06 3.12e-01
NEUROTOXICITY OF CLOSTRIDIUM TOXINS 10 3.48e-02 7.79e-02 0.6970 0.505000 -0.186000 0.392000 8.36e-03 2.09e-01 5.73e-03 3.09e-01 3.20e-02 9.63e-01 2.52e-01
TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS 15 4.01e-03 1.38e-02 0.6970 -0.020000 -0.249000 -0.267000 -5.83e-01 -1.10e-01 8.93e-01 9.56e-02 7.30e-02 9.24e-05 4.61e-01
ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT 23 1.93e-05 1.30e-04 0.6910 -0.155000 0.158000 0.310000 5.08e-01 -2.73e-01 1.99e-01 1.91e-01 1.00e-02 2.45e-05 2.36e-02
INCRETIN SYNTHESIS SECRETION AND INACTIVATION 12 2.12e-02 5.24e-02 0.6900 -0.559000 -0.013400 -0.146000 1.88e-01 -3.28e-01 8.06e-04 9.36e-01 3.82e-01 2.58e-01 4.94e-02
SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 12 2.12e-02 5.24e-02 0.6900 -0.559000 -0.013400 -0.146000 1.88e-01 -3.28e-01 8.06e-04 9.36e-01 3.82e-01 2.58e-01 4.94e-02
LYSOSPHINGOLIPID AND LPA RECEPTORS 12 3.36e-03 1.20e-02 0.6890 -0.118000 -0.063800 -0.072300 -3.35e-01 -5.83e-01 4.81e-01 7.02e-01 6.65e-01 4.45e-02 4.76e-04
DNA METHYLATION 17 9.36e-04 4.13e-03 0.6890 -0.300000 0.147000 -0.437000 3.37e-01 -2.41e-01 3.25e-02 2.95e-01 1.80e-03 1.60e-02 8.59e-02
CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES 46 8.60e-12 2.02e-10 0.6850 -0.366000 0.026200 -0.014400 5.50e-01 -1.79e-01 1.73e-05 7.59e-01 8.66e-01 1.12e-10 3.56e-02
AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA 53 3.30e-13 1.00e-11 0.6830 -0.424000 -0.016600 -0.002230 4.73e-01 -2.52e-01 9.27e-08 8.34e-01 9.78e-01 2.66e-09 1.49e-03
INTERACTION BETWEEN L1 AND ANKYRINS 27 3.92e-06 3.16e-05 0.6830 0.293000 -0.243000 0.365000 -4.10e-01 1.44e-01 8.46e-03 2.89e-02 1.04e-03 2.27e-04 1.97e-01
CA DEPENDENT EVENTS 36 4.37e-08 5.24e-07 0.6830 0.236000 -0.268000 0.264000 -4.41e-01 2.72e-01 1.44e-02 5.33e-03 6.18e-03 4.58e-06 4.77e-03
ABC TRANSPORTERS IN LIPID HOMEOSTASIS 13 6.72e-03 2.10e-02 0.6820 0.207000 -0.006690 0.046400 -3.12e-01 5.68e-01 1.96e-01 9.67e-01 7.72e-01 5.12e-02 3.87e-04
ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE 17 1.42e-03 5.75e-03 0.6810 0.486000 -0.232000 0.360000 -1.66e-01 1.30e-01 5.23e-04 9.82e-02 1.01e-02 2.36e-01 3.53e-01
SCF SKP2 MEDIATED DEGRADATION OF P27 P21 58 2.07e-14 7.21e-13 0.6760 -0.410000 0.076600 0.030300 5.07e-01 -1.58e-01 6.64e-08 3.13e-01 6.90e-01 2.47e-11 3.79e-02
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE 11 1.76e-02 4.51e-02 0.6690 0.151000 0.009130 0.059000 -3.55e-01 5.43e-01 3.87e-01 9.58e-01 7.35e-01 4.13e-02 1.83e-03
DAG AND IP3 SIGNALING 40 3.33e-08 4.08e-07 0.6680 0.292000 -0.264000 0.243000 -3.75e-01 3.02e-01 1.38e-03 3.88e-03 7.92e-03 4.03e-05 9.46e-04
THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT 172 1.29e-43 1.06e-41 0.6680 -0.265000 0.112000 -0.050000 5.86e-01 -1.29e-01 2.01e-09 1.11e-02 2.59e-01 2.95e-40 3.54e-03
COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING 34 2.84e-07 3.03e-06 0.6590 -0.423000 -0.334000 -0.055400 1.83e-01 -3.27e-01 1.94e-05 7.65e-04 5.76e-01 6.54e-02 9.76e-04
STABILIZATION OF P53 54 4.93e-13 1.38e-11 0.6580 -0.361000 -0.030400 -0.030900 5.11e-01 -1.99e-01 4.47e-06 6.99e-01 6.94e-01 8.54e-11 1.15e-02
THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT 65 1.17e-15 4.49e-14 0.6570 -0.362000 0.008960 0.032100 5.09e-01 -2.01e-01 4.49e-07 9.01e-01 6.55e-01 1.23e-12 5.05e-03
ANTIMICROBIAL PEPTIDES 13 2.90e-03 1.07e-02 0.6570 0.207000 0.331000 -0.216000 4.47e-01 1.79e-01 1.95e-01 3.87e-02 1.77e-01 5.21e-03 2.64e-01
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY 53 4.79e-13 1.38e-11 0.6560 -0.392000 -0.027800 0.004050 4.99e-01 -1.65e-01 7.87e-07 7.27e-01 9.59e-01 3.31e-10 3.74e-02
METABOLISM OF POLYAMINES 56 3.32e-14 1.12e-12 0.6560 -0.307000 0.027500 0.033700 5.71e-01 -9.31e-02 7.23e-05 7.22e-01 6.63e-01 1.45e-13 2.28e-01
SEROTONIN NEUROTRANSMITTER RELEASE CYCLE 18 9.04e-04 4.01e-03 0.6550 0.348000 -0.167000 0.449000 -2.78e-01 3.38e-02 1.05e-02 2.19e-01 9.85e-04 4.09e-02 8.04e-01
DEGRADATION OF DVL 55 1.06e-13 3.39e-12 0.6550 -0.387000 -0.037000 0.044400 4.94e-01 -1.78e-01 6.90e-07 6.35e-01 5.69e-01 2.33e-10 2.24e-02
DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS 18 4.16e-03 1.41e-02 0.6530 0.133000 0.175000 0.440000 3.14e-01 2.93e-01 3.28e-01 1.98e-01 1.23e-03 2.13e-02 3.12e-02
VOLTAGE GATED POTASSIUM CHANNELS 39 9.19e-07 8.68e-06 0.6510 0.425000 -0.077900 0.355000 -2.04e-01 2.65e-01 4.34e-06 4.00e-01 1.27e-04 2.78e-02 4.27e-03
DETOXIFICATION OF REACTIVE OXYGEN SPECIES 31 6.48e-06 5.01e-05 0.6500 -0.340000 0.205000 -0.132000 4.57e-01 -1.98e-01 1.06e-03 4.87e-02 2.04e-01 1.05e-05 5.70e-02
RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PURINE 20 8.74e-04 3.90e-03 0.6500 -0.364000 0.114000 -0.147000 4.53e-01 -2.23e-01 4.86e-03 3.78e-01 2.56e-01 4.51e-04 8.37e-02
NITRIC OXIDE STIMULATES GUANYLATE CYCLASE 21 7.70e-04 3.53e-03 0.6490 0.491000 -0.088200 0.343000 -2.05e-01 1.15e-01 9.89e-05 4.84e-01 6.49e-03 1.03e-01 3.64e-01
TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX 12 2.38e-02 5.78e-02 0.6480 0.046200 0.135000 0.451000 3.53e-01 2.68e-01 7.82e-01 4.18e-01 6.80e-03 3.42e-02 1.08e-01
SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL 13 7.61e-03 2.34e-02 0.6470 0.233000 0.314000 -0.022600 -2.48e-01 4.51e-01 1.45e-01 5.02e-02 8.88e-01 1.22e-01 4.84e-03
SHC MEDIATED CASCADE FGFR4 10 2.40e-02 5.79e-02 0.6450 -0.221000 -0.113000 -0.552000 -2.50e-05 2.24e-01 2.26e-01 5.36e-01 2.51e-03 1.00e+00 2.21e-01
HSF1 DEPENDENT TRANSACTIVATION 33 7.73e-05 4.54e-04 0.6440 -0.292000 -0.324000 -0.193000 -2.77e-01 -3.33e-01 3.75e-03 1.28e-03 5.51e-02 5.98e-03 9.34e-04
REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX 15 1.36e-02 3.75e-02 0.6440 0.275000 0.239000 0.068500 9.51e-02 5.17e-01 6.51e-02 1.08e-01 6.46e-01 5.24e-01 5.25e-04
CITRIC ACID CYCLE TCA CYCLE 22 1.01e-04 5.80e-04 0.6420 0.027500 0.200000 0.053800 4.49e-01 4.08e-01 8.24e-01 1.05e-01 6.62e-01 2.63e-04 9.27e-04
DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS 58 5.80e-13 1.57e-11 0.6390 -0.382000 0.006550 0.000855 4.78e-01 -1.86e-01 4.90e-07 9.31e-01 9.91e-01 3.08e-10 1.43e-02
COHESIN LOADING ONTO CHROMATIN 10 8.39e-02 1.55e-01 0.6380 0.049700 -0.254000 -0.187000 -5.39e-01 1.20e-01 7.85e-01 1.64e-01 3.05e-01 3.16e-03 5.10e-01
NEUREXINS AND NEUROLIGINS 54 1.11e-10 2.03e-09 0.6370 0.300000 -0.279000 0.280000 -3.82e-01 1.16e-01 1.39e-04 3.88e-04 3.81e-04 1.18e-06 1.41e-01
RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES 20 7.20e-04 3.34e-03 0.6360 0.080200 -0.278000 0.098100 -4.99e-01 2.48e-01 5.35e-01 3.12e-02 4.48e-01 1.11e-04 5.47e-02
IONOTROPIC ACTIVITY OF KAINATE RECEPTORS 10 2.64e-02 6.22e-02 0.6350 0.285000 -0.340000 0.329000 -1.96e-01 -2.43e-01 1.19e-01 6.23e-02 7.15e-02 2.82e-01 1.84e-01
FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC 19 1.04e-03 4.56e-03 0.6340 -0.449000 -0.215000 -0.083400 2.82e-01 -2.60e-01 7.00e-04 1.05e-01 5.29e-01 3.33e-02 5.00e-02
ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS 10 5.54e-02 1.12e-01 0.6330 0.050200 -0.369000 0.181000 -4.75e-01 6.05e-02 7.83e-01 4.34e-02 3.21e-01 9.23e-03 7.40e-01
TRAFFICKING OF AMPA RECEPTORS 31 2.21e-05 1.47e-04 0.6320 0.410000 -0.093600 0.436000 -1.31e-01 1.27e-01 7.82e-05 3.67e-01 2.71e-05 2.05e-01 2.19e-01
PKA ACTIVATION IN GLUCAGON SIGNALLING 16 2.12e-03 8.33e-03 0.6320 -0.025200 -0.255000 0.130000 -5.51e-01 1.16e-01 8.61e-01 7.76e-02 3.68e-01 1.35e-04 4.20e-01
MET ACTIVATES RAP1 AND RAC1 10 1.53e-01 2.40e-01 0.6320 -0.248000 -0.399000 -0.309000 -2.88e-01 -1.26e-02 1.75e-01 2.88e-02 9.12e-02 1.15e-01 9.45e-01
AMINE LIGAND BINDING RECEPTORS 28 5.79e-06 4.50e-05 0.6310 0.238000 0.040100 0.286000 -4.43e-01 2.51e-01 2.95e-02 7.14e-01 8.87e-03 5.01e-05 2.17e-02
BRANCHED CHAIN AMINO ACID CATABOLISM 21 1.65e-04 9.12e-04 0.6310 -0.099600 0.327000 -0.074200 2.99e-01 4.31e-01 4.29e-01 9.45e-03 5.56e-01 1.77e-02 6.22e-04
SIGNALING BY ROBO RECEPTORS 204 1.06e-40 7.18e-39 0.6270 -0.333000 0.026200 -0.045900 3.92e-01 -3.55e-01 2.32e-16 5.19e-01 2.60e-01 5.37e-22 2.23e-18
SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER 15 5.00e-03 1.66e-02 0.6270 -0.268000 -0.156000 0.015100 -3.28e-01 -4.35e-01 7.25e-02 2.94e-01 9.19e-01 2.79e-02 3.51e-03
SIGNALING BY FGFR4 IN DISEASE 10 1.91e-01 2.82e-01 0.6230 -0.207000 -0.428000 -0.269000 -2.66e-01 -1.39e-01 2.57e-01 1.91e-02 1.41e-01 1.45e-01 4.46e-01
MITOCHONDRIAL FATTY ACID BETA OXIDATION 33 1.51e-06 1.38e-05 0.6230 -0.089100 0.392000 -0.214000 4.16e-01 9.12e-02 3.76e-01 9.78e-05 3.36e-02 3.59e-05 3.65e-01
INHIBITION OF DNA RECOMBINATION AT TELOMERE 33 4.70e-06 3.71e-05 0.6220 -0.263000 0.093900 -0.098900 4.71e-01 -2.78e-01 8.92e-03 3.51e-01 3.25e-01 2.85e-06 5.65e-03
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE 15 1.42e-02 3.86e-02 0.6200 0.249000 -0.014700 0.349000 -2.69e-01 3.58e-01 9.55e-02 9.22e-01 1.94e-02 7.08e-02 1.63e-02
PROCESSING OF SMDT1 16 9.31e-03 2.78e-02 0.6200 -0.019600 0.310000 -0.005890 5.34e-01 5.61e-02 8.92e-01 3.19e-02 9.67e-01 2.19e-04 6.98e-01
DEGRADATION OF AXIN 53 5.62e-11 1.10e-09 0.6170 -0.381000 0.015600 0.000221 4.58e-01 -1.60e-01 1.56e-06 8.44e-01 9.98e-01 8.27e-09 4.44e-02
EFFECTS OF PIP2 HYDROLYSIS 27 3.00e-04 1.55e-03 0.6140 0.417000 -0.166000 0.250000 -1.52e-01 3.00e-01 1.78e-04 1.35e-01 2.48e-02 1.71e-01 6.89e-03
ASPARTATE AND ASPARAGINE METABOLISM 11 8.22e-02 1.52e-01 0.6100 0.140000 0.333000 0.075300 1.26e-01 4.69e-01 4.23e-01 5.55e-02 6.65e-01 4.68e-01 7.09e-03
RETROGRADE NEUROTROPHIN SIGNALLING 12 5.98e-02 1.20e-01 0.6100 0.207000 0.168000 0.446000 -7.89e-02 3.09e-01 2.14e-01 3.14e-01 7.50e-03 6.36e-01 6.37e-02
LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME 13 1.48e-02 3.96e-02 0.6080 0.105000 -0.458000 0.273000 -2.61e-01 -7.86e-02 5.14e-01 4.29e-03 8.81e-02 1.03e-01 6.24e-01
SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION 14 7.37e-03 2.28e-02 0.6070 0.025300 -0.439000 0.157000 -2.55e-01 2.91e-01 8.70e-01 4.43e-03 3.08e-01 9.90e-02 5.94e-02
NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10 11 4.17e-02 9.01e-02 0.6050 0.070100 -0.082200 -0.401000 -4.07e-01 1.68e-01 6.87e-01 6.37e-01 2.13e-02 1.94e-02 3.35e-01
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE 16 7.70e-03 2.36e-02 0.6040 0.179000 -0.012100 0.035400 -3.88e-01 4.26e-01 2.14e-01 9.33e-01 8.07e-01 7.28e-03 3.21e-03
G PROTEIN ACTIVATION 21 1.41e-03 5.75e-03 0.6030 -0.377000 -0.237000 0.020200 1.36e-01 -3.83e-01 2.81e-03 6.05e-02 8.73e-01 2.79e-01 2.36e-03
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS 80 6.68e-14 2.20e-12 0.6020 -0.375000 0.055900 -0.129000 3.88e-01 -2.27e-01 6.70e-09 3.88e-01 4.57e-02 2.09e-09 4.61e-04
PYROPTOSIS 20 1.20e-03 5.05e-03 0.5970 -0.285000 0.023200 0.025900 4.90e-01 -1.85e-01 2.74e-02 8.57e-01 8.41e-01 1.49e-04 1.51e-01
ASSEMBLY OF THE PRE REPLICATIVE COMPLEX 64 5.87e-13 1.57e-11 0.5970 -0.294000 0.054600 0.072000 5.02e-01 -9.72e-02 4.77e-05 4.50e-01 3.20e-01 3.71e-12 1.79e-01
FORMATION OF THE EARLY ELONGATION COMPLEX 33 1.04e-05 7.64e-05 0.5960 -0.155000 0.177000 0.276000 4.37e-01 -1.81e-01 1.25e-01 7.85e-02 6.01e-03 1.38e-05 7.20e-02
DECTIN 1 MEDIATED NONCANONICAL NF KB SIGNALING 58 1.81e-11 4.01e-10 0.5960 -0.325000 0.007530 0.013700 4.76e-01 -1.51e-01 1.92e-05 9.21e-01 8.57e-01 3.65e-10 4.73e-02
APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 70 2.02e-13 6.30e-12 0.5930 -0.343000 0.067900 0.030500 4.60e-01 -1.31e-01 6.93e-07 3.26e-01 6.60e-01 2.79e-11 5.91e-02
HEDGEHOG LIGAND BIOGENESIS 61 4.92e-11 1.00e-09 0.5930 -0.400000 -0.002100 -0.040600 3.86e-01 -2.04e-01 6.59e-08 9.77e-01 5.83e-01 1.89e-07 5.87e-03
CONSTITUTIVE SIGNALING BY EGFRVIII 15 8.43e-02 1.55e-01 0.5930 -0.218000 -0.368000 -0.277000 -2.21e-01 -2.08e-01 1.43e-01 1.37e-02 6.30e-02 1.38e-01 1.64e-01
PROTEIN PROTEIN INTERACTIONS AT SYNAPSES 85 4.17e-15 1.55e-13 0.5920 0.227000 -0.234000 0.262000 -3.91e-01 1.50e-01 2.94e-04 1.91e-04 3.06e-05 4.60e-10 1.72e-02
SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS 15 2.74e-03 1.02e-02 0.5920 -0.161000 -0.131000 0.000706 -3.99e-01 3.85e-01 2.81e-01 3.78e-01 9.96e-01 7.52e-03 9.88e-03
DEGRADATION OF GLI1 BY THE PROTEASOME 57 7.04e-11 1.31e-09 0.5910 -0.365000 0.014600 -0.010500 4.43e-01 -1.42e-01 1.90e-06 8.49e-01 8.91e-01 7.44e-09 6.32e-02
RORA ACTIVATES GENE EXPRESSION 18 8.13e-03 2.47e-02 0.5910 0.313000 -0.285000 -0.032600 -3.81e-01 1.53e-01 2.16e-02 3.60e-02 8.11e-01 5.17e-03 2.62e-01
APOPTOSIS INDUCED DNA FRAGMENTATION 10 4.86e-02 1.02e-01 0.5890 0.103000 0.401000 -0.267000 1.36e-01 2.92e-01 5.72e-01 2.83e-02 1.43e-01 4.56e-01 1.10e-01
REGULATION OF MECP2 EXPRESSION AND ACTIVITY 29 1.30e-04 7.36e-04 0.5870 0.190000 -0.338000 0.117000 -4.25e-01 -1.68e-02 7.60e-02 1.65e-03 2.75e-01 7.36e-05 8.76e-01
DOPAMINE NEUROTRANSMITTER RELEASE CYCLE 23 6.23e-04 2.94e-03 0.5870 0.280000 -0.228000 0.376000 -2.69e-01 3.23e-02 2.02e-02 5.86e-02 1.79e-03 2.58e-02 7.89e-01
RRNA PROCESSING IN THE MITOCHONDRION 10 9.35e-02 1.68e-01 0.5870 0.023500 0.093100 0.359000 3.61e-01 2.76e-01 8.97e-01 6.10e-01 4.91e-02 4.80e-02 1.31e-01
PURINE SALVAGE 12 2.98e-02 6.87e-02 0.5860 -0.261000 0.194000 0.190000 4.28e-01 1.36e-01 1.18e-01 2.46e-01 2.54e-01 1.03e-02 4.14e-01
METABOLISM OF AMINO ACIDS AND DERIVATIVES 304 5.08e-58 7.31e-56 0.5860 -0.244000 0.138000 -0.079800 5.01e-01 -8.52e-02 3.01e-13 3.46e-05 1.71e-02 4.48e-51 1.08e-02
MRNA SPLICING MINOR PATHWAY 52 4.20e-09 6.21e-08 0.5830 -0.280000 0.101000 0.152000 3.22e-01 -3.54e-01 4.77e-04 2.07e-01 5.86e-02 6.03e-05 1.03e-05
CHEMOKINE RECEPTORS BIND CHEMOKINES 12 8.58e-02 1.57e-01 0.5830 -0.121000 -0.318000 -0.056000 -1.98e-01 -4.26e-01 4.68e-01 5.65e-02 7.37e-01 2.36e-01 1.07e-02
LGI ADAM INTERACTIONS 14 2.75e-02 6.42e-02 0.5800 0.342000 -0.121000 0.452000 -3.17e-02 -1.24e-02 2.68e-02 4.33e-01 3.43e-03 8.37e-01 9.36e-01
SIGNALING BY FGFR3 FUSIONS IN CANCER 10 1.98e-01 2.90e-01 0.5790 -0.213000 -0.293000 -0.405000 -1.97e-01 3.06e-02 2.42e-01 1.08e-01 2.65e-02 2.82e-01 8.67e-01
MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS 18 8.64e-03 2.61e-02 0.5790 0.309000 -0.246000 0.213000 -3.64e-01 4.63e-02 2.34e-02 7.10e-02 1.19e-01 7.55e-03 7.34e-01
GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS 12 1.30e-01 2.13e-01 0.5790 -0.308000 -0.330000 -0.156000 -3.09e-01 -1.02e-01 6.43e-02 4.76e-02 3.49e-01 6.35e-02 5.42e-01
RHOBTB GTPASE CYCLE 35 6.29e-04 2.96e-03 0.5760 -0.318000 -0.287000 -0.208000 -2.05e-01 -2.52e-01 1.14e-03 3.36e-03 3.35e-02 3.56e-02 9.92e-03
NUCLEOTIDE LIKE PURINERGIC RECEPTORS 12 1.38e-01 2.23e-01 0.5760 -0.220000 -0.123000 -0.440000 -2.24e-01 -1.56e-01 1.87e-01 4.62e-01 8.31e-03 1.79e-01 3.50e-01
STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES 14 1.18e-01 2.01e-01 0.5740 -0.154000 -0.290000 -0.286000 -2.68e-01 -2.60e-01 3.18e-01 6.04e-02 6.36e-02 8.26e-02 9.22e-02
SODIUM CALCIUM EXCHANGERS 10 1.52e-01 2.40e-01 0.5740 0.257000 -0.127000 0.180000 -3.86e-01 2.56e-01 1.60e-01 4.87e-01 3.25e-01 3.44e-02 1.61e-01
FGFR2 ALTERNATIVE SPLICING 25 5.67e-04 2.71e-03 0.5720 -0.208000 -0.055100 0.023000 2.82e-01 -4.48e-01 7.22e-02 6.34e-01 8.42e-01 1.46e-02 1.07e-04
SIGNALING BY FGFR2 IIIA TM 19 3.78e-03 1.31e-02 0.5710 -0.099700 0.078000 0.010400 4.82e-01 -2.79e-01 4.52e-01 5.56e-01 9.37e-01 2.77e-04 3.54e-02
REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA 13 1.28e-01 2.11e-01 0.5710 -0.383000 -0.212000 -0.148000 -3.25e-02 -3.33e-01 1.67e-02 1.86e-01 3.54e-01 8.39e-01 3.76e-02
AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS 10 1.27e-01 2.10e-01 0.5700 0.159000 -0.478000 0.016300 -2.62e-01 -4.47e-02 3.83e-01 8.84e-03 9.29e-01 1.52e-01 8.07e-01
ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR ANDROGEN RECEPTOR REGULATED GENES KLK2 AND KLK3 19 1.09e-02 3.14e-02 0.5700 -0.365000 0.184000 -0.277000 2.52e-01 -1.32e-01 5.91e-03 1.65e-01 3.69e-02 5.70e-02 3.18e-01
INTERFERON ALPHA BETA SIGNALING 53 2.30e-07 2.52e-06 0.5700 -0.150000 -0.298000 -0.308000 -1.08e-02 -3.44e-01 5.84e-02 1.73e-04 1.08e-04 8.92e-01 1.51e-05
ERYTHROPOIETIN ACTIVATES RAS 13 2.41e-02 5.79e-02 0.5680 -0.118000 -0.436000 -0.231000 -1.17e-01 2.27e-01 4.61e-01 6.47e-03 1.49e-01 4.66e-01 1.57e-01
G1 S DNA DAMAGE CHECKPOINTS 64 1.89e-11 4.12e-10 0.5680 -0.316000 -0.009870 -0.051100 4.48e-01 -1.40e-01 1.27e-05 8.91e-01 4.80e-01 5.76e-10 5.34e-02
PINK1 PRKN MEDIATED MITOPHAGY 22 7.20e-04 3.34e-03 0.5680 -0.213000 0.025500 0.070500 5.11e-01 -9.99e-02 8.34e-02 8.36e-01 5.67e-01 3.34e-05 4.17e-01
WNT5A DEPENDENT INTERNALIZATION OF FZD4 15 2.75e-02 6.42e-02 0.5660 0.193000 -0.015700 0.506000 -1.55e-02 1.63e-01 1.95e-01 9.16e-01 6.92e-04 9.17e-01 2.73e-01
SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION 22 3.44e-03 1.22e-02 0.5640 -0.286000 0.123000 -0.335000 2.95e-01 -1.50e-01 2.04e-02 3.17e-01 6.49e-03 1.67e-02 2.24e-01
PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR 16 1.52e-02 4.05e-02 0.5630 -0.369000 -0.095100 0.037000 3.09e-01 -2.74e-01 1.06e-02 5.10e-01 7.98e-01 3.23e-02 5.75e-02
REGULATION OF HMOX1 EXPRESSION AND ACTIVITY 63 2.18e-10 3.69e-09 0.5630 -0.312000 0.074500 -0.004310 4.42e-01 -1.37e-01 1.90e-05 3.07e-01 9.53e-01 1.32e-09 6.08e-02
SIGNALING BY BMP 25 2.15e-03 8.42e-03 0.5620 -0.095100 -0.197000 -0.260000 -4.35e-01 1.07e-01 4.10e-01 8.87e-02 2.42e-02 1.67e-04 3.57e-01
CONDENSATION OF PROPHASE CHROMOSOMES 25 1.38e-03 5.66e-03 0.5610 -0.304000 0.133000 -0.377000 2.22e-01 -1.13e-01 8.44e-03 2.51e-01 1.10e-03 5.43e-02 3.26e-01
DEACTIVATION OF THE BETA CATENIN TRANSACTIVATING COMPLEX 41 1.23e-05 8.76e-05 0.5600 -0.197000 -0.152000 -0.203000 -4.21e-01 -1.82e-01 2.90e-02 9.13e-02 2.49e-02 3.06e-06 4.36e-02
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION 11 1.17e-01 1.99e-01 0.5590 0.137000 0.055800 0.280000 2.56e-01 3.84e-01 4.32e-01 7.49e-01 1.08e-01 1.42e-01 2.75e-02
PI 3K CASCADE FGFR4 10 9.71e-02 1.73e-01 0.5590 -0.034000 -0.093000 -0.501000 -1.90e-01 1.26e-01 8.52e-01 6.11e-01 6.10e-03 2.97e-01 4.89e-01
HEME SIGNALING 44 3.77e-06 3.08e-05 0.5590 0.271000 -0.267000 0.117000 -3.59e-01 1.61e-01 1.90e-03 2.15e-03 1.81e-01 3.87e-05 6.48e-02
ORC1 REMOVAL FROM CHROMATIN 66 4.95e-11 1.00e-09 0.5560 -0.311000 0.067300 0.014500 4.44e-01 -1.05e-01 1.26e-05 3.45e-01 8.39e-01 4.50e-10 1.40e-01
RHOBTB3 ATPASE CYCLE 10 3.96e-02 8.69e-02 0.5560 -0.314000 0.113000 -0.213000 -9.32e-02 3.79e-01 8.53e-02 5.36e-01 2.44e-01 6.10e-01 3.81e-02
DSCAM INTERACTIONS 10 1.28e-01 2.11e-01 0.5550 0.304000 -0.273000 0.343000 -1.52e-01 1.57e-02 9.55e-02 1.35e-01 6.05e-02 4.05e-01 9.31e-01
CALNEXIN CALRETICULIN CYCLE 26 5.00e-03 1.66e-02 0.5550 -0.365000 -0.286000 -0.229000 -1.87e-01 -7.28e-02 1.27e-03 1.17e-02 4.30e-02 9.85e-02 5.21e-01
ERK MAPK TARGETS 22 3.85e-03 1.33e-02 0.5540 0.220000 -0.229000 0.262000 -1.98e-01 3.13e-01 7.46e-02 6.29e-02 3.31e-02 1.08e-01 1.10e-02
CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2 11 1.43e-01 2.29e-01 0.5530 -0.308000 -0.284000 -0.361000 -6.12e-03 1.03e-02 7.68e-02 1.03e-01 3.84e-02 9.72e-01 9.53e-01
RNA POLYMERASE I PROMOTER ESCAPE 45 3.07e-06 2.57e-05 0.5530 -0.293000 0.138000 -0.050800 3.89e-01 -2.15e-01 6.61e-04 1.09e-01 5.56e-01 6.29e-06 1.26e-02
ANTIGEN PROCESSING CROSS PRESENTATION 91 5.24e-15 1.89e-13 0.5520 -0.305000 -0.051400 -0.185000 3.85e-01 -1.64e-01 4.97e-07 3.97e-01 2.32e-03 2.18e-10 6.96e-03
DEGRADATION OF CYSTEINE AND HOMOCYSTEINE 13 2.51e-02 5.98e-02 0.5510 -0.075000 0.134000 -0.006940 3.71e-01 3.77e-01 6.40e-01 4.04e-01 9.65e-01 2.05e-02 1.85e-02
CHOLESTEROL BIOSYNTHESIS 24 2.06e-04 1.11e-03 0.5500 -0.487000 -0.216000 0.008680 -1.25e-01 -5.51e-02 3.58e-05 6.69e-02 9.41e-01 2.91e-01 6.41e-01
SIGNALING BY ERBB2 ECD MUTANTS 16 1.23e-01 2.06e-01 0.5480 -0.265000 -0.304000 -0.269000 -1.81e-01 -1.80e-01 6.63e-02 3.52e-02 6.24e-02 2.11e-01 2.13e-01
PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR 20 1.10e-02 3.15e-02 0.5470 -0.167000 0.214000 0.120000 4.57e-01 -5.19e-02 1.97e-01 9.82e-02 3.52e-01 4.03e-04 6.88e-01
UNWINDING OF DNA 12 1.92e-01 2.82e-01 0.5470 0.113000 0.243000 0.250000 2.72e-01 3.01e-01 4.97e-01 1.45e-01 1.34e-01 1.03e-01 7.10e-02
ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC 22 2.80e-02 6.51e-02 0.5450 -0.337000 -0.223000 -0.293000 -1.92e-01 -1.04e-01 6.23e-03 6.96e-02 1.74e-02 1.20e-01 4.00e-01
MISCELLANEOUS TRANSPORT AND BINDING EVENTS 20 1.45e-02 3.91e-02 0.5440 0.296000 -0.186000 0.028700 -3.20e-01 2.67e-01 2.21e-02 1.50e-01 8.24e-01 1.33e-02 3.90e-02
NEGATIVE REGULATION OF TCF DEPENDENT SIGNALING BY WNT LIGAND ANTAGONISTS 10 4.61e-02 9.77e-02 0.5440 -0.045800 0.169000 0.012000 -3.89e-01 3.37e-01 8.02e-01 3.54e-01 9.48e-01 3.34e-02 6.50e-02
CELLULAR RESPONSE TO HYPOXIA 71 4.32e-11 9.05e-10 0.5430 -0.322000 0.025600 -0.018500 4.08e-01 -1.53e-01 2.71e-06 7.09e-01 7.87e-01 2.74e-09 2.54e-02
COMPLEMENT CASCADE 23 1.65e-05 1.14e-04 0.5430 0.186000 0.247000 -0.399000 1.58e-01 -1.22e-01 1.22e-01 4.02e-02 9.29e-04 1.89e-01 3.13e-01
INTERLEUKIN 6 SIGNALING 10 1.49e-01 2.37e-01 0.5420 0.294000 -0.263000 -0.143000 -2.70e-01 2.11e-01 1.08e-01 1.51e-01 4.32e-01 1.39e-01 2.47e-01
GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION 31 2.85e-04 1.48e-03 0.5420 -0.306000 0.084700 -0.082400 4.03e-01 -1.52e-01 3.17e-03 4.14e-01 4.27e-01 1.02e-04 1.44e-01
G PROTEIN MEDIATED EVENTS 51 5.24e-07 5.39e-06 0.5410 0.157000 -0.227000 0.115000 -3.72e-01 2.55e-01 5.28e-02 5.10e-03 1.57e-01 4.35e-06 1.63e-03
FCGR3A MEDIATED IL10 SYNTHESIS 32 4.51e-04 2.25e-03 0.5390 -0.051600 -0.292000 -0.114000 -4.02e-01 1.68e-01 6.13e-01 4.27e-03 2.66e-01 8.28e-05 9.93e-02
SEMA3A PAK DEPENDENT AXON REPULSION 16 3.89e-02 8.59e-02 0.5390 -0.140000 -0.401000 -0.003780 -3.30e-01 4.04e-02 3.34e-01 5.45e-03 9.79e-01 2.25e-02 7.80e-01
OLFACTORY SIGNALING PATHWAY 22 1.43e-04 7.98e-04 0.5390 0.152000 -0.098200 -0.298000 -3.31e-02 -4.10e-01 2.17e-01 4.26e-01 1.54e-02 7.88e-01 8.82e-04
CELLULAR HEXOSE TRANSPORT 10 3.32e-01 4.28e-01 0.5360 0.214000 0.213000 0.330000 3.23e-02 2.94e-01 2.42e-01 2.45e-01 7.06e-02 8.60e-01 1.08e-01
BETA CATENIN PHOSPHORYLATION CASCADE 16 5.92e-03 1.90e-02 0.5350 -0.118000 -0.094900 0.058900 -3.44e-01 3.76e-01 4.14e-01 5.11e-01 6.83e-01 1.71e-02 9.20e-03
GP1B IX V ACTIVATION SIGNALLING 10 1.83e-01 2.74e-01 0.5330 0.275000 0.338000 0.259000 -1.14e-01 1.18e-01 1.33e-01 6.41e-02 1.56e-01 5.31e-01 5.17e-01
CROSSLINKING OF COLLAGEN FIBRILS 14 4.14e-02 8.96e-02 0.5330 0.270000 0.137000 0.392000 -1.95e-01 3.98e-03 7.98e-02 3.76e-01 1.11e-02 2.06e-01 9.79e-01
THROMBOXANE SIGNALLING THROUGH TP RECEPTOR 21 3.46e-03 1.22e-02 0.5320 -0.322000 -0.262000 0.030500 2.11e-01 -2.57e-01 1.07e-02 3.79e-02 8.09e-01 9.48e-02 4.15e-02
MITOTIC TELOPHASE CYTOKINESIS 13 1.11e-01 1.92e-01 0.5300 0.064100 -0.201000 -0.131000 -4.69e-01 2.89e-03 6.89e-01 2.10e-01 4.13e-01 3.44e-03 9.86e-01
NEPHRIN FAMILY INTERACTIONS 21 1.09e-02 3.15e-02 0.5290 0.305000 -0.093500 0.177000 -3.62e-01 1.27e-01 1.56e-02 4.58e-01 1.60e-01 4.09e-03 3.14e-01
GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE 23 2.66e-03 1.00e-02 0.5290 0.290000 -0.306000 0.268000 -7.39e-02 1.58e-01 1.60e-02 1.11e-02 2.63e-02 5.40e-01 1.91e-01
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR 11 8.05e-02 1.49e-01 0.5280 -0.132000 0.155000 -0.443000 2.04e-01 -1.52e-02 4.49e-01 3.74e-01 1.10e-02 2.42e-01 9.30e-01
CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS 11 7.24e-02 1.37e-01 0.5280 0.087000 -0.103000 0.243000 -4.48e-01 3.25e-02 6.17e-01 5.55e-01 1.63e-01 1.00e-02 8.52e-01
INITIAL TRIGGERING OF COMPLEMENT 10 2.02e-02 5.04e-02 0.5280 0.316000 0.195000 -0.263000 1.42e-01 -2.29e-01 8.39e-02 2.87e-01 1.50e-01 4.36e-01 2.10e-01
CRMPS IN SEMA3A SIGNALING 16 2.20e-02 5.40e-02 0.5280 0.054700 -0.280000 0.250000 -3.59e-01 8.00e-02 7.05e-01 5.22e-02 8.38e-02 1.30e-02 5.79e-01
TRANSLESION SYNTHESIS BY POLK 17 5.23e-02 1.07e-01 0.5260 -0.123000 0.270000 0.080900 4.09e-01 -1.23e-01 3.78e-01 5.40e-02 5.64e-01 3.54e-03 3.80e-01
IRF3 MEDIATED INDUCTION OF TYPE I IFN 11 2.78e-01 3.75e-01 0.5260 -0.144000 -0.172000 -0.292000 -2.56e-01 -2.74e-01 4.08e-01 3.22e-01 9.39e-02 1.41e-01 1.15e-01
DISEASES OF DNA REPAIR 11 6.38e-02 1.26e-01 0.5250 -0.226000 -0.124000 0.274000 2.34e-02 -3.65e-01 1.95e-01 4.75e-01 1.15e-01 8.93e-01 3.62e-02
METABOLISM OF STEROID HORMONES 19 2.12e-02 5.24e-02 0.5230 -0.340000 0.066000 -0.031200 3.43e-01 -1.88e-01 1.04e-02 6.18e-01 8.14e-01 9.57e-03 1.57e-01
GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION 24 4.28e-03 1.44e-02 0.5220 -0.067200 0.234000 0.053400 3.97e-01 2.29e-01 5.69e-01 4.68e-02 6.51e-01 7.59e-04 5.25e-02
PIWI INTERACTING RNA PIRNA BIOGENESIS 19 1.01e-02 2.99e-02 0.5200 -0.195000 -0.123000 0.051000 3.27e-01 -3.29e-01 1.41e-01 3.55e-01 7.00e-01 1.37e-02 1.31e-02
DNA REPLICATION PRE INITIATION 78 5.15e-12 1.32e-10 0.5190 -0.251000 0.046200 0.023600 4.47e-01 -5.92e-02 1.24e-04 4.81e-01 7.18e-01 8.58e-12 3.67e-01
GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION 18 6.36e-02 1.26e-01 0.5190 0.383000 0.216000 0.159000 -4.88e-02 2.20e-01 4.96e-03 1.12e-01 2.44e-01 7.20e-01 1.07e-01
SIGNALING BY ACTIVIN 12 1.15e-01 1.97e-01 0.5180 0.121000 -0.160000 -0.097800 -4.57e-01 -1.02e-01 4.66e-01 3.38e-01 5.57e-01 6.18e-03 5.42e-01
P38MAPK EVENTS 12 3.76e-02 8.36e-02 0.5180 -0.098300 -0.451000 -0.183000 3.52e-02 1.43e-01 5.56e-01 6.83e-03 2.73e-01 8.33e-01 3.90e-01
SIGNALING BY WNT IN CANCER 30 2.11e-05 1.42e-04 0.5170 -0.084700 0.059900 -0.036800 -4.00e-01 3.09e-01 4.22e-01 5.70e-01 7.28e-01 1.51e-04 3.36e-03
REGULATION OF PTEN STABILITY AND ACTIVITY 66 3.31e-10 5.53e-09 0.5170 -0.313000 -0.072700 -0.006810 3.80e-01 -1.41e-01 1.13e-05 3.07e-01 9.24e-01 9.28e-08 4.79e-02
OTHER SEMAPHORIN INTERACTIONS 19 2.06e-02 5.14e-02 0.5170 0.044900 -0.228000 -0.054300 -3.82e-01 -2.53e-01 7.35e-01 8.59e-02 6.82e-01 3.95e-03 5.60e-02
GLUCONEOGENESIS 27 1.05e-03 4.60e-03 0.5170 -0.065600 0.142000 0.224000 3.55e-01 2.57e-01 5.55e-01 2.02e-01 4.41e-02 1.40e-03 2.09e-02
RAS ACTIVATION UPON CA2 INFLUX THROUGH NMDA RECEPTOR 20 1.70e-02 4.41e-02 0.5160 0.225000 -0.257000 0.257000 -1.94e-01 2.15e-01 8.18e-02 4.70e-02 4.66e-02 1.33e-01 9.57e-02
NRAGE SIGNALS DEATH THROUGH JNK 54 1.98e-06 1.77e-05 0.5150 0.227000 -0.106000 0.087500 -3.03e-01 3.22e-01 3.88e-03 1.79e-01 2.66e-01 1.20e-04 4.36e-05
CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION 11 1.09e-01 1.89e-01 0.5140 0.106000 -0.130000 -0.160000 -1.43e-01 4.36e-01 5.43e-01 4.55e-01 3.57e-01 4.11e-01 1.23e-02
VXPX CARGO TARGETING TO CILIUM 19 2.38e-02 5.77e-02 0.5140 0.163000 -0.244000 0.178000 -2.74e-01 2.68e-01 2.20e-01 6.59e-02 1.78e-01 3.86e-02 4.35e-02
METHYLATION 11 1.46e-01 2.33e-01 0.5140 -0.144000 0.223000 -0.122000 4.05e-01 1.22e-01 4.09e-01 2.00e-01 4.83e-01 2.00e-02 4.85e-01
MATURATION OF NUCLEOPROTEIN 10 2.51e-01 3.49e-01 0.5130 -0.230000 -0.197000 -0.004770 -2.30e-01 -3.44e-01 2.07e-01 2.82e-01 9.79e-01 2.07e-01 5.99e-02
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 19 3.25e-02 7.38e-02 0.5130 -0.403000 -0.175000 -0.089100 1.22e-01 -2.17e-01 2.35e-03 1.87e-01 5.02e-01 3.57e-01 1.02e-01
APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS 81 1.27e-11 2.92e-10 0.5120 -0.287000 0.078400 0.042100 4.08e-01 -7.48e-02 8.18e-06 2.23e-01 5.13e-01 2.28e-10 2.45e-01
INTERLEUKIN RECEPTOR SHC SIGNALING 20 2.30e-02 5.62e-02 0.5120 -0.108000 -0.229000 -0.084300 -4.32e-01 5.89e-02 4.01e-01 7.67e-02 5.14e-01 8.14e-04 6.48e-01
CONSTITUTIVE SIGNALING BY LIGAND RESPONSIVE EGFR CANCER VARIANTS 19 9.35e-02 1.68e-01 0.5110 -0.263000 -0.241000 -0.202000 -4.48e-02 -3.01e-01 4.71e-02 6.92e-02 1.27e-01 7.36e-01 2.31e-02
TRANSLESION SYNTHESIS BY POLH 19 2.58e-02 6.10e-02 0.5110 -0.021600 0.160000 0.102000 4.70e-01 -5.93e-02 8.70e-01 2.28e-01 4.42e-01 3.91e-04 6.54e-01
GLUTATHIONE CONJUGATION 29 3.00e-03 1.09e-02 0.5090 -0.116000 0.280000 -0.032900 4.02e-01 -6.90e-02 2.81e-01 9.16e-03 7.59e-01 1.79e-04 5.20e-01
ASYMMETRIC LOCALIZATION OF PCP PROTEINS 62 1.27e-08 1.70e-07 0.5090 -0.325000 0.061600 0.012800 3.76e-01 -8.61e-02 9.74e-06 4.01e-01 8.62e-01 2.97e-07 2.41e-01
BASE EXCISION REPAIR AP SITE FORMATION 27 3.69e-03 1.30e-02 0.5080 -0.198000 0.118000 -0.015700 3.93e-01 -2.25e-01 7.46e-02 2.91e-01 8.88e-01 4.12e-04 4.33e-02
PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES 13 4.21e-02 9.02e-02 0.5080 -0.138000 -0.116000 -0.236000 -1.10e-01 3.97e-01 3.89e-01 4.69e-01 1.40e-01 4.91e-01 1.33e-02
SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE 85 6.62e-12 1.66e-10 0.5060 -0.293000 0.084200 0.044500 3.94e-01 -7.32e-02 2.93e-06 1.80e-01 4.79e-01 3.42e-10 2.44e-01
MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES 31 1.05e-03 4.60e-03 0.5060 0.141000 -0.238000 0.165000 -3.29e-01 2.10e-01 1.76e-01 2.20e-02 1.11e-01 1.53e-03 4.33e-02
ACTIVATION OF RAC1 13 7.38e-02 1.39e-01 0.5060 -0.170000 -0.135000 -0.039000 -4.55e-01 -2.51e-03 2.90e-01 3.98e-01 8.08e-01 4.49e-03 9.88e-01
RNA POLYMERASE II TRANSCRIPTION TERMINATION 65 7.59e-09 1.08e-07 0.5060 -0.256000 -0.088300 0.109000 1.38e-01 -3.89e-01 3.63e-04 2.19e-01 1.28e-01 5.53e-02 5.65e-08
ANCHORING FIBRIL FORMATION 13 1.25e-01 2.08e-01 0.5050 0.219000 -0.207000 0.300000 -2.40e-01 1.31e-01 1.72e-01 1.97e-01 6.15e-02 1.34e-01 4.14e-01
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1 22 1.41e-02 3.85e-02 0.5050 -0.313000 -0.258000 -0.003260 6.55e-02 -2.93e-01 1.10e-02 3.63e-02 9.79e-01 5.95e-01 1.73e-02
INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES 29 1.50e-03 6.05e-03 0.5050 -0.369000 -0.022900 -0.060500 2.97e-01 -1.62e-01 5.90e-04 8.31e-01 5.73e-01 5.61e-03 1.32e-01
REGULATION OF TLR BY ENDOGENOUS LIGAND 10 1.61e-01 2.50e-01 0.5040 -0.298000 0.080600 -0.088200 3.80e-01 8.16e-02 1.02e-01 6.59e-01 6.29e-01 3.75e-02 6.55e-01
PROLONGED ERK ACTIVATION EVENTS 12 1.38e-01 2.23e-01 0.5000 0.076000 -0.215000 0.043100 -2.62e-01 3.58e-01 6.48e-01 1.98e-01 7.96e-01 1.16e-01 3.19e-02
RHO GTPASES ACTIVATE NADPH OXIDASES 19 7.32e-02 1.38e-01 0.5000 0.218000 0.059100 0.270000 6.67e-02 3.49e-01 1.00e-01 6.56e-01 4.18e-02 6.15e-01 8.47e-03
HIV TRANSCRIPTION ELONGATION 42 4.48e-05 2.85e-04 0.5000 -0.109000 0.149000 0.240000 3.48e-01 -1.92e-01 2.22e-01 9.54e-02 7.08e-03 9.54e-05 3.16e-02
ERKS ARE INACTIVATED 13 4.14e-02 8.96e-02 0.4990 0.006130 -0.233000 0.286000 -8.99e-02 3.24e-01 9.69e-01 1.45e-01 7.43e-02 5.75e-01 4.32e-02
SHC MEDIATED CASCADE FGFR3 12 5.15e-02 1.06e-01 0.4990 -0.050500 -0.043100 -0.425000 6.21e-02 2.45e-01 7.62e-01 7.96e-01 1.09e-02 7.10e-01 1.41e-01
CREB1 PHOSPHORYLATION THROUGH NMDA RECEPTOR MEDIATED ACTIVATION OF RAS SIGNALING 28 4.19e-03 1.42e-02 0.4970 0.206000 -0.237000 0.176000 -2.52e-01 2.33e-01 5.90e-02 3.03e-02 1.07e-01 2.10e-02 3.28e-02
REGULATION OF RUNX2 EXPRESSION AND ACTIVITY 67 3.15e-09 4.78e-08 0.4970 -0.284000 -0.073300 0.010000 3.56e-01 -1.85e-01 5.73e-05 3.00e-01 8.87e-01 4.79e-07 8.75e-03
FRS MEDIATED FGFR4 SIGNALING 12 7.40e-02 1.39e-01 0.4970 -0.082700 -0.032200 -0.450000 2.09e-05 1.92e-01 6.20e-01 8.47e-01 6.96e-03 1.00e+00 2.49e-01
NEGATIVE REGULATORS OF DDX58 IFIH1 SIGNALING 34 3.67e-03 1.29e-02 0.4970 -0.365000 -0.219000 -0.178000 -1.26e-01 -1.35e-01 2.32e-04 2.70e-02 7.26e-02 2.03e-01 1.74e-01
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES 29 3.98e-03 1.38e-02 0.4960 -0.427000 -0.036700 -0.160000 1.39e-01 -1.31e-01 6.90e-05 7.32e-01 1.37e-01 1.95e-01 2.23e-01
SULFUR AMINO ACID METABOLISM 23 1.72e-03 6.90e-03 0.4950 -0.152000 0.113000 -0.099900 3.46e-01 2.82e-01 2.06e-01 3.48e-01 4.07e-01 4.03e-03 1.94e-02
P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS 12 2.09e-01 3.02e-01 0.4950 -0.273000 -0.264000 -0.168000 -2.63e-01 6.43e-02 1.02e-01 1.14e-01 3.15e-01 1.15e-01 7.00e-01
REGULATION OF RAS BY GAPS 66 1.38e-09 2.18e-08 0.4950 -0.311000 -0.080300 0.003650 3.58e-01 -1.17e-01 1.25e-05 2.59e-01 9.59e-01 4.88e-07 1.01e-01
G BETA GAMMA SIGNALLING THROUGH CDC42 18 2.21e-02 5.42e-02 0.4940 -0.321000 -0.149000 0.045100 2.67e-01 -2.11e-01 1.83e-02 2.72e-01 7.40e-01 4.97e-02 1.21e-01
RAS PROCESSING 23 1.09e-03 4.71e-03 0.4920 -0.199000 -0.015800 -0.021400 4.29e-01 1.34e-01 9.93e-02 8.96e-01 8.59e-01 3.69e-04 2.66e-01
BBSOME MEDIATED CARGO TARGETING TO CILIUM 23 3.99e-02 8.75e-02 0.4920 -0.353000 -0.106000 -0.164000 1.12e-01 -2.58e-01 3.39e-03 3.79e-01 1.72e-01 3.52e-01 3.21e-02
POST CHAPERONIN TUBULIN FOLDING PATHWAY 17 4.18e-02 9.01e-02 0.4920 -0.219000 0.131000 0.190000 3.66e-01 -8.06e-02 1.18e-01 3.52e-01 1.76e-01 8.93e-03 5.65e-01
THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION 13 3.80e-02 8.43e-02 0.4910 0.200000 0.404000 -0.145000 9.46e-02 -8.61e-02 2.13e-01 1.16e-02 3.65e-01 5.55e-01 5.91e-01
SIGNALING BY ERBB2 IN CANCER 24 5.27e-02 1.07e-01 0.4900 -0.175000 -0.214000 -0.298000 -2.54e-01 -1.01e-01 1.39e-01 6.90e-02 1.15e-02 3.10e-02 3.90e-01
NCAM SIGNALING FOR NEURITE OUT GROWTH 55 1.13e-07 1.31e-06 0.4890 0.049500 -0.222000 0.251000 -3.53e-01 4.64e-03 5.26e-01 4.45e-03 1.29e-03 5.99e-06 9.53e-01
RUNX2 REGULATES BONE DEVELOPMENT 28 1.05e-02 3.06e-02 0.4890 -0.155000 -0.224000 -0.128000 -3.79e-01 -6.99e-02 1.56e-01 3.98e-02 2.42e-01 5.22e-04 5.22e-01
NCAM1 INTERACTIONS 35 6.87e-05 4.08e-04 0.4890 0.022700 -0.220000 0.228000 -3.48e-01 -1.30e-01 8.17e-01 2.45e-02 1.95e-02 3.67e-04 1.83e-01
RNA POLYMERASE III TRANSCRIPTION TERMINATION 23 1.15e-02 3.24e-02 0.4880 -0.001530 0.137000 0.086800 4.59e-01 2.94e-02 9.90e-01 2.54e-01 4.71e-01 1.37e-04 8.07e-01
GAP FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG NER 24 1.40e-02 3.83e-02 0.4870 -0.262000 0.128000 0.040800 3.29e-01 -2.05e-01 2.62e-02 2.79e-01 7.30e-01 5.25e-03 8.20e-02
CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY 83 5.32e-11 1.06e-09 0.4860 -0.334000 0.061900 -0.002130 3.44e-01 -4.74e-02 1.41e-07 3.30e-01 9.73e-01 6.05e-08 4.55e-01
VEGFR2 MEDIATED CELL PROLIFERATION 19 3.05e-02 7.02e-02 0.4860 0.042600 -0.328000 -0.116000 -2.20e-01 2.54e-01 7.48e-01 1.33e-02 3.83e-01 9.71e-02 5.52e-02
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM 12 9.78e-02 1.74e-01 0.4850 -0.026500 0.286000 -0.202000 2.65e-02 3.33e-01 8.74e-01 8.61e-02 2.26e-01 8.74e-01 4.59e-02
RECEPTOR MEDIATED MITOPHAGY 11 7.95e-02 1.48e-01 0.4840 -0.044500 -0.081200 0.196000 3.01e-01 3.10e-01 7.99e-01 6.41e-01 2.60e-01 8.42e-02 7.47e-02
INTERLEUKIN 6 FAMILY SIGNALING 18 1.63e-02 4.30e-02 0.4830 0.370000 -0.099300 -0.102000 -3.40e-02 2.74e-01 6.52e-03 4.66e-01 4.56e-01 8.03e-01 4.40e-02
TIGHT JUNCTION INTERACTIONS 14 5.10e-02 1.05e-01 0.4820 -0.236000 0.199000 -0.275000 4.75e-02 2.44e-01 1.27e-01 1.98e-01 7.46e-02 7.59e-01 1.13e-01
INTERFERON GAMMA SIGNALING 75 5.45e-07 5.55e-06 0.4810 -0.085900 -0.226000 -0.318000 -1.55e-01 -2.19e-01 1.99e-01 7.20e-04 1.95e-06 2.06e-02 1.04e-03
POLYMERASE SWITCHING 14 1.35e-01 2.20e-01 0.4810 -0.002920 0.178000 0.050700 4.14e-01 -1.59e-01 9.85e-01 2.48e-01 7.42e-01 7.27e-03 3.02e-01
ABC TRANSPORTER DISORDERS 68 1.35e-08 1.78e-07 0.4810 -0.275000 0.013800 0.034800 3.73e-01 -1.23e-01 8.65e-05 8.45e-01 6.20e-01 1.06e-07 7.99e-02
CD209 DC SIGN SIGNALING 18 1.10e-01 1.90e-01 0.4810 -0.086000 -0.327000 -0.190000 -2.78e-01 5.94e-02 5.27e-01 1.63e-02 1.63e-01 4.14e-02 6.62e-01
RNA POLYMERASE I TRANSCRIPTION TERMINATION 31 1.78e-03 7.09e-03 0.4810 -0.110000 0.097200 0.174000 3.50e-01 -2.39e-01 2.88e-01 3.49e-01 9.41e-02 7.54e-04 2.14e-02
SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE 52 1.84e-05 1.26e-04 0.4800 0.250000 -0.162000 0.029100 -2.09e-01 3.12e-01 1.84e-03 4.36e-02 7.17e-01 9.14e-03 9.87e-05
PREGNENOLONE BIOSYNTHESIS 12 1.83e-01 2.74e-01 0.4800 -0.321000 -0.070900 -0.033900 2.94e-01 -1.87e-01 5.45e-02 6.71e-01 8.39e-01 7.76e-02 2.63e-01
PROTEIN METHYLATION 17 5.20e-02 1.07e-01 0.4800 -0.038600 0.166000 -0.083200 3.97e-01 -1.92e-01 7.83e-01 2.36e-01 5.53e-01 4.65e-03 1.70e-01
EPHRIN SIGNALING 19 6.49e-02 1.27e-01 0.4790 -0.011400 -0.357000 0.014300 -3.19e-01 2.12e-02 9.31e-01 7.08e-03 9.14e-01 1.62e-02 8.73e-01
REPRESSION OF WNT TARGET GENES 14 2.41e-02 5.79e-02 0.4780 -0.158000 0.141000 -0.130000 -4.08e-01 -1.26e-02 3.07e-01 3.61e-01 3.98e-01 8.17e-03 9.35e-01
APC CDC20 MEDIATED DEGRADATION OF NEK2A 25 1.19e-02 3.34e-02 0.4780 -0.198000 0.182000 0.140000 3.56e-01 -9.87e-02 8.73e-02 1.16e-01 2.25e-01 2.04e-03 3.93e-01
EARLY PHASE OF HIV LIFE CYCLE 13 1.58e-01 2.46e-01 0.4780 -0.214000 0.226000 -0.227000 9.33e-02 -2.67e-01 1.82e-01 1.59e-01 1.57e-01 5.60e-01 9.50e-02
SCAVENGING BY CLASS A RECEPTORS 13 2.32e-02 5.67e-02 0.4770 0.163000 0.147000 -0.257000 9.57e-02 -3.23e-01 3.09e-01 3.59e-01 1.09e-01 5.50e-01 4.36e-02
MRNA CAPPING 29 3.14e-03 1.13e-02 0.4770 -0.189000 0.091400 0.131000 3.82e-01 -1.44e-01 7.79e-02 3.95e-01 2.21e-01 3.77e-04 1.80e-01
RHOV GTPASE CYCLE 32 2.78e-03 1.03e-02 0.4750 0.055200 -0.204000 -0.009570 -4.25e-01 1.85e-02 5.89e-01 4.62e-02 9.25e-01 3.14e-05 8.56e-01
ACTIVATION OF GENE EXPRESSION BY SREBF SREBP 43 4.98e-04 2.44e-03 0.4750 -0.102000 -0.312000 -0.062300 -3.36e-01 2.60e-02 2.49e-01 3.97e-04 4.80e-01 1.37e-04 7.68e-01
NUCLEOBASE CATABOLISM 31 4.11e-03 1.40e-02 0.4740 -0.087700 0.338000 0.109000 2.47e-01 1.74e-01 3.98e-01 1.13e-03 2.95e-01 1.73e-02 9.30e-02
PROTEIN LOCALIZATION 157 2.20e-19 1.10e-17 0.4740 -0.138000 0.141000 0.008730 4.29e-01 3.84e-02 2.92e-03 2.25e-03 8.50e-01 1.69e-20 4.07e-01
RA BIOSYNTHESIS PATHWAY 12 1.01e-01 1.79e-01 0.4730 -0.047600 0.204000 -0.359000 2.23e-01 4.32e-02 7.75e-01 2.21e-01 3.15e-02 1.81e-01 7.96e-01
SIGNALING BY EGFR IN CANCER 21 1.13e-01 1.94e-01 0.4730 -0.247000 -0.171000 -0.206000 -2.57e-02 -3.00e-01 5.01e-02 1.75e-01 1.02e-01 8.38e-01 1.72e-02
GLYCOGEN STORAGE DISEASES 12 1.22e-01 2.05e-01 0.4720 -0.427000 0.040900 -0.141000 1.11e-01 8.14e-02 1.04e-02 8.06e-01 3.99e-01 5.06e-01 6.26e-01
MITOCHONDRIAL CALCIUM ION TRANSPORT 23 2.16e-02 5.33e-02 0.4710 0.004510 0.192000 0.015300 4.27e-01 -4.43e-02 9.70e-01 1.10e-01 8.99e-01 3.91e-04 7.13e-01
BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION 25 2.34e-02 5.69e-02 0.4700 0.157000 -0.286000 -0.037200 -3.31e-01 5.51e-02 1.74e-01 1.33e-02 7.48e-01 4.16e-03 6.34e-01
PKMTS METHYLATE HISTONE LYSINES 47 2.53e-04 1.32e-03 0.4690 0.077800 -0.311000 -0.136000 -3.01e-01 -9.16e-02 3.57e-01 2.28e-04 1.06e-01 3.54e-04 2.77e-01
GLYCOGEN BREAKDOWN GLYCOGENOLYSIS 14 1.40e-01 2.25e-01 0.4680 -0.120000 -0.104000 -0.353000 -2.04e-01 1.67e-01 4.36e-01 5.01e-01 2.22e-02 1.87e-01 2.80e-01
HDR THROUGH MMEJ ALT NHEJ 10 1.84e-01 2.74e-01 0.4680 0.371000 -0.037300 0.207000 -6.75e-03 -1.91e-01 4.19e-02 8.38e-01 2.56e-01 9.71e-01 2.96e-01
SIGNALING BY ERYTHROPOIETIN 24 2.41e-02 5.79e-02 0.4670 0.044200 -0.387000 -0.055400 -2.41e-01 7.49e-02 7.08e-01 1.05e-03 6.38e-01 4.07e-02 5.25e-01
RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY 24 2.58e-02 6.10e-02 0.4670 -0.091100 0.181000 0.138000 3.96e-01 -3.06e-02 4.40e-01 1.25e-01 2.41e-01 7.79e-04 7.96e-01
TRANSCRIPTIONAL REGULATION BY MECP2 58 3.62e-06 3.00e-05 0.4670 0.221000 -0.221000 0.153000 -3.10e-01 -1.04e-02 3.61e-03 3.56e-03 4.35e-02 4.36e-05 8.91e-01
RHOU GTPASE CYCLE 33 3.71e-03 1.30e-02 0.4660 0.195000 -0.144000 0.011100 -3.50e-01 1.89e-01 5.21e-02 1.53e-01 9.12e-01 5.11e-04 5.99e-02
PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE 51 1.88e-05 1.28e-04 0.4650 0.047200 0.189000 0.010500 3.35e-01 2.59e-01 5.60e-01 1.99e-02 8.97e-01 3.60e-05 1.41e-03
MTORC1 MEDIATED SIGNALLING 24 4.02e-02 8.76e-02 0.4650 0.018400 0.213000 0.205000 2.96e-01 2.02e-01 8.76e-01 7.06e-02 8.17e-02 1.20e-02 8.64e-02
ADHERENS JUNCTIONS INTERACTIONS 30 1.29e-04 7.33e-04 0.4650 -0.205000 -0.035300 0.025600 -4.10e-01 6.66e-02 5.26e-02 7.38e-01 8.08e-01 1.03e-04 5.28e-01
GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION 29 1.71e-02 4.43e-02 0.4650 0.159000 0.219000 0.074800 2.17e-01 3.00e-01 1.38e-01 4.17e-02 4.86e-01 4.30e-02 5.17e-03
SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III 23 1.75e-02 4.49e-02 0.4640 -0.119000 0.112000 0.261000 3.35e-01 -9.23e-02 3.21e-01 3.51e-01 3.05e-02 5.40e-03 4.44e-01
PLASMA LIPOPROTEIN REMODELING 13 2.78e-01 3.75e-01 0.4640 0.290000 0.228000 0.052800 1.58e-01 2.26e-01 7.00e-02 1.54e-01 7.42e-01 3.23e-01 1.58e-01
METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS 10 3.33e-01 4.29e-01 0.4640 0.265000 0.356000 0.026400 5.68e-02 1.20e-01 1.47e-01 5.13e-02 8.85e-01 7.56e-01 5.10e-01
PEROXISOMAL LIPID METABOLISM 26 1.65e-02 4.32e-02 0.4630 0.082300 0.263000 -0.023200 3.02e-01 2.17e-01 4.68e-01 2.01e-02 8.38e-01 7.78e-03 5.54e-02
APOPTOTIC FACTOR MEDIATED RESPONSE 18 2.88e-02 6.67e-02 0.4620 -0.259000 -0.068000 -0.166000 3.38e-01 -5.78e-03 5.74e-02 6.17e-01 2.24e-01 1.30e-02 9.66e-01
SIGNAL AMPLIFICATION 29 1.29e-02 3.58e-02 0.4610 -0.320000 -0.257000 -0.066600 -7.34e-03 -2.01e-01 2.89e-03 1.68e-02 5.35e-01 9.45e-01 6.15e-02
MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE 15 5.30e-02 1.08e-01 0.4610 -0.233000 -0.046800 0.177000 3.46e-01 -7.13e-02 1.18e-01 7.54e-01 2.34e-01 2.05e-02 6.33e-01
HIV ELONGATION ARREST AND RECOVERY 32 1.95e-03 7.73e-03 0.4610 -0.080400 0.069200 0.193000 3.06e-01 -2.64e-01 4.31e-01 4.98e-01 5.86e-02 2.70e-03 9.63e-03
ZINC TRANSPORTERS 14 2.57e-01 3.54e-01 0.4590 0.365000 -0.037200 0.165000 -8.59e-02 2.02e-01 1.79e-02 8.10e-01 2.84e-01 5.78e-01 1.90e-01
PHASE 0 RAPID DEPOLARISATION 28 1.39e-02 3.81e-02 0.4590 0.253000 -0.046100 0.234000 -2.54e-01 1.59e-01 2.07e-02 6.73e-01 3.18e-02 2.01e-02 1.47e-01
TICAM1 DEPENDENT ACTIVATION OF IRF3 IRF7 12 4.21e-01 5.17e-01 0.4580 -0.299000 -0.163000 -0.226000 4.40e-02 -2.03e-01 7.29e-02 3.28e-01 1.75e-01 7.92e-01 2.24e-01
MITOPHAGY 29 1.22e-03 5.11e-03 0.4580 -0.159000 -0.011900 0.101000 4.17e-01 -1.47e-02 1.40e-01 9.11e-01 3.45e-01 1.00e-04 8.91e-01
RESOLUTION OF ABASIC SITES AP SITES 37 1.18e-03 4.97e-03 0.4580 -0.018100 0.110000 0.235000 3.53e-01 -1.32e-01 8.49e-01 2.47e-01 1.32e-02 2.04e-04 1.64e-01
VEGFR2 MEDIATED VASCULAR PERMEABILITY 26 1.90e-02 4.82e-02 0.4570 -0.078700 -0.264000 -0.172000 -2.66e-01 1.81e-01 4.87e-01 1.98e-02 1.29e-01 1.87e-02 1.11e-01
PI3K EVENTS IN ERBB2 SIGNALING 14 2.08e-01 3.02e-01 0.4570 -0.108000 -0.084300 -0.237000 -3.37e-01 -1.43e-01 4.84e-01 5.85e-01 1.25e-01 2.89e-02 3.55e-01
MEIOTIC RECOMBINATION 35 2.66e-03 1.00e-02 0.4570 -0.267000 0.205000 -0.218000 1.95e-01 -1.01e-01 6.37e-03 3.57e-02 2.56e-02 4.59e-02 3.01e-01
PRC2 METHYLATES HISTONES AND DNA 26 2.56e-02 6.08e-02 0.4570 -0.225000 0.042500 -0.211000 2.35e-01 -2.37e-01 4.70e-02 7.08e-01 6.32e-02 3.78e-02 3.62e-02
INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE 22 2.67e-02 6.29e-02 0.4570 -0.046200 0.085400 0.207000 3.93e-01 4.29e-02 7.08e-01 4.88e-01 9.28e-02 1.43e-03 7.28e-01
CELLULAR RESPONSE TO CHEMICAL STRESS 149 3.04e-16 1.30e-14 0.4560 -0.203000 0.058800 -0.006210 3.74e-01 -1.53e-01 1.84e-05 2.16e-01 8.96e-01 3.36e-15 1.33e-03
INTERLEUKIN 12 SIGNALING 36 1.30e-03 5.40e-03 0.4540 -0.275000 0.060700 -0.073500 3.38e-01 -8.47e-02 4.24e-03 5.29e-01 4.45e-01 4.52e-04 3.79e-01
ACTIVATION OF SMO 16 9.98e-02 1.77e-01 0.4540 -0.062200 -0.253000 -0.010400 -2.99e-01 2.20e-01 6.67e-01 7.94e-02 9.42e-01 3.87e-02 1.27e-01
IRAK4 DEFICIENCY TLR2 4 11 1.66e-01 2.56e-01 0.4540 -0.271000 0.034800 -0.236000 1.69e-01 2.17e-01 1.20e-01 8.42e-01 1.76e-01 3.33e-01 2.12e-01
SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL 10 1.51e-01 2.39e-01 0.4530 -0.182000 0.175000 0.240000 6.48e-02 2.84e-01 3.20e-01 3.38e-01 1.90e-01 7.23e-01 1.20e-01
DNA REPLICATION 119 4.43e-13 1.31e-11 0.4530 -0.222000 0.091800 0.029800 3.78e-01 -5.87e-02 2.98e-05 8.41e-02 5.75e-01 1.02e-12 2.69e-01
REGULATION OF GLYCOLYSIS BY FRUCTOSE 2 6 BISPHOSPHATE METABOLISM 10 1.31e-01 2.14e-01 0.4530 -0.126000 -0.081900 0.214000 -2.62e-01 2.61e-01 4.90e-01 6.54e-01 2.42e-01 1.52e-01 1.53e-01
APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B 21 5.28e-02 1.07e-01 0.4520 -0.234000 0.160000 0.059900 3.27e-01 -1.17e-01 6.38e-02 2.04e-01 6.35e-01 9.43e-03 3.54e-01
DNA DAMAGE RECOGNITION IN GG NER 38 3.77e-03 1.31e-02 0.4520 0.034000 0.188000 0.180000 3.68e-01 8.73e-03 7.17e-01 4.53e-02 5.51e-02 8.55e-05 9.26e-01
ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING 20 9.34e-02 1.68e-01 0.4520 -0.110000 -0.261000 -0.046900 -3.45e-01 -4.42e-02 3.92e-01 4.31e-02 7.17e-01 7.48e-03 7.32e-01
TNFR2 NON CANONICAL NF KB PATHWAY 76 2.14e-08 2.81e-07 0.4520 -0.276000 -0.007350 -0.028900 3.40e-01 -1.07e-01 3.14e-05 9.12e-01 6.63e-01 3.09e-07 1.08e-01
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX 10 1.87e-01 2.77e-01 0.4510 -0.420000 0.034200 0.015200 1.52e-01 4.94e-02 2.14e-02 8.52e-01 9.34e-01 4.06e-01 7.87e-01
CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS 12 3.12e-01 4.08e-01 0.4500 0.029800 0.198000 0.227000 1.40e-01 3.02e-01 8.58e-01 2.35e-01 1.74e-01 4.01e-01 7.00e-02
METABOLISM OF COFACTORS 18 8.40e-02 1.55e-01 0.4480 -0.182000 0.084000 -0.088600 3.75e-01 -1.08e-01 1.81e-01 5.37e-01 5.15e-01 5.89e-03 4.27e-01
GAP JUNCTION ASSEMBLY 20 9.31e-02 1.68e-01 0.4470 -0.120000 0.312000 0.019500 2.96e-01 -9.85e-03 3.51e-01 1.56e-02 8.80e-01 2.20e-02 9.39e-01
FGFR2 MUTANT RECEPTOR ACTIVATION 24 1.60e-02 4.24e-02 0.4460 -0.088900 0.022700 0.038600 3.88e-01 -1.96e-01 4.51e-01 8.47e-01 7.44e-01 9.92e-04 9.61e-02
REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS 84 3.47e-09 5.19e-08 0.4460 -0.296000 -0.052400 0.026900 2.85e-01 -1.63e-01 2.73e-06 4.06e-01 6.70e-01 6.22e-06 9.93e-03
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER 28 3.51e-02 7.85e-02 0.4450 0.088500 0.226000 0.125000 3.49e-01 3.41e-02 4.18e-01 3.86e-02 2.52e-01 1.37e-03 7.55e-01
FORMATION OF TC NER PRE INCISION COMPLEX 53 4.39e-05 2.81e-04 0.4430 -0.127000 0.135000 0.154000 3.72e-01 -2.92e-03 1.09e-01 9.04e-02 5.32e-02 2.76e-06 9.71e-01
PLATELET SENSITIZATION BY LDL 15 2.12e-01 3.05e-01 0.4430 -0.142000 -0.178000 -0.196000 -3.05e-01 1.14e-01 3.41e-01 2.32e-01 1.89e-01 4.05e-02 4.46e-01
NUCLEOTIDE SALVAGE 21 4.18e-02 9.01e-02 0.4430 -0.174000 0.194000 0.169000 3.05e-01 8.25e-02 1.69e-01 1.24e-01 1.80e-01 1.54e-02 5.13e-01
KERATAN SULFATE DEGRADATION 11 5.26e-01 6.09e-01 0.4420 0.237000 0.274000 0.144000 1.40e-01 1.55e-01 1.74e-01 1.16e-01 4.10e-01 4.21e-01 3.73e-01
DOWNSTREAM SIGNALING OF ACTIVATED FGFR4 17 1.12e-01 1.93e-01 0.4410 -0.076600 -0.135000 -0.385000 -1.31e-01 7.14e-02 5.85e-01 3.34e-01 5.97e-03 3.49e-01 6.10e-01
PI 3K CASCADE FGFR3 12 1.29e-01 2.12e-01 0.4410 0.106000 -0.026400 -0.382000 -9.66e-02 1.64e-01 5.27e-01 8.74e-01 2.20e-02 5.62e-01 3.24e-01
HDMS DEMETHYLATE HISTONES 26 2.70e-02 6.35e-02 0.4400 0.188000 -0.129000 -0.030300 -2.41e-01 2.88e-01 9.76e-02 2.56e-01 7.89e-01 3.38e-02 1.10e-02
DAP12 INTERACTIONS 28 1.87e-02 4.77e-02 0.4400 -0.301000 -0.243000 -0.183000 6.83e-02 -7.84e-02 5.89e-03 2.63e-02 9.41e-02 5.31e-01 4.73e-01
BASE EXCISION REPAIR 54 6.54e-05 3.91e-04 0.4390 -0.119000 0.116000 0.066800 3.73e-01 -1.47e-01 1.31e-01 1.40e-01 3.96e-01 2.10e-06 6.16e-02
RRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL 59 1.64e-05 1.14e-04 0.4380 -0.211000 0.040400 0.066300 2.94e-01 -2.35e-01 5.05e-03 5.91e-01 3.78e-01 9.68e-05 1.81e-03
JOSEPHIN DOMAIN DUBS 11 2.74e-01 3.72e-01 0.4370 -0.207000 -0.020800 0.156000 2.93e-01 -1.94e-01 2.35e-01 9.05e-01 3.71e-01 9.25e-02 2.66e-01
GLUTAMATE AND GLUTAMINE METABOLISM 13 9.16e-02 1.66e-01 0.4360 -0.049000 -0.002500 -0.081800 2.14e-01 3.67e-01 7.60e-01 9.88e-01 6.10e-01 1.81e-01 2.19e-02
VITAMIN B5 PANTOTHENATE METABOLISM 14 1.26e-01 2.09e-01 0.4360 0.057900 0.134000 -0.173000 -2.31e-02 3.72e-01 7.08e-01 3.87e-01 2.63e-01 8.81e-01 1.60e-02
RESPONSE OF EIF2AK1 HRI TO HEME DEFICIENCY 14 2.43e-01 3.41e-01 0.4350 -0.248000 -0.105000 -0.194000 2.24e-01 -1.69e-01 1.08e-01 4.98e-01 2.10e-01 1.46e-01 2.73e-01
ER QUALITY CONTROL COMPARTMENT ERQC 21 8.92e-02 1.62e-01 0.4340 -0.342000 -0.188000 -0.163000 -9.74e-02 -2.56e-02 6.73e-03 1.37e-01 1.95e-01 4.40e-01 8.39e-01
PLATELET CALCIUM HOMEOSTASIS 25 6.53e-02 1.27e-01 0.4340 0.265000 -0.005000 0.106000 -1.49e-01 2.91e-01 2.20e-02 9.66e-01 3.57e-01 1.97e-01 1.18e-02
INSULIN PROCESSING 24 3.27e-02 7.42e-02 0.4330 0.080000 -0.335000 0.072900 -2.12e-01 1.37e-01 4.98e-01 4.49e-03 5.37e-01 7.24e-02 2.46e-01
INTERLEUKIN 7 SIGNALING 18 8.73e-02 1.59e-01 0.4330 0.306000 0.090300 0.115000 -2.55e-01 8.74e-02 2.48e-02 5.07e-01 3.97e-01 6.10e-02 5.21e-01
SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS 18 1.73e-01 2.63e-01 0.4330 -0.015400 -0.213000 -0.082100 -3.63e-01 -5.31e-02 9.10e-01 1.18e-01 5.47e-01 7.60e-03 6.97e-01
PI METABOLISM 79 1.05e-06 9.81e-06 0.4320 0.192000 -0.158000 0.076300 -2.08e-01 2.76e-01 3.25e-03 1.51e-02 2.41e-01 1.42e-03 2.32e-05
SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX 13 2.45e-01 3.42e-01 0.4320 -0.092300 0.175000 -0.109000 3.67e-01 1.05e-02 5.64e-01 2.74e-01 4.95e-01 2.18e-02 9.48e-01
DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR 78 1.04e-08 1.41e-07 0.4310 -0.244000 -0.053700 0.014500 3.41e-01 -8.49e-02 1.93e-04 4.13e-01 8.25e-01 2.00e-07 1.95e-01
HIV TRANSCRIPTION INITIATION 45 5.39e-04 2.61e-03 0.4310 -0.210000 0.040700 0.029000 3.19e-01 -1.93e-01 1.48e-02 6.36e-01 7.37e-01 2.11e-04 2.50e-02
NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE 17 1.06e-01 1.85e-01 0.4310 0.246000 -0.185000 0.274000 -1.14e-01 -4.92e-02 7.91e-02 1.86e-01 5.05e-02 4.16e-01 7.25e-01
UCH PROTEINASES 89 2.76e-08 3.46e-07 0.4300 -0.230000 0.054500 -0.016200 3.37e-01 -1.24e-01 1.73e-04 3.74e-01 7.92e-01 4.12e-08 4.26e-02
HEME BIOSYNTHESIS 13 2.14e-01 3.08e-01 0.4300 0.109000 -0.022200 0.187000 2.24e-01 2.96e-01 4.95e-01 8.90e-01 2.43e-01 1.62e-01 6.51e-02
ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS 35 3.10e-03 1.12e-02 0.4300 0.169000 -0.172000 0.317000 -1.15e-01 1.13e-01 8.32e-02 7.80e-02 1.19e-03 2.40e-01 2.49e-01
NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION 10 4.35e-01 5.27e-01 0.4270 -0.224000 -0.295000 -0.171000 7.47e-02 -1.02e-01 2.21e-01 1.06e-01 3.49e-01 6.83e-01 5.75e-01
BUDDING AND MATURATION OF HIV VIRION 27 1.40e-02 3.83e-02 0.4260 -0.179000 0.076300 0.180000 3.24e-01 -7.84e-02 1.07e-01 4.93e-01 1.05e-01 3.54e-03 4.81e-01
RAF INDEPENDENT MAPK1 3 ACTIVATION 20 6.53e-02 1.27e-01 0.4260 0.101000 -0.305000 0.057200 -1.64e-01 2.19e-01 4.36e-01 1.82e-02 6.58e-01 2.04e-01 8.96e-02
REGULATION OF BACH1 ACTIVITY 11 4.39e-01 5.29e-01 0.4250 -0.021500 0.304000 0.001780 2.77e-01 -1.03e-01 9.02e-01 8.10e-02 9.92e-01 1.11e-01 5.54e-01
DEFECTS IN COBALAMIN B12 METABOLISM 12 1.03e-01 1.80e-01 0.4240 0.025800 -0.017300 -0.368000 2.05e-01 3.69e-02 8.77e-01 9.17e-01 2.72e-02 2.19e-01 8.25e-01
SIGNALING BY PDGFR IN DISEASE 20 1.43e-01 2.29e-01 0.4240 0.014400 -0.245000 -0.196000 -2.68e-01 9.58e-02 9.11e-01 5.81e-02 1.29e-01 3.79e-02 4.58e-01
RHO GTPASES ACTIVATE KTN1 11 2.88e-01 3.83e-01 0.4230 -0.140000 0.153000 -0.258000 2.37e-01 1.14e-01 4.21e-01 3.81e-01 1.39e-01 1.73e-01 5.14e-01
SYNTHESIS OF PE 13 1.02e-01 1.80e-01 0.4220 0.083900 -0.187000 -0.328000 8.90e-03 1.69e-01 6.01e-01 2.43e-01 4.05e-02 9.56e-01 2.93e-01
CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY 13 7.05e-02 1.34e-01 0.4220 0.013200 -0.302000 0.203000 1.92e-01 9.08e-02 9.34e-01 5.94e-02 2.04e-01 2.30e-01 5.71e-01
MRNA SPLICING 188 1.28e-17 5.91e-16 0.4220 -0.193000 0.012300 0.064100 1.61e-01 -3.32e-01 5.22e-06 7.72e-01 1.30e-01 1.43e-04 4.21e-15
FRS MEDIATED FGFR3 SIGNALING 14 8.41e-02 1.55e-01 0.4210 0.043900 0.016300 -0.355000 5.33e-02 2.15e-01 7.76e-01 9.16e-01 2.14e-02 7.30e-01 1.63e-01
N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE 35 1.17e-02 3.30e-02 0.4210 -0.313000 -0.219000 -0.128000 -1.14e-01 -4.64e-02 1.36e-03 2.48e-02 1.91e-01 2.44e-01 6.34e-01
GAB1 SIGNALOSOME 13 4.31e-01 5.24e-01 0.4210 -0.090300 -0.161000 -0.194000 -2.67e-01 -1.85e-01 5.73e-01 3.14e-01 2.26e-01 9.52e-02 2.48e-01
DDX58 IFIH1 MEDIATED INDUCTION OF INTERFERON ALPHA BETA 63 8.25e-04 3.74e-03 0.4200 -0.224000 -0.214000 -0.238000 -1.36e-01 -7.13e-02 2.07e-03 3.37e-03 1.10e-03 6.23e-02 3.28e-01
INSULIN RECEPTOR RECYCLING 20 1.64e-02 4.32e-02 0.4200 -0.045200 -0.097500 0.190000 2.93e-01 2.06e-01 7.27e-01 4.50e-01 1.42e-01 2.32e-02 1.11e-01
ION HOMEOSTASIS 47 2.96e-03 1.08e-02 0.4190 0.315000 -0.035800 0.154000 -4.41e-02 2.23e-01 1.91e-04 6.72e-01 6.77e-02 6.01e-01 8.20e-03
SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN 12 4.40e-01 5.29e-01 0.4180 -0.255000 -0.046300 -0.256000 1.53e-01 -1.38e-01 1.26e-01 7.81e-01 1.25e-01 3.60e-01 4.10e-01
CYTOPROTECTION BY HMOX1 119 2.14e-11 4.57e-10 0.4180 -0.170000 0.014400 0.021800 3.54e-01 -1.41e-01 1.34e-03 7.86e-01 6.81e-01 2.65e-11 7.79e-03
METABOLISM OF RNA 643 1.95e-60 3.22e-58 0.4170 -0.186000 0.005320 0.048500 2.77e-01 -2.45e-01 9.61e-16 8.19e-01 3.71e-02 6.75e-33 3.98e-26
ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS 83 2.01e-07 2.25e-06 0.4160 0.127000 -0.217000 0.205000 -1.76e-01 1.93e-01 4.63e-02 6.39e-04 1.23e-03 5.65e-03 2.40e-03
SIGNALING BY LEPTIN 10 4.49e-01 5.39e-01 0.4160 0.336000 0.046700 -0.027300 -8.41e-02 2.24e-01 6.62e-02 7.98e-01 8.81e-01 6.45e-01 2.19e-01
PLATELET ADHESION TO EXPOSED COLLAGEN 11 2.15e-01 3.09e-01 0.4160 -0.003890 0.333000 -0.245000 -3.33e-03 4.26e-02 9.82e-01 5.56e-02 1.60e-01 9.85e-01 8.07e-01
SIGNALING BY NOTCH4 83 3.27e-07 3.43e-06 0.4160 -0.241000 0.065200 0.010600 3.15e-01 -1.07e-01 1.52e-04 3.05e-01 8.68e-01 7.21e-07 9.26e-02
CHONDROITIN SULFATE BIOSYNTHESIS 18 2.52e-01 3.51e-01 0.4150 0.298000 0.161000 0.159000 -6.47e-02 1.66e-01 2.85e-02 2.38e-01 2.43e-01 6.35e-01 2.22e-01
OVARIAN TUMOR DOMAIN PROTEASES 36 3.09e-02 7.07e-02 0.4120 -0.126000 -0.268000 -0.242000 -1.42e-01 -6.06e-02 1.92e-01 5.38e-03 1.21e-02 1.40e-01 5.29e-01
TRAF6 MEDIATED NF KB ACTIVATION 21 1.04e-01 1.82e-01 0.4120 -0.060500 -0.191000 -0.302000 -1.64e-01 1.09e-01 6.31e-01 1.30e-01 1.67e-02 1.93e-01 3.88e-01
FCERI MEDIATED MAPK ACTIVATION 28 4.01e-02 8.76e-02 0.4120 -0.147000 -0.299000 -0.087700 -2.16e-01 6.80e-02 1.79e-01 6.25e-03 4.22e-01 4.82e-02 5.33e-01
DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE 34 9.98e-03 2.95e-02 0.4120 -0.164000 0.113000 -0.211000 2.64e-01 -1.23e-01 9.77e-02 2.52e-01 3.37e-02 7.62e-03 2.13e-01
RHOF GTPASE CYCLE 39 1.21e-03 5.08e-03 0.4110 0.067200 -0.005040 -0.117000 -3.72e-01 1.14e-01 4.68e-01 9.57e-01 2.06e-01 5.95e-05 2.17e-01
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER 28 9.60e-03 2.85e-02 0.4110 0.003420 0.008230 0.150000 3.66e-01 1.12e-01 9.75e-01 9.40e-01 1.70e-01 7.98e-04 3.03e-01
DUAL INCISION IN GG NER 40 5.97e-03 1.91e-02 0.4110 -0.066700 0.162000 0.174000 3.20e-01 -7.55e-02 4.66e-01 7.57e-02 5.71e-02 4.63e-04 4.09e-01
P75NTR RECRUITS SIGNALLING COMPLEXES 12 3.96e-01 4.94e-01 0.4110 -0.132000 0.019200 -0.117000 1.62e-01 -3.33e-01 4.28e-01 9.08e-01 4.84e-01 3.30e-01 4.60e-02
FORMATION OF THE CORNIFIED ENVELOPE 20 1.85e-01 2.74e-01 0.4100 0.164000 0.187000 0.319000 4.58e-02 5.31e-02 2.05e-01 1.47e-01 1.36e-02 7.23e-01 6.81e-01
KERATINIZATION 20 1.85e-01 2.74e-01 0.4100 0.164000 0.187000 0.319000 4.58e-02 5.31e-02 2.05e-01 1.47e-01 1.36e-02 7.23e-01 6.81e-01
TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES 77 8.32e-06 6.30e-05 0.4100 0.182000 -0.079800 0.037100 -2.29e-01 2.73e-01 5.67e-03 2.27e-01 5.74e-01 5.26e-04 3.44e-05
CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER 26 4.21e-02 9.02e-02 0.4100 0.250000 -0.198000 0.052100 -1.24e-01 2.19e-01 2.72e-02 8.09e-02 6.46e-01 2.76e-01 5.28e-02
STRIATED MUSCLE CONTRACTION 21 2.46e-02 5.88e-02 0.4090 0.153000 -0.055000 0.143000 1.47e-01 -3.15e-01 2.25e-01 6.63e-01 2.57e-01 2.42e-01 1.25e-02
REGULATION OF SIGNALING BY CBL 22 7.26e-02 1.37e-01 0.4090 -0.085800 -0.317000 -0.047100 -1.95e-01 1.37e-01 4.86e-01 9.98e-03 7.02e-01 1.13e-01 2.67e-01
IL 6 TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS 12 2.81e-01 3.76e-01 0.4090 0.223000 -0.066600 -0.095500 -2.86e-02 3.21e-01 1.82e-01 6.90e-01 5.67e-01 8.64e-01 5.41e-02
PERK REGULATES GENE EXPRESSION 28 9.46e-03 2.81e-02 0.4090 -0.280000 -0.224000 -0.038800 1.74e-01 -7.92e-02 1.02e-02 3.98e-02 7.22e-01 1.11e-01 4.68e-01
CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT 20 6.52e-02 1.27e-01 0.4090 -0.087900 0.184000 -0.018200 1.77e-01 3.07e-01 4.96e-01 1.55e-01 8.88e-01 1.72e-01 1.76e-02
ELASTIC FIBRE FORMATION 36 1.38e-03 5.66e-03 0.4080 0.318000 0.244000 -0.007560 -5.35e-02 5.32e-02 9.59e-04 1.14e-02 9.37e-01 5.78e-01 5.81e-01
INTERLEUKIN 10 SIGNALING 17 2.44e-01 3.42e-01 0.4080 -0.040900 -0.204000 -0.300000 -1.79e-01 2.71e-02 7.70e-01 1.45e-01 3.25e-02 2.01e-01 8.47e-01
DUAL INCISION IN TC NER 64 3.48e-05 2.25e-04 0.4060 -0.152000 0.120000 0.139000 3.23e-01 -5.85e-02 3.53e-02 9.69e-02 5.41e-02 7.82e-06 4.19e-01
DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE 26 1.07e-02 3.10e-02 0.4060 -0.050200 -0.044600 0.071900 -2.91e-01 2.65e-01 6.58e-01 6.94e-01 5.26e-01 1.01e-02 1.94e-02
FCERI MEDIATED NF KB ACTIVATION 76 7.60e-07 7.55e-06 0.4050 -0.201000 -0.008270 -0.020200 3.36e-01 -1.01e-01 2.44e-03 9.01e-01 7.60e-01 4.05e-07 1.27e-01
SHC1 EVENTS IN EGFR SIGNALING 10 6.39e-01 7.00e-01 0.4040 -0.237000 -0.123000 -0.291000 2.97e-03 -8.79e-02 1.95e-01 4.99e-01 1.11e-01 9.87e-01 6.30e-01
KSRP KHSRP BINDS AND DESTABILIZES MRNA 16 9.37e-02 1.68e-01 0.4040 -0.081500 -0.051500 0.313000 2.35e-01 2.81e-02 5.73e-01 7.21e-01 3.04e-02 1.03e-01 8.46e-01
NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION 23 9.28e-02 1.68e-01 0.4040 -0.055200 -0.141000 -0.081500 -3.33e-01 -1.50e-01 6.47e-01 2.42e-01 4.99e-01 5.69e-03 2.14e-01
INTERLEUKIN 20 FAMILY SIGNALING 12 4.50e-01 5.39e-01 0.4030 0.198000 -0.203000 0.071400 -2.64e-01 8.87e-02 2.36e-01 2.24e-01 6.68e-01 1.14e-01 5.95e-01
REGULATION OF IFNA SIGNALING 12 3.76e-01 4.73e-01 0.4030 0.066500 -0.328000 -0.092800 -1.25e-01 -1.62e-01 6.90e-01 4.91e-02 5.78e-01 4.54e-01 3.30e-01
PYRIMIDINE CATABOLISM 10 5.57e-01 6.36e-01 0.4030 -0.096900 0.304000 0.099600 2.23e-01 3.42e-02 5.96e-01 9.62e-02 5.85e-01 2.23e-01 8.51e-01
SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL 25 7.05e-02 1.34e-01 0.4020 0.191000 0.066000 0.004800 -1.55e-01 3.11e-01 9.87e-02 5.68e-01 9.67e-01 1.81e-01 7.05e-03
NICOTINAMIDE SALVAGING 15 1.73e-01 2.63e-01 0.4020 -0.231000 0.110000 0.073600 2.21e-02 -3.00e-01 1.22e-01 4.61e-01 6.22e-01 8.82e-01 4.41e-02
GENERATION OF SECOND MESSENGER MOLECULES 17 5.08e-02 1.05e-01 0.4000 0.015800 0.220000 -0.158000 -5.26e-02 -2.90e-01 9.10e-01 1.17e-01 2.58e-01 7.07e-01 3.87e-02
SIGNALING BY RETINOIC ACID 31 1.20e-02 3.35e-02 0.3990 0.087500 0.223000 -0.123000 2.31e-01 1.83e-01 3.99e-01 3.14e-02 2.36e-01 2.59e-02 7.83e-02
NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION 11 2.71e-01 3.69e-01 0.3990 0.139000 0.186000 -0.066900 -2.83e-01 1.44e-01 4.26e-01 2.86e-01 7.01e-01 1.04e-01 4.08e-01
ROLE OF SECOND MESSENGERS IN NETRIN 1 SIGNALING 10 4.79e-01 5.66e-01 0.3990 0.298000 0.021000 0.248000 -4.03e-02 -7.97e-02 1.02e-01 9.08e-01 1.75e-01 8.25e-01 6.63e-01
RND3 GTPASE CYCLE 37 5.26e-03 1.73e-02 0.3990 -0.082500 -0.095900 -0.065700 -3.64e-01 -7.67e-02 3.85e-01 3.13e-01 4.89e-01 1.26e-04 4.19e-01
CD28 DEPENDENT PI3K AKT SIGNALING 20 1.36e-01 2.21e-01 0.3990 0.177000 -0.131000 0.070500 -9.05e-02 3.12e-01 1.71e-01 3.10e-01 5.85e-01 4.84e-01 1.58e-02
ONCOGENIC MAPK SIGNALING 76 8.76e-06 6.55e-05 0.3990 0.041600 -0.290000 0.049200 -2.36e-01 1.22e-01 5.31e-01 1.25e-05 4.59e-01 3.69e-04 6.69e-02
RHOBTB1 GTPASE CYCLE 23 2.44e-01 3.42e-01 0.3990 -0.208000 -0.214000 -0.203000 -1.35e-01 -1.02e-01 8.42e-02 7.59e-02 9.23e-02 2.61e-01 3.97e-01
AMYLOID FIBER FORMATION 54 5.16e-04 2.51e-03 0.3980 -0.202000 0.031700 -0.189000 2.57e-01 -1.22e-01 1.04e-02 6.87e-01 1.63e-02 1.09e-03 1.20e-01
STIMULI SENSING CHANNELS 73 5.17e-05 3.17e-04 0.3970 0.313000 0.002700 0.053500 -9.12e-02 2.21e-01 3.91e-06 9.68e-01 4.29e-01 1.78e-01 1.08e-03
CYTOCHROME C MEDIATED APOPTOTIC RESPONSE 12 2.25e-01 3.20e-01 0.3960 -0.191000 -0.146000 -0.236000 1.49e-01 1.45e-01 2.51e-01 3.83e-01 1.57e-01 3.71e-01 3.83e-01
CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND 12 3.31e-01 4.28e-01 0.3960 -0.091200 -0.080200 -0.373000 4.95e-02 -2.28e-02 5.85e-01 6.31e-01 2.53e-02 7.67e-01 8.91e-01
ZBP1 DAI MEDIATED INDUCTION OF TYPE I IFNS 18 2.02e-01 2.94e-01 0.3960 -0.053300 -0.168000 -0.338000 -1.05e-01 -1.44e-02 6.95e-01 2.18e-01 1.29e-02 4.43e-01 9.16e-01
PLASMA LIPOPROTEIN ASSEMBLY 11 5.08e-01 5.94e-01 0.3960 -0.026000 0.340000 0.031100 1.63e-01 1.13e-01 8.81e-01 5.09e-02 8.58e-01 3.48e-01 5.17e-01
DERMATAN SULFATE BIOSYNTHESIS 11 1.82e-01 2.74e-01 0.3960 0.041800 0.299000 0.172000 -1.36e-01 -1.33e-01 8.10e-01 8.65e-02 3.23e-01 4.36e-01 4.46e-01
CD28 DEPENDENT VAV1 PATHWAY 11 4.27e-01 5.21e-01 0.3950 -0.345000 -0.119000 -0.028400 -9.79e-02 -1.14e-01 4.78e-02 4.96e-01 8.70e-01 5.74e-01 5.11e-01
LYSINE CATABOLISM 11 3.84e-01 4.81e-01 0.3950 0.052800 0.316000 -0.141000 1.02e-01 1.52e-01 7.62e-01 6.93e-02 4.19e-01 5.57e-01 3.82e-01
ERBB2 ACTIVATES PTK6 SIGNALING 10 4.18e-01 5.15e-01 0.3950 -0.021300 0.029200 -0.221000 -3.24e-01 -3.04e-02 9.07e-01 8.73e-01 2.27e-01 7.62e-02 8.68e-01
HS GAG BIOSYNTHESIS 29 4.02e-03 1.38e-02 0.3940 0.002530 0.065100 0.222000 -2.60e-01 1.85e-01 9.81e-01 5.44e-01 3.83e-02 1.54e-02 8.52e-02
REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP SREBF 56 5.67e-04 2.71e-03 0.3940 -0.027300 -0.229000 -0.022700 -2.91e-01 1.30e-01 7.24e-01 3.06e-03 7.69e-01 1.66e-04 9.20e-02
TRIGLYCERIDE CATABOLISM 14 3.01e-01 3.96e-01 0.3940 -0.278000 0.047600 -0.024900 2.67e-01 -6.30e-02 7.19e-02 7.58e-01 8.72e-01 8.42e-02 6.83e-01
TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR TC NER 77 7.90e-06 6.03e-05 0.3930 -0.137000 0.116000 0.124000 3.23e-01 -4.81e-02 3.72e-02 7.79e-02 6.08e-02 9.40e-07 4.66e-01
GLYCOSPHINGOLIPID METABOLISM 37 2.93e-03 1.08e-02 0.3930 0.013600 0.050100 0.033600 2.65e-02 3.87e-01 8.86e-01 5.98e-01 7.24e-01 7.80e-01 4.62e-05
FORMATION OF APOPTOSOME 10 3.38e-01 4.34e-01 0.3920 -0.117000 -0.193000 -0.279000 1.39e-01 7.51e-02 5.22e-01 2.92e-01 1.26e-01 4.46e-01 6.81e-01
CHAPERONE MEDIATED AUTOPHAGY 19 1.76e-01 2.65e-01 0.3920 -0.115000 0.086200 -0.096700 2.86e-01 -2.05e-01 3.85e-01 5.16e-01 4.65e-01 3.09e-02 1.22e-01
BETA OXIDATION OF VERY LONG CHAIN FATTY ACIDS 11 4.23e-01 5.18e-01 0.3910 0.191000 0.121000 0.056000 3.13e-01 -1.83e-02 2.73e-01 4.88e-01 7.48e-01 7.20e-02 9.16e-01
NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION 62 2.25e-04 1.19e-03 0.3910 -0.186000 0.040300 -0.019400 2.81e-01 -1.91e-01 1.11e-02 5.83e-01 7.92e-01 1.28e-04 9.23e-03
HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR 48 2.68e-03 1.00e-02 0.3890 -0.313000 -0.183000 -0.060200 9.16e-03 -1.27e-01 1.77e-04 2.80e-02 4.71e-01 9.13e-01 1.29e-01
NEURONAL SYSTEM 362 3.97e-26 2.18e-24 0.3890 0.186000 -0.108000 0.180000 -2.08e-01 1.70e-01 1.27e-09 4.13e-04 4.22e-09 1.30e-11 2.78e-08
ION TRANSPORT BY P TYPE ATPASES 46 5.94e-03 1.90e-02 0.3890 0.192000 0.057100 0.110000 -1.76e-01 2.61e-01 2.44e-02 5.03e-01 1.97e-01 3.91e-02 2.24e-03
SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS 20 6.48e-02 1.27e-01 0.3880 -0.079700 0.189000 -0.171000 -9.80e-03 2.81e-01 5.37e-01 1.44e-01 1.87e-01 9.40e-01 2.94e-02
PHASE II CONJUGATION OF COMPOUNDS 60 5.71e-04 2.72e-03 0.3870 -0.125000 0.225000 -0.014800 2.89e-01 1.50e-02 9.55e-02 2.54e-03 8.43e-01 1.11e-04 8.41e-01
RUNX1 INTERACTS WITH CO FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN 37 1.35e-02 3.72e-02 0.3870 -0.013200 -0.291000 0.049100 -1.69e-01 -1.85e-01 8.90e-01 2.22e-03 6.05e-01 7.46e-02 5.14e-02
ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT 30 1.43e-02 3.89e-02 0.3870 -0.157000 0.052700 0.195000 2.91e-01 6.02e-04 1.36e-01 6.17e-01 6.45e-02 5.89e-03 9.95e-01
MAPK6 MAPK4 SIGNALING 83 2.13e-06 1.88e-05 0.3870 -0.275000 -0.128000 -0.019700 1.75e-01 -1.62e-01 1.52e-05 4.32e-02 7.57e-01 5.80e-03 1.06e-02
NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS 10 5.19e-01 6.03e-01 0.3870 0.237000 0.286000 -0.001000 3.23e-02 1.02e-01 1.95e-01 1.17e-01 9.96e-01 8.60e-01 5.78e-01
HEPARAN SULFATE HEPARIN HS GAG METABOLISM 51 3.12e-04 1.58e-03 0.3850 0.110000 0.140000 0.247000 -1.78e-01 1.56e-01 1.74e-01 8.44e-02 2.32e-03 2.81e-02 5.40e-02
RECOGNITION OF DNA DAMAGE BY PCNA CONTAINING REPLICATION COMPLEX 28 5.07e-02 1.05e-01 0.3850 -0.139000 0.139000 0.119000 3.08e-01 1.52e-02 2.02e-01 2.04e-01 2.75e-01 4.80e-03 8.89e-01
B WICH COMPLEX POSITIVELY REGULATES RRNA EXPRESSION 45 6.19e-03 1.95e-02 0.3850 -0.189000 0.029200 -0.073700 2.49e-01 -2.09e-01 2.81e-02 7.35e-01 3.92e-01 3.84e-03 1.53e-02
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL 12 4.10e-01 5.08e-01 0.3840 0.018500 0.208000 -0.053600 1.13e-01 2.98e-01 9.12e-01 2.12e-01 7.48e-01 4.99e-01 7.42e-02
ASSEMBLY OF THE HIV VIRION 16 1.80e-01 2.71e-01 0.3830 -0.212000 -0.139000 0.064500 2.29e-01 -1.61e-01 1.42e-01 3.35e-01 6.55e-01 1.12e-01 2.65e-01
NETRIN 1 SIGNALING 48 2.71e-03 1.02e-02 0.3830 0.176000 -0.088600 0.213000 -2.29e-01 1.00e-01 3.49e-02 2.89e-01 1.07e-02 6.14e-03 2.30e-01
SIGNALING BY FGFR1 IN DISEASE 32 7.42e-02 1.39e-01 0.3820 -0.014700 -0.202000 -0.174000 -2.72e-01 2.37e-02 8.86e-01 4.77e-02 8.77e-02 7.73e-03 8.17e-01
TERMINATION OF TRANSLESION DNA SYNTHESIS 31 3.71e-02 8.26e-02 0.3820 -0.208000 0.073800 0.062600 2.58e-01 -1.63e-01 4.47e-02 4.77e-01 5.47e-01 1.30e-02 1.15e-01
MOLECULES ASSOCIATED WITH ELASTIC FIBRES 31 6.06e-03 1.93e-02 0.3810 0.300000 0.217000 -0.072500 -2.06e-02 5.19e-02 3.81e-03 3.69e-02 4.85e-01 8.43e-01 6.17e-01
LATE ENDOSOMAL MICROAUTOPHAGY 30 3.31e-02 7.50e-02 0.3810 -0.092900 0.057300 0.133000 3.29e-01 -8.57e-02 3.78e-01 5.87e-01 2.09e-01 1.82e-03 4.17e-01
NUCLEAR PORE COMPLEX NPC DISASSEMBLY 31 4.94e-02 1.03e-01 0.3800 0.186000 -0.175000 0.104000 -1.51e-01 2.14e-01 7.37e-02 9.13e-02 3.14e-01 1.45e-01 3.97e-02
REGULATED NECROSIS 45 5.04e-03 1.66e-02 0.3800 -0.224000 -0.001270 -0.084000 2.60e-01 -1.39e-01 9.24e-03 9.88e-01 3.30e-01 2.53e-03 1.07e-01
MYOGENESIS 24 1.14e-01 1.95e-01 0.3800 0.111000 -0.130000 0.030300 -2.14e-01 2.62e-01 3.49e-01 2.71e-01 7.97e-01 7.02e-02 2.63e-02
TICAM1 RIP1 MEDIATED IKK COMPLEX RECRUITMENT 18 1.86e-01 2.76e-01 0.3800 -0.156000 -0.144000 -0.304000 8.01e-02 1.09e-03 2.52e-01 2.91e-01 2.53e-02 5.56e-01 9.94e-01
INOSITOL PHOSPHATE METABOLISM 46 1.71e-03 6.88e-03 0.3790 0.075300 0.168000 0.047900 -1.30e-01 3.01e-01 3.77e-01 4.88e-02 5.74e-01 1.28e-01 4.15e-04
SIGNALING BY KIT IN DISEASE 20 1.84e-01 2.74e-01 0.3790 0.007820 -0.333000 -0.039700 -1.63e-01 6.54e-02 9.52e-01 9.95e-03 7.59e-01 2.07e-01 6.13e-01
DAP12 SIGNALING 24 1.02e-01 1.79e-01 0.3780 -0.293000 -0.206000 -0.113000 2.26e-02 -3.69e-02 1.29e-02 8.07e-02 3.36e-01 8.48e-01 7.55e-01
SUMOYLATION OF DNA METHYLATION PROTEINS 15 3.33e-01 4.29e-01 0.3780 -0.023600 -0.269000 0.086600 -2.03e-01 -1.46e-01 8.74e-01 7.11e-02 5.61e-01 1.74e-01 3.26e-01
SYNTHESIS OF PC 26 1.48e-02 3.96e-02 0.3780 0.158000 -0.063300 -0.072400 1.53e-01 2.92e-01 1.63e-01 5.76e-01 5.23e-01 1.77e-01 9.92e-03
DNA STRAND ELONGATION 32 6.59e-02 1.28e-01 0.3780 0.026800 0.186000 0.078300 3.08e-01 8.33e-02 7.93e-01 6.89e-02 4.43e-01 2.61e-03 4.15e-01
PENTOSE PHOSPHATE PATHWAY 13 3.72e-01 4.70e-01 0.3780 -0.105000 0.243000 -0.183000 1.34e-01 -1.47e-01 5.11e-01 1.30e-01 2.55e-01 4.04e-01 3.60e-01
NEUROTRANSMITTER RELEASE CYCLE 48 6.64e-03 2.08e-02 0.3770 0.286000 -0.067700 0.082900 -9.21e-02 2.01e-01 5.97e-04 4.17e-01 3.21e-01 2.70e-01 1.60e-02
PCP CE PATHWAY 88 5.69e-07 5.70e-06 0.3770 -0.247000 0.038600 0.057200 2.70e-01 -6.38e-02 6.45e-05 5.32e-01 3.54e-01 1.24e-05 3.01e-01
AMINO ACIDS REGULATE MTORC1 51 8.35e-04 3.76e-03 0.3760 0.035200 0.019100 0.213000 2.14e-01 2.22e-01 6.64e-01 8.13e-01 8.58e-03 8.37e-03 6.18e-03
SIGNALING BY FLT3 FUSION PROTEINS 18 3.01e-01 3.96e-01 0.3760 -0.013100 -0.197000 -0.123000 -2.61e-01 1.37e-01 9.23e-01 1.47e-01 3.67e-01 5.54e-02 3.14e-01
REGULATION OF HSF1 MEDIATED HEAT SHOCK RESPONSE 75 6.24e-04 2.94e-03 0.3750 -0.186000 -0.207000 -0.108000 -2.12e-01 -8.18e-02 5.28e-03 1.96e-03 1.06e-01 1.53e-03 2.21e-01
SIGNALLING TO RAS 17 9.78e-02 1.74e-01 0.3750 -0.024400 -0.325000 -0.106000 2.43e-02 1.49e-01 8.62e-01 2.02e-02 4.48e-01 8.62e-01 2.87e-01
GLYCOGEN METABOLISM 25 6.31e-02 1.25e-01 0.3750 -0.186000 -0.043700 -0.275000 -6.07e-02 1.57e-01 1.08e-01 7.05e-01 1.74e-02 5.99e-01 1.73e-01
PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION 22 1.57e-01 2.45e-01 0.3740 -0.170000 0.062700 -0.320000 -1.15e-02 -6.87e-02 1.67e-01 6.11e-01 9.37e-03 9.25e-01 5.77e-01
ANTIGEN ACTIVATES B CELL RECEPTOR BCR LEADING TO GENERATION OF SECOND MESSENGERS 26 9.92e-02 1.76e-01 0.3740 -0.032000 -0.212000 -0.160000 -2.02e-01 1.65e-01 7.78e-01 6.11e-02 1.59e-01 7.41e-02 1.45e-01
ENOS ACTIVATION 11 5.89e-01 6.61e-01 0.3740 -0.181000 0.004300 -0.322000 6.20e-04 -6.04e-02 3.00e-01 9.80e-01 6.47e-02 9.97e-01 7.29e-01
PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS 19 1.12e-01 1.93e-01 0.3740 -0.216000 -0.105000 0.130000 2.09e-01 -1.46e-01 1.03e-01 4.30e-01 3.27e-01 1.15e-01 2.70e-01
CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND 10 5.67e-01 6.44e-01 0.3730 0.288000 0.048000 -0.002820 -1.85e-01 1.40e-01 1.14e-01 7.93e-01 9.88e-01 3.12e-01 4.44e-01
WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 13 3.02e-01 3.96e-01 0.3720 -0.000872 0.291000 0.224000 -2.04e-02 6.02e-02 9.96e-01 6.97e-02 1.62e-01 8.99e-01 7.07e-01
MTOR SIGNALLING 40 9.25e-03 2.77e-02 0.3720 0.029100 0.073000 0.144000 2.03e-01 2.66e-01 7.50e-01 4.24e-01 1.16e-01 2.66e-02 3.65e-03
G2 M CHECKPOINTS 128 7.34e-09 1.06e-07 0.3720 -0.229000 -0.000811 -0.061000 2.59e-01 -1.22e-01 7.73e-06 9.87e-01 2.34e-01 4.17e-07 1.71e-02
AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL 14 2.38e-01 3.36e-01 0.3720 0.203000 -0.156000 0.058300 1.03e-01 2.43e-01 1.89e-01 3.12e-01 7.06e-01 5.04e-01 1.16e-01
NOTCH HLH TRANSCRIPTION PATHWAY 28 4.92e-02 1.03e-01 0.3720 0.148000 -0.151000 -0.064300 -2.73e-01 -1.22e-01 1.76e-01 1.67e-01 5.56e-01 1.26e-02 2.62e-01
DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX 82 3.02e-06 2.55e-05 0.3710 -0.294000 0.020900 0.001290 2.19e-01 -5.57e-02 4.31e-06 7.44e-01 9.84e-01 6.17e-04 3.84e-01
ERBB2 REGULATES CELL MOTILITY 13 4.05e-01 5.02e-01 0.3700 -0.118000 -0.002600 -0.230000 -2.55e-01 7.13e-02 4.62e-01 9.87e-01 1.51e-01 1.12e-01 6.56e-01
TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION 16 4.29e-01 5.23e-01 0.3690 -0.313000 -0.014600 -0.148000 4.50e-02 -1.18e-01 3.02e-02 9.20e-01 3.06e-01 7.55e-01 4.16e-01
INTERLEUKIN 3 INTERLEUKIN 5 AND GM CSF SIGNALING 41 1.68e-02 4.38e-02 0.3690 -0.082700 -0.191000 -0.058700 -2.88e-01 7.88e-02 3.59e-01 3.42e-02 5.16e-01 1.43e-03 3.83e-01
TELOMERE MAINTENANCE 75 4.57e-05 2.88e-04 0.3680 -0.100000 0.056000 -0.054100 2.94e-01 -1.82e-01 1.33e-01 4.02e-01 4.18e-01 1.08e-05 6.48e-03
ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION 14 4.24e-01 5.19e-01 0.3680 -0.106000 -0.216000 -0.117000 -2.06e-01 1.46e-01 4.93e-01 1.62e-01 4.48e-01 1.81e-01 3.43e-01
RAC1 GTPASE CYCLE 176 1.48e-11 3.34e-10 0.3670 0.096200 -0.103000 -0.051600 -2.85e-01 1.76e-01 2.79e-02 1.90e-02 2.38e-01 6.81e-11 6.03e-05
INTERLEUKIN 2 FAMILY SIGNALING 33 7.09e-02 1.35e-01 0.3670 0.010200 -0.198000 -0.055700 -3.00e-01 4.79e-02 9.19e-01 4.92e-02 5.80e-01 2.90e-03 6.34e-01
GABA RECEPTOR ACTIVATION 53 1.16e-03 4.95e-03 0.3670 -0.143000 -0.162000 -0.035100 -2.85e-01 7.41e-02 7.12e-02 4.16e-02 6.58e-01 3.41e-04 3.51e-01
GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR GG NER 83 6.30e-05 3.80e-04 0.3670 -0.086500 0.160000 0.121000 2.94e-01 -1.96e-02 1.73e-01 1.16e-02 5.77e-02 3.78e-06 7.58e-01
LAGGING STRAND SYNTHESIS 20 2.16e-01 3.10e-01 0.3660 -0.025200 0.151000 -0.024700 3.28e-01 -4.76e-02 8.45e-01 2.42e-01 8.48e-01 1.10e-02 7.13e-01
FORMATION OF INCISION COMPLEX IN GG NER 43 1.49e-02 3.98e-02 0.3660 -0.091300 0.204000 0.151000 2.43e-01 4.79e-02 3.00e-01 2.10e-02 8.68e-02 5.83e-03 5.87e-01
GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK 16 3.40e-01 4.36e-01 0.3660 -0.076300 -0.296000 -0.039800 -1.75e-01 8.91e-02 5.97e-01 4.01e-02 7.83e-01 2.26e-01 5.37e-01
INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS 20 2.28e-01 3.23e-01 0.3660 -0.125000 0.138000 0.114000 2.93e-01 -1.08e-02 3.32e-01 2.87e-01 3.76e-01 2.33e-02 9.33e-01
RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION 22 2.16e-01 3.10e-01 0.3660 -0.087000 -0.169000 -0.062700 -3.06e-01 -1.37e-02 4.80e-01 1.71e-01 6.11e-01 1.30e-02 9.11e-01
FATTY ACID METABOLISM 143 2.04e-10 3.51e-09 0.3650 0.013100 0.222000 -0.113000 2.17e-01 1.55e-01 7.87e-01 4.46e-06 1.97e-02 7.63e-06 1.42e-03
ATF4 ACTIVATES GENES IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS 23 4.08e-02 8.86e-02 0.3650 -0.212000 -0.170000 0.057500 2.30e-01 -5.38e-02 7.78e-02 1.58e-01 6.33e-01 5.59e-02 6.55e-01
N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI 23 1.08e-01 1.88e-01 0.3650 -0.122000 -0.022900 -0.183000 -2.69e-01 1.09e-01 3.12e-01 8.50e-01 1.29e-01 2.54e-02 3.64e-01
METABOLISM OF NUCLEOTIDES 92 1.91e-06 1.72e-05 0.3650 -0.194000 0.162000 0.046200 2.53e-01 5.49e-02 1.33e-03 7.12e-03 4.44e-01 2.72e-05 3.64e-01
SURFACTANT METABOLISM 15 4.71e-01 5.58e-01 0.3640 -0.206000 -0.021500 -0.276000 -1.13e-01 -2.91e-02 1.67e-01 8.86e-01 6.44e-02 4.50e-01 8.45e-01
RAF ACTIVATION 34 6.17e-03 1.95e-02 0.3640 -0.078300 -0.219000 0.082600 -1.37e-01 2.30e-01 4.30e-01 2.73e-02 4.05e-01 1.66e-01 2.04e-02
BLOOD GROUP SYSTEMS BIOSYNTHESIS 12 3.24e-01 4.21e-01 0.3640 -0.094400 0.049300 -0.110000 4.05e-02 3.28e-01 5.71e-01 7.68e-01 5.10e-01 8.08e-01 4.94e-02
INTEGRIN SIGNALING 24 1.43e-01 2.29e-01 0.3640 -0.043300 -0.219000 -0.092500 -2.14e-01 1.68e-01 7.14e-01 6.32e-02 4.33e-01 7.00e-02 1.54e-01
TRANSCRIPTIONAL REGULATION OF GRANULOPOIESIS 42 1.27e-02 3.54e-02 0.3640 -0.205000 0.153000 -0.222000 3.75e-02 -1.27e-01 2.16e-02 8.67e-02 1.26e-02 6.74e-01 1.56e-01
PROCESSING OF CAPPED INTRONLESS PRE MRNA 28 3.07e-02 7.04e-02 0.3640 -0.156000 -0.048600 0.201000 1.35e-01 -2.17e-01 1.54e-01 6.56e-01 6.62e-02 2.17e-01 4.69e-02
THE NLRP3 INFLAMMASOME 15 4.33e-01 5.26e-01 0.3630 -0.126000 -0.006160 -0.312000 -9.52e-02 -9.93e-02 3.99e-01 9.67e-01 3.65e-02 5.23e-01 5.05e-01
ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK 28 3.88e-02 8.59e-02 0.3630 0.005690 0.041300 0.079600 1.46e-01 3.20e-01 9.58e-01 7.05e-01 4.66e-01 1.81e-01 3.35e-03
CELL CELL JUNCTION ORGANIZATION 46 1.76e-04 9.59e-04 0.3620 -0.196000 0.021400 -0.031300 -2.79e-01 1.18e-01 2.15e-02 8.02e-01 7.14e-01 1.07e-03 1.68e-01
RHOB GTPASE CYCLE 67 5.67e-04 2.71e-03 0.3620 0.134000 -0.085700 0.001200 -2.49e-01 2.10e-01 5.76e-02 2.25e-01 9.86e-01 4.30e-04 3.01e-03
RUNX3 REGULATES NOTCH SIGNALING 13 2.62e-01 3.60e-01 0.3620 0.127000 0.095400 -0.186000 -2.66e-01 2.41e-02 4.27e-01 5.52e-01 2.47e-01 9.70e-02 8.81e-01
PI 3K CASCADE FGFR2 14 3.61e-01 4.58e-01 0.3620 0.093800 -0.198000 -0.232000 -1.44e-01 9.18e-02 5.43e-01 2.00e-01 1.33e-01 3.51e-01 5.52e-01
DARPP 32 EVENTS 23 4.86e-02 1.02e-01 0.3620 -0.029200 -0.080100 0.215000 -6.54e-02 2.71e-01 8.08e-01 5.06e-01 7.47e-02 5.87e-01 2.46e-02
RAP1 SIGNALLING 15 4.14e-01 5.12e-01 0.3610 0.149000 -0.133000 0.144000 -1.02e-01 2.44e-01 3.18e-01 3.74e-01 3.33e-01 4.93e-01 1.02e-01
NUCLEOTIDE EXCISION REPAIR 109 1.20e-06 1.10e-05 0.3610 -0.091800 0.130000 0.130000 2.95e-01 -3.60e-02 9.80e-02 1.91e-02 1.93e-02 1.07e-07 5.17e-01
GLYCOGEN SYNTHESIS 14 3.62e-01 4.59e-01 0.3610 -0.252000 -0.056900 -0.224000 7.18e-02 9.07e-02 1.03e-01 7.12e-01 1.47e-01 6.42e-01 5.57e-01
ACTIVATION OF MATRIX METALLOPROTEINASES 14 1.20e-01 2.03e-01 0.3610 -0.067300 0.192000 0.017900 -2.95e-01 4.09e-02 6.63e-01 2.14e-01 9.08e-01 5.63e-02 7.91e-01
IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 20 1.43e-01 2.28e-01 0.3610 -0.086400 -0.184000 -0.291000 6.32e-02 -6.13e-03 5.03e-01 1.55e-01 2.42e-02 6.25e-01 9.62e-01
INACTIVATION OF CSF3 G CSF SIGNALING 24 1.62e-01 2.51e-01 0.3600 -0.237000 -0.138000 -0.213000 8.86e-02 -3.64e-02 4.45e-02 2.42e-01 7.08e-02 4.52e-01 7.57e-01
SIGNALING BY PDGFRA TRANSMEMBRANE JUXTAMEMBRANE AND KINASE DOMAIN MUTANTS 12 5.48e-01 6.29e-01 0.3600 0.053000 -0.255000 -0.125000 -1.75e-01 1.22e-01 7.50e-01 1.25e-01 4.55e-01 2.93e-01 4.63e-01
THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS 26 7.80e-02 1.46e-01 0.3590 -0.242000 -0.193000 0.026300 9.11e-02 -1.56e-01 3.30e-02 8.83e-02 8.17e-01 4.21e-01 1.68e-01
YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION 11 5.88e-01 6.61e-01 0.3590 0.137000 -0.065200 -0.076100 -2.77e-01 1.53e-01 4.30e-01 7.08e-01 6.62e-01 1.12e-01 3.79e-01
TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS 54 2.26e-03 8.72e-03 0.3590 0.175000 -0.257000 0.069700 -1.56e-01 5.60e-02 2.64e-02 1.11e-03 3.76e-01 4.70e-02 4.77e-01
NS1 MEDIATED EFFECTS ON HOST PATHWAYS 37 2.00e-02 5.04e-02 0.3590 0.029200 -0.255000 0.100000 -1.96e-01 1.20e-01 7.59e-01 7.36e-03 2.90e-01 3.88e-02 2.06e-01
DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY 23 1.49e-01 2.36e-01 0.3590 0.054900 -0.168000 0.116000 -2.87e-01 4.68e-02 6.49e-01 1.64e-01 3.37e-01 1.74e-02 6.98e-01
NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS 26 7.08e-02 1.35e-01 0.3590 -0.168000 -0.050100 0.077700 -5.31e-02 -2.98e-01 1.38e-01 6.58e-01 4.93e-01 6.39e-01 8.48e-03
DOWNSTREAM SIGNALING OF ACTIVATED FGFR3 19 1.56e-01 2.45e-01 0.3580 0.016000 -0.088900 -0.322000 -7.83e-02 1.01e-01 9.04e-01 5.02e-01 1.50e-02 5.55e-01 4.45e-01
CYTOSOLIC TRNA AMINOACYLATION 24 3.92e-02 8.63e-02 0.3580 -0.141000 0.015600 0.041700 2.47e-01 2.13e-01 2.32e-01 8.95e-01 7.24e-01 3.61e-02 7.13e-02
SUMOYLATION OF TRANSCRIPTION FACTORS 16 5.72e-01 6.48e-01 0.3570 -0.245000 -0.078800 -0.199000 -2.61e-02 -1.46e-01 8.97e-02 5.85e-01 1.69e-01 8.57e-01 3.14e-01
EPHB MEDIATED FORWARD SIGNALING 42 1.11e-02 3.17e-02 0.3570 -0.107000 -0.293000 0.064500 -1.33e-01 -8.96e-02 2.31e-01 1.01e-03 4.70e-01 1.37e-01 3.15e-01
TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS 10 5.88e-01 6.61e-01 0.3570 0.065600 -0.045500 -0.230000 -2.24e-01 1.32e-01 7.20e-01 8.03e-01 2.07e-01 2.19e-01 4.71e-01
TRANSFERRIN ENDOCYTOSIS AND RECYCLING 26 4.03e-02 8.78e-02 0.3560 0.017100 -0.008860 0.061800 2.51e-01 2.45e-01 8.80e-01 9.38e-01 5.85e-01 2.70e-02 3.07e-02
HEDGEHOG ON STATE 82 9.44e-06 7.02e-05 0.3560 -0.294000 -0.097500 -0.049700 1.58e-01 -5.95e-02 4.27e-06 1.27e-01 4.37e-01 1.37e-02 3.52e-01
POTASSIUM CHANNELS 89 4.99e-05 3.08e-04 0.3550 0.149000 -0.045700 0.235000 -1.15e-01 1.82e-01 1.54e-02 4.56e-01 1.27e-04 6.15e-02 3.01e-03
PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA 237 9.24e-16 3.67e-14 0.3550 -0.169000 -0.015900 0.063900 1.36e-01 -2.73e-01 7.43e-06 6.74e-01 9.08e-02 3.29e-04 5.27e-13
SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX 12 5.10e-01 5.96e-01 0.3540 0.242000 -0.004160 0.165000 1.97e-01 2.62e-02 1.46e-01 9.80e-01 3.21e-01 2.37e-01 8.75e-01
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE 13 5.25e-01 6.07e-01 0.3540 -0.141000 0.236000 0.079100 1.98e-01 -6.27e-02 3.79e-01 1.40e-01 6.21e-01 2.17e-01 6.95e-01
TRP CHANNELS 18 2.09e-01 3.02e-01 0.3530 0.317000 -0.053400 -0.037000 -8.09e-02 1.16e-01 1.98e-02 6.95e-01 7.86e-01 5.53e-01 3.95e-01
CIRCADIAN CLOCK 67 1.16e-03 4.95e-03 0.3530 0.050500 -0.237000 0.021900 -2.41e-01 8.53e-02 4.75e-01 8.01e-04 7.56e-01 6.36e-04 2.27e-01
RIP MEDIATED NFKB ACTIVATION VIA ZBP1 15 1.96e-01 2.88e-01 0.3530 0.101000 -0.126000 -0.299000 -2.58e-02 9.11e-02 4.99e-01 3.97e-01 4.48e-02 8.63e-01 5.41e-01
CDC42 GTPASE CYCLE 152 8.83e-09 1.24e-07 0.3530 0.132000 -0.112000 0.006080 -2.73e-01 1.40e-01 4.93e-03 1.72e-02 8.97e-01 6.24e-09 2.89e-03
INTERLEUKIN 12 FAMILY SIGNALING 42 1.14e-02 3.23e-02 0.3510 -0.193000 -0.015600 -0.097200 2.66e-01 -7.61e-02 3.08e-02 8.61e-01 2.76e-01 2.91e-03 3.94e-01
PHOSPHORYLATION OF THE APC C 17 2.95e-01 3.92e-01 0.3500 -0.223000 0.095000 0.091800 2.29e-01 -5.69e-02 1.12e-01 4.98e-01 5.12e-01 1.02e-01 6.84e-01
SIGNALING BY NTRK2 TRKB 23 1.99e-01 2.91e-01 0.3490 0.060600 -0.192000 0.094700 -2.64e-01 5.21e-02 6.15e-01 1.12e-01 4.32e-01 2.81e-02 6.66e-01
S PHASE 152 4.47e-10 7.36e-09 0.3480 -0.213000 0.075500 -0.000865 2.64e-01 -6.60e-03 5.72e-06 1.09e-01 9.85e-01 2.00e-08 8.88e-01
DISEASES OF IMMUNE SYSTEM 22 1.31e-01 2.14e-01 0.3480 -0.106000 -0.081000 -0.289000 -2.10e-03 1.39e-01 3.87e-01 5.11e-01 1.89e-02 9.86e-01 2.58e-01
EXTRA NUCLEAR ESTROGEN SIGNALING 65 7.65e-03 2.35e-02 0.3470 -0.205000 -0.187000 -0.124000 -1.52e-01 -7.05e-02 4.25e-03 9.18e-03 8.38e-02 3.45e-02 3.26e-01
E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS 48 1.74e-02 4.48e-02 0.3470 -0.229000 -0.027600 -0.165000 1.67e-01 -1.10e-01 6.07e-03 7.40e-01 4.81e-02 4.53e-02 1.89e-01
COPI MEDIATED ANTEROGRADE TRANSPORT 90 3.03e-06 2.55e-05 0.3460 0.007690 0.000491 0.239000 1.52e-01 1.99e-01 9.00e-01 9.94e-01 8.74e-05 1.30e-02 1.10e-03
SPRY REGULATION OF FGF SIGNALING 16 3.50e-01 4.48e-01 0.3460 0.081300 -0.023400 0.326000 7.76e-02 1.62e-02 5.73e-01 8.71e-01 2.38e-02 5.91e-01 9.11e-01
UPTAKE AND FUNCTION OF ANTHRAX TOXINS 11 5.56e-01 6.36e-01 0.3460 0.172000 -0.146000 -0.030800 -6.11e-02 2.53e-01 3.24e-01 4.00e-01 8.59e-01 7.26e-01 1.46e-01
PYRUVATE METABOLISM 27 1.28e-01 2.11e-01 0.3460 0.041500 0.164000 -0.021400 2.47e-01 1.72e-01 7.09e-01 1.40e-01 8.47e-01 2.64e-02 1.22e-01
SIGNALLING TO ERKS 31 2.02e-02 5.04e-02 0.3460 -0.019200 -0.234000 -0.052500 -4.42e-02 2.44e-01 8.53e-01 2.43e-02 6.13e-01 6.70e-01 1.85e-02
PROTEIN FOLDING 87 2.50e-06 2.15e-05 0.3450 -0.192000 -0.079200 0.082000 2.38e-01 -1.14e-01 2.03e-03 2.02e-01 1.87e-01 1.26e-04 6.66e-02
IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL 43 1.13e-02 3.21e-02 0.3450 -0.069500 0.057100 -0.200000 3.53e-02 -2.64e-01 4.31e-01 5.17e-01 2.36e-02 6.89e-01 2.77e-03
PHASE 2 PLATEAU PHASE 11 3.37e-01 4.34e-01 0.3430 0.147000 0.154000 0.085300 -2.10e-01 -1.45e-01 3.98e-01 3.77e-01 6.24e-01 2.29e-01 4.05e-01
GABA B RECEPTOR ACTIVATION 39 1.30e-02 3.60e-02 0.3430 -0.164000 -0.183000 0.040200 -2.34e-01 2.80e-02 7.56e-02 4.82e-02 6.64e-01 1.16e-02 7.62e-01
ION CHANNEL TRANSPORT 136 2.72e-06 2.32e-05 0.3430 0.226000 0.015100 0.095700 -6.46e-02 2.30e-01 5.37e-06 7.61e-01 5.42e-02 1.94e-01 3.87e-06
METALLOPROTEASE DUBS 26 1.76e-01 2.66e-01 0.3420 -0.235000 0.060100 -0.143000 1.86e-01 -5.03e-02 3.79e-02 5.96e-01 2.06e-01 9.99e-02 6.57e-01
MICRORNA MIRNA BIOGENESIS 24 1.20e-01 2.03e-01 0.3420 -0.065400 -0.142000 -0.008690 1.65e-01 -2.55e-01 5.79e-01 2.28e-01 9.41e-01 1.62e-01 3.08e-02
SIGNALING BY BRAF AND RAF FUSIONS 60 4.03e-03 1.38e-02 0.3410 0.062500 -0.231000 0.041800 -2.17e-01 9.80e-02 4.02e-01 1.94e-03 5.75e-01 3.64e-03 1.89e-01
CTLA4 INHIBITORY SIGNALING 20 1.68e-01 2.58e-01 0.3400 -0.142000 -0.201000 -0.031900 -1.39e-01 1.86e-01 2.72e-01 1.19e-01 8.05e-01 2.83e-01 1.49e-01
AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE 24 2.54e-01 3.53e-01 0.3400 0.161000 -0.004330 0.087600 -1.74e-01 2.27e-01 1.72e-01 9.71e-01 4.58e-01 1.40e-01 5.38e-02
PROTEIN UBIQUITINATION 67 2.25e-03 8.69e-03 0.3400 -0.268000 -0.047600 -0.146000 1.21e-01 -7.42e-02 1.48e-04 5.00e-01 3.89e-02 8.79e-02 2.94e-01
INTRA GOLGI TRAFFIC 43 1.79e-02 4.58e-02 0.3400 0.077800 -0.023800 0.143000 -4.35e-02 2.94e-01 3.77e-01 7.87e-01 1.04e-01 6.21e-01 8.59e-04
FCERI MEDIATED CA 2 MOBILIZATION 25 1.24e-01 2.07e-01 0.3390 -0.083100 -0.155000 -0.230000 -7.07e-02 1.61e-01 4.72e-01 1.80e-01 4.64e-02 5.40e-01 1.64e-01
DOWNSTREAM SIGNAL TRANSDUCTION 29 1.20e-01 2.03e-01 0.3390 0.090300 -0.195000 -0.015000 -1.69e-01 1.99e-01 4.00e-01 6.99e-02 8.89e-01 1.15e-01 6.33e-02
DCC MEDIATED ATTRACTIVE SIGNALING 14 2.81e-01 3.76e-01 0.3380 -0.186000 -0.137000 0.090800 -2.20e-01 6.69e-02 2.28e-01 3.76e-01 5.56e-01 1.54e-01 6.65e-01
REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS 12 5.95e-01 6.66e-01 0.3380 0.113000 -0.241000 -0.071900 -1.55e-01 1.20e-01 4.99e-01 1.49e-01 6.66e-01 3.53e-01 4.73e-01
ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS 32 9.40e-02 1.68e-01 0.3370 -0.167000 -0.105000 -0.029300 -2.05e-01 -1.78e-01 1.02e-01 3.03e-01 7.74e-01 4.49e-02 8.15e-02
FORMATION OF RNA POL II ELONGATION COMPLEX 57 2.27e-03 8.72e-03 0.3370 -0.082800 0.043600 0.165000 1.98e-01 -1.95e-01 2.80e-01 5.69e-01 3.12e-02 9.76e-03 1.08e-02
CLEC7A DECTIN 1 SIGNALING 93 5.02e-06 3.93e-05 0.3370 -0.188000 0.009090 -0.065800 2.71e-01 -2.16e-03 1.70e-03 8.80e-01 2.73e-01 6.44e-06 9.71e-01
MITOTIC G1 PHASE AND G1 S TRANSITION 139 5.59e-09 8.16e-08 0.3360 -0.202000 0.041000 -0.012500 2.65e-01 2.33e-03 3.91e-05 4.05e-01 7.99e-01 6.87e-08 9.62e-01
RNA POLYMERASE I TRANSCRIPTION 65 2.68e-03 1.00e-02 0.3360 -0.158000 0.074300 0.024000 2.30e-01 -1.70e-01 2.79e-02 3.00e-01 7.38e-01 1.33e-03 1.81e-02
CS DS DEGRADATION 14 2.56e-01 3.54e-01 0.3350 0.165000 0.132000 0.120000 -1.83e-01 -1.41e-01 2.85e-01 3.94e-01 4.38e-01 2.35e-01 3.60e-01
IRS MEDIATED SIGNALLING 35 5.75e-02 1.16e-01 0.3350 0.092000 -0.178000 -0.107000 -1.61e-01 1.87e-01 3.46e-01 6.90e-02 2.74e-01 9.97e-02 5.53e-02
SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP 59 7.78e-03 2.38e-02 0.3350 -0.207000 0.106000 -0.084900 1.96e-01 -1.12e-01 5.98e-03 1.58e-01 2.60e-01 9.19e-03 1.38e-01
DISEASES ASSOCIATED WITH N GLYCOSYLATION OF PROTEINS 17 1.34e-01 2.19e-01 0.3350 -0.078000 -0.131000 0.147000 1.97e-01 1.69e-01 5.78e-01 3.49e-01 2.93e-01 1.61e-01 2.28e-01
NR1H2 AND NR1H3 MEDIATED SIGNALING 38 2.60e-02 6.15e-02 0.3340 0.175000 -0.024500 -0.099600 -2.55e-01 7.55e-02 6.22e-02 7.94e-01 2.88e-01 6.60e-03 4.21e-01
NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION 20 1.71e-01 2.62e-01 0.3330 0.155000 0.119000 -0.082300 -2.31e-01 1.13e-01 2.30e-01 3.58e-01 5.24e-01 7.33e-02 3.82e-01
HOST INTERACTIONS OF HIV FACTORS 122 2.34e-08 3.03e-07 0.3330 -0.203000 -0.051200 0.032900 2.50e-01 -5.80e-02 1.10e-04 3.30e-01 5.30e-01 1.81e-06 2.69e-01
BIOLOGICAL OXIDATIONS 120 8.55e-06 6.44e-05 0.3330 -0.065800 0.227000 0.006760 2.29e-01 5.27e-02 2.14e-01 1.81e-05 8.98e-01 1.54e-05 3.19e-01
INSULIN RECEPTOR SIGNALLING CASCADE 40 4.19e-02 9.01e-02 0.3330 0.145000 -0.130000 -0.061300 -1.71e-01 1.99e-01 1.12e-01 1.55e-01 5.03e-01 6.09e-02 2.96e-02
L1CAM INTERACTIONS 107 2.50e-06 2.15e-05 0.3330 0.085800 -0.078000 0.176000 -2.26e-01 1.23e-01 1.25e-01 1.64e-01 1.62e-03 5.58e-05 2.84e-02
CELLULAR RESPONSE TO HEAT STRESS 94 7.43e-04 3.44e-03 0.3320 -0.145000 -0.204000 -0.075200 -1.86e-01 -8.87e-02 1.55e-02 6.37e-04 2.08e-01 1.89e-03 1.38e-01
GLUCAGON SIGNALING IN METABOLIC REGULATION 29 8.03e-02 1.49e-01 0.3320 -0.168000 -0.172000 0.063900 -2.03e-01 -8.56e-02 1.18e-01 1.10e-01 5.52e-01 5.82e-02 4.25e-01
REGULATION OF FOXO TRANSCRIPTIONAL ACTIVITY BY ACETYLATION 10 5.07e-01 5.94e-01 0.3320 0.054700 -0.241000 -0.142000 6.64e-03 1.70e-01 7.65e-01 1.87e-01 4.36e-01 9.71e-01 3.51e-01
RHOA GTPASE CYCLE 142 2.34e-07 2.54e-06 0.3320 0.075300 -0.109000 -0.069300 -2.47e-01 1.64e-01 1.22e-01 2.53e-02 1.55e-01 4.02e-07 7.55e-04
ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING 28 5.20e-02 1.07e-01 0.3320 -0.070600 -0.186000 0.176000 8.45e-02 -1.79e-01 5.18e-01 8.78e-02 1.07e-01 4.39e-01 1.01e-01
GLUCAGON TYPE LIGAND RECEPTORS 23 2.15e-01 3.10e-01 0.3320 -0.134000 -0.047700 0.051300 1.87e-01 -2.28e-01 2.65e-01 6.92e-01 6.71e-01 1.20e-01 5.84e-02
COBALAMIN CBL VITAMIN B12 TRANSPORT AND METABOLISM 13 2.55e-01 3.53e-01 0.3310 0.045000 -0.064700 -0.268000 1.75e-01 3.82e-02 7.79e-01 6.87e-01 9.46e-02 2.76e-01 8.11e-01
TRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL 43 3.39e-02 7.62e-02 0.3310 0.108000 0.092200 0.143000 2.52e-01 -7.32e-02 2.20e-01 2.96e-01 1.05e-01 4.26e-03 4.07e-01
TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER 43 3.93e-02 8.64e-02 0.3300 -0.068700 -0.156000 -0.022500 -2.79e-01 -3.89e-02 4.36e-01 7.60e-02 7.99e-01 1.55e-03 6.59e-01
TRANSMISSION ACROSS CHEMICAL SYNAPSES 235 6.80e-12 1.67e-10 0.3300 0.151000 -0.122000 0.138000 -1.76e-01 1.46e-01 6.89e-05 1.32e-03 2.79e-04 3.49e-06 1.17e-04
SIGNALING BY FLT3 ITD AND TKD MUTANTS 15 5.32e-01 6.14e-01 0.3300 0.108000 0.118000 0.011300 9.48e-02 2.72e-01 4.69e-01 4.27e-01 9.40e-01 5.25e-01 6.80e-02
TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN 20 4.14e-01 5.12e-01 0.3290 -0.062400 -0.233000 -0.003240 -2.18e-01 -5.09e-02 6.29e-01 7.13e-02 9.80e-01 9.12e-02 6.94e-01
CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE 19 2.79e-01 3.75e-01 0.3290 -0.142000 0.101000 0.083000 2.48e-01 9.91e-02 2.84e-01 4.46e-01 5.31e-01 6.17e-02 4.55e-01
CELL EXTRACELLULAR MATRIX INTERACTIONS 18 3.85e-01 4.82e-01 0.3290 -0.106000 0.000619 -0.293000 -1.04e-01 1.74e-02 4.38e-01 9.96e-01 3.15e-02 4.45e-01 8.98e-01
EXPORT OF VIRAL RIBONUCLEOPROTEINS FROM NUCLEUS 31 1.12e-01 1.93e-01 0.3280 0.065100 -0.234000 0.087000 -1.74e-01 1.01e-01 5.30e-01 2.39e-02 4.02e-01 9.34e-02 3.29e-01
REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS 13 4.39e-01 5.29e-01 0.3270 0.112000 0.041300 -0.159000 -2.56e-01 4.51e-02 4.83e-01 7.97e-01 3.20e-01 1.10e-01 7.78e-01
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX 18 2.20e-01 3.14e-01 0.3270 -0.153000 0.053500 -0.152000 7.90e-02 2.27e-01 2.60e-01 6.94e-01 2.64e-01 5.62e-01 9.58e-02
DOWNSTREAM SIGNALING OF ACTIVATED FGFR2 21 2.83e-01 3.79e-01 0.3270 0.016800 -0.197000 -0.228000 -1.12e-01 5.88e-02 8.94e-01 1.17e-01 7.04e-02 3.76e-01 6.41e-01
INTERLEUKIN 1 SIGNALING 93 1.12e-05 8.10e-05 0.3270 -0.127000 0.018500 -0.017800 3.00e-01 -2.33e-02 3.50e-02 7.59e-01 7.67e-01 5.98e-07 6.98e-01
COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES 58 2.18e-03 8.53e-03 0.3260 -0.113000 -0.067300 0.004040 -2.20e-01 -2.02e-01 1.38e-01 3.76e-01 9.58e-01 3.81e-03 7.68e-03
CELL JUNCTION ORGANIZATION 70 2.30e-04 1.21e-03 0.3260 -0.149000 -0.024500 -0.113000 -2.42e-01 1.10e-01 3.06e-02 7.23e-01 1.04e-01 4.77e-04 1.13e-01
TRANSCRIPTION OF THE HIV GENOME 67 2.07e-03 8.18e-03 0.3250 -0.149000 0.045200 0.068300 2.29e-01 -1.56e-01 3.51e-02 5.22e-01 3.34e-01 1.18e-03 2.68e-02
TRANSCRIPTIONAL REGULATION BY RUNX2 105 1.98e-05 1.33e-04 0.3250 -0.230000 -0.102000 -0.018800 1.36e-01 -1.54e-01 4.71e-05 6.98e-02 7.39e-01 1.64e-02 6.56e-03
AGGREPHAGY 34 6.54e-02 1.27e-01 0.3250 -0.084100 0.010700 0.119000 2.41e-01 -1.63e-01 3.96e-01 9.14e-01 2.31e-01 1.51e-02 1.01e-01
FORMATION OF THE BETA CATENIN TCF TRANSACTIVATING COMPLEX 44 4.73e-02 9.94e-02 0.3250 -0.158000 -0.036900 -0.130000 -1.83e-01 -1.70e-01 6.95e-02 6.72e-01 1.35e-01 3.62e-02 5.06e-02
NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION 58 1.02e-02 2.99e-02 0.3250 0.131000 -0.172000 0.099500 -1.98e-01 9.74e-02 8.38e-02 2.33e-02 1.90e-01 9.06e-03 2.00e-01
SIGNALING BY NODAL 15 5.60e-01 6.38e-01 0.3240 0.191000 -0.117000 -0.012000 -1.82e-01 1.47e-01 2.00e-01 4.35e-01 9.36e-01 2.22e-01 3.23e-01
RHOC GTPASE CYCLE 73 8.33e-04 3.76e-03 0.3230 0.039900 -0.049700 -0.133000 -2.48e-01 1.46e-01 5.56e-01 4.63e-01 4.95e-02 2.54e-04 3.08e-02
REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN 29 1.66e-01 2.56e-01 0.3230 0.130000 -0.176000 0.134000 -1.37e-01 1.39e-01 2.25e-01 1.01e-01 2.11e-01 2.01e-01 1.94e-01
INTERLEUKIN 37 SIGNALING 17 2.98e-01 3.94e-01 0.3230 0.118000 -0.102000 -0.250000 -1.30e-01 8.81e-03 4.00e-01 4.65e-01 7.40e-02 3.53e-01 9.50e-01
RND2 GTPASE CYCLE 38 1.60e-02 4.24e-02 0.3230 0.051500 0.005430 -0.031600 -3.11e-01 -6.24e-02 5.83e-01 9.54e-01 7.36e-01 9.21e-04 5.06e-01
METAL ION SLC TRANSPORTERS 23 2.89e-01 3.84e-01 0.3230 0.251000 -0.020000 0.028300 -1.65e-01 1.12e-01 3.73e-02 8.68e-01 8.15e-01 1.71e-01 3.52e-01
ERCC6 CSB AND EHMT2 G9A POSITIVELY REGULATE RRNA EXPRESSION 30 2.20e-01 3.14e-01 0.3220 -0.181000 0.046900 -0.137000 1.48e-01 -1.68e-01 8.58e-02 6.56e-01 1.93e-01 1.62e-01 1.11e-01
SIGNALING BY VEGF 100 4.80e-05 2.99e-04 0.3220 0.001420 -0.173000 -0.032400 -2.06e-01 1.75e-01 9.80e-01 2.85e-03 5.76e-01 3.83e-04 2.52e-03
ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3 10 8.20e-01 8.54e-01 0.3220 -0.136000 -0.204000 -0.153000 -1.41e-01 1.60e-02 4.58e-01 2.64e-01 4.01e-01 4.39e-01 9.30e-01
NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION 176 2.52e-09 3.92e-08 0.3220 0.083000 -0.155000 0.143000 -1.98e-01 1.15e-01 5.79e-02 3.89e-04 1.09e-03 6.20e-06 8.86e-03
SIGNALING BY NOTCH3 48 1.67e-02 4.36e-02 0.3210 -0.109000 -0.091300 0.002830 -1.80e-01 -2.25e-01 1.90e-01 2.74e-01 9.73e-01 3.11e-02 6.98e-03
G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA 23 1.22e-01 2.05e-01 0.3210 -0.158000 -0.214000 -0.012900 1.66e-01 -6.70e-02 1.90e-01 7.50e-02 9.15e-01 1.68e-01 5.78e-01
SMOOTH MUSCLE CONTRACTION 32 2.12e-02 5.24e-02 0.3210 0.217000 0.175000 -0.068600 1.15e-01 -8.57e-02 3.34e-02 8.67e-02 5.02e-01 2.60e-01 4.01e-01
SHC1 EVENTS IN ERBB2 SIGNALING 20 4.25e-01 5.20e-01 0.3210 0.004470 -0.126000 -0.182000 -2.21e-01 7.13e-02 9.72e-01 3.30e-01 1.59e-01 8.76e-02 5.81e-01
METABOLISM OF FOLATE AND PTERINES 15 5.38e-01 6.19e-01 0.3200 -0.075100 0.094800 0.034500 2.94e-01 -1.49e-02 6.15e-01 5.25e-01 8.17e-01 4.86e-02 9.20e-01
RHO GTPASES ACTIVATE PKNS 45 5.36e-02 1.08e-01 0.3200 -0.175000 0.093700 -0.142000 1.70e-01 -1.18e-01 4.21e-02 2.77e-01 1.00e-01 4.79e-02 1.70e-01
RHOQ GTPASE CYCLE 57 2.01e-02 5.04e-02 0.3200 0.061400 -0.164000 -0.095000 -2.46e-01 4.45e-02 4.23e-01 3.20e-02 2.15e-01 1.33e-03 5.61e-01
SIGNALING BY NOTCH1 75 3.06e-03 1.11e-02 0.3190 -0.076400 -0.158000 -0.035200 -2.46e-01 -9.87e-02 2.53e-01 1.82e-02 5.98e-01 2.37e-04 1.40e-01
NF KB IS ACTIVATED AND SIGNALS SURVIVAL 12 6.60e-01 7.14e-01 0.3190 -0.070600 0.099500 -0.082100 2.12e-01 -1.88e-01 6.72e-01 5.50e-01 6.22e-01 2.04e-01 2.60e-01
REGULATION OF INSULIN LIKE GROWTH FACTOR IGF TRANSPORT AND UPTAKE BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS 85 1.21e-05 8.69e-05 0.3180 0.168000 0.234000 -0.109000 7.06e-02 4.12e-02 7.59e-03 1.98e-04 8.28e-02 2.61e-01 5.12e-01
FGFR1 MUTANT RECEPTOR ACTIVATION 25 2.84e-01 3.79e-01 0.3180 0.051600 -0.109000 -0.121000 -2.62e-01 5.57e-02 6.55e-01 3.47e-01 2.94e-01 2.33e-02 6.30e-01
PHASE 4 RESTING MEMBRANE POTENTIAL 13 3.28e-01 4.25e-01 0.3180 -0.092600 0.049100 0.195000 -1.17e-01 1.95e-01 5.63e-01 7.59e-01 2.23e-01 4.64e-01 2.24e-01
SIGNALING BY NTRK3 TRKC 16 5.17e-01 6.03e-01 0.3170 0.009240 -0.208000 0.064000 -2.03e-01 -1.10e-01 9.49e-01 1.50e-01 6.58e-01 1.60e-01 4.46e-01
SIGNALING BY FGFR2 IN DISEASE 34 7.29e-02 1.38e-01 0.3170 -0.124000 -0.110000 -0.051900 1.96e-01 -1.80e-01 2.12e-01 2.67e-01 6.00e-01 4.82e-02 7.00e-02
SEMAPHORIN INTERACTIONS 64 1.14e-02 3.23e-02 0.3170 -0.003280 -0.197000 -0.020200 -2.23e-01 -1.09e-01 9.64e-01 6.53e-03 7.80e-01 2.09e-03 1.32e-01
HYALURONAN METABOLISM 15 3.61e-01 4.58e-01 0.3170 0.178000 0.165000 0.099400 -1.77e-01 -5.83e-03 2.31e-01 2.68e-01 5.05e-01 2.36e-01 9.69e-01
SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS 11 6.11e-01 6.78e-01 0.3170 0.120000 -0.237000 0.058900 -6.90e-02 -1.47e-01 4.91e-01 1.74e-01 7.35e-01 6.92e-01 3.99e-01
INTERLEUKIN 17 SIGNALING 66 7.12e-03 2.22e-02 0.3170 0.167000 -0.128000 0.032600 -1.61e-01 1.70e-01 1.87e-02 7.30e-02 6.47e-01 2.41e-02 1.67e-02
TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE 38 8.72e-02 1.59e-01 0.3160 -0.115000 0.095700 0.066200 2.54e-01 -9.14e-02 2.18e-01 3.08e-01 4.80e-01 6.72e-03 3.30e-01
METABOLISM OF PORPHYRINS 19 4.48e-01 5.39e-01 0.3160 0.082800 0.047000 0.153000 2.10e-01 1.52e-01 5.32e-01 7.23e-01 2.47e-01 1.13e-01 2.52e-01
CHROMOSOME MAINTENANCE 97 9.24e-05 5.38e-04 0.3160 -0.078100 0.068200 -0.056400 2.52e-01 -1.49e-01 1.84e-01 2.46e-01 3.37e-01 1.82e-05 1.13e-02
ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS 22 3.65e-01 4.61e-01 0.3150 0.166000 -0.095900 -0.026900 -1.85e-01 1.67e-01 1.79e-01 4.36e-01 8.27e-01 1.33e-01 1.75e-01
GLYCOSAMINOGLYCAN METABOLISM 113 1.02e-05 7.55e-05 0.3140 0.107000 0.159000 0.176000 -1.06e-01 1.41e-01 5.01e-02 3.61e-03 1.25e-03 5.20e-02 9.51e-03
FORMATION OF SENESCENCE ASSOCIATED HETEROCHROMATIN FOCI SAHF 14 3.48e-01 4.45e-01 0.3140 0.200000 0.219000 -0.077400 -6.77e-02 -2.68e-05 1.94e-01 1.56e-01 6.16e-01 6.61e-01 1.00e+00
INTERLEUKIN 4 AND INTERLEUKIN 13 SIGNALING 75 2.46e-03 9.38e-03 0.3130 -0.092300 -0.086700 -0.273000 -8.25e-02 2.73e-02 1.67e-01 1.95e-01 4.47e-05 2.17e-01 6.83e-01
INTERFERON SIGNALING 163 3.65e-06 3.00e-05 0.3130 -0.065300 -0.211000 -0.153000 -8.33e-02 -1.36e-01 1.51e-01 3.46e-06 7.37e-04 6.68e-02 2.76e-03
NEGATIVE REGULATION OF THE PI3K AKT NETWORK 88 4.84e-04 2.38e-03 0.3120 0.107000 -0.131000 -0.064700 -1.71e-01 1.88e-01 8.20e-02 3.43e-02 2.94e-01 5.48e-03 2.30e-03
TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES 37 1.07e-01 1.87e-01 0.3120 0.069900 0.149000 0.005200 2.37e-01 1.18e-01 4.62e-01 1.16e-01 9.56e-01 1.27e-02 2.13e-01
ACTIVATION OF AMPK DOWNSTREAM OF NMDARS 20 1.87e-01 2.77e-01 0.3120 -0.051000 -0.066400 0.198000 1.96e-01 1.12e-01 6.93e-01 6.07e-01 1.25e-01 1.28e-01 3.87e-01
HS GAG DEGRADATION 20 4.38e-01 5.29e-01 0.3120 0.156000 0.104000 0.206000 -9.99e-02 9.70e-02 2.28e-01 4.19e-01 1.10e-01 4.39e-01 4.53e-01
RET SIGNALING 35 1.22e-01 2.05e-01 0.3120 0.102000 -0.117000 0.093300 -2.36e-01 9.17e-02 2.96e-01 2.29e-01 3.40e-01 1.57e-02 3.48e-01
SIALIC ACID METABOLISM 32 1.73e-01 2.63e-01 0.3110 0.096600 0.174000 0.037200 -1.79e-02 2.36e-01 3.45e-01 8.87e-02 7.16e-01 8.61e-01 2.10e-02
SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS 41 3.45e-02 7.76e-02 0.3110 0.013400 -0.239000 0.082800 -1.32e-01 1.24e-01 8.82e-01 8.12e-03 3.59e-01 1.44e-01 1.71e-01
NONHOMOLOGOUS END JOINING NHEJ 41 1.68e-01 2.58e-01 0.3110 -0.147000 -0.082200 -0.201000 -7.96e-03 -1.67e-01 1.03e-01 3.62e-01 2.57e-02 9.30e-01 6.50e-02
REGULATED PROTEOLYSIS OF P75NTR 12 5.96e-01 6.66e-01 0.3100 -0.030900 -0.075100 -0.299000 -1.38e-02 1.48e-02 8.53e-01 6.53e-01 7.30e-02 9.34e-01 9.29e-01
ABC FAMILY PROTEINS MEDIATED TRANSPORT 92 2.60e-05 1.71e-04 0.3100 -0.190000 -0.012300 0.043600 2.39e-01 -2.33e-02 1.62e-03 8.39e-01 4.70e-01 7.49e-05 7.00e-01
A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS 26 2.71e-01 3.69e-01 0.3100 0.153000 0.192000 0.147000 -6.76e-02 9.64e-02 1.78e-01 8.98e-02 1.94e-01 5.51e-01 3.95e-01
LDL CLEARANCE 15 4.54e-01 5.42e-01 0.3100 -0.148000 -0.134000 -0.014500 -2.04e-01 1.20e-01 3.22e-01 3.68e-01 9.23e-01 1.72e-01 4.22e-01
SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER 59 1.67e-02 4.36e-02 0.3090 -0.069600 -0.121000 -0.041300 -2.06e-01 -1.79e-01 3.56e-01 1.09e-01 5.84e-01 6.34e-03 1.75e-02
TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES 11 5.00e-01 5.88e-01 0.3090 0.175000 -0.169000 -0.183000 -4.35e-02 -2.68e-02 3.15e-01 3.33e-01 2.92e-01 8.03e-01 8.78e-01
CELLULAR RESPONSES TO EXTERNAL STIMULI 593 8.78e-29 5.32e-27 0.3080 -0.175000 -0.020600 -0.040500 2.05e-01 -1.42e-01 4.24e-13 3.93e-01 9.40e-02 1.98e-17 4.00e-09
SHC1 EVENTS IN ERBB4 SIGNALING 12 6.54e-01 7.10e-01 0.3080 -0.070800 -0.032200 -0.238000 -1.27e-01 1.27e-01 6.71e-01 8.47e-01 1.54e-01 4.48e-01 4.45e-01
REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION 30 1.56e-01 2.45e-01 0.3080 0.185000 -0.158000 0.172000 -2.03e-02 7.39e-02 7.97e-02 1.34e-01 1.03e-01 8.48e-01 4.84e-01
IRE1ALPHA ACTIVATES CHAPERONES 49 2.72e-02 6.36e-02 0.3070 -0.062000 -0.269000 0.010700 -1.33e-01 2.68e-02 4.53e-01 1.15e-03 8.97e-01 1.07e-01 7.45e-01
POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION 26 1.80e-01 2.71e-01 0.3070 0.028600 -0.198000 0.046000 -1.08e-01 2.01e-01 8.01e-01 8.00e-02 6.85e-01 3.40e-01 7.64e-02
SIGNALING BY TGFB FAMILY MEMBERS 97 1.10e-03 4.71e-03 0.3070 -0.143000 -0.134000 -0.105000 -2.11e-01 -2.09e-02 1.51e-02 2.24e-02 7.46e-02 3.36e-04 7.22e-01
APOPTOTIC EXECUTION PHASE 43 1.04e-02 3.05e-02 0.3070 -0.063100 0.114000 -0.128000 -1.76e-01 1.73e-01 4.74e-01 1.95e-01 1.47e-01 4.58e-02 4.99e-02
SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R 40 5.77e-02 1.16e-01 0.3070 0.130000 -0.119000 -0.139000 -1.60e-01 1.34e-01 1.56e-01 1.93e-01 1.29e-01 7.92e-02 1.41e-01
FRS MEDIATED FGFR2 SIGNALING 16 3.39e-01 4.35e-01 0.3070 0.041400 -0.139000 -0.228000 -6.86e-03 1.45e-01 7.75e-01 3.35e-01 1.15e-01 9.62e-01 3.14e-01
NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS 18 2.31e-01 3.27e-01 0.3070 -0.129000 -0.172000 0.180000 1.02e-01 -6.93e-02 3.42e-01 2.06e-01 1.86e-01 4.54e-01 6.11e-01
NEGATIVE REGULATION OF FGFR1 SIGNALING 25 3.79e-01 4.76e-01 0.3060 0.182000 -0.030900 0.210000 5.11e-02 1.14e-01 1.16e-01 7.89e-01 6.90e-02 6.58e-01 3.22e-01
PEROXISOMAL PROTEIN IMPORT 58 5.42e-03 1.77e-02 0.3060 -0.047500 0.110000 -0.094800 2.53e-01 7.78e-02 5.31e-01 1.47e-01 2.12e-01 8.44e-04 3.05e-01
G ALPHA 12 13 SIGNALLING EVENTS 74 2.52e-03 9.59e-03 0.3060 0.062100 -0.131000 0.036700 -1.73e-01 2.02e-01 3.56e-01 5.10e-02 5.85e-01 9.91e-03 2.63e-03
N GLYCAN ANTENNAE ELONGATION 15 6.09e-01 6.77e-01 0.3050 -0.046100 -0.060700 -0.152000 -2.53e-01 1.60e-02 7.57e-01 6.84e-01 3.09e-01 8.93e-02 9.15e-01
DEREGULATED CDK5 TRIGGERS MULTIPLE NEURODEGENERATIVE PATHWAYS IN ALZHEIMER S DISEASE MODELS 19 5.46e-01 6.27e-01 0.3050 0.247000 0.063800 0.163000 -4.07e-03 3.77e-02 6.19e-02 6.30e-01 2.20e-01 9.75e-01 7.76e-01
OPIOID SIGNALLING 85 3.06e-04 1.57e-03 0.3050 0.037000 -0.157000 0.137000 -1.70e-01 1.38e-01 5.55e-01 1.25e-02 2.89e-02 6.72e-03 2.77e-02
VLDLR INTERNALISATION AND DEGRADATION 11 8.33e-01 8.63e-01 0.3040 0.143000 0.138000 0.170000 -2.62e-02 1.53e-01 4.12e-01 4.29e-01 3.30e-01 8.80e-01 3.79e-01
NUCLEAR ENVELOPE BREAKDOWN 48 6.18e-02 1.22e-01 0.3040 0.168000 -0.106000 0.152000 -9.15e-02 1.46e-01 4.43e-02 2.02e-01 6.88e-02 2.73e-01 8.03e-02
SIGNALING BY CSF3 G CSF 29 1.70e-01 2.60e-01 0.3030 -0.192000 -0.094000 -0.190000 9.79e-02 2.33e-02 7.35e-02 3.81e-01 7.62e-02 3.62e-01 8.28e-01
REGULATION OF FZD BY UBIQUITINATION 19 2.88e-01 3.83e-01 0.3030 -0.132000 0.096400 -0.172000 -1.42e-01 1.24e-01 3.18e-01 4.67e-01 1.95e-01 2.82e-01 3.50e-01
RECYCLING PATHWAY OF L1 40 8.78e-02 1.60e-01 0.3030 0.085500 0.030000 0.215000 -6.90e-02 1.80e-01 3.49e-01 7.43e-01 1.85e-02 4.51e-01 4.84e-02
ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON 15 6.30e-01 6.94e-01 0.3020 -0.111000 -0.173000 -0.187000 4.84e-02 -1.07e-01 4.57e-01 2.45e-01 2.09e-01 7.45e-01 4.75e-01
PI3K AKT SIGNALING IN CANCER 83 1.25e-03 5.20e-03 0.3020 0.150000 -0.097600 -0.078700 -1.72e-01 1.53e-01 1.83e-02 1.25e-01 2.15e-01 6.89e-03 1.59e-02
VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS 35 6.45e-02 1.27e-01 0.3020 -0.165000 -0.185000 0.070400 -1.54e-01 -2.97e-02 9.09e-02 5.84e-02 4.71e-01 1.15e-01 7.61e-01
NUCLEAR IMPORT OF REV PROTEIN 32 1.61e-01 2.50e-01 0.3010 0.117000 -0.189000 0.090500 -1.07e-01 1.47e-01 2.51e-01 6.41e-02 3.75e-01 2.95e-01 1.50e-01
P75NTR SIGNALS VIA NF KB 15 5.69e-01 6.45e-01 0.3010 -0.062300 0.027100 -0.129000 1.49e-01 -2.18e-01 6.76e-01 8.56e-01 3.88e-01 3.18e-01 1.44e-01
PROCESSING OF INTRONLESS PRE MRNAS 19 2.99e-01 3.95e-01 0.3010 0.018600 -0.132000 0.224000 -6.47e-02 -1.36e-01 8.88e-01 3.18e-01 9.15e-02 6.25e-01 3.03e-01
PRE NOTCH PROCESSING IN GOLGI 17 5.47e-01 6.28e-01 0.3010 0.081800 0.085500 0.041900 -5.33e-02 2.68e-01 5.59e-01 5.42e-01 7.65e-01 7.04e-01 5.55e-02
SUMOYLATION OF UBIQUITINYLATION PROTEINS 37 1.04e-01 1.82e-01 0.3000 0.079000 -0.189000 0.092200 -1.36e-01 1.46e-01 4.06e-01 4.66e-02 3.32e-01 1.53e-01 1.26e-01
PARASITE INFECTION 54 1.48e-02 3.96e-02 0.3000 0.042200 -0.141000 0.096900 -1.44e-01 1.96e-01 5.92e-01 7.40e-02 2.18e-01 6.67e-02 1.29e-02
NRIF SIGNALS CELL DEATH FROM THE NUCLEUS 16 5.96e-01 6.66e-01 0.3000 -0.143000 0.053000 -0.047300 2.33e-01 -1.01e-01 3.20e-01 7.14e-01 7.43e-01 1.07e-01 4.84e-01
SIGNALING BY ERBB4 56 6.65e-02 1.28e-01 0.3000 -0.150000 -0.045400 -0.208000 -1.15e-01 -9.45e-02 5.25e-02 5.57e-01 7.05e-03 1.38e-01 2.22e-01
BILE ACID AND BILE SALT METABOLISM 25 2.49e-01 3.47e-01 0.3000 0.120000 0.127000 -0.082700 -4.29e-02 2.25e-01 2.97e-01 2.71e-01 4.74e-01 7.11e-01 5.20e-02
ABERRANT REGULATION OF MITOTIC EXIT IN CANCER DUE TO RB1 DEFECTS 19 3.00e-01 3.95e-01 0.3000 -0.239000 0.131000 0.075200 9.76e-02 -2.17e-02 7.14e-02 3.25e-01 5.71e-01 4.62e-01 8.70e-01
SLC TRANSPORTER DISORDERS 64 1.49e-02 3.98e-02 0.3000 0.180000 -0.091500 0.038300 -9.39e-02 1.97e-01 1.30e-02 2.06e-01 5.96e-01 1.94e-01 6.46e-03
ARACHIDONIC ACID METABOLISM 37 6.75e-02 1.30e-01 0.2990 0.059400 0.140000 -0.087100 2.36e-01 5.53e-02 5.32e-01 1.40e-01 3.60e-01 1.31e-02 5.61e-01
POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE 25 2.69e-01 3.68e-01 0.2990 0.047500 0.060100 0.079300 2.54e-01 -1.11e-01 6.81e-01 6.03e-01 4.93e-01 2.77e-02 3.36e-01
TCR SIGNALING 98 3.55e-04 1.80e-03 0.2980 -0.162000 0.009010 -0.053800 2.21e-01 -1.05e-01 5.52e-03 8.78e-01 3.58e-01 1.61e-04 7.33e-02
DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE 41 6.10e-02 1.21e-01 0.2980 -0.100000 0.157000 -0.201000 1.09e-01 -4.44e-02 2.66e-01 8.20e-02 2.60e-02 2.28e-01 6.23e-01
APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS 32 6.04e-02 1.20e-01 0.2970 -0.097100 0.047300 -0.073200 -2.24e-01 1.45e-01 3.42e-01 6.43e-01 4.74e-01 2.81e-02 1.56e-01
CARDIAC CONDUCTION 102 1.48e-03 5.99e-03 0.2970 0.180000 -0.022800 0.125000 -1.26e-01 1.53e-01 1.69e-03 6.90e-01 2.90e-02 2.85e-02 7.46e-03
RHOD GTPASE CYCLE 49 1.77e-02 4.53e-02 0.2970 0.070800 -0.020400 0.061500 -2.77e-01 4.37e-02 3.91e-01 8.05e-01 4.57e-01 7.94e-04 5.97e-01
SIGNALING BY THE B CELL RECEPTOR BCR 103 1.08e-05 7.85e-05 0.2960 -0.190000 -0.088200 -0.026600 2.06e-01 -2.78e-02 8.89e-04 1.22e-01 6.41e-01 3.09e-04 6.27e-01
TRANSCRIPTIONAL REGULATION BY E2F6 34 2.64e-01 3.62e-01 0.2950 -0.128000 -0.219000 -0.079700 -1.27e-01 -2.33e-02 1.96e-01 2.75e-02 4.21e-01 2.01e-01 8.14e-01
TRANSPORT OF BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS 58 5.66e-03 1.84e-02 0.2950 0.201000 0.135000 -0.046000 -1.22e-01 1.05e-01 8.00e-03 7.44e-02 5.45e-01 1.09e-01 1.66e-01
ESTROGEN DEPENDENT GENE EXPRESSION 99 5.85e-03 1.89e-02 0.2950 -0.156000 -0.079100 -0.140000 -1.02e-01 -1.62e-01 7.41e-03 1.74e-01 1.59e-02 7.90e-02 5.50e-03
SLC MEDIATED TRANSMEMBRANE TRANSPORT 172 8.51e-07 8.24e-06 0.2950 0.165000 0.042000 0.014300 -1.26e-01 2.05e-01 1.98e-04 3.43e-01 7.47e-01 4.53e-03 3.72e-06
FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES 15 5.55e-01 6.35e-01 0.2940 0.087400 -0.144000 -0.037300 -7.41e-02 2.26e-01 5.58e-01 3.33e-01 8.03e-01 6.19e-01 1.29e-01
FANCONI ANEMIA PATHWAY 36 1.84e-01 2.74e-01 0.2940 0.180000 0.157000 0.057400 1.59e-01 2.78e-02 6.18e-02 1.03e-01 5.51e-01 9.84e-02 7.73e-01
DOWNSTREAM SIGNALING OF ACTIVATED FGFR1 24 4.03e-01 5.01e-01 0.2940 0.046100 -0.201000 -0.140000 -1.52e-01 3.34e-02 6.96e-01 8.81e-02 2.35e-01 1.99e-01 7.77e-01
CYTOSOLIC SULFONATION OF SMALL MOLECULES 15 6.98e-01 7.47e-01 0.2930 0.004630 0.144000 0.204000 1.38e-01 6.62e-02 9.75e-01 3.35e-01 1.72e-01 3.53e-01 6.57e-01
DEFECTS IN VITAMIN AND COFACTOR METABOLISM 20 4.36e-01 5.28e-01 0.2920 0.030600 0.199000 -0.088100 1.41e-01 1.32e-01 8.13e-01 1.24e-01 4.95e-01 2.75e-01 3.08e-01
LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS 19 4.40e-01 5.29e-01 0.2920 -0.165000 -0.142000 0.040000 -1.65e-01 -9.68e-02 2.13e-01 2.83e-01 7.63e-01 2.14e-01 4.65e-01
SPHINGOLIPID METABOLISM 78 2.68e-04 1.40e-03 0.2920 -0.024200 -0.011300 -0.090500 -8.32e-03 2.77e-01 7.12e-01 8.63e-01 1.67e-01 8.99e-01 2.44e-05
PEXOPHAGY 11 8.29e-01 8.61e-01 0.2920 0.032800 0.158000 0.103000 2.08e-01 -7.48e-02 8.51e-01 3.63e-01 5.56e-01 2.33e-01 6.67e-01
RND1 GTPASE CYCLE 37 1.24e-01 2.07e-01 0.2920 0.042000 -0.050800 -0.127000 -2.52e-01 3.42e-02 6.58e-01 5.93e-01 1.80e-01 8.04e-03 7.19e-01
NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS 23 2.85e-01 3.79e-01 0.2920 -0.144000 -0.005840 0.020700 -1.12e-01 -2.27e-01 2.31e-01 9.61e-01 8.63e-01 3.54e-01 6.00e-02
INFLAMMASOMES 19 4.51e-01 5.40e-01 0.2910 -0.062200 0.043200 -0.248000 -7.66e-02 -1.08e-01 6.39e-01 7.44e-01 6.17e-02 5.63e-01 4.15e-01
HIV INFECTION 218 1.24e-10 2.20e-09 0.2900 -0.161000 -0.003830 0.057800 2.23e-01 -7.34e-02 4.37e-05 9.22e-01 1.42e-01 1.49e-08 6.24e-02
CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE 72 9.02e-03 2.71e-02 0.2900 0.094500 -0.050400 0.043900 -1.72e-01 2.02e-01 1.66e-01 4.60e-01 5.20e-01 1.16e-02 3.05e-03
ONCOGENE INDUCED SENESCENCE 32 2.67e-01 3.65e-01 0.2890 -0.032900 -0.165000 -0.044800 -1.02e-01 -2.07e-01 7.48e-01 1.07e-01 6.61e-01 3.16e-01 4.24e-02
TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53 DEPENDENT APOPTOSIS REMAIN UNCERTAIN 12 7.95e-01 8.33e-01 0.2890 0.162000 0.081700 0.057400 1.53e-01 1.54e-01 3.31e-01 6.24e-01 7.31e-01 3.59e-01 3.55e-01
BUTYRATE RESPONSE FACTOR 1 BRF1 BINDS AND DESTABILIZES MRNA 16 4.21e-01 5.17e-01 0.2890 -0.154000 0.037200 0.171000 1.64e-01 4.51e-02 2.88e-01 7.97e-01 2.35e-01 2.56e-01 7.55e-01
SYNTHESIS OF BILE ACIDS AND BILE SALTS 22 4.79e-01 5.66e-01 0.2870 0.121000 0.097400 0.002570 -1.28e-02 2.41e-01 3.28e-01 4.29e-01 9.83e-01 9.17e-01 5.02e-02
DEPOLYMERISATION OF THE NUCLEAR LAMINA 13 8.13e-01 8.47e-01 0.2860 0.194000 -0.009890 0.133000 -9.06e-02 1.36e-01 2.26e-01 9.51e-01 4.08e-01 5.72e-01 3.97e-01
GLUTATHIONE SYNTHESIS AND RECYCLING 11 8.03e-01 8.39e-01 0.2860 -0.015800 0.146000 -0.011100 2.22e-01 1.04e-01 9.28e-01 4.01e-01 9.49e-01 2.02e-01 5.50e-01
COLLAGEN CHAIN TRIMERIZATION 36 6.04e-02 1.20e-01 0.2860 -0.000401 -0.031000 0.042100 -2.29e-01 -1.63e-01 9.97e-01 7.47e-01 6.62e-01 1.74e-02 8.98e-02
SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION 31 3.53e-01 4.50e-01 0.2860 -0.141000 -0.108000 -0.062400 -1.50e-01 -1.54e-01 1.73e-01 2.96e-01 5.48e-01 1.49e-01 1.38e-01
RAC2 GTPASE CYCLE 86 8.88e-04 3.95e-03 0.2850 0.061800 0.016900 -0.087500 -2.00e-01 1.72e-01 3.22e-01 7.87e-01 1.61e-01 1.34e-03 5.81e-03
REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS 12 6.47e-01 7.07e-01 0.2850 0.124000 -0.219000 0.033900 -1.99e-02 1.29e-01 4.58e-01 1.89e-01 8.39e-01 9.05e-01 4.39e-01
KERATAN SULFATE BIOSYNTHESIS 24 4.94e-01 5.81e-01 0.2850 0.056600 0.152000 0.071000 8.73e-02 2.06e-01 6.32e-01 1.97e-01 5.47e-01 4.59e-01 8.08e-02
BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS SPMS 11 6.14e-01 6.80e-01 0.2850 0.054200 -0.000370 -0.063000 2.66e-01 -5.95e-02 7.56e-01 9.98e-01 7.18e-01 1.26e-01 7.32e-01
SPHINGOLIPID DE NOVO BIOSYNTHESIS 41 5.15e-02 1.06e-01 0.2850 -0.058300 -0.066700 -0.202000 -3.97e-02 1.75e-01 5.19e-01 4.60e-01 2.52e-02 6.60e-01 5.19e-02
CLASS B 2 SECRETIN FAMILY RECEPTORS 63 5.73e-03 1.85e-02 0.2840 -0.242000 0.107000 -0.004110 2.23e-02 -1.02e-01 9.07e-04 1.44e-01 9.55e-01 7.60e-01 1.63e-01
PHOSPHOLIPID METABOLISM 184 2.78e-07 3.00e-06 0.2840 0.132000 -0.107000 0.032900 -7.96e-02 2.10e-01 1.99e-03 1.21e-02 4.42e-01 6.30e-02 9.62e-07
GLUCOSE METABOLISM 79 2.23e-03 8.69e-03 0.2830 0.028200 0.008260 0.174000 4.29e-02 2.17e-01 6.65e-01 8.99e-01 7.45e-03 5.10e-01 8.37e-04
LAMININ INTERACTIONS 27 1.92e-01 2.82e-01 0.2830 0.088300 0.019200 -0.105000 -2.47e-01 -3.90e-03 4.27e-01 8.63e-01 3.44e-01 2.64e-02 9.72e-01
NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX 32 1.60e-01 2.50e-01 0.2830 0.182000 -0.052600 -0.071600 -1.97e-01 1.93e-02 7.55e-02 6.07e-01 4.84e-01 5.35e-02 8.50e-01
TP53 REGULATES METABOLIC GENES 85 8.50e-04 3.81e-03 0.2830 -0.171000 -0.022100 -0.033700 2.19e-01 -3.48e-02 6.50e-03 7.25e-01 5.91e-01 4.79e-04 5.79e-01
NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION 48 1.21e-01 2.05e-01 0.2830 -0.052300 -0.143000 -0.042100 -2.16e-01 -9.13e-02 5.31e-01 8.62e-02 6.14e-01 9.74e-03 2.74e-01
PROCESSING AND ACTIVATION OF SUMO 10 8.21e-01 8.54e-01 0.2830 -0.116000 0.097200 0.025600 2.35e-01 3.48e-02 5.26e-01 5.94e-01 8.89e-01 1.99e-01 8.49e-01
TRISTETRAPROLIN TTP ZFP36 BINDS AND DESTABILIZES MRNA 16 4.71e-01 5.58e-01 0.2820 -0.136000 0.017300 0.123000 2.05e-01 6.29e-02 3.47e-01 9.05e-01 3.94e-01 1.56e-01 6.63e-01
SIGNALING BY NTRKS 126 1.34e-04 7.50e-04 0.2820 0.096600 -0.131000 0.098300 -1.67e-01 1.25e-01 6.15e-02 1.13e-02 5.70e-02 1.26e-03 1.54e-02
CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER 56 2.40e-02 5.79e-02 0.2820 0.118000 -0.037200 -0.128000 -1.81e-01 1.22e-01 1.27e-01 6.30e-01 9.68e-02 1.91e-02 1.15e-01
TOLL LIKE RECEPTOR 9 TLR9 CASCADE 89 3.38e-03 1.20e-02 0.2810 0.137000 -0.124000 -0.011400 -1.41e-01 1.59e-01 2.61e-02 4.38e-02 8.52e-01 2.18e-02 9.54e-03
POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION 60 3.34e-02 7.56e-02 0.2810 -0.120000 -0.015800 -0.010100 1.53e-01 -2.02e-01 1.08e-01 8.32e-01 8.93e-01 4.09e-02 6.72e-03
FATTY ACYL COA BIOSYNTHESIS 32 1.42e-01 2.28e-01 0.2810 -0.011800 0.106000 -0.084600 1.52e-02 2.45e-01 9.08e-01 2.98e-01 4.08e-01 8.81e-01 1.65e-02
SEPARATION OF SISTER CHROMATIDS 165 3.73e-08 4.52e-07 0.2800 -0.191000 -0.024900 0.018200 2.03e-01 -1.13e-02 2.39e-05 5.82e-01 6.87e-01 7.34e-06 8.02e-01
SELECTIVE AUTOPHAGY 71 2.25e-03 8.69e-03 0.2790 -0.060200 -0.025500 0.086500 2.56e-01 -2.22e-02 3.81e-01 7.10e-01 2.08e-01 1.92e-04 7.46e-01
PROLACTIN RECEPTOR SIGNALING 11 6.53e-01 7.10e-01 0.2790 -0.030700 0.116000 -0.031900 -1.82e-01 1.71e-01 8.60e-01 5.06e-01 8.55e-01 2.96e-01 3.26e-01
INTRAFLAGELLAR TRANSPORT 49 2.49e-02 5.94e-02 0.2780 -0.127000 0.168000 0.152000 8.60e-02 -4.73e-02 1.23e-01 4.16e-02 6.49e-02 2.98e-01 5.67e-01
PI 3K CASCADE FGFR1 14 6.43e-01 7.03e-01 0.2780 0.199000 -0.102000 -0.059500 -7.65e-02 1.35e-01 1.98e-01 5.08e-01 7.00e-01 6.20e-01 3.83e-01
C TYPE LECTIN RECEPTORS CLRS 110 5.00e-05 3.08e-04 0.2780 -0.171000 -0.042200 -0.079900 1.99e-01 -3.39e-03 1.91e-03 4.44e-01 1.48e-01 3.08e-04 9.51e-01
O LINKED GLYCOSYLATION OF MUCINS 40 9.00e-02 1.63e-01 0.2780 0.025300 0.067800 0.047800 -1.10e-01 2.40e-01 7.82e-01 4.58e-01 6.01e-01 2.30e-01 8.65e-03
CD28 CO STIMULATION 30 2.09e-01 3.02e-01 0.2780 0.022200 -0.198000 0.004880 -9.27e-02 1.69e-01 8.33e-01 6.04e-02 9.63e-01 3.80e-01 1.08e-01
NEGATIVE REGULATION OF MAPK PATHWAY 41 2.01e-02 5.04e-02 0.2780 -0.048900 -0.199000 0.120000 1.08e-02 1.43e-01 5.88e-01 2.73e-02 1.82e-01 9.05e-01 1.14e-01
METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION 15 6.06e-01 6.74e-01 0.2770 -0.113000 0.078300 -0.224000 5.05e-02 7.28e-02 4.49e-01 6.00e-01 1.33e-01 7.35e-01 6.26e-01
PECAM1 INTERACTIONS 12 7.90e-01 8.30e-01 0.2770 0.109000 -0.084000 -0.027000 -2.37e-01 3.14e-02 5.13e-01 6.15e-01 8.71e-01 1.55e-01 8.50e-01
RIPK1 MEDIATED REGULATED NECROSIS 25 5.32e-01 6.14e-01 0.2770 -0.175000 -0.020900 -0.172000 7.58e-02 -1.02e-01 1.29e-01 8.57e-01 1.37e-01 5.12e-01 3.79e-01
SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS 55 4.47e-02 9.48e-02 0.2770 0.067700 -0.218000 0.075700 -1.34e-01 2.97e-02 3.86e-01 5.17e-03 3.32e-01 8.66e-02 7.03e-01
RHOJ GTPASE CYCLE 54 5.19e-02 1.07e-01 0.2760 0.112000 -0.060300 -0.076500 -2.15e-01 9.05e-02 1.56e-01 4.44e-01 3.31e-01 6.26e-03 2.50e-01
PLATELET AGGREGATION PLUG FORMATION 31 2.33e-01 3.29e-01 0.2760 0.005310 -0.059400 -0.021000 -1.96e-01 1.84e-01 9.59e-01 5.67e-01 8.40e-01 5.91e-02 7.67e-02
GAP JUNCTION TRAFFICKING AND REGULATION 32 2.79e-01 3.75e-01 0.2760 -0.084900 0.210000 0.054700 1.40e-01 4.65e-02 4.06e-01 4.00e-02 5.92e-01 1.71e-01 6.49e-01
SYNTHESIS OF PA 28 2.99e-01 3.95e-01 0.2760 -0.054900 -0.176000 -0.031300 -1.49e-01 1.36e-01 6.15e-01 1.07e-01 7.75e-01 1.71e-01 2.12e-01
MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE 15 5.88e-01 6.61e-01 0.2750 0.119000 0.081800 0.047800 1.79e-01 -1.44e-01 4.25e-01 5.83e-01 7.49e-01 2.31e-01 3.34e-01
ER TO GOLGI ANTEROGRADE TRANSPORT 138 1.55e-05 1.09e-04 0.2750 0.024200 0.019500 0.165000 9.48e-02 1.96e-01 6.23e-01 6.93e-01 8.28e-04 5.48e-02 7.02e-05
SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI 18 3.26e-01 4.24e-01 0.2750 0.109000 -0.208000 0.075000 1.03e-01 -6.63e-02 4.24e-01 1.27e-01 5.82e-01 4.50e-01 6.26e-01
FCGAMMA RECEPTOR FCGR DEPENDENT PHAGOCYTOSIS 81 6.95e-03 2.17e-02 0.2750 0.076800 -0.141000 0.067100 -1.41e-01 1.59e-01 2.33e-01 2.85e-02 2.96e-01 2.84e-02 1.33e-02
ACTIVATION OF THE PRE REPLICATIVE COMPLEX 28 2.75e-01 3.73e-01 0.2750 -0.009110 0.089700 -0.013700 1.97e-01 1.68e-01 9.33e-01 4.11e-01 9.00e-01 7.09e-02 1.24e-01
CARNITINE METABOLISM 14 6.58e-01 7.13e-01 0.2740 0.140000 0.114000 -0.093900 -4.03e-04 1.84e-01 3.64e-01 4.62e-01 5.43e-01 9.98e-01 2.33e-01
SIGNAL TRANSDUCTION BY L1 21 3.85e-01 4.82e-01 0.2740 0.011300 -0.093400 0.141000 -2.16e-01 8.32e-03 9.29e-01 4.59e-01 2.64e-01 8.71e-02 9.47e-01
INTERLEUKIN 15 SIGNALING 13 6.34e-01 6.95e-01 0.2740 0.059400 0.049500 -0.006000 -2.54e-01 6.83e-02 7.11e-01 7.57e-01 9.70e-01 1.13e-01 6.70e-01
CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN 34 2.37e-01 3.35e-01 0.2730 -0.045800 0.162000 0.110000 1.16e-01 1.44e-01 6.44e-01 1.03e-01 2.68e-01 2.41e-01 1.46e-01
TBC RABGAPS 41 7.75e-02 1.45e-01 0.2720 0.015000 -0.037100 0.161000 -1.76e-02 2.15e-01 8.68e-01 6.81e-01 7.47e-02 8.46e-01 1.71e-02
NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY 40 1.78e-01 2.69e-01 0.2720 -0.000768 -0.100000 -0.032200 -2.41e-01 6.96e-02 9.93e-01 2.73e-01 7.25e-01 8.32e-03 4.47e-01
SUMOYLATION OF TRANSCRIPTION COFACTORS 42 1.32e-01 2.15e-01 0.2710 -0.029400 -0.144000 0.049900 -2.02e-01 -9.22e-02 7.41e-01 1.06e-01 5.76e-01 2.32e-02 3.02e-01
COLLAGEN DEGRADATION 47 8.34e-03 2.52e-02 0.2710 0.008080 0.099700 -0.015700 -2.02e-01 -1.50e-01 9.24e-01 2.37e-01 8.52e-01 1.67e-02 7.47e-02
TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 RBL1 AND P130 RBL2 IN COMPLEX WITH HDAC1 15 5.59e-01 6.38e-01 0.2710 -0.174000 -0.023100 -0.129000 -8.99e-03 1.61e-01 2.43e-01 8.77e-01 3.86e-01 9.52e-01 2.80e-01
GRB2 EVENTS IN ERBB2 SIGNALING 14 7.63e-01 8.08e-01 0.2710 -0.091900 -0.039400 -0.200000 -1.47e-01 4.21e-02 5.52e-01 7.98e-01 1.95e-01 3.41e-01 7.85e-01
HDACS DEACETYLATE HISTONES 44 1.81e-01 2.72e-01 0.2710 -0.094500 -0.075600 -0.127000 5.73e-02 -1.99e-01 2.78e-01 3.86e-01 1.47e-01 5.11e-01 2.28e-02
TELOMERE C STRAND SYNTHESIS INITIATION 13 6.39e-01 7.00e-01 0.2700 0.138000 0.021200 0.028200 2.29e-01 -2.01e-02 3.90e-01 8.95e-01 8.60e-01 1.53e-01 9.00e-01
PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS 12 6.30e-01 6.94e-01 0.2690 -0.131000 0.027800 -0.015200 9.97e-02 2.11e-01 4.33e-01 8.68e-01 9.28e-01 5.50e-01 2.06e-01
INWARDLY RECTIFYING K CHANNELS 31 7.02e-02 1.34e-01 0.2690 -0.187000 -0.152000 0.104000 1.56e-03 6.00e-02 7.21e-02 1.43e-01 3.15e-01 9.88e-01 5.63e-01
SHC MEDIATED CASCADE FGFR1 14 5.24e-01 6.07e-01 0.2690 0.064800 -0.117000 -0.096100 5.95e-02 2.04e-01 6.75e-01 4.50e-01 5.34e-01 7.00e-01 1.86e-01
UPTAKE AND ACTIONS OF BACTERIAL TOXINS 27 2.52e-01 3.51e-01 0.2690 0.115000 -0.194000 -0.008460 -2.96e-02 1.42e-01 3.00e-01 8.09e-02 9.39e-01 7.90e-01 2.01e-01
NOD1 2 SIGNALING PATHWAY 34 5.31e-02 1.08e-01 0.2690 0.131000 -0.194000 -0.124000 2.68e-02 2.99e-02 1.86e-01 4.98e-02 2.09e-01 7.87e-01 7.63e-01
GAP JUNCTION DEGRADATION 11 6.67e-01 7.20e-01 0.2680 -0.053700 0.187000 0.081300 -8.17e-02 1.44e-01 7.58e-01 2.82e-01 6.41e-01 6.39e-01 4.08e-01
AUTOPHAGY 137 4.61e-06 3.69e-05 0.2680 -0.024200 -0.000777 0.112000 2.26e-01 8.78e-02 6.25e-01 9.87e-01 2.37e-02 4.94e-06 7.64e-02
RMTS METHYLATE HISTONE ARGININES 42 1.08e-01 1.88e-01 0.2680 -0.111000 -0.088400 -0.031200 1.75e-01 -1.42e-01 2.15e-01 3.22e-01 7.26e-01 4.95e-02 1.10e-01
CELL CELL COMMUNICATION 101 8.15e-04 3.71e-03 0.2680 -0.022100 -0.053800 -0.041500 -2.41e-01 9.22e-02 7.01e-01 3.51e-01 4.72e-01 2.84e-05 1.10e-01
PROCESSING OF DNA DOUBLE STRAND BREAK ENDS 67 7.00e-02 1.34e-01 0.2680 -0.168000 -0.049800 -0.116000 8.76e-02 -1.40e-01 1.73e-02 4.81e-01 9.98e-02 2.15e-01 4.74e-02
GPVI MEDIATED ACTIVATION CASCADE 31 1.61e-01 2.50e-01 0.2680 -0.060400 -0.030600 -0.139000 -1.84e-02 2.18e-01 5.61e-01 7.68e-01 1.81e-01 8.59e-01 3.58e-02
ACYL CHAIN REMODELLING OF PS 14 6.24e-01 6.90e-01 0.2670 0.059700 -0.027400 0.234000 -7.27e-02 -8.52e-02 6.99e-01 8.59e-01 1.30e-01 6.38e-01 5.81e-01
TRANSCRIPTIONAL REGULATION BY RUNX3 93 7.96e-03 2.43e-02 0.2670 -0.185000 0.023100 -0.059200 1.46e-01 -1.09e-01 2.10e-03 7.00e-01 3.24e-01 1.53e-02 7.03e-02
REGULATION OF IFNG SIGNALING 13 4.59e-01 5.46e-01 0.2670 0.100000 -0.086100 -0.167000 1.37e-01 8.36e-02 5.31e-01 5.91e-01 2.96e-01 3.94e-01 6.02e-01
COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC 44 1.52e-02 4.05e-02 0.2670 -0.138000 -0.024300 0.109000 8.51e-02 1.80e-01 1.13e-01 7.80e-01 2.12e-01 3.29e-01 3.93e-02
PROCESSIVE SYNTHESIS ON THE LAGGING STRAND 15 5.90e-01 6.62e-01 0.2660 -0.064700 0.039400 -0.153000 1.97e-01 5.64e-02 6.64e-01 7.92e-01 3.05e-01 1.87e-01 7.05e-01
RHO GTPASES ACTIVATE CIT 18 3.79e-01 4.76e-01 0.2660 0.120000 0.054700 0.007380 1.57e-02 -2.30e-01 3.78e-01 6.88e-01 9.57e-01 9.08e-01 9.10e-02
HEDGEHOG OFF STATE 106 2.04e-04 1.10e-03 0.2660 -0.236000 -0.030800 0.025600 9.84e-02 -5.74e-02 2.62e-05 5.84e-01 6.49e-01 8.03e-02 3.08e-01
SIGNALING BY TGF BETA RECEPTOR COMPLEX 72 3.53e-02 7.88e-02 0.2650 -0.146000 -0.132000 -0.065700 -1.64e-01 -1.15e-02 3.19e-02 5.26e-02 3.36e-01 1.61e-02 8.67e-01
NGF STIMULATED TRANSCRIPTION 36 2.61e-01 3.59e-01 0.2650 0.092200 -0.138000 0.011300 -2.00e-01 -5.00e-02 3.38e-01 1.52e-01 9.07e-01 3.83e-02 6.04e-01
G PROTEIN BETA GAMMA SIGNALLING 30 1.29e-01 2.12e-01 0.2640 -0.130000 -0.163000 0.005310 1.62e-01 -9.60e-03 2.18e-01 1.22e-01 9.60e-01 1.24e-01 9.28e-01
RNA POLYMERASE I TRANSCRIPTION INITIATION 47 6.03e-02 1.20e-01 0.2640 -0.054800 -0.019900 0.167000 1.34e-01 -1.43e-01 5.16e-01 8.13e-01 4.72e-02 1.11e-01 9.06e-02
SENSORY PROCESSING OF SOUND BY OUTER HAIR CELLS OF THE COCHLEA 39 8.38e-02 1.55e-01 0.2640 0.097600 0.157000 -0.020700 -1.55e-01 1.06e-01 2.92e-01 9.06e-02 8.23e-01 9.40e-02 2.53e-01
TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM 79 2.88e-03 1.07e-02 0.2640 -0.097200 -0.115000 0.120000 3.65e-02 -1.77e-01 1.36e-01 7.86e-02 6.48e-02 5.76e-01 6.64e-03
SIGNALING BY SCF KIT 41 2.38e-01 3.35e-01 0.2630 0.003780 -0.177000 -0.101000 -1.45e-01 7.93e-02 9.67e-01 4.95e-02 2.65e-01 1.08e-01 3.80e-01
ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA 15 6.58e-01 7.13e-01 0.2620 -0.112000 0.048500 0.077700 2.11e-01 5.65e-02 4.51e-01 7.45e-01 6.02e-01 1.57e-01 7.05e-01
AQUAPORIN MEDIATED TRANSPORT 37 1.34e-01 2.18e-01 0.2610 -0.137000 -0.163000 0.062700 -1.37e-01 -3.93e-03 1.48e-01 8.60e-02 5.09e-01 1.48e-01 9.67e-01
DISEASES OF PROGRAMMED CELL DEATH 51 4.71e-02 9.94e-02 0.2610 -0.003050 0.101000 -0.124000 1.99e-01 -5.43e-02 9.70e-01 2.13e-01 1.25e-01 1.40e-02 5.02e-01
GROWTH HORMONE RECEPTOR SIGNALING 20 6.43e-01 7.03e-01 0.2600 0.086700 -0.121000 -0.039900 -2.09e-01 -1.30e-02 5.02e-01 3.49e-01 7.57e-01 1.05e-01 9.20e-01
SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS 62 6.51e-02 1.27e-01 0.2600 0.062800 0.029800 0.148000 1.25e-01 1.59e-01 3.92e-01 6.85e-01 4.46e-02 8.92e-02 3.06e-02
DOWNREGULATION OF ERBB2 SIGNALING 27 6.24e-01 6.90e-01 0.2600 -0.140000 -0.093300 -0.143000 9.83e-03 -1.36e-01 2.07e-01 4.01e-01 1.99e-01 9.30e-01 2.21e-01
RHO GTPASES ACTIVATE WASPS AND WAVES 36 2.00e-01 2.93e-01 0.2590 0.064400 -0.089300 0.200000 -2.91e-02 1.20e-01 5.04e-01 3.54e-01 3.81e-02 7.63e-01 2.14e-01
ELEVATION OF CYTOSOLIC CA2 LEVELS 14 7.83e-01 8.25e-01 0.2590 0.122000 0.127000 -0.023500 -1.55e-02 1.87e-01 4.29e-01 4.09e-01 8.79e-01 9.20e-01 2.25e-01
NEDDYLATION 214 2.77e-09 4.25e-08 0.2590 -0.080100 0.031600 0.101000 1.86e-01 1.21e-01 4.39e-02 4.26e-01 1.13e-02 2.73e-06 2.23e-03
TRANSCRIPTIONAL REGULATION BY VENTX 35 2.67e-01 3.65e-01 0.2580 -0.081800 -0.075000 -0.023500 -2.02e-01 -1.14e-01 4.02e-01 4.43e-01 8.10e-01 3.84e-02 2.45e-01
TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS 41 1.67e-01 2.57e-01 0.2580 0.089200 -0.125000 0.175000 -6.33e-02 9.32e-02 3.23e-01 1.67e-01 5.31e-02 4.83e-01 3.02e-01
MISMATCH REPAIR 14 7.01e-01 7.49e-01 0.2580 -0.208000 0.057100 -0.019100 1.37e-01 3.11e-02 1.78e-01 7.12e-01 9.01e-01 3.74e-01 8.40e-01
INTEGRATION OF ENERGY METABOLISM 96 3.25e-03 1.17e-02 0.2570 0.053000 -0.116000 0.125000 -1.60e-01 9.15e-02 3.70e-01 5.05e-02 3.44e-02 6.66e-03 1.22e-01
TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES 30 4.39e-01 5.29e-01 0.2570 0.065300 0.125000 0.010100 9.58e-02 1.91e-01 5.36e-01 2.35e-01 9.24e-01 3.64e-01 6.96e-02
G0 AND EARLY G1 24 3.51e-01 4.48e-01 0.2560 -0.122000 0.056000 -0.137000 3.90e-02 1.66e-01 3.03e-01 6.35e-01 2.45e-01 7.41e-01 1.60e-01
SENSORY PROCESSING OF SOUND 59 7.67e-02 1.44e-01 0.2560 0.142000 0.043400 0.116000 -1.45e-01 9.55e-02 5.99e-02 5.64e-01 1.24e-01 5.38e-02 2.05e-01
TNFR1 INDUCED PROAPOPTOTIC SIGNALING 12 8.47e-01 8.73e-01 0.2560 0.150000 -0.123000 -0.004520 -1.24e-01 1.11e-01 3.67e-01 4.59e-01 9.78e-01 4.58e-01 5.04e-01
CYCLIN D ASSOCIATED EVENTS IN G1 45 8.77e-02 1.60e-01 0.2560 -0.228000 0.078100 -0.055000 6.33e-02 2.63e-02 8.29e-03 3.65e-01 5.23e-01 4.63e-01 7.60e-01
CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM 48 1.16e-01 1.97e-01 0.2560 0.137000 0.140000 0.119000 -9.40e-02 6.14e-02 1.00e-01 9.26e-02 1.53e-01 2.60e-01 4.62e-01
RNA POLYMERASE III TRANSCRIPTION 41 1.18e-01 2.01e-01 0.2550 0.021000 -0.001380 0.066700 2.45e-01 -5.09e-03 8.16e-01 9.88e-01 4.60e-01 6.58e-03 9.55e-01
ADRENALINE NORADRENALINE INHIBITS INSULIN SECRETION 26 3.16e-01 4.12e-01 0.2540 -0.094800 -0.091000 0.120000 -9.35e-02 -1.55e-01 4.03e-01 4.22e-01 2.89e-01 4.09e-01 1.70e-01
ACYL CHAIN REMODELLING OF PG 10 7.46e-01 7.93e-01 0.2540 -0.100000 -0.117000 0.177000 -9.26e-02 -3.29e-02 5.84e-01 5.22e-01 3.34e-01 6.12e-01 8.57e-01
ROS AND RNS PRODUCTION IN PHAGOCYTES 29 2.64e-01 3.62e-01 0.2540 -0.042000 0.046000 -0.082700 2.16e-01 8.42e-02 6.95e-01 6.69e-01 4.41e-01 4.42e-02 4.33e-01
UNFOLDED PROTEIN RESPONSE UPR 84 4.42e-03 1.48e-02 0.2540 -0.120000 -0.222000 -0.011500 -2.39e-02 4.22e-03 5.78e-02 4.36e-04 8.56e-01 7.05e-01 9.47e-01
DOWNREGULATION OF ERBB2 ERBB3 SIGNALING 13 8.33e-01 8.63e-01 0.2540 -0.169000 -0.092000 -0.034900 9.77e-02 -1.28e-01 2.90e-01 5.66e-01 8.27e-01 5.42e-01 4.23e-01
HYALURONAN UPTAKE AND DEGRADATION 11 7.79e-01 8.22e-01 0.2540 0.136000 0.164000 0.051600 -1.23e-01 3.59e-02 4.35e-01 3.47e-01 7.67e-01 4.81e-01 8.37e-01
COPII MEDIATED VESICLE TRANSPORT 63 6.64e-02 1.28e-01 0.2530 0.075800 0.039700 0.063500 7.63e-02 2.17e-01 2.99e-01 5.86e-01 3.84e-01 2.95e-01 2.93e-03
ESR MEDIATED SIGNALING 160 2.07e-03 8.18e-03 0.2530 -0.150000 -0.113000 -0.108000 -9.31e-02 -9.29e-02 1.11e-03 1.37e-02 1.84e-02 4.23e-02 4.29e-02
PHASE I FUNCTIONALIZATION OF COMPOUNDS 57 1.28e-01 2.11e-01 0.2530 -0.011200 0.201000 0.011800 1.34e-01 7.30e-02 8.83e-01 8.67e-03 8.78e-01 7.94e-02 3.41e-01
TCF DEPENDENT SIGNALING IN RESPONSE TO WNT 173 4.58e-05 2.88e-04 0.2530 -0.227000 -0.039400 -0.092100 -2.64e-02 -4.23e-02 2.69e-07 3.72e-01 3.69e-02 5.50e-01 3.37e-01
CA2 PATHWAY 55 1.13e-01 1.94e-01 0.2530 0.006530 -0.083900 -0.051700 -2.29e-01 3.98e-02 9.33e-01 2.82e-01 5.07e-01 3.30e-03 6.10e-01
G2 M DNA DAMAGE CHECKPOINT 63 1.46e-01 2.32e-01 0.2530 -0.169000 -0.032600 -0.126000 6.24e-02 -1.20e-01 2.04e-02 6.55e-01 8.35e-02 3.92e-01 9.95e-02
INTERLEUKIN 1 FAMILY SIGNALING 118 1.15e-04 6.56e-04 0.2530 -0.082300 -0.003210 -0.053300 2.33e-01 3.08e-03 1.23e-01 9.52e-01 3.18e-01 1.28e-05 9.54e-01
E2F MEDIATED REGULATION OF DNA REPLICATION 19 5.04e-01 5.92e-01 0.2520 -0.196000 -0.026700 -0.097300 -1.20e-02 1.22e-01 1.39e-01 8.40e-01 4.63e-01 9.28e-01 3.59e-01
TRNA AMINOACYLATION 42 1.04e-01 1.82e-01 0.2520 -0.124000 0.063600 0.071600 1.65e-01 1.07e-01 1.63e-01 4.76e-01 4.22e-01 6.42e-02 2.30e-01
RNA POLYMERASE II TRANSCRIBES SNRNA GENES 74 1.25e-02 3.47e-02 0.2510 -0.070200 -0.159000 0.032700 7.40e-02 -1.63e-01 2.97e-01 1.84e-02 6.27e-01 2.72e-01 1.54e-02
ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS 17 5.77e-01 6.52e-01 0.2510 -0.231000 0.019400 0.030000 -2.16e-02 -8.92e-02 9.89e-02 8.90e-01 8.30e-01 8.78e-01 5.24e-01
SIGNALING BY FGFR1 42 2.78e-01 3.75e-01 0.2510 -0.006710 -0.195000 -0.006330 -1.56e-01 2.80e-02 9.40e-01 2.91e-02 9.43e-01 8.05e-02 7.54e-01
COLLAGEN FORMATION 74 1.12e-02 3.21e-02 0.2510 -0.083100 -0.047500 0.012800 -1.82e-01 -1.43e-01 2.17e-01 4.80e-01 8.49e-01 6.89e-03 3.30e-02
INTEGRIN CELL SURFACE INTERACTIONS 66 1.08e-02 3.13e-02 0.2510 0.017900 0.033400 -0.141000 -1.57e-01 -1.30e-01 8.01e-01 6.39e-01 4.80e-02 2.72e-02 6.87e-02
FRS MEDIATED FGFR1 SIGNALING 16 5.78e-01 6.52e-01 0.2510 0.133000 -0.055400 -0.076500 5.21e-02 1.83e-01 3.57e-01 7.01e-01 5.96e-01 7.18e-01 2.05e-01
POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS 56 6.06e-02 1.20e-01 0.2500 0.132000 0.060600 0.189000 -6.06e-02 -4.81e-02 8.74e-02 4.33e-01 1.46e-02 4.33e-01 5.33e-01
RHO GTPASE CYCLE 421 1.27e-12 3.32e-11 0.2500 0.029800 -0.083600 -0.046500 -2.22e-01 5.89e-02 2.97e-01 3.35e-03 1.03e-01 7.58e-15 3.90e-02
MEIOSIS 61 5.81e-02 1.16e-01 0.2490 -0.113000 0.173000 -0.087400 7.29e-02 -8.01e-02 1.27e-01 1.94e-02 2.38e-01 3.25e-01 2.79e-01
REGULATION OF TP53 ACTIVITY THROUGH METHYLATION 18 7.88e-01 8.29e-01 0.2490 -0.096800 -0.087800 -0.125000 2.48e-02 -1.70e-01 4.77e-01 5.19e-01 3.60e-01 8.56e-01 2.12e-01
EPHA MEDIATED GROWTH CONE COLLAPSE 27 2.71e-01 3.69e-01 0.2490 0.108000 -0.019700 -0.014800 -1.58e-01 -1.58e-01 3.33e-01 8.59e-01 8.94e-01 1.57e-01 1.56e-01
TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA 34 2.81e-01 3.76e-01 0.2490 0.069100 -0.166000 0.123000 -7.35e-02 9.39e-02 4.86e-01 9.40e-02 2.13e-01 4.59e-01 3.44e-01
INTERACTIONS OF REV WITH HOST CELLULAR PROTEINS 35 3.08e-01 4.03e-01 0.2490 0.068300 -0.173000 0.067400 -1.05e-01 1.08e-01 4.84e-01 7.69e-02 4.91e-01 2.83e-01 2.69e-01
MITOTIC METAPHASE AND ANAPHASE 205 2.51e-08 3.21e-07 0.2470 -0.166000 -0.021200 0.045300 1.76e-01 5.00e-03 4.49e-05 6.01e-01 2.65e-01 1.46e-05 9.02e-01
CARGO CONCENTRATION IN THE ER 29 4.05e-01 5.02e-01 0.2470 0.029100 -0.037200 -0.064000 -1.34e-01 1.91e-01 7.86e-01 7.29e-01 5.51e-01 2.13e-01 7.45e-02
RHO GTPASES ACTIVATE PAKS 21 4.19e-01 5.16e-01 0.2440 0.132000 -0.018300 0.052900 -5.56e-02 -1.90e-01 2.94e-01 8.85e-01 6.75e-01 6.59e-01 1.33e-01
NUCLEOBASE BIOSYNTHESIS 15 6.20e-01 6.86e-01 0.2440 -0.175000 0.061900 -0.019200 6.72e-02 1.43e-01 2.41e-01 6.78e-01 8.98e-01 6.52e-01 3.39e-01
MYD88 INDEPENDENT TLR4 CASCADE 91 1.06e-02 3.10e-02 0.2440 0.086300 -0.130000 -0.070500 -1.08e-01 1.36e-01 1.55e-01 3.28e-02 2.46e-01 7.45e-02 2.52e-02
ECM PROTEOGLYCANS 62 2.79e-02 6.48e-02 0.2430 0.210000 0.046700 0.006660 -1.12e-01 4.25e-05 4.22e-03 5.25e-01 9.28e-01 1.27e-01 1.00e+00
MEIOTIC SYNAPSIS 38 3.11e-01 4.06e-01 0.2430 -0.092300 0.140000 -0.083100 9.24e-02 -1.24e-01 3.25e-01 1.36e-01 3.75e-01 3.24e-01 1.87e-01
DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE 20 6.33e-01 6.95e-01 0.2430 0.096200 0.177000 0.096600 -6.20e-02 7.22e-02 4.56e-01 1.72e-01 4.54e-01 6.31e-01 5.76e-01
METABOLISM OF WATER SOLUBLE VITAMINS AND COFACTORS 100 1.88e-02 4.77e-02 0.2420 0.028300 0.134000 0.031500 1.39e-01 1.41e-01 6.25e-01 2.09e-02 5.86e-01 1.64e-02 1.51e-02
KERATAN SULFATE KERATIN METABOLISM 30 5.34e-01 6.15e-01 0.2420 0.021900 0.133000 0.086800 7.92e-02 1.64e-01 8.35e-01 2.07e-01 4.11e-01 4.53e-01 1.21e-01
SIGNALING BY INSULIN RECEPTOR 59 4.25e-02 9.09e-02 0.2420 0.067800 -0.112000 0.011800 -8.26e-03 2.04e-01 3.68e-01 1.39e-01 8.75e-01 9.13e-01 6.78e-03
DEFECTIVE EXT2 CAUSES EXOSTOSES 2 14 8.52e-01 8.77e-01 0.2420 0.082300 0.062500 0.174000 -3.88e-02 1.28e-01 5.94e-01 6.86e-01 2.61e-01 8.01e-01 4.06e-01
SUPPRESSION OF PHAGOSOMAL MATURATION 13 8.43e-01 8.71e-01 0.2420 -0.163000 -0.067900 -0.115000 1.11e-01 -4.29e-02 3.10e-01 6.72e-01 4.71e-01 4.87e-01 7.89e-01
TRANSCRIPTIONAL REGULATION BY RUNX1 174 4.39e-04 2.20e-03 0.2410 -0.143000 -0.103000 -0.037900 2.83e-02 -1.58e-01 1.13e-03 1.94e-02 3.89e-01 5.20e-01 3.34e-04
RHOG GTPASE CYCLE 73 2.21e-02 5.42e-02 0.2410 0.034000 0.017500 -0.097300 -1.00e-01 1.93e-01 6.16e-01 7.97e-01 1.51e-01 1.39e-01 4.40e-03
SIGNALING BY HEDGEHOG 141 1.54e-04 8.51e-04 0.2410 -0.221000 -0.082400 -0.010800 -1.72e-02 -4.70e-02 6.22e-06 9.14e-02 8.24e-01 7.24e-01 3.36e-01
TRNA PROCESSING 105 2.30e-03 8.80e-03 0.2400 0.028300 -0.018800 0.150000 1.82e-01 -2.07e-02 6.17e-01 7.40e-01 7.78e-03 1.26e-03 7.14e-01
G ALPHA Z SIGNALLING EVENTS 44 2.06e-01 3.01e-01 0.2390 -0.054900 -0.155000 0.062700 -1.56e-01 -4.34e-02 5.29e-01 7.47e-02 4.72e-01 7.32e-02 6.18e-01
TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES 61 6.74e-02 1.30e-01 0.2380 -0.064600 0.002010 0.108000 1.37e-01 -1.50e-01 3.83e-01 9.78e-01 1.46e-01 6.52e-02 4.31e-02
REGULATION OF TP53 EXPRESSION AND DEGRADATION 33 1.73e-01 2.63e-01 0.2380 0.059800 -0.175000 -0.074500 2.39e-02 1.28e-01 5.53e-01 8.13e-02 4.59e-01 8.12e-01 2.03e-01
SIGNALING BY ERBB2 47 3.82e-01 4.79e-01 0.2370 -0.105000 -0.167000 -0.095700 -7.80e-02 -4.61e-02 2.13e-01 4.73e-02 2.56e-01 3.55e-01 5.84e-01
GLYCOLYSIS 65 5.24e-02 1.07e-01 0.2370 0.047200 -0.058200 0.158000 -2.17e-02 1.59e-01 5.11e-01 4.17e-01 2.79e-02 7.63e-01 2.64e-02
SIGNALING BY EGFR 46 3.29e-01 4.27e-01 0.2360 -0.105000 -0.118000 -0.050700 -1.63e-01 -4.31e-02 2.19e-01 1.67e-01 5.52e-01 5.60e-02 6.13e-01
REGULATION OF BETA CELL DEVELOPMENT 24 6.26e-01 6.91e-01 0.2360 0.088600 -0.058700 -0.033500 -1.99e-01 6.15e-02 4.53e-01 6.19e-01 7.76e-01 9.14e-02 6.02e-01
EGR2 AND SOX10 MEDIATED INITIATION OF SCHWANN CELL MYELINATION 26 4.59e-01 5.47e-01 0.2360 0.008660 -0.014500 -0.037100 -2.32e-01 -8.59e-03 9.39e-01 8.98e-01 7.44e-01 4.05e-02 9.40e-01
KILLING MECHANISMS 10 8.81e-01 9.01e-01 0.2360 -0.009600 -0.087600 0.077400 -2.04e-01 4.81e-03 9.58e-01 6.32e-01 6.72e-01 2.63e-01 9.79e-01
TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING 13 8.40e-01 8.68e-01 0.2350 -0.062500 0.003410 -0.131000 1.34e-01 -1.28e-01 6.97e-01 9.83e-01 4.15e-01 4.03e-01 4.24e-01
CELL CYCLE CHECKPOINTS 235 9.81e-08 1.15e-06 0.2350 -0.165000 -0.034600 -0.025800 1.61e-01 -1.73e-02 1.42e-05 3.62e-01 4.97e-01 2.20e-05 6.49e-01
REPRODUCTION 70 8.48e-02 1.56e-01 0.2350 -0.145000 0.110000 -0.094000 6.37e-02 -9.49e-02 3.56e-02 1.12e-01 1.74e-01 3.57e-01 1.70e-01
CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY 22 4.60e-01 5.47e-01 0.2340 0.081400 -0.021900 -0.205000 -5.70e-02 5.11e-02 5.09e-01 8.59e-01 9.64e-02 6.44e-01 6.78e-01
MITOCHONDRIAL BIOGENESIS 92 3.04e-04 1.56e-03 0.2340 0.024700 -0.168000 0.035000 1.54e-01 -2.98e-02 6.83e-01 5.25e-03 5.62e-01 1.08e-02 6.21e-01
REGULATION OF INSULIN SECRETION 70 3.37e-02 7.60e-02 0.2340 0.025500 -0.101000 0.137000 -1.57e-01 2.07e-02 7.12e-01 1.43e-01 4.77e-02 2.32e-02 7.64e-01
METABOLISM OF CARBOHYDRATES 255 1.13e-06 1.05e-05 0.2340 0.032000 0.105000 0.115000 -7.27e-04 1.71e-01 3.80e-01 4.07e-03 1.56e-03 9.84e-01 2.60e-06
REGULATION OF KIT SIGNALING 16 8.09e-01 8.44e-01 0.2330 -0.054200 -0.175000 -0.027500 -1.26e-01 6.57e-02 7.07e-01 2.26e-01 8.49e-01 3.83e-01 6.49e-01
RHO GTPASES ACTIVATE ROCKS 19 5.07e-01 5.94e-01 0.2330 0.105000 0.032000 -0.007100 4.67e-02 -2.00e-01 4.27e-01 8.09e-01 9.57e-01 7.24e-01 1.31e-01
SIGNALING BY NOTCH 186 4.02e-04 2.02e-03 0.2320 -0.171000 -0.083500 -0.039400 3.48e-02 -1.22e-01 6.01e-05 4.98e-02 3.54e-01 4.14e-01 4.11e-03
PROGRAMMED CELL DEATH 182 2.49e-05 1.65e-04 0.2320 -0.131000 0.020600 -0.014500 1.89e-01 -1.04e-02 2.28e-03 6.33e-01 7.37e-01 1.14e-05 8.09e-01
INLB MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL 15 8.31e-01 8.62e-01 0.2310 -0.121000 -0.074900 0.026800 -1.72e-02 -1.79e-01 4.15e-01 6.15e-01 8.58e-01 9.08e-01 2.29e-01
DNA DAMAGE BYPASS 46 2.57e-01 3.54e-01 0.2310 -0.067700 0.066100 0.084600 1.93e-01 -1.02e-02 4.27e-01 4.38e-01 3.21e-01 2.38e-02 9.05e-01
INFECTIOUS DISEASE 711 1.29e-18 6.17e-17 0.2310 -0.153000 -0.035000 -0.016500 1.24e-01 -1.14e-01 5.29e-12 1.14e-01 4.55e-01 1.95e-08 2.93e-07
NON INTEGRIN MEMBRANE ECM INTERACTIONS 55 7.16e-02 1.36e-01 0.2300 0.119000 -0.005590 -0.046400 -1.87e-01 -4.22e-02 1.28e-01 9.43e-01 5.52e-01 1.68e-02 5.88e-01
PYRIMIDINE SALVAGE 10 8.70e-01 8.91e-01 0.2300 -0.127000 0.078400 0.087200 1.25e-01 8.43e-02 4.86e-01 6.68e-01 6.33e-01 4.93e-01 6.44e-01
RAB GEFS EXCHANGE GTP FOR GDP ON RABS 86 7.31e-03 2.26e-02 0.2290 -0.033200 -0.040100 0.005270 -7.61e-02 2.10e-01 5.95e-01 5.20e-01 9.33e-01 2.23e-01 7.65e-04
RAC3 GTPASE CYCLE 88 1.74e-02 4.48e-02 0.2290 0.060600 0.027900 0.002210 -1.72e-01 1.36e-01 3.26e-01 6.51e-01 9.71e-01 5.28e-03 2.74e-02
BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN 76 4.40e-02 9.34e-02 0.2290 0.038600 0.005120 0.114000 1.33e-01 1.41e-01 5.61e-01 9.39e-01 8.46e-02 4.46e-02 3.39e-02
SUMOYLATION OF SUMOYLATION PROTEINS 33 4.30e-01 5.24e-01 0.2280 0.055200 -0.151000 0.094900 -9.69e-02 8.95e-02 5.83e-01 1.35e-01 3.45e-01 3.35e-01 3.74e-01
CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE 49 4.00e-01 4.99e-01 0.2280 -0.137000 -0.140000 -0.075600 -6.09e-02 -6.57e-02 9.73e-02 9.05e-02 3.60e-01 4.61e-01 4.26e-01
SUMOYLATION OF RNA BINDING PROTEINS 45 2.43e-01 3.41e-01 0.2280 0.038300 -0.168000 0.098800 -1.08e-01 2.52e-02 6.57e-01 5.08e-02 2.52e-01 2.12e-01 7.70e-01
NUCLEAR SIGNALING BY ERBB4 30 3.91e-01 4.88e-01 0.2270 -0.085900 0.133000 -0.120000 -3.16e-02 -1.07e-01 4.16e-01 2.08e-01 2.57e-01 7.65e-01 3.11e-01
RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION 48 2.73e-01 3.71e-01 0.2270 -0.012100 -0.079800 -0.095500 -8.70e-02 -1.69e-01 8.85e-01 3.39e-01 2.53e-01 2.97e-01 4.34e-02
DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN METABOLISM 39 5.19e-01 6.03e-01 0.2270 0.110000 0.162000 0.055700 5.34e-02 8.51e-02 2.33e-01 8.03e-02 5.47e-01 5.64e-01 3.58e-01
PTEN REGULATION 132 8.06e-04 3.68e-03 0.2260 -0.140000 -0.109000 0.033400 9.04e-02 -1.01e-01 5.61e-03 3.03e-02 5.08e-01 7.31e-02 4.43e-02
DEADENYLATION OF MRNA 25 5.44e-01 6.25e-01 0.2260 0.054500 -0.108000 0.176000 -7.34e-02 2.39e-03 6.37e-01 3.48e-01 1.28e-01 5.26e-01 9.83e-01
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST 15 6.28e-01 6.93e-01 0.2250 -0.134000 -0.042600 0.027800 2.76e-02 1.72e-01 3.69e-01 7.75e-01 8.52e-01 8.53e-01 2.50e-01
G1 S SPECIFIC TRANSCRIPTION 25 4.54e-01 5.42e-01 0.2250 -0.045100 0.016000 -0.014600 1.02e-01 1.94e-01 6.96e-01 8.90e-01 8.99e-01 3.80e-01 9.30e-02
ALPHA PROTEIN KINASE 1 SIGNALING PATHWAY 11 7.62e-01 8.08e-01 0.2250 0.067200 -0.104000 -0.039700 1.54e-01 -9.95e-02 7.00e-01 5.52e-01 8.20e-01 3.76e-01 5.68e-01
TRANSCRIPTIONAL REGULATION BY THE AP 2 TFAP2 FAMILY OF TRANSCRIPTION FACTORS 28 3.31e-01 4.28e-01 0.2240 -0.064200 0.116000 -0.018000 -8.20e-02 -1.60e-01 5.57e-01 2.89e-01 8.69e-01 4.53e-01 1.43e-01
APOPTOSIS 161 2.18e-04 1.16e-03 0.2230 -0.138000 0.014000 -0.030300 1.72e-01 -2.72e-03 2.63e-03 7.60e-01 5.08e-01 1.64e-04 9.53e-01
DISEASES OF CARBOHYDRATE METABOLISM 29 4.15e-01 5.13e-01 0.2230 -0.080600 0.171000 0.095100 3.84e-02 5.93e-02 4.53e-01 1.11e-01 3.76e-01 7.21e-01 5.80e-01
INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS 34 4.73e-01 5.60e-01 0.2230 0.101000 -0.099300 0.072000 -4.26e-02 1.50e-01 3.07e-01 3.16e-01 4.68e-01 6.68e-01 1.30e-01
IRON UPTAKE AND TRANSPORT 52 1.38e-01 2.23e-01 0.2230 -0.080300 0.055600 -0.052200 1.72e-01 8.80e-02 3.17e-01 4.88e-01 5.15e-01 3.18e-02 2.72e-01
SIGNALING BY FGFR2 60 1.26e-01 2.09e-01 0.2230 -0.069100 -0.079500 0.019900 9.33e-02 -1.72e-01 3.55e-01 2.87e-01 7.90e-01 2.12e-01 2.16e-02
CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE 31 5.66e-01 6.43e-01 0.2230 0.162000 0.127000 0.020300 5.25e-02 6.38e-02 1.19e-01 2.20e-01 8.45e-01 6.13e-01 5.39e-01
PEPTIDE LIGAND BINDING RECEPTORS 84 5.31e-03 1.74e-02 0.2230 -0.095200 0.096000 -0.005220 -9.07e-02 -1.52e-01 1.32e-01 1.29e-01 9.34e-01 1.51e-01 1.63e-02
RESOLUTION OF D LOOP STRUCTURES THROUGH SYNTHESIS DEPENDENT STRAND ANNEALING SDSA 24 4.89e-01 5.77e-01 0.2230 0.048200 0.022800 -0.154000 -1.28e-01 -8.09e-02 6.83e-01 8.47e-01 1.91e-01 2.78e-01 4.93e-01
MUSCLE CONTRACTION 150 3.06e-03 1.11e-02 0.2230 0.191000 0.006950 0.091400 -5.32e-02 4.19e-02 5.39e-05 8.83e-01 5.36e-02 2.61e-01 3.76e-01
DISEASES OF MITOTIC CELL CYCLE 37 2.81e-01 3.76e-01 0.2230 -0.186000 0.043800 0.054400 3.60e-02 -9.32e-02 5.00e-02 6.45e-01 5.67e-01 7.05e-01 3.27e-01
RAB REGULATION OF TRAFFICKING 115 1.33e-03 5.47e-03 0.2220 -0.016400 -0.038000 0.060800 -5.37e-02 2.03e-01 7.62e-01 4.82e-01 2.60e-01 3.20e-01 1.73e-04
INITIATION OF NUCLEAR ENVELOPE NE REFORMATION 16 7.65e-01 8.09e-01 0.2220 -0.103000 0.114000 0.125000 9.88e-02 2.29e-02 4.75e-01 4.32e-01 3.88e-01 4.94e-01 8.74e-01
THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS 24 3.56e-01 4.54e-01 0.2220 -0.151000 -0.120000 0.088200 2.30e-02 6.25e-02 2.02e-01 3.10e-01 4.54e-01 8.46e-01 5.96e-01
ACYL CHAIN REMODELLING OF PC 16 6.93e-01 7.43e-01 0.2220 -0.120000 -0.091900 0.113000 -8.67e-02 -7.70e-02 4.06e-01 5.25e-01 4.34e-01 5.48e-01 5.94e-01
FC EPSILON RECEPTOR FCERI SIGNALING 122 1.07e-03 4.64e-03 0.2210 -0.157000 -0.083500 -0.045900 1.23e-01 7.69e-04 2.74e-03 1.12e-01 3.82e-01 1.90e-02 9.88e-01
MITOTIC G2 G2 M PHASES 182 4.64e-05 2.91e-04 0.2210 -0.125000 0.012400 0.059300 1.69e-01 -3.14e-02 3.67e-03 7.74e-01 1.68e-01 8.50e-05 4.66e-01
RETROGRADE TRANSPORT AT THE TRANS GOLGI NETWORK 48 1.88e-01 2.77e-01 0.2210 0.011100 -0.011200 0.121000 2.86e-02 1.82e-01 8.95e-01 8.94e-01 1.46e-01 7.32e-01 2.93e-02
TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION 166 1.32e-04 7.41e-04 0.2210 0.006790 0.009890 0.114000 2.83e-02 1.87e-01 8.80e-01 8.26e-01 1.17e-02 5.30e-01 3.28e-05
DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING 26 6.81e-01 7.33e-01 0.2200 -0.195000 -0.040100 -0.072000 -3.84e-02 -4.94e-02 8.60e-02 7.23e-01 5.25e-01 7.34e-01 6.63e-01
ANTIVIRAL MECHANISM BY IFN STIMULATED GENES 74 4.38e-02 9.33e-02 0.2200 -0.049600 -0.201000 0.037300 -6.10e-02 2.15e-02 4.61e-01 2.80e-03 5.80e-01 3.65e-01 7.49e-01
WNT LIGAND BIOGENESIS AND TRAFFICKING 18 6.52e-01 7.10e-01 0.2200 -0.163000 -0.125000 -0.029600 1.32e-02 7.18e-02 2.31e-01 3.60e-01 8.28e-01 9.23e-01 5.98e-01
VIRAL MESSENGER RNA SYNTHESIS 42 1.73e-01 2.63e-01 0.2200 0.030800 -0.110000 0.148000 1.12e-01 -2.93e-02 7.30e-01 2.17e-01 9.77e-02 2.10e-01 7.43e-01
CHROMATIN MODIFYING ENZYMES 216 7.62e-05 4.50e-04 0.2190 0.058100 -0.167000 0.025500 -1.19e-01 -4.21e-02 1.42e-01 2.38e-05 5.19e-01 2.59e-03 2.87e-01
P75 NTR RECEPTOR MEDIATED SIGNALLING 93 5.08e-02 1.05e-01 0.2190 0.079300 -0.068200 0.033700 -1.16e-01 1.50e-01 1.87e-01 2.56e-01 5.74e-01 5.42e-02 1.27e-02
OXIDATIVE STRESS INDUCED SENESCENCE 76 1.68e-01 2.58e-01 0.2190 -0.104000 -0.131000 -0.046800 -9.80e-03 -1.33e-01 1.16e-01 4.93e-02 4.81e-01 8.83e-01 4.58e-02
TNF RECEPTOR SUPERFAMILY TNFSF MEMBERS MEDIATING NON CANONICAL NF KB PATHWAY 11 9.29e-01 9.39e-01 0.2180 -0.168000 -0.105000 -0.081200 2.89e-02 -2.41e-02 3.34e-01 5.46e-01 6.41e-01 8.68e-01 8.90e-01
NEUTROPHIL DEGRANULATION 378 7.04e-11 1.31e-09 0.2180 -0.104000 -0.006310 -0.135000 1.33e-01 2.21e-02 5.52e-04 8.34e-01 6.56e-06 9.62e-06 4.61e-01
TRIGLYCERIDE METABOLISM 22 5.53e-01 6.33e-01 0.2160 -0.105000 -0.018900 -0.076000 1.39e-01 1.01e-01 3.93e-01 8.78e-01 5.37e-01 2.58e-01 4.11e-01
TOLL LIKE RECEPTOR TLR1 TLR2 CASCADE 90 4.72e-02 9.94e-02 0.2160 0.079700 -0.083100 -0.018400 -9.16e-02 1.58e-01 1.92e-01 1.73e-01 7.63e-01 1.33e-01 9.81e-03
CLASS A 1 RHODOPSIN LIKE RECEPTORS 150 1.08e-05 7.85e-05 0.2160 -0.046800 0.049200 0.017400 -1.91e-01 -7.44e-02 3.23e-01 2.99e-01 7.14e-01 5.73e-05 1.16e-01
IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX 10 9.29e-01 9.39e-01 0.2160 0.026700 0.101000 -0.018800 1.65e-01 -9.10e-02 8.84e-01 5.81e-01 9.18e-01 3.67e-01 6.18e-01
OTHER INTERLEUKIN SIGNALING 19 6.77e-01 7.29e-01 0.2160 0.086700 -0.190000 0.028800 -1.25e-02 4.57e-02 5.13e-01 1.52e-01 8.28e-01 9.25e-01 7.30e-01
BASIGIN INTERACTIONS 22 6.33e-01 6.95e-01 0.2150 -0.136000 0.135000 -0.095900 -1.21e-02 8.71e-04 2.69e-01 2.72e-01 4.36e-01 9.22e-01 9.94e-01
MAP2K AND MAPK ACTIVATION 36 3.64e-01 4.61e-01 0.2150 -0.104000 -0.177000 0.001510 -5.02e-02 3.90e-02 2.81e-01 6.60e-02 9.88e-01 6.02e-01 6.86e-01
EPH EPHRIN MEDIATED REPULSION OF CELLS 49 1.40e-01 2.25e-01 0.2140 -0.012100 -0.045300 0.114000 -1.73e-01 2.48e-02 8.83e-01 5.83e-01 1.69e-01 3.62e-02 7.64e-01
ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS 32 4.03e-01 5.01e-01 0.2130 -0.048500 0.037700 -0.124000 1.51e-01 5.82e-02 6.35e-01 7.12e-01 2.23e-01 1.39e-01 5.69e-01
MATURATION OF SARS COV 2 SPIKE PROTEIN 29 5.18e-01 6.03e-01 0.2130 -0.071100 -0.157000 -0.013500 -7.98e-02 9.59e-02 5.08e-01 1.44e-01 9.00e-01 4.57e-01 3.71e-01
G ALPHA S SIGNALLING EVENTS 94 1.88e-02 4.77e-02 0.2120 0.071700 -0.020600 0.117000 -1.61e-01 2.65e-03 2.30e-01 7.30e-01 5.04e-02 7.12e-03 9.65e-01
TELOMERE C STRAND LAGGING STRAND SYNTHESIS 33 5.16e-01 6.02e-01 0.2110 0.040100 0.062900 0.018000 1.92e-01 -4.38e-02 6.90e-01 5.32e-01 8.58e-01 5.70e-02 6.63e-01
SIGNALING BY NOTCH2 33 3.17e-01 4.13e-01 0.2110 -0.075500 0.040800 0.003380 -1.48e-01 -1.23e-01 4.53e-01 6.85e-01 9.73e-01 1.42e-01 2.21e-01
SNRNP ASSEMBLY 51 1.50e-01 2.38e-01 0.2100 -0.066800 -0.055600 0.123000 1.34e-01 -5.95e-02 4.09e-01 4.92e-01 1.29e-01 9.79e-02 4.63e-01
THE PHOTOTRANSDUCTION CASCADE 18 7.86e-01 8.28e-01 0.2100 0.123000 -0.030300 0.149000 1.83e-02 -7.41e-02 3.65e-01 8.24e-01 2.75e-01 8.93e-01 5.86e-01
PLATELET HOMEOSTASIS 77 1.57e-01 2.46e-01 0.2100 0.114000 -0.071500 0.091700 -1.06e-01 7.87e-02 8.32e-02 2.79e-01 1.65e-01 1.09e-01 2.33e-01
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST 12 7.98e-01 8.35e-01 0.2090 -0.119000 -0.005810 0.041100 3.71e-02 1.63e-01 4.76e-01 9.72e-01 8.05e-01 8.24e-01 3.28e-01
TRANSLOCATION OF SLC2A4 GLUT4 TO THE PLASMA MEMBRANE 63 2.95e-02 6.81e-02 0.2080 -0.041400 -0.121000 0.085600 7.32e-02 1.20e-01 5.70e-01 9.71e-02 2.40e-01 3.16e-01 9.90e-02
NEGATIVE REGULATION OF FGFR2 SIGNALING 25 7.05e-01 7.52e-01 0.2080 0.123000 -0.084500 0.113000 1.33e-02 9.05e-02 2.88e-01 4.65e-01 3.26e-01 9.08e-01 4.34e-01
SUMOYLATION OF DNA REPLICATION PROTEINS 43 2.43e-01 3.41e-01 0.2080 -0.021800 -0.142000 0.082400 -6.32e-02 1.09e-01 8.05e-01 1.07e-01 3.50e-01 4.73e-01 2.16e-01
RAB GERANYLGERANYLATION 57 1.20e-01 2.03e-01 0.2080 -0.090000 0.026300 0.019000 1.55e-01 1.00e-01 2.40e-01 7.32e-01 8.04e-01 4.26e-02 1.92e-01
METABOLISM OF VITAMINS AND COFACTORS 147 1.10e-02 3.15e-02 0.2080 0.016500 0.132000 -0.002480 1.40e-01 7.60e-02 7.31e-01 5.70e-03 9.59e-01 3.43e-03 1.12e-01
DEGRADATION OF THE EXTRACELLULAR MATRIX 101 4.78e-03 1.59e-02 0.2080 0.107000 0.090900 0.031500 -1.50e-01 -4.98e-03 6.32e-02 1.15e-01 5.85e-01 9.43e-03 9.31e-01
FOXO MEDIATED TRANSCRIPTION OF OXIDATIVE STRESS METABOLIC AND NEURONAL GENES 23 7.01e-01 7.49e-01 0.2070 0.105000 -0.076000 -0.038700 -1.46e-01 -5.72e-02 3.85e-01 5.28e-01 7.48e-01 2.24e-01 6.35e-01
MET ACTIVATES PTK2 SIGNALING 28 4.31e-01 5.24e-01 0.2070 0.127000 0.025400 -0.003080 -1.35e-01 -8.91e-02 2.46e-01 8.16e-01 9.78e-01 2.16e-01 4.14e-01
EPIGENETIC REGULATION OF GENE EXPRESSION 100 3.23e-02 7.36e-02 0.2070 -0.047000 -0.052900 0.010800 6.55e-02 -1.83e-01 4.17e-01 3.61e-01 8.52e-01 2.58e-01 1.60e-03
TRANSLATION OF SARS COV 2 STRUCTURAL PROTEINS 44 4.02e-01 5.01e-01 0.2060 -0.160000 -0.105000 -0.008940 -5.54e-02 -5.33e-02 6.68e-02 2.27e-01 9.18e-01 5.25e-01 5.41e-01
TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES 44 2.09e-01 3.02e-01 0.2040 -0.101000 -0.097500 0.036700 -9.87e-02 1.05e-01 2.48e-01 2.63e-01 6.74e-01 2.57e-01 2.30e-01
NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS 52 1.56e-01 2.45e-01 0.2040 0.053500 -0.114000 -0.159000 -2.02e-02 -7.37e-03 5.04e-01 1.55e-01 4.76e-02 8.01e-01 9.27e-01
SIGNALING BY FGFR 70 1.92e-01 2.82e-01 0.2040 -0.071700 -0.111000 0.001370 7.68e-03 -1.55e-01 3.00e-01 1.10e-01 9.84e-01 9.12e-01 2.48e-02
ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS 37 2.20e-01 3.14e-01 0.2030 -0.031200 -0.109000 0.054700 1.51e-01 5.10e-02 7.43e-01 2.52e-01 5.65e-01 1.11e-01 5.92e-01
SIGNALING BY GPCR 437 8.34e-10 1.33e-08 0.2030 0.040800 -0.046200 0.062600 -1.74e-01 5.64e-02 1.45e-01 9.87e-02 2.53e-02 5.67e-10 4.42e-02
NEGATIVE REGULATION OF FGFR3 SIGNALING 23 8.33e-01 8.63e-01 0.2020 0.131000 0.014900 0.065300 5.17e-02 1.28e-01 2.75e-01 9.01e-01 5.88e-01 6.68e-01 2.87e-01
METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES 20 7.78e-01 8.22e-01 0.2010 -0.008610 0.108000 -0.099900 1.35e-01 -2.30e-02 9.47e-01 4.02e-01 4.39e-01 2.96e-01 8.59e-01
DEATH RECEPTOR SIGNALLING 132 2.45e-02 5.86e-02 0.2010 0.075200 -0.089300 0.024200 -1.22e-01 1.07e-01 1.36e-01 7.67e-02 6.32e-01 1.59e-02 3.43e-02
MHC CLASS II ANTIGEN PRESENTATION 101 1.22e-01 2.05e-01 0.2010 0.065600 0.060500 0.082700 8.30e-02 1.37e-01 2.55e-01 2.94e-01 1.51e-01 1.50e-01 1.78e-02
SUMOYLATION 157 1.64e-02 4.32e-02 0.2010 -0.003700 -0.139000 -0.016400 -1.42e-01 -2.39e-02 9.36e-01 2.69e-03 7.23e-01 2.18e-03 6.06e-01
NEGATIVE REGULATION OF FLT3 14 8.69e-01 8.91e-01 0.2010 0.086400 -0.006480 0.089600 1.35e-01 -8.00e-02 5.76e-01 9.67e-01 5.62e-01 3.80e-01 6.04e-01
TOLL LIKE RECEPTOR CASCADES 134 5.65e-03 1.84e-02 0.2000 0.041700 -0.047400 -0.099600 -7.10e-02 1.45e-01 4.05e-01 3.44e-01 4.66e-02 1.56e-01 3.71e-03
EXTRACELLULAR MATRIX ORGANIZATION 232 8.73e-07 8.38e-06 0.2000 0.092200 0.054500 -0.044400 -1.62e-01 -1.84e-02 1.58e-02 1.53e-01 2.45e-01 2.31e-05 6.29e-01
GPCR LIGAND BINDING 224 1.32e-07 1.50e-06 0.2000 -0.095900 0.058300 0.022600 -1.44e-01 -7.74e-02 1.36e-02 1.34e-01 5.61e-01 2.06e-04 4.65e-02
NUCLEAR ENVELOPE NE REASSEMBLY 63 9.44e-02 1.69e-01 0.2000 -0.061200 -0.004340 0.147000 1.05e-01 5.72e-02 4.01e-01 9.52e-01 4.32e-02 1.49e-01 4.33e-01
RESOLUTION OF D LOOP STRUCTURES 30 3.73e-01 4.70e-01 0.1990 0.167000 0.063200 -0.068600 -4.78e-02 -3.19e-02 1.14e-01 5.49e-01 5.16e-01 6.50e-01 7.63e-01
PLASMA LIPOPROTEIN ASSEMBLY REMODELING AND CLEARANCE 46 4.51e-01 5.40e-01 0.1990 0.030100 0.118000 0.046500 4.08e-03 1.51e-01 7.24e-01 1.66e-01 5.85e-01 9.62e-01 7.69e-02
UB SPECIFIC PROCESSING PROTEASES 163 5.08e-04 2.48e-03 0.1990 -0.117000 -0.126000 -0.056100 8.42e-02 -8.80e-03 1.02e-02 5.75e-03 2.17e-01 6.40e-02 8.47e-01
TRNA PROCESSING IN THE NUCLEUS 56 1.13e-01 1.94e-01 0.1980 -0.006390 -0.114000 0.125000 1.00e-01 -2.34e-02 9.34e-01 1.39e-01 1.05e-01 1.96e-01 7.62e-01
SUMOYLATION OF INTRACELLULAR RECEPTORS 24 5.99e-01 6.67e-01 0.1980 -0.014000 0.051500 -0.023200 -1.78e-01 6.39e-02 9.05e-01 6.62e-01 8.44e-01 1.30e-01 5.88e-01
DISEASES ASSOCIATED WITH O GLYCOSYLATION OF PROTEINS 48 2.80e-01 3.76e-01 0.1980 0.079400 0.056900 -0.033800 -1.52e-01 7.45e-02 3.41e-01 4.95e-01 6.86e-01 6.92e-02 3.72e-01
EPH EPHRIN SIGNALING 90 5.10e-02 1.05e-01 0.1980 -0.006840 -0.111000 0.094500 -1.26e-01 -4.49e-02 9.11e-01 6.80e-02 1.21e-01 3.94e-02 4.62e-01
O GLYCOSYLATION OF TSR DOMAIN CONTAINING PROTEINS 33 3.73e-01 4.70e-01 0.1980 0.108000 0.036700 -0.080900 -1.31e-01 -4.99e-02 2.83e-01 7.16e-01 4.21e-01 1.94e-01 6.20e-01
HIV LIFE CYCLE 142 5.89e-03 1.89e-02 0.1980 -0.089100 0.006920 0.074300 1.41e-01 -7.57e-02 6.70e-02 8.87e-01 1.27e-01 3.78e-03 1.20e-01
GOLGI ASSOCIATED VESICLE BIOGENESIS 54 1.74e-01 2.64e-01 0.1970 -0.044100 -0.002730 -0.017500 -3.99e-02 1.87e-01 5.75e-01 9.72e-01 8.24e-01 6.13e-01 1.73e-02
O LINKED GLYCOSYLATION 82 1.26e-01 2.09e-01 0.1970 0.083700 0.053000 0.030100 -1.11e-01 1.26e-01 1.90e-01 4.07e-01 6.38e-01 8.28e-02 4.84e-02
DNA REPAIR 287 3.23e-05 2.10e-04 0.1970 -0.009010 0.052800 0.065600 1.74e-01 -3.75e-02 7.93e-01 1.25e-01 5.65e-02 4.03e-07 2.76e-01
SARS COV 1 INFECTION 48 2.20e-01 3.14e-01 0.1970 -0.070500 0.016700 0.162000 8.11e-02 2.80e-02 3.98e-01 8.41e-01 5.28e-02 3.31e-01 7.37e-01
BETA CATENIN INDEPENDENT WNT SIGNALING 136 4.72e-03 1.57e-02 0.1960 -0.162000 -0.027700 0.014800 1.02e-01 -3.30e-02 1.16e-03 5.78e-01 7.67e-01 4.03e-02 5.08e-01
SYNDECAN INTERACTIONS 26 4.58e-01 5.46e-01 0.1950 0.131000 0.086700 -0.088600 -5.72e-02 -4.92e-02 2.48e-01 4.44e-01 4.34e-01 6.14e-01 6.64e-01
TIE2 SIGNALING 17 9.10e-01 9.24e-01 0.1940 0.000365 -0.147000 -0.079500 -9.30e-02 3.04e-02 9.98e-01 2.93e-01 5.70e-01 5.07e-01 8.28e-01
IRAK1 RECRUITS IKK COMPLEX 14 9.48e-01 9.56e-01 0.1930 -0.065600 -0.025900 -0.124000 -6.47e-02 -1.14e-01 6.71e-01 8.67e-01 4.23e-01 6.75e-01 4.60e-01
DEADENYLATION DEPENDENT MRNA DECAY 55 2.28e-01 3.23e-01 0.1930 -0.006500 -0.039800 0.142000 1.10e-01 -5.78e-02 9.34e-01 6.10e-01 6.94e-02 1.59e-01 4.59e-01
ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION 282 9.99e-09 1.39e-07 0.1930 -0.077400 -0.038600 0.092400 6.60e-02 1.29e-01 2.57e-02 2.66e-01 7.75e-03 5.70e-02 1.95e-04
SIGNALING BY PDGF 53 4.25e-01 5.20e-01 0.1910 0.079300 -0.120000 -0.006770 -9.76e-02 7.86e-02 3.18e-01 1.30e-01 9.32e-01 2.19e-01 3.23e-01
SUMOYLATION OF IMMUNE RESPONSE PROTEINS 11 9.54e-01 9.61e-01 0.1910 -0.064300 0.093400 -0.045100 6.06e-02 -1.34e-01 7.12e-01 5.92e-01 7.95e-01 7.28e-01 4.42e-01
TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE 19 8.93e-01 9.10e-01 0.1900 0.029800 0.137000 -0.009190 1.28e-01 5.08e-03 8.22e-01 3.02e-01 9.45e-01 3.36e-01 9.69e-01
SIGNALING BY WNT 260 2.02e-04 1.09e-03 0.1900 -0.158000 -0.082800 -0.059500 -2.29e-02 -8.03e-03 1.21e-05 2.18e-02 9.96e-02 5.26e-01 8.24e-01
GLYCEROPHOSPHOLIPID BIOSYNTHESIS 106 2.81e-02 6.51e-02 0.1890 0.080000 -0.073900 0.001810 1.35e-02 1.54e-01 1.55e-01 1.89e-01 9.74e-01 8.11e-01 6.09e-03
DISEASES OF GLYCOSYLATION 121 1.38e-01 2.23e-01 0.1890 0.074400 0.086700 0.083600 3.08e-02 1.21e-01 1.58e-01 1.00e-01 1.13e-01 5.58e-01 2.14e-02
NICOTINATE METABOLISM 24 6.98e-01 7.47e-01 0.1890 -0.152000 0.090700 0.034600 5.22e-02 -1.65e-02 1.97e-01 4.42e-01 7.70e-01 6.58e-01 8.89e-01
MITOCHONDRIAL TRNA AMINOACYLATION 21 7.12e-01 7.59e-01 0.1880 -0.125000 0.051100 0.100000 7.87e-02 2.95e-02 3.20e-01 6.85e-01 4.26e-01 5.32e-01 8.15e-01
CLATHRIN MEDIATED ENDOCYTOSIS 128 4.31e-02 9.20e-02 0.1880 0.064400 -0.035800 0.081100 -9.55e-02 1.19e-01 2.09e-01 4.84e-01 1.14e-01 6.24e-02 2.00e-02
ENDOGENOUS STEROLS 20 7.15e-01 7.62e-01 0.1870 0.082400 -0.009480 -0.007610 2.49e-02 -1.66e-01 5.24e-01 9.42e-01 9.53e-01 8.47e-01 2.00e-01
PROCESSIVE SYNTHESIS ON THE C STRAND OF THE TELOMERE 19 8.17e-01 8.51e-01 0.1860 -0.116000 0.051200 -0.043600 9.91e-02 8.26e-02 3.81e-01 6.99e-01 7.42e-01 4.55e-01 5.33e-01
INTRINSIC PATHWAY FOR APOPTOSIS 52 3.26e-01 4.24e-01 0.1850 -0.039200 0.007170 0.030700 1.77e-01 1.90e-02 6.25e-01 9.29e-01 7.02e-01 2.76e-02 8.13e-01
POLO LIKE KINASE MEDIATED EVENTS 13 9.18e-01 9.30e-01 0.1840 0.016100 -0.090900 0.051600 4.04e-03 -1.51e-01 9.20e-01 5.70e-01 7.47e-01 9.80e-01 3.47e-01
MEMBRANE TRAFFICKING 567 7.79e-12 1.87e-10 0.1840 0.004150 -0.026000 0.061200 -3.87e-02 1.67e-01 8.67e-01 2.92e-01 1.32e-02 1.17e-01 1.34e-11
ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES 48 3.53e-01 4.50e-01 0.1830 0.039400 -0.034300 0.083200 -1.45e-01 -5.39e-02 6.37e-01 6.82e-01 3.19e-01 8.33e-02 5.19e-01
REGULATION OF PTEN GENE TRANSCRIPTION 57 3.02e-01 3.96e-01 0.1830 -0.010300 -0.101000 0.088600 -1.12e-01 -5.11e-02 8.93e-01 1.87e-01 2.47e-01 1.43e-01 5.05e-01
TICAM1 TRAF6 DEPENDENT INDUCTION OF TAK1 COMPLEX 11 9.70e-01 9.74e-01 0.1830 -0.083200 0.089800 -0.029300 8.83e-02 -9.87e-02 6.33e-01 6.06e-01 8.66e-01 6.12e-01 5.71e-01
FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES 15 7.99e-01 8.35e-01 0.1810 0.011500 -0.157000 -0.006370 8.69e-02 2.46e-02 9.39e-01 2.93e-01 9.66e-01 5.60e-01 8.69e-01
EXTENSION OF TELOMERES 48 4.20e-01 5.17e-01 0.1810 0.014400 0.028900 -0.000120 1.58e-01 -8.30e-02 8.63e-01 7.29e-01 9.99e-01 5.83e-02 3.20e-01
ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS 63 2.76e-01 3.73e-01 0.1810 -0.016500 -0.045800 -0.048300 6.34e-02 -1.55e-01 8.20e-01 5.30e-01 5.08e-01 3.84e-01 3.30e-02
GOLGI TO ER RETROGRADE TRANSPORT 119 9.83e-03 2.91e-02 0.1810 -0.038000 0.001860 0.100000 -7.34e-03 1.46e-01 4.74e-01 9.72e-01 5.96e-02 8.90e-01 6.00e-03
GENE SILENCING BY RNA 81 1.40e-01 2.25e-01 0.1800 -0.024100 -0.123000 -0.041800 5.29e-02 -1.10e-01 7.08e-01 5.64e-02 5.16e-01 4.10e-01 8.74e-02
PRE NOTCH EXPRESSION AND PROCESSING 61 4.67e-01 5.54e-01 0.1800 -0.041800 -0.039000 -0.150000 -6.93e-02 -4.16e-02 5.72e-01 5.98e-01 4.32e-02 3.49e-01 5.74e-01
DISEASES OF SIGNAL TRANSDUCTION BY GROWTH FACTOR RECEPTORS AND SECOND MESSENGERS 358 9.66e-05 5.59e-04 0.1800 -0.046000 -0.130000 -0.039100 -1.06e-01 2.08e-02 1.36e-01 2.46e-05 2.05e-01 6.03e-04 5.00e-01
SIGNALING BY PTK6 50 4.92e-01 5.80e-01 0.1790 -0.098100 -0.049500 -0.105000 -6.99e-02 6.44e-02 2.30e-01 5.45e-01 1.98e-01 3.92e-01 4.31e-01
TRANSPORT OF SMALL MOLECULES 547 3.71e-07 3.85e-06 0.1790 0.086900 0.027800 0.043100 -6.04e-03 1.48e-01 5.43e-04 2.69e-01 8.60e-02 8.10e-01 3.70e-09
MET PROMOTES CELL MOTILITY 38 6.71e-01 7.24e-01 0.1780 0.030800 -0.051400 -0.070000 -1.51e-01 -2.04e-02 7.42e-01 5.83e-01 4.56e-01 1.07e-01 8.28e-01
INTRA GOLGI AND RETROGRADE GOLGI TO ER TRAFFIC 185 7.03e-04 3.29e-03 0.1780 -0.023200 -0.010100 0.069300 -1.40e-03 1.62e-01 5.87e-01 8.14e-01 1.04e-01 9.74e-01 1.47e-04
MAPK FAMILY SIGNALING CASCADES 279 2.72e-05 1.78e-04 0.1770 -0.053000 -0.149000 0.024800 -5.81e-02 4.92e-02 1.29e-01 1.94e-05 4.76e-01 9.57e-02 1.58e-01
RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES 78 1.69e-01 2.60e-01 0.1750 -0.010800 0.053800 0.149000 1.49e-02 7.36e-02 8.70e-01 4.12e-01 2.32e-02 8.21e-01 2.62e-01
ASPARAGINE N LINKED GLYCOSYLATION 279 2.39e-06 2.10e-05 0.1750 -0.032700 -0.037100 0.091200 4.73e-02 1.33e-01 3.48e-01 2.88e-01 8.93e-03 1.75e-01 1.35e-04
COSTIMULATION BY THE CD28 FAMILY 47 5.93e-01 6.64e-01 0.1750 0.013200 -0.073000 -0.056200 -1.12e-01 9.65e-02 8.76e-01 3.87e-01 5.05e-01 1.85e-01 2.52e-01
TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX 29 5.62e-01 6.39e-01 0.1740 0.039900 0.011500 -0.144000 7.71e-02 -4.23e-02 7.10e-01 9.15e-01 1.78e-01 4.72e-01 6.93e-01
NERVOUS SYSTEM DEVELOPMENT 537 1.01e-08 1.39e-07 0.1740 -0.081800 -0.076400 0.044500 8.54e-03 -1.25e-01 1.25e-03 2.58e-03 7.88e-02 7.36e-01 7.61e-07
VESICLE MEDIATED TRANSPORT 596 5.73e-11 1.10e-09 0.1740 0.004450 -0.023800 0.051600 -4.00e-02 1.59e-01 8.54e-01 3.23e-01 3.23e-02 9.74e-02 3.87e-11
METABOLISM OF STEROIDS 110 6.67e-02 1.29e-01 0.1740 -0.098100 -0.065700 -0.050100 -8.90e-02 7.61e-02 7.56e-02 2.35e-01 3.65e-01 1.07e-01 1.69e-01
INTRACELLULAR SIGNALING BY SECOND MESSENGERS 274 3.10e-04 1.58e-03 0.1740 0.025900 -0.140000 0.026000 -7.25e-02 6.36e-02 4.62e-01 7.21e-05 4.60e-01 3.94e-02 7.07e-02
TNFR1 INDUCED NFKAPPAB SIGNALING PATHWAY 29 6.86e-01 7.36e-01 0.1730 0.081300 -0.148000 0.028600 -1.24e-02 -2.56e-02 4.49e-01 1.68e-01 7.90e-01 9.08e-01 8.11e-01
POTENTIAL THERAPEUTICS FOR SARS 76 3.47e-01 4.44e-01 0.1730 -0.047100 -0.081500 -0.003730 -8.36e-02 -1.19e-01 4.78e-01 2.20e-01 9.55e-01 2.08e-01 7.28e-02
JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 22 8.65e-01 8.88e-01 0.1730 0.135000 -0.023200 -0.022300 -8.24e-02 6.28e-02 2.74e-01 8.51e-01 8.57e-01 5.03e-01 6.10e-01
TRANSCRIPTIONAL REGULATION BY SMALL RNAS 59 3.64e-01 4.61e-01 0.1730 -0.077800 -0.039800 -0.012700 1.33e-01 -6.59e-02 3.02e-01 5.97e-01 8.66e-01 7.70e-02 3.82e-01
REGULATION OF TNFR1 SIGNALING 34 6.48e-01 7.07e-01 0.1720 0.022200 -0.166000 0.010400 -1.38e-02 -3.87e-02 8.23e-01 9.48e-02 9.17e-01 8.89e-01 6.97e-01
ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION 23 6.28e-01 6.93e-01 0.1720 0.115000 -0.073000 -0.099400 3.16e-02 -1.88e-02 3.41e-01 5.45e-01 4.09e-01 7.93e-01 8.76e-01
METABOLISM OF FAT SOLUBLE VITAMINS 30 6.05e-01 6.73e-01 0.1720 0.086200 0.134000 -0.036600 1.08e-02 -5.35e-02 4.14e-01 2.06e-01 7.29e-01 9.18e-01 6.12e-01
TNF SIGNALING 43 6.54e-01 7.10e-01 0.1710 0.016600 -0.152000 0.006770 -7.09e-02 -3.09e-02 8.51e-01 8.48e-02 9.39e-01 4.22e-01 7.26e-01
ANTI INFLAMMATORY RESPONSE FAVOURING LEISHMANIA PARASITE INFECTION 105 1.01e-01 1.78e-01 0.1710 -0.048800 -0.068100 0.014300 -1.49e-01 3.16e-03 3.88e-01 2.28e-01 8.01e-01 8.59e-03 9.55e-01
LYSOSOME VESICLE BIOGENESIS 32 6.49e-01 7.08e-01 0.1710 -0.097800 0.056100 0.070600 9.19e-02 5.60e-02 3.38e-01 5.83e-01 4.89e-01 3.68e-01 5.84e-01
SIGNALING BY RHO GTPASES MIRO GTPASES AND RHOBTB3 620 3.19e-08 3.95e-07 0.1700 0.009000 -0.069800 -0.017800 -1.39e-01 6.48e-02 7.04e-01 3.15e-03 4.52e-01 4.33e-09 6.11e-03
HCMV LATE EVENTS 63 2.08e-01 3.02e-01 0.1690 -0.074700 -0.031300 0.021300 1.39e-01 4.77e-02 3.05e-01 6.67e-01 7.70e-01 5.67e-02 5.13e-01
DISORDERS OF TRANSMEMBRANE TRANSPORTERS 132 1.13e-02 3.21e-02 0.1690 -0.055000 -0.037500 0.036700 1.47e-01 3.23e-02 2.76e-01 4.58e-01 4.67e-01 3.54e-03 5.22e-01
SEMA4D IN SEMAPHORIN SIGNALING 24 7.76e-01 8.20e-01 0.1670 0.046700 -0.065900 -0.121000 -1.90e-02 -8.09e-02 6.92e-01 5.77e-01 3.05e-01 8.72e-01 4.93e-01
CYTOKINE SIGNALING IN IMMUNE SYSTEM 528 2.29e-07 2.52e-06 0.1670 -0.052200 -0.112000 -0.113000 -4.67e-03 3.84e-03 4.10e-02 1.22e-05 9.89e-06 8.55e-01 8.80e-01
KINESINS 48 5.08e-01 5.94e-01 0.1670 0.008540 -0.027100 0.026600 -1.61e-01 2.54e-02 9.18e-01 7.46e-01 7.50e-01 5.43e-02 7.60e-01
TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS 32 8.52e-01 8.77e-01 0.1670 -0.132000 -0.070500 -0.053200 -2.75e-02 -4.33e-02 1.96e-01 4.90e-01 6.02e-01 7.88e-01 6.72e-01
G ALPHA I SIGNALLING EVENTS 184 6.30e-03 1.98e-02 0.1670 -0.007140 -0.074800 0.072200 -1.28e-01 2.22e-02 8.68e-01 8.06e-02 9.19e-02 2.76e-03 6.04e-01
EGFR DOWNREGULATION 27 6.62e-01 7.15e-01 0.1660 -0.059900 -0.008850 0.121000 -5.41e-02 -7.99e-02 5.90e-01 9.37e-01 2.75e-01 6.27e-01 4.72e-01
MITOTIC SPINDLE CHECKPOINT 96 3.16e-02 7.23e-02 0.1660 -0.108000 -0.077200 0.023500 4.14e-02 8.72e-02 6.65e-02 1.91e-01 6.91e-01 4.84e-01 1.40e-01
DNA DOUBLE STRAND BREAK RESPONSE 50 6.82e-01 7.33e-01 0.1660 -0.096800 0.010200 -0.037100 7.95e-02 -1.01e-01 2.37e-01 9.00e-01 6.50e-01 3.31e-01 2.15e-01
CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION 337 7.62e-08 9.04e-07 0.1650 -0.099700 -0.049400 0.020000 6.54e-02 1.01e-01 1.71e-03 1.20e-01 5.28e-01 3.96e-02 1.46e-03
RHO GTPASES ACTIVATE IQGAPS 23 7.48e-01 7.94e-01 0.1650 -0.104000 -0.026900 0.092500 8.02e-02 2.29e-02 3.86e-01 8.23e-01 4.42e-01 5.06e-01 8.49e-01
VISUAL PHOTOTRANSDUCTION 54 3.02e-01 3.96e-01 0.1650 0.073400 0.139000 -0.011800 -3.36e-02 -3.24e-02 3.51e-01 7.68e-02 8.81e-01 6.70e-01 6.81e-01
ADORA2B MEDIATED ANTI INFLAMMATORY CYTOKINES PRODUCTION 81 8.85e-02 1.61e-01 0.1640 -0.053200 -0.007640 0.071700 -1.32e-01 -3.86e-02 4.08e-01 9.06e-01 2.65e-01 3.95e-02 5.49e-01
TRANS GOLGI NETWORK VESICLE BUDDING 69 1.61e-01 2.50e-01 0.1640 -0.099100 -0.003850 -0.009330 -5.75e-03 1.30e-01 1.55e-01 9.56e-01 8.93e-01 9.34e-01 6.22e-02
M PHASE 336 3.90e-06 3.16e-05 0.1640 -0.096600 -0.007270 0.043000 1.21e-01 2.99e-02 2.41e-03 8.19e-01 1.77e-01 1.41e-04 3.48e-01
INFECTION WITH MYCOBACTERIUM TUBERCULOSIS 25 8.90e-01 9.09e-01 0.1630 -0.095300 -0.005250 -0.119000 5.44e-02 -1.62e-02 4.09e-01 9.64e-01 3.02e-01 6.38e-01 8.88e-01
CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION 20 9.27e-01 9.38e-01 0.1620 -0.099300 -0.089700 -0.024100 -8.80e-02 -1.88e-04 4.42e-01 4.88e-01 8.52e-01 4.96e-01 9.99e-01
TELOMERE EXTENSION BY TELOMERASE 21 9.05e-01 9.20e-01 0.1610 -0.053200 -0.018900 0.008320 1.13e-01 -9.96e-02 6.73e-01 8.81e-01 9.47e-01 3.68e-01 4.30e-01
ACTIVATION OF BH3 ONLY PROTEINS 30 7.91e-01 8.30e-01 0.1610 -0.009110 0.009000 0.138000 7.99e-02 1.26e-02 9.31e-01 9.32e-01 1.90e-01 4.49e-01 9.05e-01
BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS 31 7.18e-01 7.64e-01 0.1610 0.004220 0.018000 -0.155000 -5.47e-03 -3.76e-02 9.68e-01 8.63e-01 1.35e-01 9.58e-01 7.17e-01
SIGNALING BY NUCLEAR RECEPTORS 215 5.69e-02 1.15e-01 0.1600 -0.090300 -0.037200 -0.115000 -4.14e-02 -3.23e-02 2.27e-02 3.48e-01 3.82e-03 2.96e-01 4.15e-01
SENSORY PERCEPTION 133 1.65e-02 4.32e-02 0.1590 0.121000 0.058200 -0.008490 -7.63e-02 -3.79e-02 1.65e-02 2.47e-01 8.66e-01 1.29e-01 4.51e-01
RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES 85 2.57e-01 3.54e-01 0.1580 -0.009160 0.065500 0.125000 1.94e-02 6.83e-02 8.84e-01 2.97e-01 4.64e-02 7.57e-01 2.77e-01
HOMOLOGY DIRECTED REPAIR 103 2.33e-01 3.29e-01 0.1580 -0.076700 -0.019300 -0.045600 1.07e-01 -7.18e-02 1.79e-01 7.35e-01 4.24e-01 6.13e-02 2.08e-01
SARS COV 2 INFECTION 65 1.97e-01 2.89e-01 0.1570 -0.099000 -0.061200 0.102000 2.38e-02 4.42e-03 1.68e-01 3.94e-01 1.56e-01 7.40e-01 9.51e-01
COPI DEPENDENT GOLGI TO ER RETROGRADE TRAFFIC 86 2.41e-01 3.39e-01 0.1560 -0.001750 0.033600 0.107000 -1.07e-02 1.08e-01 9.78e-01 5.91e-01 8.74e-02 8.64e-01 8.27e-02
TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX 14 9.12e-01 9.24e-01 0.1560 0.059300 0.014600 -0.067900 1.25e-01 -1.67e-02 7.01e-01 9.25e-01 6.60e-01 4.18e-01 9.14e-01
REGULATION OF LIPID METABOLISM BY PPARALPHA 105 2.22e-01 3.16e-01 0.1560 0.054500 -0.087800 0.081500 -8.30e-02 7.18e-03 3.35e-01 1.20e-01 1.49e-01 1.42e-01 8.99e-01
SIGNALING BY RECEPTOR TYROSINE KINASES 449 8.65e-05 5.06e-04 0.1560 0.013100 -0.083500 -0.002390 -1.18e-01 5.64e-02 6.36e-01 2.53e-03 9.31e-01 2.00e-05 4.12e-02
AURKA ACTIVATION BY TPX2 71 4.32e-01 5.25e-01 0.1540 -0.010600 0.055900 0.097100 4.09e-02 9.66e-02 8.77e-01 4.16e-01 1.57e-01 5.52e-01 1.59e-01
RESOLUTION OF SISTER CHROMATID COHESION 100 6.61e-02 1.28e-01 0.1540 -0.083800 -0.077400 0.002790 8.02e-03 1.03e-01 1.48e-01 1.81e-01 9.62e-01 8.90e-01 7.57e-02
MAP3K8 TPL2 DEPENDENT MAPK1 3 ACTIVATION 16 9.69e-01 9.74e-01 0.1530 0.081400 0.050000 0.020500 -5.72e-02 1.04e-01 5.73e-01 7.29e-01 8.87e-01 6.92e-01 4.74e-01
DISEASES OF METABOLISM 194 8.03e-02 1.49e-01 0.1530 0.027300 0.107000 0.040700 4.61e-02 8.63e-02 5.12e-01 1.03e-02 3.29e-01 2.69e-01 3.86e-02
PLASMA LIPOPROTEIN CLEARANCE 25 7.56e-01 8.02e-01 0.1510 -0.130000 0.027600 0.004160 -5.63e-02 4.55e-02 2.61e-01 8.11e-01 9.71e-01 6.26e-01 6.93e-01
FLT3 SIGNALING 36 7.91e-01 8.30e-01 0.1510 0.023200 -0.098000 0.013900 -5.83e-02 9.48e-02 8.10e-01 3.09e-01 8.86e-01 5.45e-01 3.25e-01
HDR THROUGH HOMOLOGOUS RECOMBINATION HRR 62 5.98e-01 6.67e-01 0.1490 -0.034200 0.041000 -0.028200 1.14e-01 -7.48e-02 6.42e-01 5.77e-01 7.01e-01 1.20e-01 3.09e-01
METABOLISM OF LIPIDS 600 2.68e-08 3.39e-07 0.1490 0.013300 0.003830 -0.019000 3.20e-02 1.44e-01 5.80e-01 8.73e-01 4.28e-01 1.83e-01 2.09e-09
LEISHMANIA INFECTION 183 3.79e-02 8.41e-02 0.1490 -0.023300 -0.060300 0.011700 -1.27e-01 4.17e-02 5.87e-01 1.60e-01 7.84e-01 3.08e-03 3.32e-01
CELL CYCLE MITOTIC 468 8.42e-07 8.22e-06 0.1480 -0.082800 -0.004240 0.024200 1.17e-01 2.92e-02 2.23e-03 8.76e-01 3.71e-01 1.61e-05 2.80e-01
FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION 119 1.72e-01 2.62e-01 0.1480 0.015100 -0.005820 0.012200 -9.38e-02 1.12e-01 7.77e-01 9.13e-01 8.19e-01 7.74e-02 3.46e-02
DEUBIQUITINATION 237 3.99e-03 1.38e-02 0.1470 -0.078400 -0.110000 -0.047800 3.21e-02 1.33e-02 3.79e-02 3.70e-03 2.06e-01 3.96e-01 7.25e-01
SIGNALING BY FGFR4 31 8.96e-01 9.11e-01 0.1470 -0.024700 -0.105000 -0.067900 -6.20e-02 3.86e-02 8.12e-01 3.14e-01 5.13e-01 5.50e-01 7.10e-01
MITOTIC PROPHASE 91 2.08e-01 3.02e-01 0.1450 0.018900 -0.038000 0.012000 5.37e-02 1.27e-01 7.55e-01 5.31e-01 8.43e-01 3.76e-01 3.64e-02
RHO GTPASES ACTIVATE FORMINS 117 5.28e-02 1.07e-01 0.1440 -0.086000 -0.082500 0.031900 2.29e-03 7.38e-02 1.08e-01 1.24e-01 5.51e-01 9.66e-01 1.68e-01
INNATE IMMUNE SYSTEM 760 1.19e-10 2.15e-09 0.1440 -0.057200 -0.030200 -0.096400 7.10e-02 4.58e-02 7.65e-03 1.59e-01 6.96e-06 9.43e-04 3.30e-02
FLT3 SIGNALING IN DISEASE 27 8.59e-01 8.83e-01 0.1430 0.021100 -0.093900 -0.033800 -1.83e-02 9.86e-02 8.49e-01 3.98e-01 7.61e-01 8.69e-01 3.75e-01
SIGNALING BY FGFR IN DISEASE 53 7.95e-01 8.33e-01 0.1420 -0.057100 -0.090000 -0.061500 5.10e-03 -7.13e-02 4.72e-01 2.57e-01 4.39e-01 9.49e-01 3.70e-01
GLUCAGON LIKE PEPTIDE 1 GLP1 REGULATES INSULIN SECRETION 38 8.72e-01 8.92e-01 0.1420 -0.063200 -0.094500 -0.006740 -8.06e-02 -2.65e-02 5.00e-01 3.13e-01 9.43e-01 3.90e-01 7.77e-01
PEPTIDE HORMONE METABOLISM 56 6.68e-01 7.20e-01 0.1410 -0.102000 -0.063300 -0.012900 -7.25e-02 -8.99e-03 1.87e-01 4.13e-01 8.67e-01 3.48e-01 9.07e-01
REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION 86 4.37e-01 5.29e-01 0.1410 -0.059800 -0.074400 -0.014200 5.83e-02 -8.43e-02 3.38e-01 2.34e-01 8.20e-01 3.50e-01 1.77e-01
RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 102 2.90e-01 3.85e-01 0.1400 -0.003280 0.092700 -0.072800 7.52e-02 -2.72e-03 9.54e-01 1.06e-01 2.04e-01 1.90e-01 9.62e-01
SIGNALING BY INTERLEUKINS 337 1.07e-04 6.12e-04 0.1390 -0.034200 -0.071600 -0.089500 4.52e-02 5.49e-02 2.82e-01 2.43e-02 4.86e-03 1.55e-01 8.40e-02
NEGATIVE REGULATION OF FGFR4 SIGNALING 21 9.63e-01 9.68e-01 0.1380 0.067400 -0.012900 0.051200 2.11e-02 1.07e-01 5.93e-01 9.19e-01 6.85e-01 8.67e-01 3.97e-01
HCMV INFECTION 101 1.53e-01 2.41e-01 0.1380 -0.068600 -0.069200 0.048900 8.48e-02 -3.25e-03 2.34e-01 2.30e-01 3.96e-01 1.41e-01 9.55e-01
CYTOSOLIC SENSORS OF PATHOGEN ASSOCIATED DNA 59 5.27e-01 6.09e-01 0.1380 -0.017400 -0.021800 -0.091100 9.23e-02 -3.65e-02 8.18e-01 7.73e-01 2.26e-01 2.20e-01 6.28e-01
TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION 73 5.80e-01 6.54e-01 0.1380 0.042000 -0.066400 0.067400 -9.00e-02 1.01e-02 5.35e-01 3.27e-01 3.20e-01 1.84e-01 8.82e-01
SARS COV INFECTIONS 139 1.44e-01 2.29e-01 0.1370 -0.085000 -0.072400 0.039000 -2.90e-02 -6.33e-02 8.40e-02 1.41e-01 4.28e-01 5.55e-01 1.98e-01
SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE 20 8.91e-01 9.09e-01 0.1350 0.052400 0.028900 -0.103000 3.37e-03 -6.43e-02 6.85e-01 8.23e-01 4.26e-01 9.79e-01 6.19e-01
CELL CYCLE 583 2.44e-06 2.13e-05 0.1340 -0.073500 -0.010600 0.021700 1.09e-01 -7.67e-03 2.55e-03 6.64e-01 3.73e-01 7.60e-06 7.53e-01
HCMV EARLY EVENTS 78 5.15e-01 6.02e-01 0.1340 -0.058600 -0.119000 -0.005320 -4.81e-03 -1.82e-02 3.71e-01 7.01e-02 9.35e-01 9.41e-01 7.82e-01
CELL SURFACE INTERACTIONS AT THE VASCULAR WALL 88 2.98e-01 3.94e-01 0.1330 0.026300 0.069100 -0.093100 -4.79e-02 3.65e-02 6.70e-01 2.63e-01 1.32e-01 4.38e-01 5.55e-01
SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS 73 6.62e-01 7.15e-01 0.1320 0.001420 -0.087900 0.024500 -9.45e-02 -1.61e-02 9.83e-01 1.94e-01 7.18e-01 1.63e-01 8.12e-01
HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE 40 8.73e-01 8.93e-01 0.1300 -0.039600 0.012900 -0.109000 1.50e-02 -5.42e-02 6.65e-01 8.88e-01 2.31e-01 8.70e-01 5.54e-01
DEVELOPMENTAL BIOLOGY 787 5.52e-07 5.58e-06 0.1300 -0.050800 -0.060700 0.037100 -2.21e-02 -9.31e-02 1.61e-02 4.04e-03 7.86e-02 2.96e-01 1.03e-05
CARGO RECOGNITION FOR CLATHRIN MEDIATED ENDOCYTOSIS 88 5.95e-01 6.66e-01 0.1290 0.046200 -0.010200 0.046100 -7.05e-02 8.55e-02 4.54e-01 8.69e-01 4.55e-01 2.53e-01 1.66e-01
FOXO MEDIATED TRANSCRIPTION 56 5.70e-01 6.45e-01 0.1270 -0.021600 -0.111000 -0.016200 2.60e-02 4.96e-02 7.80e-01 1.50e-01 8.34e-01 7.36e-01 5.21e-01
TRANSCRIPTIONAL REGULATION BY TP53 339 1.42e-03 5.75e-03 0.1260 -0.053100 -0.027800 0.042500 1.02e-01 -1.43e-03 9.37e-02 3.81e-01 1.80e-01 1.29e-03 9.64e-01
DNA DOUBLE STRAND BREAK REPAIR 132 2.76e-01 3.73e-01 0.1250 -0.039500 -0.018500 -0.019200 1.00e-01 -5.80e-02 4.34e-01 7.13e-01 7.04e-01 4.66e-02 2.50e-01
SIGNALING BY MET 74 7.20e-01 7.66e-01 0.1240 -0.028900 -0.052600 -0.030800 -9.80e-02 3.41e-02 6.68e-01 4.34e-01 6.47e-01 1.45e-01 6.12e-01
NOTCH4 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS 12 9.90e-01 9.90e-01 0.1210 -0.030600 0.103000 0.013000 3.05e-02 -4.51e-02 8.55e-01 5.38e-01 9.38e-01 8.55e-01 7.87e-01
REGULATION OF TP53 ACTIVITY 148 1.74e-01 2.64e-01 0.1210 0.027000 -0.106000 0.037500 -5.26e-03 3.48e-02 5.71e-01 2.64e-02 4.31e-01 9.12e-01 4.66e-01
ACYL CHAIN REMODELLING OF PE 16 9.61e-01 9.68e-01 0.1200 -0.040000 -0.004430 0.059700 -6.38e-02 7.14e-02 7.82e-01 9.76e-01 6.79e-01 6.59e-01 6.21e-01
INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 13 9.80e-01 9.82e-01 0.1190 -0.099200 -0.037100 -0.015700 6.09e-03 5.25e-02 5.36e-01 8.17e-01 9.22e-01 9.70e-01 7.43e-01
TRANSLATION OF SARS COV 1 STRUCTURAL PROTEINS 28 8.92e-01 9.09e-01 0.1180 -0.111000 -0.008190 0.034500 -1.60e-02 -1.52e-02 3.10e-01 9.40e-01 7.52e-01 8.84e-01 8.89e-01
RESPONSE OF MTB TO PHAGOCYTOSIS 22 9.78e-01 9.81e-01 0.1160 -0.106000 -0.021800 -0.018400 5.52e-03 -3.62e-02 3.87e-01 8.59e-01 8.81e-01 9.64e-01 7.69e-01
ADAPTIVE IMMUNE SYSTEM 585 4.68e-06 3.71e-05 0.1140 -0.042700 -0.036700 0.005640 3.12e-02 9.40e-02 7.90e-02 1.31e-01 8.17e-01 1.99e-01 1.10e-04
HATS ACETYLATE HISTONES 90 5.63e-01 6.40e-01 0.1110 0.011900 -0.073200 0.077800 -7.26e-03 -2.82e-02 8.45e-01 2.30e-01 2.03e-01 9.05e-01 6.44e-01
NEGATIVE REGULATION OF MET ACTIVITY 20 9.88e-01 9.89e-01 0.1090 0.008960 -0.094400 -0.011400 -4.46e-02 -2.73e-02 9.45e-01 4.65e-01 9.30e-01 7.30e-01 8.32e-01
G ALPHA Q SIGNALLING EVENTS 140 4.92e-01 5.80e-01 0.1070 -0.005610 -0.056400 0.022900 -8.55e-02 1.73e-02 9.09e-01 2.50e-01 6.40e-01 8.12e-02 7.25e-01
CILIUM ASSEMBLY 189 9.91e-02 1.76e-01 0.1060 -0.075800 0.015200 0.045600 -3.04e-02 -4.82e-02 7.27e-02 7.19e-01 2.81e-01 4.71e-01 2.54e-01
RHOH GTPASE CYCLE 37 8.95e-01 9.10e-01 0.1060 0.012200 0.038900 -0.084900 -2.85e-02 -3.85e-02 8.98e-01 6.82e-01 3.72e-01 7.64e-01 6.86e-01
HDR THROUGH SINGLE STRAND ANNEALING SSA 36 9.34e-01 9.43e-01 0.1050 -0.003690 0.027100 -0.053700 4.70e-02 -7.22e-02 9.69e-01 7.79e-01 5.77e-01 6.25e-01 4.53e-01
RNA POLYMERASE II TRANSCRIPTION 1069 5.82e-05 3.53e-04 0.1040 -0.054900 -0.078100 -0.004530 -1.83e-02 -3.55e-02 2.69e-03 1.95e-05 8.04e-01 3.16e-01 5.23e-02
SIGNALING BY FGFR3 34 9.71e-01 9.74e-01 0.1010 -0.001750 -0.074200 -0.046000 -4.13e-02 2.80e-02 9.86e-01 4.54e-01 6.43e-01 6.77e-01 7.78e-01
MITOTIC PROMETAPHASE 175 1.97e-01 2.89e-01 0.0989 -0.035500 -0.012800 0.041600 -6.18e-03 8.11e-02 4.18e-01 7.71e-01 3.43e-01 8.88e-01 6.46e-02
HEMOSTASIS 463 3.19e-02 7.28e-02 0.0979 0.028100 0.011300 -0.011900 -5.35e-02 7.53e-02 3.01e-01 6.78e-01 6.62e-01 4.96e-02 5.70e-03
POST TRANSLATIONAL PROTEIN MODIFICATION 1184 3.21e-07 3.39e-06 0.0969 -0.006020 -0.015400 0.029200 2.58e-02 8.72e-02 7.30e-01 3.77e-01 9.44e-02 1.38e-01 5.66e-07
ORGANELLE BIOGENESIS AND MAINTENANCE 281 1.38e-01 2.23e-01 0.0920 -0.043100 -0.045500 0.042400 3.04e-02 -4.25e-02 2.15e-01 1.90e-01 2.22e-01 3.82e-01 2.22e-01
REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION 84 8.52e-01 8.77e-01 0.0909 -0.015900 0.037400 0.062900 4.09e-02 3.13e-02 8.02e-01 5.53e-01 3.20e-01 5.18e-01 6.20e-01
ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE 96 5.87e-01 6.61e-01 0.0889 -0.051400 0.012800 0.053700 -3.90e-02 -2.63e-02 3.84e-01 8.28e-01 3.64e-01 5.09e-01 6.56e-01
CELLULAR SENESCENCE 138 8.38e-01 8.67e-01 0.0879 -0.040100 -0.037600 -0.033300 -7.44e-03 -5.95e-02 4.17e-01 4.46e-01 5.00e-01 8.80e-01 2.28e-01
RHO GTPASE EFFECTORS 243 2.55e-01 3.53e-01 0.0790 -0.028200 -0.040000 0.022200 -1.32e-03 5.79e-02 4.49e-01 2.84e-01 5.51e-01 9.72e-01 1.21e-01
PLATELET ACTIVATION SIGNALING AND AGGREGATION 216 5.22e-01 6.06e-01 0.0737 -0.013100 -0.021400 -0.027400 -7.26e-03 6.32e-02 7.40e-01 5.88e-01 4.88e-01 8.54e-01 1.10e-01



Detailed Gene set reports


EUKARYOTIC TRANSLATION ELONGATION

EUKARYOTIC TRANSLATION ELONGATION
metric value
setSize 87
pMANOVA 4.25e-70
p.adjustMANOVA 2.45e-67
s.dist 1.23
s.hyp -0.512
s.hip 0.137
s.amy -0.204
s.pag 0.857
s.ni -0.678
p.hyp 1.54e-16
p.hip 0.0273
p.amy 0.00102
p.pag 1.2e-43
p.ni 7.01e-28



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag ni
Rps29 7482 -7465
Rpl38 7427 -7458
Rps28 7397 -7470
Rpl39 7435 -7398
Rps27 7449 -7364
Rps21 7488 -7191
Rpl37a 7353 -7233
Rpl37 7169 -7308
Rpl23 6983 -7403
Rpl35a 7450 -6779
Rpl36al 7142 -7041
Rpl35 7203 -6944
Rps23 6890 -7067
Rps17 7182 -6746
Rpl36a 6846 -6933
Rps8 7004 -6741
Rpl30 6489 -7269
Rpl21 6613 -7105
Rpl31 7055 -6596
Rpl36 7394 -6244

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Eef1a1 -4411 2294 -379 5219 -1585
Eef1a2 -2588 1169 4877 143 6668
Eef1b2 -4710 2420 473 6170 -4981
Eef1d -3728 5506 -4520 6179 -1242
Eef1g -4818 -581 -3602 5481 -4562
Eef2 3372 350 -1855 1302 5577
Fau -5907 1583 1608 7212 -5383
Rpl10 7552 2305 -6483 1980 1798
Rpl10a -4754 5887 -3904 6315 -6264
Rpl11 -7040 -1610 -1752 7106 -5100
Rpl12 -1293 111 -1276 5593 -4815
Rpl13 -5435 705 -309 7111 -4751
Rpl13a -6127 -800 -4926 6137 -3678
Rpl14 -4973 3377 -3827 6231 -6184
Rpl15 -1081 4664 -97 5670 -5225
Rpl17 -6154 1812 -4356 5972 -3587
Rpl18 -3623 1407 1250 6814 -5632
Rpl18a -1090 3984 -5189 6777 -4423
Rpl19 -6145 1844 1393 7139 -5256
Rpl21 -5242 1494 -2632 6613 -7105
Rpl22 2309 1493 135 7361 -5393
Rpl22l1 -6274 -4977 -2367 6270 -5683
Rpl23 -4886 -1314 -5284 6983 -7403
Rpl23a -5685 181 -4668 5986 -6814
Rpl24 -6576 1391 -3886 6934 -6380
Rpl26 -6659 1690 -587 7025 -6436
Rpl27 -6845 1737 -3419 6972 -3911
Rpl27a -5517 3660 -2513 5849 -4735
Rpl28 -1279 5641 -1248 5705 -5460
Rpl29 -1125 4140 -4187 6593 -5922
Rpl3 -4393 97 1158 6008 -4443
Rpl30 -3489 -1769 -4305 6489 -7269
Rpl31 -6836 -3203 -1412 7055 -6596
Rpl32 -4734 -2231 1048 7325 -5634
Rpl34 -5472 -4039 -1304 7052 -5665
Rpl35 -5746 -5044 -3769 7203 -6944
Rpl35a -5482 -3840 570 7450 -6779
Rpl36 -4150 -526 -925 7394 -6244
Rpl36a -5737 966 -3217 6846 -6933
Rpl36al -5513 1911 -471 7142 -7041
Rpl37 -4803 -2009 -157 7169 -7308
Rpl37a -5196 -2693 70 7353 -7233
Rpl38 -4285 -3890 857 7427 -7458
Rpl39 -6226 -2451 1477 7435 -7398
Rpl4 -4925 1852 -4074 6135 -4712
Rpl5 5744 -2476 -3141 5665 42
Rpl6 -5411 5527 -1164 5021 -4217
Rpl7 -5113 1762 151 6242 -4040
Rpl7a -3564 4076 1931 6938 -2667
Rpl8 -3703 3543 -3664 6481 -4491
Rpl9 -5504 344 903 6756 -2526
Rplp0 -3763 4412 -942 6357 956
Rplp1 -3659 -3603 -814 6990 -6512
Rplp2 -1405 721 5081 7200 -5799
Rps10 -5436 1596 -1596 7118 -2524
Rps11 -6088 -966 -1330 6240 -6425
Rps12 -6536 2445 -4827 7047 -5574
Rps13 -2674 -235 -1978 6430 -3919
Rps14 -3675 1734 3410 7146 -3493
Rps15 -5634 2477 239 7130 -5513
Rps15a 369 608 -3369 6779 -5204
Rps16 -4792 2799 -1537 6267 -5455
Rps17 -5260 -1557 1246 7182 -6746
Rps18 -4838 1158 194 6830 -4753
Rps19 -6105 -2857 -5576 6611 -5782
Rps2 -2017 387 -812 6266 -3726
Rps20 -4819 -1197 -4402 5625 -7090
Rps21 -4549 -3950 -722 7488 -7191
Rps23 -6959 2961 -3533 6890 -7067
Rps24 -6377 -301 -5394 5997 -5015
Rps25 -6573 -1150 -1883 6238 -5538
Rps26 -5325 3572 -3697 5769 -6007
Rps27 -5449 -2098 2068 7449 -7364
Rps27a -6372 -7132 -2043 6853 -6401
Rps27l -4990 -3246 -4325 6048 -3758
Rps28 -2854 -2799 2837 7397 -7470
Rps29 -234 -4717 -446 7482 -7465
Rps3 -5535 1738 -2705 6117 -1500
Rps3a1 -6001 295 -2164 5731 -4251
Rps4x -3555 -300 -4680 5409 -4453
Rps5 -4284 1344 -1916 5993 -4583
Rps6 -4272 4707 1599 6014 -5295
Rps7 -5696 1849 -3387 6808 -5804
Rps8 -6704 -566 -5243 7004 -6741
Rps9 -5004 1757 -844 6794 -4576
Rpsa -5034 -2245 -4844 5145 -2970
Uba52 -2504 5042 585 6605 -5655





RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY

RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY
metric value
setSize 94
pMANOVA 8.77e-65
p.adjustMANOVA 2.53e-62
s.dist 1.14
s.hyp -0.487
s.hip 0.0738
s.amy -0.211
s.pag 0.762
s.ni -0.66
p.hyp 3.28e-16
p.hip 0.217
p.amy 0.000401
p.pag 1.89e-37
p.ni 1.8e-28



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag ni
Rps29 7482 -7465
Rpl38 7427 -7458
Rps28 7397 -7470
Rpl39 7435 -7398
Rps27 7449 -7364
Rps21 7488 -7191
Rpl37a 7353 -7233
Rpl37 7169 -7308
Rpl23 6983 -7403
Rpl35a 7450 -6779
Rpl36al 7142 -7041
Rpl35 7203 -6944
Rps23 6890 -7067
Rps17 7182 -6746
Rpl36a 6846 -6933
Rps8 7004 -6741
Rpl30 6489 -7269
Rpl21 6613 -7105
Rpl31 7055 -6596
Rpl36 7394 -6244

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Asns 3882 -6268 3921 -1608 3670
Atf2 -2259 -2053 -1225 -6889 4100
Atf3 -7700 -7800 -7270 402 -7377
Atf4 -5109 -7556 -3593 7029 -2762
Cebpb 1867 5859 3905 1566 1301
Cebpg -5947 -3335 -491 -484 -5918
Ddit3 -8087 -8557 -6904 5070 -7401
Eif2ak4 6067 4810 662 -4836 -2491
Eif2s1 -6701 -39 -1217 5813 2921
Eif2s2 -4538 -2403 -5282 4050 -5700
Eif2s3x 17 -3878 -3881 -646 1396
Fau -5907 1583 1608 7212 -5383
Gcn1 6541 -4336 5274 -6548 2059
Impact -6033 2687 -5811 -5272 -4307
Rpl10 7552 2305 -6483 1980 1798
Rpl10a -4754 5887 -3904 6315 -6264
Rpl11 -7040 -1610 -1752 7106 -5100
Rpl12 -1293 111 -1276 5593 -4815
Rpl13 -5435 705 -309 7111 -4751
Rpl13a -6127 -800 -4926 6137 -3678
Rpl14 -4973 3377 -3827 6231 -6184
Rpl15 -1081 4664 -97 5670 -5225
Rpl17 -6154 1812 -4356 5972 -3587
Rpl18 -3623 1407 1250 6814 -5632
Rpl18a -1090 3984 -5189 6777 -4423
Rpl19 -6145 1844 1393 7139 -5256
Rpl21 -5242 1494 -2632 6613 -7105
Rpl22 2309 1493 135 7361 -5393
Rpl22l1 -6274 -4977 -2367 6270 -5683
Rpl23 -4886 -1314 -5284 6983 -7403
Rpl23a -5685 181 -4668 5986 -6814
Rpl24 -6576 1391 -3886 6934 -6380
Rpl26 -6659 1690 -587 7025 -6436
Rpl27 -6845 1737 -3419 6972 -3911
Rpl27a -5517 3660 -2513 5849 -4735
Rpl28 -1279 5641 -1248 5705 -5460
Rpl29 -1125 4140 -4187 6593 -5922
Rpl3 -4393 97 1158 6008 -4443
Rpl30 -3489 -1769 -4305 6489 -7269
Rpl31 -6836 -3203 -1412 7055 -6596
Rpl32 -4734 -2231 1048 7325 -5634
Rpl34 -5472 -4039 -1304 7052 -5665
Rpl35 -5746 -5044 -3769 7203 -6944
Rpl35a -5482 -3840 570 7450 -6779
Rpl36 -4150 -526 -925 7394 -6244
Rpl36a -5737 966 -3217 6846 -6933
Rpl36al -5513 1911 -471 7142 -7041
Rpl37 -4803 -2009 -157 7169 -7308
Rpl37a -5196 -2693 70 7353 -7233
Rpl38 -4285 -3890 857 7427 -7458
Rpl39 -6226 -2451 1477 7435 -7398
Rpl4 -4925 1852 -4074 6135 -4712
Rpl5 5744 -2476 -3141 5665 42
Rpl6 -5411 5527 -1164 5021 -4217
Rpl7 -5113 1762 151 6242 -4040
Rpl7a -3564 4076 1931 6938 -2667
Rpl8 -3703 3543 -3664 6481 -4491
Rpl9 -5504 344 903 6756 -2526
Rplp0 -3763 4412 -942 6357 956
Rplp1 -3659 -3603 -814 6990 -6512
Rplp2 -1405 721 5081 7200 -5799
Rps10 -5436 1596 -1596 7118 -2524
Rps11 -6088 -966 -1330 6240 -6425
Rps12 -6536 2445 -4827 7047 -5574
Rps13 -2674 -235 -1978 6430 -3919
Rps14 -3675 1734 3410 7146 -3493
Rps15 -5634 2477 239 7130 -5513
Rps15a 369 608 -3369 6779 -5204
Rps16 -4792 2799 -1537 6267 -5455
Rps17 -5260 -1557 1246 7182 -6746
Rps18 -4838 1158 194 6830 -4753
Rps19 -6105 -2857 -5576 6611 -5782
Rps2 -2017 387 -812 6266 -3726
Rps20 -4819 -1197 -4402 5625 -7090
Rps21 -4549 -3950 -722 7488 -7191
Rps23 -6959 2961 -3533 6890 -7067
Rps24 -6377 -301 -5394 5997 -5015
Rps25 -6573 -1150 -1883 6238 -5538
Rps26 -5325 3572 -3697 5769 -6007
Rps27 -5449 -2098 2068 7449 -7364
Rps27a -6372 -7132 -2043 6853 -6401
Rps27l -4990 -3246 -4325 6048 -3758
Rps28 -2854 -2799 2837 7397 -7470
Rps29 -234 -4717 -446 7482 -7465
Rps3 -5535 1738 -2705 6117 -1500
Rps3a1 -6001 295 -2164 5731 -4251
Rps4x -3555 -300 -4680 5409 -4453
Rps5 -4284 1344 -1916 5993 -4583
Rps6 -4272 4707 1599 6014 -5295
Rps7 -5696 1849 -3387 6808 -5804
Rps8 -6704 -566 -5243 7004 -6741
Rps9 -5004 1757 -844 6794 -4576
Rpsa -5034 -2245 -4844 5145 -2970
Uba52 -2504 5042 585 6605 -5655





SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE

SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE
metric value
setSize 106
pMANOVA 6.08e-69
p.adjustMANOVA 2.33e-66
s.dist 1.1
s.hyp -0.481
s.hip 0.0605
s.amy -0.206
s.pag 0.755
s.ni -0.611
p.hyp 1.13e-17
p.hip 0.282
p.amy 0.000243
p.pag 2.89e-41
p.ni 1.58e-27



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag ni
Rps29 7482 -7465
Rpl38 7427 -7458
Rps28 7397 -7470
Rpl39 7435 -7398
Rps27 7449 -7364
Rps21 7488 -7191
Rpl37a 7353 -7233
Rpl37 7169 -7308
Rpl23 6983 -7403
Rpl35a 7450 -6779
Rpl36al 7142 -7041
Rpl35 7203 -6944
Sec61b 7337 -6763
Rps23 6890 -7067
Rps17 7182 -6746
Rpl36a 6846 -6933
Rps8 7004 -6741
Rpl30 6489 -7269
Rpl21 6613 -7105
Rpl31 7055 -6596

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Ddost -3345 -3221 2102 2616 -4771
Fau -5907 1583 1608 7212 -5383
Rpl10 7552 2305 -6483 1980 1798
Rpl10a -4754 5887 -3904 6315 -6264
Rpl11 -7040 -1610 -1752 7106 -5100
Rpl12 -1293 111 -1276 5593 -4815
Rpl13 -5435 705 -309 7111 -4751
Rpl13a -6127 -800 -4926 6137 -3678
Rpl14 -4973 3377 -3827 6231 -6184
Rpl15 -1081 4664 -97 5670 -5225
Rpl17 -6154 1812 -4356 5972 -3587
Rpl18 -3623 1407 1250 6814 -5632
Rpl18a -1090 3984 -5189 6777 -4423
Rpl19 -6145 1844 1393 7139 -5256
Rpl21 -5242 1494 -2632 6613 -7105
Rpl22 2309 1493 135 7361 -5393
Rpl22l1 -6274 -4977 -2367 6270 -5683
Rpl23 -4886 -1314 -5284 6983 -7403
Rpl23a -5685 181 -4668 5986 -6814
Rpl24 -6576 1391 -3886 6934 -6380
Rpl26 -6659 1690 -587 7025 -6436
Rpl27 -6845 1737 -3419 6972 -3911
Rpl27a -5517 3660 -2513 5849 -4735
Rpl28 -1279 5641 -1248 5705 -5460
Rpl29 -1125 4140 -4187 6593 -5922
Rpl3 -4393 97 1158 6008 -4443
Rpl30 -3489 -1769 -4305 6489 -7269
Rpl31 -6836 -3203 -1412 7055 -6596
Rpl32 -4734 -2231 1048 7325 -5634
Rpl34 -5472 -4039 -1304 7052 -5665
Rpl35 -5746 -5044 -3769 7203 -6944
Rpl35a -5482 -3840 570 7450 -6779
Rpl36 -4150 -526 -925 7394 -6244
Rpl36a -5737 966 -3217 6846 -6933
Rpl36al -5513 1911 -471 7142 -7041
Rpl37 -4803 -2009 -157 7169 -7308
Rpl37a -5196 -2693 70 7353 -7233
Rpl38 -4285 -3890 857 7427 -7458
Rpl39 -6226 -2451 1477 7435 -7398
Rpl4 -4925 1852 -4074 6135 -4712
Rpl5 5744 -2476 -3141 5665 42
Rpl6 -5411 5527 -1164 5021 -4217
Rpl7 -5113 1762 151 6242 -4040
Rpl7a -3564 4076 1931 6938 -2667
Rpl8 -3703 3543 -3664 6481 -4491
Rpl9 -5504 344 903 6756 -2526
Rplp0 -3763 4412 -942 6357 956
Rplp1 -3659 -3603 -814 6990 -6512
Rplp2 -1405 721 5081 7200 -5799
Rpn1 -4337 -7680 -5653 954 -6688
Rpn2 567 2281 -341 -1514 -2629
Rps10 -5436 1596 -1596 7118 -2524
Rps11 -6088 -966 -1330 6240 -6425
Rps12 -6536 2445 -4827 7047 -5574
Rps13 -2674 -235 -1978 6430 -3919
Rps14 -3675 1734 3410 7146 -3493
Rps15 -5634 2477 239 7130 -5513
Rps15a 369 608 -3369 6779 -5204
Rps16 -4792 2799 -1537 6267 -5455
Rps17 -5260 -1557 1246 7182 -6746
Rps18 -4838 1158 194 6830 -4753
Rps19 -6105 -2857 -5576 6611 -5782
Rps2 -2017 387 -812 6266 -3726
Rps20 -4819 -1197 -4402 5625 -7090
Rps21 -4549 -3950 -722 7488 -7191
Rps23 -6959 2961 -3533 6890 -7067
Rps24 -6377 -301 -5394 5997 -5015
Rps25 -6573 -1150 -1883 6238 -5538
Rps26 -5325 3572 -3697 5769 -6007
Rps27 -5449 -2098 2068 7449 -7364
Rps27a -6372 -7132 -2043 6853 -6401
Rps27l -4990 -3246 -4325 6048 -3758
Rps28 -2854 -2799 2837 7397 -7470
Rps29 -234 -4717 -446 7482 -7465
Rps3 -5535 1738 -2705 6117 -1500
Rps3a1 -6001 295 -2164 5731 -4251
Rps4x -3555 -300 -4680 5409 -4453
Rps5 -4284 1344 -1916 5993 -4583
Rps6 -4272 4707 1599 6014 -5295
Rps7 -5696 1849 -3387 6808 -5804
Rps8 -6704 -566 -5243 7004 -6741
Rps9 -5004 1757 -844 6794 -4576
Rpsa -5034 -2245 -4844 5145 -2970
Sec11a -7127 -6550 -5434 6199 -3396
Sec11c -6474 -2330 -1390 7039 -5441
Sec61a1 -1747 -8379 -6972 893 -2327
Sec61a2 2624 -7285 696 1163 -1570
Sec61b -3658 2229 2906 7337 -6763
Sec61g -2940 -4761 -6122 6367 3468
Spcs1 -4369 1863 -1685 6189 -4700
Spcs2 -5799 -5164 -4098 4006 -4171
Spcs3 -5662 -7747 582 5 7366
Srp14 -6588 1875 1614 6416 -5439
Srp19 -5268 6274 -2237 5258 -5856
Srp54a 1906 -2837 -5232 1541 -2688
Srp68 1016 -7311 1841 -1098 6797
Srp72 3704 4824 509 -5882 1592
Srp9 -4785 4091 702 6767 -1805
Srpr 2424 -3797 -3773 -5219 6962
Srprb -4307 -4558 -1862 4654 -2825
Ssr1 1409 -340 -3512 -2483 1323
Ssr2 -3113 4494 3015 5354 -290
Ssr3 -5658 1122 -2992 2453 3971
Ssr4 -4733 232 2302 5827 -2902
Tram1 -5082 -1901 -2689 -6019 -2866
Uba52 -2504 5042 585 6605 -5655





ATTENUATION PHASE

ATTENUATION PHASE
metric value
setSize 23
pMANOVA 8.18e-10
p.adjustMANOVA 1.33e-08
s.dist 1.09
s.hyp -0.555
s.hip -0.474
s.amy -0.39
s.pag -0.382
s.ni -0.594
p.hyp 4.09e-06
p.hip 8.3e-05
p.amy 0.0012
p.pag 0.00153
p.ni 8.16e-07



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene ni hyp
Serpinh1 -7457 -8169
Hspb1 -7148 -8007
Hspa1b -6798 -8134
Hsph1 -6613 -8099
Fkbp4 -6510 -8071
Hspa1a -6471 -8073
Hsp90ab1 -6462 -7658
Hsp90aa1 -6162 -7973
Hspa8 -6347 -7640
Dnajb1 -5879 -8118
Ptges3 -6040 -7744
Hsf1 -6216 -5123
Hsbp1 -4395 -5762
Ubb -5290 -4378
Dnajb6 -3746 -5164
Mrpl18 -3037 -5890
Hspa1l -6233 -2214

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Col4a6 7726 1733 -5086 -2425 2423
Crebbp 5856 -6540 2739 -5698 -6903
Dedd2 -6503 -6839 -6868 -4963 2937
Dnajb1 -8118 -8530 -7783 -7821 -5879
Dnajb6 -5164 1333 -1168 4244 -3746
Ep300 1346 -3349 -2137 -4410 4066
Fkbp4 -8071 -8446 -7982 -4084 -6510
Hsbp1 -5762 4518 3646 6500 -4395
Hsf1 -5123 -2646 2144 75 -6216
Hsp90aa1 -7973 -8277 -7326 -4822 -6162
Hsp90ab1 -7658 -7115 -4184 -3700 -6462
Hspa1a -8073 -7910 -7847 -7813 -6471
Hspa1b -8134 -8449 -7884 -8270 -6798
Hspa1l -2214 5884 2957 -7401 -6233
Hspa2 2167 -541 7295 -5357 -3387
Hspa8 -7640 -8365 -7244 -4298 -6347
Hspb1 -8007 -8589 -7986 -8289 -7148
Hsph1 -8099 -8525 -7948 -8014 -6613
Mrpl18 -5890 -1549 -1994 5860 -3037
Ptges3 -7744 -7847 -6150 -2080 -6040
Serpinh1 -8169 -8568 -7988 -8376 -7457
Tnfrsf21 -435 -6492 5944 -5259 3980
Ubb -4378 3667 1287 6541 -5290





ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES

ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES
metric value
setSize 10
pMANOVA 0.000453
p.adjustMANOVA 0.00225
s.dist 1.08
s.hyp -0.516
s.hip -0.662
s.amy -0.503
s.pag -0.171
s.ni -0.414
p.hyp 0.0047
p.hip 0.000289
p.amy 0.00589
p.pag 0.35
p.ni 0.0234



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene hip hyp
Hspa5 -8614 -8142
Ddit3 -8557 -8087
Xbp1 -8605 -7999
Hsp90b1 -8424 -7732
Calr -8556 -7354
Atf4 -7556 -5109
Nfyb -3590 -6572
Nfya -6390 -1638

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Atf4 -5109 -7556 -3593 7029 -2762
Atf6 7586 -2375 5449 -3372 8083
Calr -7354 -8556 -7756 -5638 -7238
Ddit3 -8087 -8557 -6904 5070 -7401
Hsp90b1 -7732 -8424 -7893 -4419 -7388
Hspa5 -8142 -8614 -7975 -8202 -7402
Nfya -1638 -6390 -7828 -4497 891
Nfyb -6572 -3590 4348 455 -2550
Nfyc 1976 3520 -45 3546 4908
Xbp1 -7999 -8605 -7945 -7851 -7288





EUKARYOTIC TRANSLATION INITIATION

EUKARYOTIC TRANSLATION INITIATION
metric value
setSize 114
pMANOVA 4.37e-62
p.adjustMANOVA 8.39e-60
s.dist 1.01
s.hyp -0.426
s.hip 0.106
s.amy -0.135
s.pag 0.744
s.ni -0.501
p.hyp 3.8e-15
p.hip 0.0503
p.amy 0.0128
p.pag 5.38e-43
p.ni 2.36e-20



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag ni
Rps29 7482 -7465
Rpl38 7427 -7458
Rps28 7397 -7470
Rpl39 7435 -7398
Rps27 7449 -7364
Rps21 7488 -7191
Rpl37a 7353 -7233
Rpl37 7169 -7308
Rpl23 6983 -7403
Rpl35a 7450 -6779
Rpl36al 7142 -7041
Rpl35 7203 -6944
Rps23 6890 -7067
Rps17 7182 -6746
Rpl36a 6846 -6933
Rps8 7004 -6741
Rpl30 6489 -7269
Rpl21 6613 -7105
Rpl31 7055 -6596
Rpl36 7394 -6244

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Eif1ax -5050 563 -1955 -625 7369
Eif2b1 2982 1450 -901 6024 5116
Eif2b2 -5516 -4454 2377 5658 8178
Eif2b3 2215 2475 828 -950 -3759
Eif2b4 7283 38 2725 4551 2240
Eif2b5 1288 -5596 2078 3337 6169
Eif2s1 -6701 -39 -1217 5813 2921
Eif2s2 -4538 -2403 -5282 4050 -5700
Eif2s3x 17 -3878 -3881 -646 1396
Eif3a -6953 -3944 1407 -5013 -7267
Eif3b 1168 -6669 317 185 1132
Eif3c 5026 1285 6212 1990 -609
Eif3d -246 5830 31 5012 3393
Eif3e -3996 -271 -1571 3711 -2173
Eif3f -1429 -114 5534 4747 1677
Eif3g -6158 4506 -1026 6812 -3309
Eif3h -5774 4130 -1152 6092 398
Eif3i -5204 989 3667 6588 1783
Eif3j1 -933 -3758 -6113 5970 -3553
Eif3j2 -7756 -7169 -7559 -7227 -640
Eif3k -5937 2750 -2777 5339 -2714
Eif3l 1203 1231 2859 4204 1293
Eif3m -3122 5534 -872 6520 2334
Eif4a1 -5925 -6104 4369 5645 -6174
Eif4a2 -6255 2282 -1778 4032 6477
Eif4b 7049 1455 4759 -676 3264
Eif4e -2868 336 -2621 4261 2119
Eif4ebp1 -884 6714 2834 3590 -216
Eif4g1 3439 953 4989 -4135 2939
Eif4h 3731 704 3643 3900 5149
Eif5 1858 2090 1643 4507 7317
Eif5b -1320 -3993 -2163 2055 -7070
Fau -5907 1583 1608 7212 -5383
Pabpc1 -4196 -1362 4329 -2356 -620
Rpl10 7552 2305 -6483 1980 1798
Rpl10a -4754 5887 -3904 6315 -6264
Rpl11 -7040 -1610 -1752 7106 -5100
Rpl12 -1293 111 -1276 5593 -4815
Rpl13 -5435 705 -309 7111 -4751
Rpl13a -6127 -800 -4926 6137 -3678
Rpl14 -4973 3377 -3827 6231 -6184
Rpl15 -1081 4664 -97 5670 -5225
Rpl17 -6154 1812 -4356 5972 -3587
Rpl18 -3623 1407 1250 6814 -5632
Rpl18a -1090 3984 -5189 6777 -4423
Rpl19 -6145 1844 1393 7139 -5256
Rpl21 -5242 1494 -2632 6613 -7105
Rpl22 2309 1493 135 7361 -5393
Rpl22l1 -6274 -4977 -2367 6270 -5683
Rpl23 -4886 -1314 -5284 6983 -7403
Rpl23a -5685 181 -4668 5986 -6814
Rpl24 -6576 1391 -3886 6934 -6380
Rpl26 -6659 1690 -587 7025 -6436
Rpl27 -6845 1737 -3419 6972 -3911
Rpl27a -5517 3660 -2513 5849 -4735
Rpl28 -1279 5641 -1248 5705 -5460
Rpl29 -1125 4140 -4187 6593 -5922
Rpl3 -4393 97 1158 6008 -4443
Rpl30 -3489 -1769 -4305 6489 -7269
Rpl31 -6836 -3203 -1412 7055 -6596
Rpl32 -4734 -2231 1048 7325 -5634
Rpl34 -5472 -4039 -1304 7052 -5665
Rpl35 -5746 -5044 -3769 7203 -6944
Rpl35a -5482 -3840 570 7450 -6779
Rpl36 -4150 -526 -925 7394 -6244
Rpl36a -5737 966 -3217 6846 -6933
Rpl36al -5513 1911 -471 7142 -7041
Rpl37 -4803 -2009 -157 7169 -7308
Rpl37a -5196 -2693 70 7353 -7233
Rpl38 -4285 -3890 857 7427 -7458
Rpl39 -6226 -2451 1477 7435 -7398
Rpl4 -4925 1852 -4074 6135 -4712
Rpl5 5744 -2476 -3141 5665 42
Rpl6 -5411 5527 -1164 5021 -4217
Rpl7 -5113 1762 151 6242 -4040
Rpl7a -3564 4076 1931 6938 -2667
Rpl8 -3703 3543 -3664 6481 -4491
Rpl9 -5504 344 903 6756 -2526
Rplp0 -3763 4412 -942 6357 956
Rplp1 -3659 -3603 -814 6990 -6512
Rplp2 -1405 721 5081 7200 -5799
Rps10 -5436 1596 -1596 7118 -2524
Rps11 -6088 -966 -1330 6240 -6425
Rps12 -6536 2445 -4827 7047 -5574
Rps13 -2674 -235 -1978 6430 -3919
Rps14 -3675 1734 3410 7146 -3493
Rps15 -5634 2477 239 7130 -5513
Rps15a 369 608 -3369 6779 -5204
Rps16 -4792 2799 -1537 6267 -5455
Rps17 -5260 -1557 1246 7182 -6746
Rps18 -4838 1158 194 6830 -4753
Rps19 -6105 -2857 -5576 6611 -5782
Rps2 -2017 387 -812 6266 -3726
Rps20 -4819 -1197 -4402 5625 -7090
Rps21 -4549 -3950 -722 7488 -7191
Rps23 -6959 2961 -3533 6890 -7067
Rps24 -6377 -301 -5394 5997 -5015
Rps25 -6573 -1150 -1883 6238 -5538
Rps26 -5325 3572 -3697 5769 -6007
Rps27 -5449 -2098 2068 7449 -7364
Rps27a -6372 -7132 -2043 6853 -6401
Rps27l -4990 -3246 -4325 6048 -3758
Rps28 -2854 -2799 2837 7397 -7470
Rps29 -234 -4717 -446 7482 -7465
Rps3 -5535 1738 -2705 6117 -1500
Rps3a1 -6001 295 -2164 5731 -4251
Rps4x -3555 -300 -4680 5409 -4453
Rps5 -4284 1344 -1916 5993 -4583
Rps6 -4272 4707 1599 6014 -5295
Rps7 -5696 1849 -3387 6808 -5804
Rps8 -6704 -566 -5243 7004 -6741
Rps9 -5004 1757 -844 6794 -4576
Rpsa -5034 -2245 -4844 5145 -2970
Uba52 -2504 5042 585 6605 -5655





SELENOAMINO ACID METABOLISM

SELENOAMINO ACID METABOLISM
metric value
setSize 107
pMANOVA 6.38e-57
p.adjustMANOVA 8.17e-55
s.dist 1.01
s.hyp -0.423
s.hip 0.128
s.amy -0.158
s.pag 0.717
s.ni -0.525
p.hyp 4.1e-14
p.hip 0.0227
p.amy 0.00468
p.pag 1.01e-37
p.ni 5.83e-21



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag ni
Rps29 7482 -7465
Rpl38 7427 -7458
Rps28 7397 -7470
Rpl39 7435 -7398
Rps27 7449 -7364
Rps21 7488 -7191
Rpl37a 7353 -7233
Rpl37 7169 -7308
Rpl23 6983 -7403
Rpl35a 7450 -6779
Rpl36al 7142 -7041
Rpl35 7203 -6944
Rps23 6890 -7067
Rps17 7182 -6746
Rpl36a 6846 -6933
Rps8 7004 -6741
Rpl30 6489 -7269
Rpl21 6613 -7105
Rpl31 7055 -6596
Rpl36 7394 -6244

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Ahcy -1194 3109 1954 3885 -3002
Aimp1 -2821 5719 3587 6197 -3383
Aimp2 -6494 1723 1316 5025 -1429
Cbs 7220 3331 -1267 3524 5933
Cth -1300 5137 -4665 -4102 6059
Dars -7892 5922 -3590 920 4739
Eef1e1 -4089 2160 -2652 3568 -2112
Eefsec 4076 -2075 7260 -1847 -2318
Eprs 7535 -3999 5735 731 -722
Fau -5907 1583 1608 7212 -5383
Gsr -7789 149 -1532 -1326 -4520
Hnmt -7450 -1938 -4403 5600 -1750
Iars 3479 -5780 -3489 -6464 6023
Kars -3919 -5643 -4095 4476 3554
Lars 7141 5295 6692 2736 1842
Mars1 1094 -4538 4234 181 -4294
Papss1 156 1462 207 -2761 1131
Papss2 -4890 4821 -7690 -4656 892
Pstk -983 419 4484 7232 2128
Qars -1177 -2125 1998 -1044 5216
Rars -1491 -2819 -3228 5096 3454
Rpl10 7552 2305 -6483 1980 1798
Rpl10a -4754 5887 -3904 6315 -6264
Rpl11 -7040 -1610 -1752 7106 -5100
Rpl12 -1293 111 -1276 5593 -4815
Rpl13 -5435 705 -309 7111 -4751
Rpl13a -6127 -800 -4926 6137 -3678
Rpl14 -4973 3377 -3827 6231 -6184
Rpl15 -1081 4664 -97 5670 -5225
Rpl17 -6154 1812 -4356 5972 -3587
Rpl18 -3623 1407 1250 6814 -5632
Rpl18a -1090 3984 -5189 6777 -4423
Rpl19 -6145 1844 1393 7139 -5256
Rpl21 -5242 1494 -2632 6613 -7105
Rpl22 2309 1493 135 7361 -5393
Rpl22l1 -6274 -4977 -2367 6270 -5683
Rpl23 -4886 -1314 -5284 6983 -7403
Rpl23a -5685 181 -4668 5986 -6814
Rpl24 -6576 1391 -3886 6934 -6380
Rpl26 -6659 1690 -587 7025 -6436
Rpl27 -6845 1737 -3419 6972 -3911
Rpl27a -5517 3660 -2513 5849 -4735
Rpl28 -1279 5641 -1248 5705 -5460
Rpl29 -1125 4140 -4187 6593 -5922
Rpl3 -4393 97 1158 6008 -4443
Rpl30 -3489 -1769 -4305 6489 -7269
Rpl31 -6836 -3203 -1412 7055 -6596
Rpl32 -4734 -2231 1048 7325 -5634
Rpl34 -5472 -4039 -1304 7052 -5665
Rpl35 -5746 -5044 -3769 7203 -6944
Rpl35a -5482 -3840 570 7450 -6779
Rpl36 -4150 -526 -925 7394 -6244
Rpl36a -5737 966 -3217 6846 -6933
Rpl36al -5513 1911 -471 7142 -7041
Rpl37 -4803 -2009 -157 7169 -7308
Rpl37a -5196 -2693 70 7353 -7233
Rpl38 -4285 -3890 857 7427 -7458
Rpl39 -6226 -2451 1477 7435 -7398
Rpl4 -4925 1852 -4074 6135 -4712
Rpl5 5744 -2476 -3141 5665 42
Rpl6 -5411 5527 -1164 5021 -4217
Rpl7 -5113 1762 151 6242 -4040
Rpl7a -3564 4076 1931 6938 -2667
Rpl8 -3703 3543 -3664 6481 -4491
Rpl9 -5504 344 903 6756 -2526
Rplp0 -3763 4412 -942 6357 956
Rplp1 -3659 -3603 -814 6990 -6512
Rplp2 -1405 721 5081 7200 -5799
Rps10 -5436 1596 -1596 7118 -2524
Rps11 -6088 -966 -1330 6240 -6425
Rps12 -6536 2445 -4827 7047 -5574
Rps13 -2674 -235 -1978 6430 -3919
Rps14 -3675 1734 3410 7146 -3493
Rps15 -5634 2477 239 7130 -5513
Rps15a 369 608 -3369 6779 -5204
Rps16 -4792 2799 -1537 6267 -5455
Rps17 -5260 -1557 1246 7182 -6746
Rps18 -4838 1158 194 6830 -4753
Rps19 -6105 -2857 -5576 6611 -5782
Rps2 -2017 387 -812 6266 -3726
Rps20 -4819 -1197 -4402 5625 -7090
Rps21 -4549 -3950 -722 7488 -7191
Rps23 -6959 2961 -3533 6890 -7067
Rps24 -6377 -301 -5394 5997 -5015
Rps25 -6573 -1150 -1883 6238 -5538
Rps26 -5325 3572 -3697 5769 -6007
Rps27 -5449 -2098 2068 7449 -7364
Rps27a -6372 -7132 -2043 6853 -6401
Rps27l -4990 -3246 -4325 6048 -3758
Rps28 -2854 -2799 2837 7397 -7470
Rps29 -234 -4717 -446 7482 -7465
Rps3 -5535 1738 -2705 6117 -1500
Rps3a1 -6001 295 -2164 5731 -4251
Rps4x -3555 -300 -4680 5409 -4453
Rps5 -4284 1344 -1916 5993 -4583
Rps6 -4272 4707 1599 6014 -5295
Rps7 -5696 1849 -3387 6808 -5804
Rps8 -6704 -566 -5243 7004 -6741
Rps9 -5004 1757 -844 6794 -4576
Rpsa -5034 -2245 -4844 5145 -2970
Sars -523 3642 2351 4931 712
Scly 3231 4894 -1268 1064 6874
Secisbp2 -2948 -2734 3184 -1713 387
Sephs2 -5146 2835 7038 3598 6996
Sepsecs 6714 -2336 -3554 1576 -1467
Txnrd1 -6413 -4368 -7174 -4169 1474
Uba52 -2504 5042 585 6605 -5655





NONSENSE MEDIATED DECAY NMD

NONSENSE MEDIATED DECAY NMD
metric value
setSize 109
pMANOVA 1.23e-54
p.adjustMANOVA 1.29e-52
s.dist 0.972
s.hyp -0.385
s.hip 0.0938
s.amy -0.12
s.pag 0.669
s.ni -0.572
p.hyp 3.96e-12
p.hip 0.0908
p.amy 0.0307
p.pag 1.36e-33
p.ni 5.59e-25



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag ni
Rps29 7482 -7465
Rpl38 7427 -7458
Rps28 7397 -7470
Rpl39 7435 -7398
Rps27 7449 -7364
Rps21 7488 -7191
Rpl37a 7353 -7233
Rpl37 7169 -7308
Rpl23 6983 -7403
Rpl35a 7450 -6779
Rpl36al 7142 -7041
Rpl35 7203 -6944
Rps23 6890 -7067
Rps17 7182 -6746
Rpl36a 6846 -6933
Rps8 7004 -6741
Rpl30 6489 -7269
Rpl21 6613 -7105
Rpl31 7055 -6596
Rpl36 7394 -6244

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Casc3 4984 -4302 1439 -5352 371
Dcp1a 6453 -2002 1514 -4220 6808
Eif4a3 1584 3787 6555 6201 -4877
Eif4g1 3439 953 4989 -4135 2939
Etf1 -4514 -1719 -5831 2237 745
Fau -5907 1583 1608 7212 -5383
Gspt1 1609 -582 -4047 -5342 6563
Gspt2 -5177 6055 689 -4954 -1529
Magoh -6703 -2382 1798 7239 -4713
Magohb -8083 -7545 1819 6954 -6268
Ncbp1 472 -1721 5922 1206 2493
Ncbp2 -2016 5799 659 5157 -5666
Pabpc1 -4196 -1362 4329 -2356 -620
Pnrc2 -7026 -2716 -7067 2666 2349
Ppp2ca -1717 760 -1274 4992 1219
Ppp2r1a 2450 -1919 5720 293 3525
Ppp2r2a -3671 -864 -3361 -1611 -2344
Rbm8a -7955 -5212 -6869 2235 -7128
Rnps1 -2423 1730 4062 1254 -2459
Rpl10 7552 2305 -6483 1980 1798
Rpl10a -4754 5887 -3904 6315 -6264
Rpl11 -7040 -1610 -1752 7106 -5100
Rpl12 -1293 111 -1276 5593 -4815
Rpl13 -5435 705 -309 7111 -4751
Rpl13a -6127 -800 -4926 6137 -3678
Rpl14 -4973 3377 -3827 6231 -6184
Rpl15 -1081 4664 -97 5670 -5225
Rpl17 -6154 1812 -4356 5972 -3587
Rpl18 -3623 1407 1250 6814 -5632
Rpl18a -1090 3984 -5189 6777 -4423
Rpl19 -6145 1844 1393 7139 -5256
Rpl21 -5242 1494 -2632 6613 -7105
Rpl22 2309 1493 135 7361 -5393
Rpl22l1 -6274 -4977 -2367 6270 -5683
Rpl23 -4886 -1314 -5284 6983 -7403
Rpl23a -5685 181 -4668 5986 -6814
Rpl24 -6576 1391 -3886 6934 -6380
Rpl26 -6659 1690 -587 7025 -6436
Rpl27 -6845 1737 -3419 6972 -3911
Rpl27a -5517 3660 -2513 5849 -4735
Rpl28 -1279 5641 -1248 5705 -5460
Rpl29 -1125 4140 -4187 6593 -5922
Rpl3 -4393 97 1158 6008 -4443
Rpl30 -3489 -1769 -4305 6489 -7269
Rpl31 -6836 -3203 -1412 7055 -6596
Rpl32 -4734 -2231 1048 7325 -5634
Rpl34 -5472 -4039 -1304 7052 -5665
Rpl35 -5746 -5044 -3769 7203 -6944
Rpl35a -5482 -3840 570 7450 -6779
Rpl36 -4150 -526 -925 7394 -6244
Rpl36a -5737 966 -3217 6846 -6933
Rpl36al -5513 1911 -471 7142 -7041
Rpl37 -4803 -2009 -157 7169 -7308
Rpl37a -5196 -2693 70 7353 -7233
Rpl38 -4285 -3890 857 7427 -7458
Rpl39 -6226 -2451 1477 7435 -7398
Rpl4 -4925 1852 -4074 6135 -4712
Rpl5 5744 -2476 -3141 5665 42
Rpl6 -5411 5527 -1164 5021 -4217
Rpl7 -5113 1762 151 6242 -4040
Rpl7a -3564 4076 1931 6938 -2667
Rpl8 -3703 3543 -3664 6481 -4491
Rpl9 -5504 344 903 6756 -2526
Rplp0 -3763 4412 -942 6357 956
Rplp1 -3659 -3603 -814 6990 -6512
Rplp2 -1405 721 5081 7200 -5799
Rps10 -5436 1596 -1596 7118 -2524
Rps11 -6088 -966 -1330 6240 -6425
Rps12 -6536 2445 -4827 7047 -5574
Rps13 -2674 -235 -1978 6430 -3919
Rps14 -3675 1734 3410 7146 -3493
Rps15 -5634 2477 239 7130 -5513
Rps15a 369 608 -3369 6779 -5204
Rps16 -4792 2799 -1537 6267 -5455
Rps17 -5260 -1557 1246 7182 -6746
Rps18 -4838 1158 194 6830 -4753
Rps19 -6105 -2857 -5576 6611 -5782
Rps2 -2017 387 -812 6266 -3726
Rps20 -4819 -1197 -4402 5625 -7090
Rps21 -4549 -3950 -722 7488 -7191
Rps23 -6959 2961 -3533 6890 -7067
Rps24 -6377 -301 -5394 5997 -5015
Rps25 -6573 -1150 -1883 6238 -5538
Rps26 -5325 3572 -3697 5769 -6007
Rps27 -5449 -2098 2068 7449 -7364
Rps27a -6372 -7132 -2043 6853 -6401
Rps27l -4990 -3246 -4325 6048 -3758
Rps28 -2854 -2799 2837 7397 -7470
Rps29 -234 -4717 -446 7482 -7465
Rps3 -5535 1738 -2705 6117 -1500
Rps3a1 -6001 295 -2164 5731 -4251
Rps4x -3555 -300 -4680 5409 -4453
Rps5 -4284 1344 -1916 5993 -4583
Rps6 -4272 4707 1599 6014 -5295
Rps7 -5696 1849 -3387 6808 -5804
Rps8 -6704 -566 -5243 7004 -6741
Rps9 -5004 1757 -844 6794 -4576
Rpsa -5034 -2245 -4844 5145 -2970
Smg1 3917 -8033 -5095 -7406 321
Smg5 7469 3553 7051 4369 8104
Smg6 6779 2126 5259 -6151 -687
Smg7 2631 -6546 414 -7610 2309
Smg8 4635 2703 2249 -3912 -2190
Smg9 5772 5707 7473 5784 335
Uba52 -2504 5042 585 6605 -5655
Upf1 3691 -5182 7561 -6027 2672
Upf2 -3464 -2789 -5456 1772 -4025
Upf3a 6309 4755 7420 4843 -6023
Upf3b -5155 749 -5684 2733 -7352





COMPLEX I BIOGENESIS

COMPLEX I BIOGENESIS
metric value
setSize 56
pMANOVA 3.98e-28
p.adjustMANOVA 2.29e-26
s.dist 0.971
s.hyp -0.504
s.hip 0.0518
s.amy -0.0644
s.pag 0.722
s.ni -0.402
p.hyp 6.85e-11
p.hip 0.502
p.amy 0.405
p.pag 8.79e-21
p.ni 1.9e-07



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag hyp
Ndufaf2 7198 -7557
Ndufa6 7289 -6844
Ndufc1 7415 -6020
Ndufb5 6768 -6381
Ndufv2 6958 -6176
Ndufaf5 5854 -7301
Tmem186 6454 -6371
Ndufaf6 6296 -6441
Ndufs5 7341 -5414
Ndufb8 7254 -5455
Ndufb1 7534 -5136
mt-Nd3 5046 -7666
Ndufb7 7060 -5348
Ndufb2 6803 -5495
Ndufb9 7322 -5088
Ndufs4 7305 -4999
Ndufb3 7318 -4901
Ndufa7 7181 -4884
Ndufa11 7197 -4843
Ndufb6 6739 -5142

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Acad9 -5676 366 -1294 -1492 6692
Ecsit -1051 -2710 -1024 3059 4374
mt-Nd1 -6928 -5185 -7660 -3622 -4224
mt-Nd2 -7861 -4570 -7273 -8198 -1645
mt-Nd3 -7666 -6680 -4666 5046 -7075
mt-Nd4 -7348 -6449 -7717 -6517 -1867
mt-Nd5 -7124 -4082 -7797 -7940 4926
mt-Nd6 -8023 2876 -4700 100 -6865
Ndufa1 -1642 -1771 25 7523 -7305
Ndufa10 -1375 769 49 6233 457
Ndufa11 -4843 2880 3522 7197 -608
Ndufa12 -1267 1783 -1884 7022 -5851
Ndufa13 -493 -2327 -476 7372 -6180
Ndufa2 -4537 -3358 2985 7507 -6445
Ndufa3 -2637 -3209 4823 7520 -6859
Ndufa5 -2620 2624 -4109 7373 -7195
Ndufa6 -6844 2822 1084 7289 -7245
Ndufa7 -4884 3044 195 7181 -719
Ndufa8 -3930 4826 -2935 6143 -2093
Ndufa9 -2068 488 2622 5779 4053
Ndufab1 -719 -1773 1653 6967 -4334
Ndufaf1 -5335 2520 -173 4543 -403
Ndufaf2 -7557 -2229 -89 7198 -1969
Ndufaf3 1992 -3493 6320 6633 -5590
Ndufaf4 -7221 -8261 -7354 3011 -2079
Ndufaf5 -7301 6059 -4640 5854 32
Ndufaf6 -6441 -1241 977 6296 -2306
Ndufaf7 -846 -862 647 5389 -1634
Ndufb1 -5136 -4408 4888 7534 -6898
Ndufb10 -2943 -2704 -955 6844 -5638
Ndufb11 -5045 1491 -1381 6729 -6277
Ndufb2 -5495 -3363 -493 6803 -4662
Ndufb3 -4901 1103 1115 7318 -6494
Ndufb4 -4431 4159 -2771 6606 -1293
Ndufb5 -6381 -2510 270 6768 -3161
Ndufb6 -5142 -5657 1899 6739 -1364
Ndufb7 -5348 4587 1129 7060 -5502
Ndufb8 -5455 591 1725 7254 -333
Ndufb9 -5088 -751 661 7322 -4018
Ndufc1 -6020 -136 -2495 7415 -6066
Ndufc2 -4295 417 -4151 7276 -4063
Ndufs1 3181 5455 2072 1262 6289
Ndufs2 449 1114 1294 6867 -257
Ndufs3 -1117 -2046 2011 6166 -1401
Ndufs4 -4999 3455 -2569 7305 -2336
Ndufs5 -5414 852 1064 7341 -6250
Ndufs6 -3788 -280 2472 7369 -6459
Ndufs7 -1023 4628 -348 5983 355
Ndufs8 -2992 3128 -1185 6711 -1521
Ndufv1 -847 -2170 5300 6852 121
Ndufv2 -6176 1293 -2541 6958 -2516
Ndufv3 -2781 4189 58 6995 -6906
Nubpl -5005 -3952 -2336 6663 2142
Timmdc1 -4766 -2177 3005 6897 95
Tmem126b -5439 2670 -3406 6075 -4984
Tmem186 -6371 6143 5973 6454 -2551





HSF1 ACTIVATION

HSF1 ACTIVATION
metric value
setSize 25
pMANOVA 1.2e-07
p.adjustMANOVA 1.38e-06
s.dist 0.942
s.hyp -0.587
s.hip -0.399
s.amy -0.418
s.pag -0.186
s.ni -0.417
p.hyp 3.83e-07
p.hip 0.000547
p.amy 0.000293
p.pag 0.107
p.ni 0.000306



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene hyp amy
Serpinh1 -8169 -7988
Fkbp4 -8071 -7982
Hsph1 -8099 -7948
Hspa1b -8134 -7884
Hspb1 -8007 -7986
Hspa1a -8073 -7847
Dnajb1 -8118 -7783
Hsp90aa1 -7973 -7326
Ptges3 -7744 -6150
Dedd2 -6503 -6868
Rpa1 -6591 -6403
Hsp90ab1 -7658 -4184
Mrpl18 -5890 -1994
Rpa2 -4626 -2263
Dnajb6 -5164 -1168
Ywhae -4153 -914
Eef1a1 -4411 -379

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Col4a6 7726 1733 -5086 -2425 2423
Dedd2 -6503 -6839 -6868 -4963 2937
Dnajb1 -8118 -8530 -7783 -7821 -5879
Dnajb6 -5164 1333 -1168 4244 -3746
Eef1a1 -4411 2294 -379 5219 -1585
Fkbp4 -8071 -8446 -7982 -4084 -6510
Hdac6 4648 -5277 523 -2780 -1869
Hsbp1 -5762 4518 3646 6500 -4395
Hsf1 -5123 -2646 2144 75 -6216
Hsp90aa1 -7973 -8277 -7326 -4822 -6162
Hsp90ab1 -7658 -7115 -4184 -3700 -6462
Hspa1a -8073 -7910 -7847 -7813 -6471
Hspa1b -8134 -8449 -7884 -8270 -6798
Hspb1 -8007 -8589 -7986 -8289 -7148
Hsph1 -8099 -8525 -7948 -8014 -6613
Mrpl18 -5890 -1549 -1994 5860 -3037
Ptges3 -7744 -7847 -6150 -2080 -6040
Rpa1 -6591 136 -6403 2511 6252
Rpa2 -4626 3845 -2263 -1754 4156
Rpa3 879 -5021 451 2729 6924
Serpinh1 -8169 -8568 -7988 -8376 -7457
Tnfrsf21 -435 -6492 5944 -5259 3980
Ubb -4378 3667 1287 6541 -5290
Vcp -1766 -4700 754 -1631 -5028
Ywhae -4153 1888 -914 603 -860





ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S

ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S
metric value
setSize 59
pMANOVA 6.17e-25
p.adjustMANOVA 3.23e-23
s.dist 0.908
s.hyp -0.448
s.hip 0.0815
s.amy -0.113
s.pag 0.659
s.ni -0.412
p.hyp 2.57e-09
p.hip 0.279
p.amy 0.134
p.pag 2.03e-18
p.ni 4.51e-08



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag hyp
Rps23 6890 -6959
Rps8 7004 -6704
Rps12 7047 -6536
Rps27a 6853 -6372
Fau 7212 -5907
Eif3g 6812 -6158
Rps25 6238 -6573
Rps27 7449 -5449
Rps19 6611 -6105
Rps15 7130 -5634
Eif2s1 5813 -6701
Rps7 6808 -5696
Rps10 7118 -5436
Rps24 5997 -6377
Rps11 6240 -6088
Rps17 7182 -5260
Eif3h 6092 -5774
Rps3a1 5731 -6001
Eif3i 6588 -5204
Rps21 7488 -4549

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Eif1ax -5050 563 -1955 -625 7369
Eif2s1 -6701 -39 -1217 5813 2921
Eif2s2 -4538 -2403 -5282 4050 -5700
Eif2s3x 17 -3878 -3881 -646 1396
Eif3a -6953 -3944 1407 -5013 -7267
Eif3b 1168 -6669 317 185 1132
Eif3c 5026 1285 6212 1990 -609
Eif3d -246 5830 31 5012 3393
Eif3e -3996 -271 -1571 3711 -2173
Eif3f -1429 -114 5534 4747 1677
Eif3g -6158 4506 -1026 6812 -3309
Eif3h -5774 4130 -1152 6092 398
Eif3i -5204 989 3667 6588 1783
Eif3j1 -933 -3758 -6113 5970 -3553
Eif3j2 -7756 -7169 -7559 -7227 -640
Eif3k -5937 2750 -2777 5339 -2714
Eif3l 1203 1231 2859 4204 1293
Eif3m -3122 5534 -872 6520 2334
Eif4a1 -5925 -6104 4369 5645 -6174
Eif4a2 -6255 2282 -1778 4032 6477
Eif4b 7049 1455 4759 -676 3264
Eif4e -2868 336 -2621 4261 2119
Eif4ebp1 -884 6714 2834 3590 -216
Eif4g1 3439 953 4989 -4135 2939
Eif4h 3731 704 3643 3900 5149
Fau -5907 1583 1608 7212 -5383
Pabpc1 -4196 -1362 4329 -2356 -620
Rps10 -5436 1596 -1596 7118 -2524
Rps11 -6088 -966 -1330 6240 -6425
Rps12 -6536 2445 -4827 7047 -5574
Rps13 -2674 -235 -1978 6430 -3919
Rps14 -3675 1734 3410 7146 -3493
Rps15 -5634 2477 239 7130 -5513
Rps15a 369 608 -3369 6779 -5204
Rps16 -4792 2799 -1537 6267 -5455
Rps17 -5260 -1557 1246 7182 -6746
Rps18 -4838 1158 194 6830 -4753
Rps19 -6105 -2857 -5576 6611 -5782
Rps2 -2017 387 -812 6266 -3726
Rps20 -4819 -1197 -4402 5625 -7090
Rps21 -4549 -3950 -722 7488 -7191
Rps23 -6959 2961 -3533 6890 -7067
Rps24 -6377 -301 -5394 5997 -5015
Rps25 -6573 -1150 -1883 6238 -5538
Rps26 -5325 3572 -3697 5769 -6007
Rps27 -5449 -2098 2068 7449 -7364
Rps27a -6372 -7132 -2043 6853 -6401
Rps27l -4990 -3246 -4325 6048 -3758
Rps28 -2854 -2799 2837 7397 -7470
Rps29 -234 -4717 -446 7482 -7465
Rps3 -5535 1738 -2705 6117 -1500
Rps3a1 -6001 295 -2164 5731 -4251
Rps4x -3555 -300 -4680 5409 -4453
Rps5 -4284 1344 -1916 5993 -4583
Rps6 -4272 4707 1599 6014 -5295
Rps7 -5696 1849 -3387 6808 -5804
Rps8 -6704 -566 -5243 7004 -6741
Rps9 -5004 1757 -844 6794 -4576
Rpsa -5034 -2245 -4844 5145 -2970





MITOCHONDRIAL TRANSLATION

MITOCHONDRIAL TRANSLATION
metric value
setSize 93
pMANOVA 8.92e-39
p.adjustMANOVA 5.71e-37
s.dist 0.893
s.hyp -0.317
s.hip 0.256
s.amy -0.0359
s.pag 0.748
s.ni -0.267
p.hyp 1.24e-07
p.hip 2.01e-05
p.amy 0.55
p.pag 9.42e-36
p.ni 8.92e-06



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag hyp
Mrps18c 7176 -7065
Mrps28 7418 -6811
Mrpl14 6661 -7286
Mrpl53 7284 -6639
Mrpl20 7258 -6519
Mrps7 6239 -7344
Mrpl46 6237 -7085
Mrpl52 7390 -5954
Mrps22 5476 -7948
Mrpl48 6942 -6124
Mrpl33 6503 -6497
Gadd45gip1 7248 -5657
Mrpl13 6553 -6207
Mrrf 5073 -7772
Mrpl12 6609 -5882
Mrpl57 6037 -6419
Tsfm 6095 -6083
Mrpl11 6839 -5254
Mrpl28 6773 -5222
Mrpl18 5860 -5890

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Aurkaip1 -3086 3022 42 6936 -4705
Chchd1 -4961 1272 -3652 4586 -4442
Dap3 -1253 -4822 1211 3216 -3270
Eral1 -4952 934 643 4929 3792
Gadd45gip1 -5657 6927 -2559 7248 -6665
Gfm1 -2018 -937 1527 1626 6987
Gfm2 1062 -7473 -3525 -6490 -3291
Mrpl1 992 5947 -2443 6649 5258
Mrpl10 1879 1361 -2761 4599 -1740
Mrpl11 -5254 5334 1665 6839 -3134
Mrpl12 -5882 4072 -2217 6609 -276
Mrpl13 -6207 2695 -1459 6553 -5019
Mrpl14 -7286 -119 1512 6661 -4211
Mrpl15 -2305 1549 863 6178 4693
Mrpl16 -1284 5083 2305 5753 -2518
Mrpl17 -1714 3409 3223 5890 1456
Mrpl18 -5890 -1549 -1994 5860 -3037
Mrpl19 596 -6654 -4785 4294 663
Mrpl2 1870 1052 3513 7315 -2532
Mrpl20 -6519 2377 2323 7258 -3749
Mrpl21 -2110 5249 -981 6671 -4232
Mrpl22 -2060 2064 -5366 5105 -5899
Mrpl23 4859 6608 7517 6345 5644
Mrpl24 -3031 -2024 -898 3526 -4571
Mrpl27 -4208 5727 2391 6774 -4936
Mrpl28 -5222 -318 115 6773 -3335
Mrpl3 1174 5406 2209 4493 5245
Mrpl30 -4723 -7449 -4961 7085 -4843
Mrpl32 -744 1078 -2106 5355 -5809
Mrpl33 -6497 1202 -4073 6503 -5647
Mrpl34 -4227 4066 1161 6463 664
Mrpl35 -4084 -7926 -2449 6136 -3332
Mrpl36 1669 -4014 -3043 5490 899
Mrpl37 -4200 -2415 6182 3310 -2662
Mrpl38 -5630 -1707 -140 5052 5520
Mrpl39 -2052 -2049 -2448 6571 4690
Mrpl4 2848 -3719 587 4090 4241
Mrpl40 -1688 -635 2112 6926 -149
Mrpl41 -1196 4119 -114 7186 -2810
Mrpl42 -4711 1149 -1566 6210 -5136
Mrpl43 2128 6123 3105 6914 -1411
Mrpl44 -330 1775 -2714 6957 -236
Mrpl46 -7085 4523 2912 6237 715
Mrpl47 -5944 2207 -1391 4451 -6722
Mrpl48 -6124 -2533 -1624 6942 -1540
Mrpl49 -2365 5073 -1722 6491 4270
Mrpl50 -1198 1058 -5051 4751 -72
Mrpl51 -4570 404 -5422 7040 -4837
Mrpl52 -5954 1977 -1130 7390 -7235
Mrpl53 -6639 1342 2774 7284 1770
Mrpl54 -2430 6666 1091 7299 -113
Mrpl55 -1268 4941 3529 6330 -3406
Mrpl57 -6419 3753 294 6037 -1433
Mrpl58 -644 7271 -505 7526 -1114
Mrpl9 4967 -648 5546 6962 8185
Mrps10 -1298 2599 1556 6347 -6188
Mrps11 -3356 4316 -4616 4464 -2541
Mrps12 -4618 -969 -2510 7009 -1687
Mrps14 -4998 3422 -1075 6290 -4505
Mrps15 3255 4779 5761 6181 -7028
Mrps16 -3689 -728 3672 7136 -2981
Mrps17 -3198 -4205 721 6176 -2111
Mrps18a -5153 773 375 5147 -4985
Mrps18b 1882 4699 6568 5615 3311
Mrps18c -7065 5718 1280 7176 -4449
Mrps2 -5187 3643 -3063 3194 -1712
Mrps21 -1319 -1469 -1393 7411 -6422
Mrps22 -7948 2226 -3386 5476 27
Mrps23 -1105 2061 446 6563 1203
Mrps24 -3065 4540 -715 6986 -5226
Mrps25 -2151 -2197 1641 4566 -4358
Mrps26 -2660 6707 1526 7237 -2044
Mrps27 -2279 2536 5187 6772 2400
Mrps28 -6811 5250 -284 7418 4481
Mrps30 -1493 -76 -340 2793 7545
Mrps31 -2956 5290 -6391 1471 -6530
Mrps33 -3032 2817 2967 7164 -5463
Mrps34 -1524 5391 4883 7215 -2980
Mrps35 -4109 -2386 -4247 5154 -5105
Mrps36 -528 1971 -5580 6482 -2136
Mrps5 -3252 4678 -5618 1452 -3187
Mrps6 -6365 -347 -3933 5125 -5302
Mrps7 -7344 2502 -1725 6239 -3589
Mrps9 -2595 4672 -159 6221 -6523
Mrrf -7772 1183 -3588 5073 2464
Mtfmt 1689 -5402 6027 5724 -7073
Mtif2 4688 4640 -1816 4425 -3488
Mtif3 -1214 -341 2008 4991 -1724
Mtrf1l -1708 -2289 -7824 -4404 -4230
Oxa1l 2952 3978 5784 2108 7131
Ptcd3 -2581 -4130 -1696 1339 1168
Tsfm -6083 -3471 -166 6095 -696
Tufm 2 -3435 -3801 3887 -1319





RESPIRATORY ELECTRON TRANSPORT

RESPIRATORY ELECTRON TRANSPORT
metric value
setSize 102
pMANOVA 1.1e-43
p.adjustMANOVA 9.74e-42
s.dist 0.882
s.hyp -0.44
s.hip 0.0842
s.amy -0.0591
s.pag 0.697
s.ni -0.298
p.hyp 1.7e-14
p.hip 0.142
p.amy 0.302
p.pag 3.7e-34
p.ni 2.11e-07



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag hyp
Ndufaf2 7198 -7557
Ndufa6 7289 -6844
Ndufc1 7415 -6020
Ndufb5 6768 -6381
Ndufv2 6958 -6176
Uqcr10 7414 -5777
Ndufaf5 5854 -7301
Ndufa4 7443 -5550
Tmem186 6454 -6371
Cox16 6517 -6282
Ndufaf6 6296 -6441
Uqcrh 7167 -5590
Ndufs5 7341 -5414
Ndufb8 7254 -5455
Ndufb1 7534 -5136
mt-Nd3 5046 -7666
Ndufb7 7060 -5348
Ndufb2 6803 -5495
Ndufb9 7322 -5088
Ndufs4 7305 -4999

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Acad9 -5676 366 -1294 -1492 6692
Coq10a -872 174 5512 5642 391
Coq10b -6767 -4385 -6656 -1657 4691
Cox11 -5932 7313 440 3726 8009
Cox14 706 4447 -776 7356 -1516
Cox16 -6282 2257 -655 6517 -6680
Cox18 -3104 -1376 5803 3205 -3296
Cox19 -5148 -5349 3732 5991 873
Cox20 -1044 4893 -7512 6453 -7393
Cox4i1 -3460 -1188 515 7220 -2439
Cox5a -4271 1133 261 7346 -4824
Cox5b -2705 2950 1495 7376 -6255
Cox6a1 -1788 328 -119 7216 -4900
Cox6b1 -3261 -444 1867 7386 -3016
Cox6c -4918 -2459 -1646 7401 -6749
Cox7a2l -4693 1079 -1681 6310 -3384
Cox7b -4523 1796 982 7333 -4507
Cox7c -4742 -5409 -360 7511 -6259
Cox8a -2866 -1850 3090 7510 -4137
Cyc1 -2233 4850 3117 7172 3586
Cycs -4981 -5765 -4663 5515 -1835
Ecsit -1051 -2710 -1024 3059 4374
Etfa -752 6447 -2498 4988 3243
Etfb -1476 2943 -3519 6573 -4684
Etfdh -2121 -2201 843 4969 4804
Lrpprc 4844 219 3885 -1624 4485
mt-Co1 -6566 -5691 -7888 -4846 3504
mt-Co2 -6934 -6438 -7852 -408 -6525
mt-Co3 -7004 -7097 -7148 3668 -3117
mt-Cytb -6223 -5636 -7841 -2825 -4086
mt-Nd1 -6928 -5185 -7660 -3622 -4224
mt-Nd2 -7861 -4570 -7273 -8198 -1645
mt-Nd3 -7666 -6680 -4666 5046 -7075
mt-Nd4 -7348 -6449 -7717 -6517 -1867
mt-Nd5 -7124 -4082 -7797 -7940 4926
mt-Nd6 -8023 2876 -4700 100 -6865
Ndufa1 -1642 -1771 25 7523 -7305
Ndufa10 -1375 769 49 6233 457
Ndufa11 -4843 2880 3522 7197 -608
Ndufa12 -1267 1783 -1884 7022 -5851
Ndufa13 -493 -2327 -476 7372 -6180
Ndufa2 -4537 -3358 2985 7507 -6445
Ndufa3 -2637 -3209 4823 7520 -6859
Ndufa4 -5550 879 695 7443 -6311
Ndufa5 -2620 2624 -4109 7373 -7195
Ndufa6 -6844 2822 1084 7289 -7245
Ndufa7 -4884 3044 195 7181 -719
Ndufa8 -3930 4826 -2935 6143 -2093
Ndufa9 -2068 488 2622 5779 4053
Ndufab1 -719 -1773 1653 6967 -4334
Ndufaf1 -5335 2520 -173 4543 -403
Ndufaf2 -7557 -2229 -89 7198 -1969
Ndufaf3 1992 -3493 6320 6633 -5590
Ndufaf4 -7221 -8261 -7354 3011 -2079
Ndufaf5 -7301 6059 -4640 5854 32
Ndufaf6 -6441 -1241 977 6296 -2306
Ndufaf7 -846 -862 647 5389 -1634
Ndufb1 -5136 -4408 4888 7534 -6898
Ndufb10 -2943 -2704 -955 6844 -5638
Ndufb11 -5045 1491 -1381 6729 -6277
Ndufb2 -5495 -3363 -493 6803 -4662
Ndufb3 -4901 1103 1115 7318 -6494
Ndufb4 -4431 4159 -2771 6606 -1293
Ndufb5 -6381 -2510 270 6768 -3161
Ndufb6 -5142 -5657 1899 6739 -1364
Ndufb7 -5348 4587 1129 7060 -5502
Ndufb8 -5455 591 1725 7254 -333
Ndufb9 -5088 -751 661 7322 -4018
Ndufc1 -6020 -136 -2495 7415 -6066
Ndufc2 -4295 417 -4151 7276 -4063
Ndufs1 3181 5455 2072 1262 6289
Ndufs2 449 1114 1294 6867 -257
Ndufs3 -1117 -2046 2011 6166 -1401
Ndufs4 -4999 3455 -2569 7305 -2336
Ndufs5 -5414 852 1064 7341 -6250
Ndufs6 -3788 -280 2472 7369 -6459
Ndufs7 -1023 4628 -348 5983 355
Ndufs8 -2992 3128 -1185 6711 -1521
Ndufv1 -847 -2170 5300 6852 121
Ndufv2 -6176 1293 -2541 6958 -2516
Ndufv3 -2781 4189 58 6995 -6906
Nubpl -5005 -3952 -2336 6663 2142
Sco1 6003 3379 -1586 -23 -4234
Sco2 -4440 7309 -4790 2005 3240
Sdha 1625 412 -402 -307 2983
Sdhb -3060 1036 4033 6049 2667
Sdhc -3701 1262 -4103 4609 2812
Sdhd -1537 -1697 3628 7189 6034
Surf1 -295 6094 -2113 6860 2659
Taco1 -2002 843 2808 -4123 7664
Timmdc1 -4766 -2177 3005 6897 95
Tmem126b -5439 2670 -3406 6075 -4984
Tmem186 -6371 6143 5973 6454 -2551
Trap1 3061 3914 4469 4129 8176
Uqcr10 -5777 2680 4091 7414 -4487
Uqcr11 -2063 -1401 976 7430 -5850
Uqcrb -3491 -4744 1751 7153 -5743
Uqcrc1 -3385 3074 2069 7101 2064
Uqcrc2 -3878 2883 -1300 5852 5995
Uqcrfs1 -1882 3351 1810 6908 2495
Uqcrh -5590 1885 -1120 7167 -1739
Uqcrq -4697 -513 -713 7472 -5260





ADENYLATE CYCLASE ACTIVATING PATHWAY

ADENYLATE CYCLASE ACTIVATING PATHWAY
metric value
setSize 10
pMANOVA 0.00118
p.adjustMANOVA 0.00497
s.dist 0.875
s.hyp 0.302
s.hip -0.261
s.amy 0.177
s.pag -0.736
s.ni 0.18
p.hyp 0.0983
p.hip 0.153
p.amy 0.332
p.pag 5.54e-05
p.ni 0.323



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag hyp
Adcy5 -7109 5698
Gnal -6523 6117
Adcy2 -5988 5238
Adcy6 -8137 3415
Adcy7 -8304 2896
Adcy3 -7195 2809
Adcy9 -4061 4621
Adcy1 -569 6550

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Adcy1 6550 -5883 1481 -569 7791
Adcy2 5238 -6343 5164 -5988 4022
Adcy3 2809 -8015 5837 -7195 2370
Adcy4 -7925 -7008 -6394 -8405 -6896
Adcy5 5698 1302 4984 -7109 2333
Adcy6 3415 -2399 428 -8137 -2772
Adcy7 2896 1967 -689 -8304 5066
Adcy8 -7137 349 -3569 -6760 -2592
Adcy9 4621 -3268 6495 -4061 4438
Gnal 6117 2185 443 -6523 5570





MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS

MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS
metric value
setSize 13
pMANOVA 0.000223
p.adjustMANOVA 0.00118
s.dist 0.867
s.hyp -0.398
s.hip 0.221
s.amy -0.161
s.pag 0.631
s.ni -0.349
p.hyp 0.0129
p.hip 0.169
p.amy 0.314
p.pag 8.26e-05
p.ni 0.0295



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag hyp
Fdx1 6415 -8058
Lyrm4 6845 -6982
Fxn 6236 -7245
Slc25a28 3934 -7502
Iscu 5975 -4062
Glrx5 6734 -3215
Fdxr 4484 -4599
Hscb 5971 -1232
Isca2 4233 -1561
Nfs1 5681 -697
Fdx2 5881 -436

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Fdx1 -8058 -4624 2558 6415 -4440
Fdx2 -436 605 1510 5881 -4668
Fdxr -4599 -3512 -5745 4484 -2693
Fxn -7245 3296 -7061 6236 -4353
Glrx5 -3215 3846 -912 6734 -4911
Hscb -1232 -1359 412 5971 3881
Isca1 1604 -2045 -5126 4994 3655
Isca2 -1561 5953 -524 4233 -5852
Iscu -4062 4877 -3860 5975 -3034
Lyrm4 -6982 4014 -1683 6845 -4536
Nfs1 -697 6247 2962 5681 -602
Slc25a28 -7502 -200 2247 3934 -6708
Slc25a37 248 -2360 -1480 -7456 4461





REGULATION OF EXPRESSION OF SLITS AND ROBOS

REGULATION OF EXPRESSION OF SLITS AND ROBOS
metric value
setSize 159
pMANOVA 1.64e-62
p.adjustMANOVA 3.77e-60
s.dist 0.866
s.hyp -0.413
s.hip 0.0693
s.amy -0.0752
s.pag 0.593
s.ni -0.466
p.hyp 2.84e-19
p.hip 0.132
p.amy 0.102
p.pag 3.09e-38
p.ni 3.43e-24



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag ni
Rps29 7482 -7465
Rpl38 7427 -7458
Rps28 7397 -7470
Rpl39 7435 -7398
Rps27 7449 -7364
Rps21 7488 -7191
Rpl37a 7353 -7233
Rpl37 7169 -7308
Rpl23 6983 -7403
Rpl35a 7450 -6779
Rpl36al 7142 -7041
Rpl35 7203 -6944
Rps23 6890 -7067
Rps17 7182 -6746
Rpl36a 6846 -6933
Rps8 7004 -6741
Rpl30 6489 -7269
Rpl21 6613 -7105
Rpl31 7055 -6596
Sem1 6969 -6676

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Casc3 4984 -4302 1439 -5352 371
Col4a5 -3232 -4673 1386 -5890 -2276
Cul2 -6654 -515 -1156 1450 2026
Dag1 -866 -1433 -3459 -6302 4086
Eif4a3 1584 3787 6555 6201 -4877
Eif4g1 3439 953 4989 -4135 2939
Elob -4620 2590 -1125 5610 -6996
Eloc -6626 458 -2989 5900 190
Etf1 -4514 -1719 -5831 2237 745
Fau -5907 1583 1608 7212 -5383
Gspt1 1609 -582 -4047 -5342 6563
Gspt2 -5177 6055 689 -4954 -1529
Ldb1 1262 -2548 5905 -492 -5188
Lhx2 7722 1201 -528 -8323 -2401
Lhx9 1585 4716 -7335 -8123 -3999
Magoh -6703 -2382 1798 7239 -4713
Magohb -8083 -7545 1819 6954 -6268
Msi1 -732 -116 -626 -5345 -5783
Ncbp1 472 -1721 5922 1206 2493
Ncbp2 -2016 5799 659 5157 -5666
Pabpc1 -4196 -1362 4329 -2356 -620
Psma1 -7420 -4010 -2108 4832 1858
Psma2 -5644 3865 -2900 6209 1865
Psma3 -6066 979 -2046 7155 -4041
Psma4 -7504 977 368 6831 -5642
Psma5 -2124 -1232 2483 4725 2300
Psma6 -5994 3421 -370 6511 835
Psma7 -6285 2069 2339 6865 571
Psmb1 -5858 -1406 -2701 5823 -2062
Psmb10 -3492 4071 526 5974 -4727
Psmb2 -634 4648 5325 7007 830
Psmb3 -6332 -4121 2181 7151 -84
Psmb4 -4320 1432 -1045 6715 -3833
Psmb5 -3602 1198 3279 7354 -522
Psmb6 -5672 -1356 -959 6933 -4272
Psmb7 -1170 1445 2791 7138 -1108
Psmb8 -4080 -6385 -7753 1678 -7164
Psmb9 -4395 2842 -6017 -1361 -6203
Psmc1 -3306 -2805 3510 5660 -2811
Psmc2 -6518 3638 311 5333 14
Psmc3 -2810 -6533 330 5063 -1709
Psmc4 -1805 -523 3727 6567 -1984
Psmc5 -3339 1551 -4032 5126 -3280
Psmc6 -6889 -1882 -5077 3383 2777
Psmd1 -6211 -4112 2043 1517 1743
Psmd10 -5057 5662 -811 3277 1494
Psmd11 -3954 -7414 -6745 -3634 -2989
Psmd12 -7136 -641 -4440 3580 -1003
Psmd13 -420 3420 1880 6754 -3079
Psmd14 -6510 -4665 1516 5163 1500
Psmd2 5901 -1504 6553 -254 4336
Psmd3 6 -1368 4418 6572 -1820
Psmd4 -3476 -556 3530 4997 -899
Psmd5 -7412 -4455 -6171 -4153 7500
Psmd6 -5055 -1678 -1384 2086 1811
Psmd7 88 -5762 6557 6395 -2888
Psmd8 -1002 758 5775 5963 -933
Psmd9 -869 -4765 -1399 6885 -2353
Psme1 -4847 4903 2140 6188 -6113
Psme2 -5948 -131 -860 4745 -6182
Psme3 2209 -3777 5865 -3604 6598
Psme4 6160 -6527 -5452 -4504 4226
Psmf1 2377 3789 7161 2699 6535
Rbm8a -7955 -5212 -6869 2235 -7128
Rbx1 234 -1186 -2007 6309 -3980
Rnps1 -2423 1730 4062 1254 -2459
Robo1 -2715 -456 -179 -7831 6091
Robo2 6889 -5001 6428 -4801 7272
Robo3 6257 -7159 4337 -6539 -164
Rpl10 7552 2305 -6483 1980 1798
Rpl10a -4754 5887 -3904 6315 -6264
Rpl11 -7040 -1610 -1752 7106 -5100
Rpl12 -1293 111 -1276 5593 -4815
Rpl13 -5435 705 -309 7111 -4751
Rpl13a -6127 -800 -4926 6137 -3678
Rpl14 -4973 3377 -3827 6231 -6184
Rpl15 -1081 4664 -97 5670 -5225
Rpl17 -6154 1812 -4356 5972 -3587
Rpl18 -3623 1407 1250 6814 -5632
Rpl18a -1090 3984 -5189 6777 -4423
Rpl19 -6145 1844 1393 7139 -5256
Rpl21 -5242 1494 -2632 6613 -7105
Rpl22 2309 1493 135 7361 -5393
Rpl22l1 -6274 -4977 -2367 6270 -5683
Rpl23 -4886 -1314 -5284 6983 -7403
Rpl23a -5685 181 -4668 5986 -6814
Rpl24 -6576 1391 -3886 6934 -6380
Rpl26 -6659 1690 -587 7025 -6436
Rpl27 -6845 1737 -3419 6972 -3911
Rpl27a -5517 3660 -2513 5849 -4735
Rpl28 -1279 5641 -1248 5705 -5460
Rpl29 -1125 4140 -4187 6593 -5922
Rpl3 -4393 97 1158 6008 -4443
Rpl30 -3489 -1769 -4305 6489 -7269
Rpl31 -6836 -3203 -1412 7055 -6596
Rpl32 -4734 -2231 1048 7325 -5634
Rpl34 -5472 -4039 -1304 7052 -5665
Rpl35 -5746 -5044 -3769 7203 -6944
Rpl35a -5482 -3840 570 7450 -6779
Rpl36 -4150 -526 -925 7394 -6244
Rpl36a -5737 966 -3217 6846 -6933
Rpl36al -5513 1911 -471 7142 -7041
Rpl37 -4803 -2009 -157 7169 -7308
Rpl37a -5196 -2693 70 7353 -7233
Rpl38 -4285 -3890 857 7427 -7458
Rpl39 -6226 -2451 1477 7435 -7398
Rpl4 -4925 1852 -4074 6135 -4712
Rpl5 5744 -2476 -3141 5665 42
Rpl6 -5411 5527 -1164 5021 -4217
Rpl7 -5113 1762 151 6242 -4040
Rpl7a -3564 4076 1931 6938 -2667
Rpl8 -3703 3543 -3664 6481 -4491
Rpl9 -5504 344 903 6756 -2526
Rplp0 -3763 4412 -942 6357 956
Rplp1 -3659 -3603 -814 6990 -6512
Rplp2 -1405 721 5081 7200 -5799
Rps10 -5436 1596 -1596 7118 -2524
Rps11 -6088 -966 -1330 6240 -6425
Rps12 -6536 2445 -4827 7047 -5574
Rps13 -2674 -235 -1978 6430 -3919
Rps14 -3675 1734 3410 7146 -3493
Rps15 -5634 2477 239 7130 -5513
Rps15a 369 608 -3369 6779 -5204
Rps16 -4792 2799 -1537 6267 -5455
Rps17 -5260 -1557 1246 7182 -6746
Rps18 -4838 1158 194 6830 -4753
Rps19 -6105 -2857 -5576 6611 -5782
Rps2 -2017 387 -812 6266 -3726
Rps20 -4819 -1197 -4402 5625 -7090
Rps21 -4549 -3950 -722 7488 -7191
Rps23 -6959 2961 -3533 6890 -7067
Rps24 -6377 -301 -5394 5997 -5015
Rps25 -6573 -1150 -1883 6238 -5538
Rps26 -5325 3572 -3697 5769 -6007
Rps27 -5449 -2098 2068 7449 -7364
Rps27a -6372 -7132 -2043 6853 -6401
Rps27l -4990 -3246 -4325 6048 -3758
Rps28 -2854 -2799 2837 7397 -7470
Rps29 -234 -4717 -446 7482 -7465
Rps3 -5535 1738 -2705 6117 -1500
Rps3a1 -6001 295 -2164 5731 -4251
Rps4x -3555 -300 -4680 5409 -4453
Rps5 -4284 1344 -1916 5993 -4583
Rps6 -4272 4707 1599 6014 -5295
Rps7 -5696 1849 -3387 6808 -5804
Rps8 -6704 -566 -5243 7004 -6741
Rps9 -5004 1757 -844 6794 -4576
Rpsa -5034 -2245 -4844 5145 -2970
Sem1 -6006 529 -1985 6969 -6676
Slit1 3871 -1008 4020 -7294 120
Slit2 -4111 2740 7297 -5917 3522
Uba52 -2504 5042 585 6605 -5655
Ubb -4378 3667 1287 6541 -5290
Ubc -1247 3415 2683 -2012 -1479
Upf2 -3464 -2789 -5456 1772 -4025
Upf3a 6309 4755 7420 4843 -6023
Upf3b -5155 749 -5684 2733 -7352
Usp33 -6044 -3231 -1192 -7282 6858
Zswim8 1963 -2865 6580 -8108 285





FORMATION OF ATP BY CHEMIOSMOTIC COUPLING

FORMATION OF ATP BY CHEMIOSMOTIC COUPLING
metric value
setSize 18
pMANOVA 1.68e-07
p.adjustMANOVA 1.89e-06
s.dist 0.857
s.hyp -0.307
s.hip -0.0183
s.amy -0.129
s.pag 0.744
s.ni -0.265
p.hyp 0.0242
p.hip 0.893
p.amy 0.345
p.pag 4.54e-08
p.ni 0.0515



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag hyp
Atp5pb 7041 -6320
Atp5h 6974 -6360
Atp5l 6883 -5052
Atp5g1 7378 -4692
Atp5j2 7316 -4698
Atp5o 6868 -4664
Atp5c1 7028 -4528
Atp5j 7355 -3873
Atp5e 7347 -3475
Atp5k 7555 -1416
mt-Atp8 7195 -903
Atp5g3 7058 -864
Atp5b 6630 -231
mt-Atp6 106 -5861

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Atp5a1 85 172 1149 1994 5105
Atp5b -231 -1196 -507 6630 4246
Atp5c1 -4528 1091 -16 7028 3513
Atp5d 2242 2763 3781 6545 638
Atp5e -3475 1465 39 7347 -5736
Atp5g1 -4692 -4063 -1542 7378 -921
Atp5g2 26 -1871 -3640 -7013 752
Atp5g3 -864 42 -460 7058 -4178
Atp5h -6360 541 267 6974 -4132
Atp5j -3873 1215 163 7355 -6047
Atp5j2 -4698 -1005 213 7316 -5367
Atp5k -1416 -6858 5172 7555 -7273
Atp5l -5052 -1318 -3961 6883 -3766
Atp5o -4664 4376 2037 6868 43
Atp5pb -6320 3248 -2868 7041 -1118
Dmac2l 3196 -3702 -4386 5033 7358
mt-Atp6 -5861 -4290 -7296 106 -5176
mt-Atp8 -903 -4537 -6588 7195 -7172





RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS

RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS
metric value
setSize 125
pMANOVA 1.57e-49
p.adjustMANOVA 1.51e-47
s.dist 0.841
s.hyp -0.389
s.hip 0.0804
s.amy -0.0697
s.pag 0.687
s.ni -0.27
p.hyp 5.65e-14
p.hip 0.121
p.amy 0.179
p.pag 3.01e-40
p.ni 1.81e-07



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag hyp
Ndufaf2 7198 -7557
Ndufa6 7289 -6844
Ndufc1 7415 -6020
Atp5pb 7041 -6320
Atp5h 6974 -6360
Ndufb5 6768 -6381
Ndufv2 6958 -6176
Uqcr10 7414 -5777
Ndufaf5 5854 -7301
Ndufa4 7443 -5550
Tmem186 6454 -6371
Cox16 6517 -6282
Ndufaf6 6296 -6441
Uqcrh 7167 -5590
Ndufs5 7341 -5414
Ndufb8 7254 -5455
Ndufb1 7534 -5136
mt-Nd3 5046 -7666
Ndufb7 7060 -5348
Ndufb2 6803 -5495

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Acad9 -5676 366 -1294 -1492 6692
Atp5a1 85 172 1149 1994 5105
Atp5b -231 -1196 -507 6630 4246
Atp5c1 -4528 1091 -16 7028 3513
Atp5d 2242 2763 3781 6545 638
Atp5e -3475 1465 39 7347 -5736
Atp5g1 -4692 -4063 -1542 7378 -921
Atp5g2 26 -1871 -3640 -7013 752
Atp5g3 -864 42 -460 7058 -4178
Atp5h -6360 541 267 6974 -4132
Atp5j -3873 1215 163 7355 -6047
Atp5j2 -4698 -1005 213 7316 -5367
Atp5k -1416 -6858 5172 7555 -7273
Atp5l -5052 -1318 -3961 6883 -3766
Atp5o -4664 4376 2037 6868 43
Atp5pb -6320 3248 -2868 7041 -1118
Coq10a -872 174 5512 5642 391
Coq10b -6767 -4385 -6656 -1657 4691
Cox11 -5932 7313 440 3726 8009
Cox14 706 4447 -776 7356 -1516
Cox16 -6282 2257 -655 6517 -6680
Cox18 -3104 -1376 5803 3205 -3296
Cox19 -5148 -5349 3732 5991 873
Cox20 -1044 4893 -7512 6453 -7393
Cox4i1 -3460 -1188 515 7220 -2439
Cox5a -4271 1133 261 7346 -4824
Cox5b -2705 2950 1495 7376 -6255
Cox6a1 -1788 328 -119 7216 -4900
Cox6b1 -3261 -444 1867 7386 -3016
Cox6c -4918 -2459 -1646 7401 -6749
Cox7a2l -4693 1079 -1681 6310 -3384
Cox7b -4523 1796 982 7333 -4507
Cox7c -4742 -5409 -360 7511 -6259
Cox8a -2866 -1850 3090 7510 -4137
Cyc1 -2233 4850 3117 7172 3586
Cycs -4981 -5765 -4663 5515 -1835
Dmac2l 3196 -3702 -4386 5033 7358
Ecsit -1051 -2710 -1024 3059 4374
Etfa -752 6447 -2498 4988 3243
Etfb -1476 2943 -3519 6573 -4684
Etfdh -2121 -2201 843 4969 4804
Lrpprc 4844 219 3885 -1624 4485
mt-Atp6 -5861 -4290 -7296 106 -5176
mt-Atp8 -903 -4537 -6588 7195 -7172
mt-Co1 -6566 -5691 -7888 -4846 3504
mt-Co2 -6934 -6438 -7852 -408 -6525
mt-Co3 -7004 -7097 -7148 3668 -3117
mt-Cytb -6223 -5636 -7841 -2825 -4086
mt-Nd1 -6928 -5185 -7660 -3622 -4224
mt-Nd2 -7861 -4570 -7273 -8198 -1645
mt-Nd3 -7666 -6680 -4666 5046 -7075
mt-Nd4 -7348 -6449 -7717 -6517 -1867
mt-Nd5 -7124 -4082 -7797 -7940 4926
mt-Nd6 -8023 2876 -4700 100 -6865
Ndufa1 -1642 -1771 25 7523 -7305
Ndufa10 -1375 769 49 6233 457
Ndufa11 -4843 2880 3522 7197 -608
Ndufa12 -1267 1783 -1884 7022 -5851
Ndufa13 -493 -2327 -476 7372 -6180
Ndufa2 -4537 -3358 2985 7507 -6445
Ndufa3 -2637 -3209 4823 7520 -6859
Ndufa4 -5550 879 695 7443 -6311
Ndufa5 -2620 2624 -4109 7373 -7195
Ndufa6 -6844 2822 1084 7289 -7245
Ndufa7 -4884 3044 195 7181 -719
Ndufa8 -3930 4826 -2935 6143 -2093
Ndufa9 -2068 488 2622 5779 4053
Ndufab1 -719 -1773 1653 6967 -4334
Ndufaf1 -5335 2520 -173 4543 -403
Ndufaf2 -7557 -2229 -89 7198 -1969
Ndufaf3 1992 -3493 6320 6633 -5590
Ndufaf4 -7221 -8261 -7354 3011 -2079
Ndufaf5 -7301 6059 -4640 5854 32
Ndufaf6 -6441 -1241 977 6296 -2306
Ndufaf7 -846 -862 647 5389 -1634
Ndufb1 -5136 -4408 4888 7534 -6898
Ndufb10 -2943 -2704 -955 6844 -5638
Ndufb11 -5045 1491 -1381 6729 -6277
Ndufb2 -5495 -3363 -493 6803 -4662
Ndufb3 -4901 1103 1115 7318 -6494
Ndufb4 -4431 4159 -2771 6606 -1293
Ndufb5 -6381 -2510 270 6768 -3161
Ndufb6 -5142 -5657 1899 6739 -1364
Ndufb7 -5348 4587 1129 7060 -5502
Ndufb8 -5455 591 1725 7254 -333
Ndufb9 -5088 -751 661 7322 -4018
Ndufc1 -6020 -136 -2495 7415 -6066
Ndufc2 -4295 417 -4151 7276 -4063
Ndufs1 3181 5455 2072 1262 6289
Ndufs2 449 1114 1294 6867 -257
Ndufs3 -1117 -2046 2011 6166 -1401
Ndufs4 -4999 3455 -2569 7305 -2336
Ndufs5 -5414 852 1064 7341 -6250
Ndufs6 -3788 -280 2472 7369 -6459
Ndufs7 -1023 4628 -348 5983 355
Ndufs8 -2992 3128 -1185 6711 -1521
Ndufv1 -847 -2170 5300 6852 121
Ndufv2 -6176 1293 -2541 6958 -2516
Ndufv3 -2781 4189 58 6995 -6906
Nubpl -5005 -3952 -2336 6663 2142
Pm20d1 -460 195 -6635 -7154 6408
Sco1 6003 3379 -1586 -23 -4234
Sco2 -4440 7309 -4790 2005 3240
Sdha 1625 412 -402 -307 2983
Sdhb -3060 1036 4033 6049 2667
Sdhc -3701 1262 -4103 4609 2812
Sdhd -1537 -1697 3628 7189 6034
Slc25a14 -4554 1014 1518 4345 -2419
Slc25a27 2994 -4140 -508 -4968 -6824
Surf1 -295 6094 -2113 6860 2659
Taco1 -2002 843 2808 -4123 7664
Timmdc1 -4766 -2177 3005 6897 95
Tmem126b -5439 2670 -3406 6075 -4984
Tmem186 -6371 6143 5973 6454 -2551
Trap1 3061 3914 4469 4129 8176
Ucp2 7565 7355 6397 7529 7955
Ucp3 7787 6629 -3444 6988 8403
Uqcr10 -5777 2680 4091 7414 -4487
Uqcr11 -2063 -1401 976 7430 -5850
Uqcrb -3491 -4744 1751 7153 -5743
Uqcrc1 -3385 3074 2069 7101 2064
Uqcrc2 -3878 2883 -1300 5852 5995
Uqcrfs1 -1882 3351 1810 6908 2495
Uqcrh -5590 1885 -1120 7167 -1739
Uqcrq -4697 -513 -713 7472 -5260





SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS

SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS
metric value
setSize 11
pMANOVA 0.00116
p.adjustMANOVA 0.00495
s.dist 0.826
s.hyp -0.442
s.hip 0.165
s.amy 0.199
s.pag 0.537
s.ni -0.364
p.hyp 0.0112
p.hip 0.342
p.amy 0.254
p.pag 0.00205
p.ni 0.0368



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag hyp
Snrpf 6924 -6604
Snrpd3 6759 -6090
Snrpe 7364 -5188
Slbp 3956 -5763
Snrpb 5392 -3753
Snrpg 7388 -1736
Ncbp2 5157 -2016
Lsm10 2625 -2737

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Lsm10 -2737 -1568 -945 2625 -5055
Lsm11 -5856 -4711 -456 -4122 6156
Ncbp1 472 -1721 5922 1206 2493
Ncbp2 -2016 5799 659 5157 -5666
Slbp -5763 1364 -4150 3956 2727
Snrpb -3753 314 2874 5392 3672
Snrpd3 -6090 4113 4393 6759 -6403
Snrpe -5188 5342 -793 7364 -7018
Snrpf -6604 2566 4624 6924 -7296
Snrpg -1736 -3264 3990 7388 -6388
Zfp473 -1563 -599 1377 -177 -3755





REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO

REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO
metric value
setSize 10
pMANOVA 0.00107
p.adjustMANOVA 0.00464
s.dist 0.818
s.hyp 0.233
s.hip -0.103
s.amy 0.567
s.pag -0.49
s.ni 0.208
p.hyp 0.202
p.hip 0.572
p.amy 0.00191
p.pag 0.00729
p.ni 0.256



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene amy pag
Slit2 7297 -5917
Robo2 6428 -4801
Nell2 7862 -3820
Slit1 4020 -7294
Robo3 4337 -6539
Src 4443 -3308

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Dcc 2883 -1945 -439 -4529 -3180
Nell2 2237 -2354 7862 -3820 1923
Ntn1 -2865 4380 4528 310 246
Robo1 -2715 -456 -179 -7831 6091
Robo2 6889 -5001 6428 -4801 7272
Robo3 6257 -7159 4337 -6539 -164
Slit1 3871 -1008 4020 -7294 120
Slit2 -4111 2740 7297 -5917 3522
Slit3 2750 -1245 6994 337 4722
Src 1566 -2471 4443 -3308 949





FORMATION OF FIBRIN CLOT CLOTTING CASCADE

FORMATION OF FIBRIN CLOT CLOTTING CASCADE
metric value
setSize 18
pMANOVA 8.81e-07
p.adjustMANOVA 8.38e-06
s.dist 0.811
s.hyp 0.169
s.hip 0.631
s.amy -0.293
s.pag 0.297
s.ni 0.239
p.hyp 0.214
p.hip 3.56e-06
p.amy 0.0312
p.pag 0.0291
p.ni 0.0793



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene hip pag
F3 7347 7540
C1qbp 6114 6818
A2m 7332 4005
Serping1 7036 3323
Prtn3 4107 4779
Serpind1 3258 4959
F2r 7343 1908
Tfpi 5643 2305
Thbd 3380 3778
Gp5 6378 1645
Serpine2 4514 1992
Pros1 6697 1068
F13a1 1662 3998
Serpinc1 2102 295

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
A2m 7498 7332 -134 4005 7093
C1qbp -3397 6114 -1786 6818 -2779
F13a1 3798 1662 -3575 3998 1155
F2r -7968 7343 -5298 1908 3947
F3 5900 7347 3843 7540 8225
F8 1136 6657 -5904 -4104 3109
Gp1ba -5216 2836 7902 -1184 -6285
Gp5 512 6378 -3029 1645 7244
Prcp 1683 -8538 -5058 15 3328
Pros1 7448 6697 -6566 1068 4927
Prtn3 7056 4107 -1808 4779 2459
Serpinc1 -7866 2102 -3199 295 399
Serpind1 -531 3258 -5931 4959 -2730
Serpine2 -6505 4514 -7197 1992 2502
Serping1 6485 7036 -3977 3323 4054
Tfpi 5240 5643 4935 2305 -1591
Thbd 6199 3380 923 3778 6939
Vwf -443 5512 -6247 -8107 1199





SIGNALING BY HIPPO

SIGNALING BY HIPPO
metric value
setSize 20
pMANOVA 7.87e-07
p.adjustMANOVA 7.75e-06
s.dist 0.806
s.hyp -0.401
s.hip -0.0681
s.amy -0.418
s.pag -0.543
s.ni 0.12
p.hyp 0.0019
p.hip 0.598
p.amy 0.0012
p.pag 2.62e-05
p.ni 0.351



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag amy
Amotl1 -8365 -6810
Tjp1 -7565 -6804
Amotl2 -6699 -7126
Tjp2 -6064 -7580
Wwtr1 -8101 -5538
Mob1a -6528 -6360
Stk4 -7287 -5361
Sav1 -5365 -6935
Lats1 -6521 -5335
Mob1b -5983 -5177
Lats2 -3760 -4410
Amot -3116 -3776

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Amot -6433 -859 -3776 -3116 7624
Amotl1 -5853 2512 -6810 -8365 -3295
Amotl2 -8138 -5509 -7126 -6699 4014
Casp3 -7115 6951 -6261 928 3348
Dvl2 2016 -5381 6196 -6308 -166
Lats1 80 1772 -5335 -6521 6386
Lats2 2611 1907 -4410 -3760 7696
Mob1a 5394 642 -6360 -6528 2753
Mob1b 549 -783 -5177 -5983 1607
Nphp4 7608 798 7898 -6590 4611
Sav1 -3347 3437 -6935 -5365 -4599
Stk3 -6397 316 -6437 3080 5683
Stk4 -3164 -5734 -5361 -7287 -1814
Tjp1 -5127 -7568 -6804 -7565 2138
Tjp2 -7727 -5398 -7580 -6064 -1128
Wwc1 -7838 -8161 1453 -8191 -5332
Wwtr1 -7972 -4885 -5538 -8101 -3716
Yap1 -7159 -1987 1051 -6878 -1741
Ywhab -5536 2615 1474 3514 5870
Ywhae -4153 1888 -914 603 -860





RHOBTB2 GTPASE CYCLE

RHOBTB2 GTPASE CYCLE
metric value
setSize 23
pMANOVA 3.79e-05
p.adjustMANOVA 0.000244
s.dist 0.796
s.hyp -0.422
s.hip -0.385
s.amy -0.236
s.pag -0.238
s.ni -0.442
p.hyp 0.000466
p.hip 0.00139
p.amy 0.0498
p.pag 0.0484
p.ni 0.000245



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene ni hyp
Hsp90ab1 -6462 -7658
Hsp90aa1 -6162 -7973
Cct7 -5938 -7381
Phip -5523 -6508
Rhobtb2 -5900 -5283
Cct6a -3098 -7949
Cct2 -2928 -6976
Hnrnpc -3095 -5645
Actn1 -4047 -4097
Cdc37 -4820 -2511
Actg1 -2859 -2521
Ddx39b -5153 -1086
Tra2b -492 -7711
Cul3 -655 -4616
Twf1 -1296 -1485
Stk38 -4956 -287
Tmod3 -246 -4900
Msi2 -106 -758

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Actg1 -2521 -3285 4182 1997 -2859
Actn1 -4097 -7609 5452 -8249 -4047
Cct2 -6976 -6216 -4431 2670 -2928
Cct6a -7949 -4985 -4197 -717 -3098
Cct7 -7381 -8123 -2899 2117 -5938
Cdc37 -2511 3489 3276 5313 -4820
Cul3 -4616 3239 -5743 -5327 -655
Dbn1 2269 -5035 7132 -2838 -2637
Ddx39b -1086 -3497 7087 -532 -5153
Hnrnpc -5645 -3175 -3758 3345 -3095
Hsp90aa1 -7973 -8277 -7326 -4822 -6162
Hsp90ab1 -7658 -7115 -4184 -3700 -6462
Msi2 -758 2558 -5875 -4796 -106
Myo6 1005 -4877 -6881 -4886 3954
Phip -6508 -8397 -6152 -7991 -5523
Rbmx 6518 175 6256 -1963 -6001
Rhobtb2 -5283 -8473 -667 -5498 -5900
Srrm1 1839 -924 2000 -7322 -2672
Stk38 -287 -7128 -5626 -3111 -4956
Tmod3 -4900 -5727 -5963 -4093 -246
Tra2b -7711 -6188 -5181 -722 -492
Twf1 -1485 3077 -6347 -4481 -1296
Txnl1 -7879 1400 -3468 2165 1326





CAMK IV MEDIATED PHOSPHORYLATION OF CREB

CAMK IV MEDIATED PHOSPHORYLATION OF CREB
metric value
setSize 10
pMANOVA 0.00828
p.adjustMANOVA 0.0251
s.dist 0.781
s.hyp 0.349
s.hip -0.255
s.amy 0.496
s.pag -0.14
s.ni 0.398
p.hyp 0.0563
p.hip 0.163
p.amy 0.00662
p.pag 0.444
p.ni 0.0295



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene amy ni
Camkk1 7760 7583
Camkk2 7829 5886
Camk4 4549 7655
Camk2g 2753 7086
Camk2a 6629 2594
Camk2d 4117 3253

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Calm1 -3210 -5777 -2383 480 4856
Camk2a 7207 -4146 6629 -5758 2594
Camk2b 7405 -663 7585 1811 -336
Camk2d 3624 5724 4117 -6480 3253
Camk2g -2481 -772 2753 2961 7086
Camk4 6681 -5705 4549 -2352 7655
Camkk1 7495 669 7760 687 7583
Camkk2 7234 -7198 7829 -2116 5886
Creb1 -6520 -8363 -6284 -8066 984
Kpna2 -1424 -416 7080 3403 -2875





CRISTAE FORMATION

CRISTAE FORMATION
metric value
setSize 31
pMANOVA 1.6e-10
p.adjustMANOVA 2.79e-09
s.dist 0.781
s.hyp -0.275
s.hip 0.052
s.amy -0.0763
s.pag 0.69
s.ni -0.222
p.hyp 0.00811
p.hip 0.617
p.amy 0.462
p.pag 2.84e-11
p.ni 0.0323



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag hyp
Micos13 7227 -6812
Atp5pb 7041 -6320
Atp5h 6974 -6360
Chchd6 6724 -5426
Atp5l 6883 -5052
Atp5g1 7378 -4692
Atp5j2 7316 -4698
Tmem11 6817 -5012
Atp5o 6868 -4664
Atp5c1 7028 -4528
Micos10 6275 -4831
Atp5j 7355 -3873
Atp5e 7347 -3475
Apoo 7345 -2439
Chchd3 7175 -2013
Atp5k 7555 -1416
Apool 3540 -2029
mt-Atp8 7195 -903
Atp5g3 7058 -864
Immt 2423 -2338

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Apoo -2439 5138 -1870 7345 1517
Apool -2029 -799 498 3540 -2403
Atp5a1 85 172 1149 1994 5105
Atp5b -231 -1196 -507 6630 4246
Atp5c1 -4528 1091 -16 7028 3513
Atp5d 2242 2763 3781 6545 638
Atp5e -3475 1465 39 7347 -5736
Atp5g1 -4692 -4063 -1542 7378 -921
Atp5g2 26 -1871 -3640 -7013 752
Atp5g3 -864 42 -460 7058 -4178
Atp5h -6360 541 267 6974 -4132
Atp5j -3873 1215 163 7355 -6047
Atp5j2 -4698 -1005 213 7316 -5367
Atp5k -1416 -6858 5172 7555 -7273
Atp5l -5052 -1318 -3961 6883 -3766
Atp5o -4664 4376 2037 6868 43
Atp5pb -6320 3248 -2868 7041 -1118
Chchd3 -2013 -2411 1394 7175 -2172
Chchd6 -5426 3359 716 6724 -690
Dmac2l 3196 -3702 -4386 5033 7358
Dnajc11 4680 -1605 3615 397 2249
Hspa9 -1762 1791 -3119 -402 2721
Immt -2338 874 -2881 2423 6108
Micos10 -4831 664 -1419 6275 -4875
Micos13 -6812 3871 -2735 7227 -5800
mt-Atp6 -5861 -4290 -7296 106 -5176
mt-Atp8 -903 -4537 -6588 7195 -7172
Mtx1 2550 1923 6338 6889 -1599
Mtx2 -179 -787 2691 5561 -181
Samm50 -638 -7884 1078 -1768 -1324
Tmem11 -5012 3191 -4657 6817 -3983





TRANSLATION

TRANSLATION
metric value
setSize 286
pMANOVA 8.05e-94
p.adjustMANOVA 9.27e-91
s.dist 0.78
s.hyp -0.335
s.hip 0.141
s.amy -0.0779
s.pag 0.618
s.ni -0.298
p.hyp 1.99e-22
p.hip 4.36e-05
p.amy 0.0238
p.pag 1.27e-72
p.ni 4.67e-18



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag hyp
Mrps18c 7176 -7065
Mrps28 7418 -6811
Rpl11 7106 -7040
Mrpl14 6661 -7286
Mrpl53 7284 -6639
Rpl31 7055 -6836
Rps23 6890 -6959
Rpl27 6972 -6845
Mrpl20 7258 -6519
Rps8 7004 -6704
Rpl26 7025 -6659
Rpl39 7435 -6226
Rps12 7047 -6536
Mrps7 6239 -7344
Rpl24 6934 -6576
Sec11c 7039 -6474
Mrpl46 6237 -7085
Sec11a 6199 -7127
Mrpl52 7390 -5954
Rpl19 7139 -6145

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Aars 3200 -1243 4761 -5430 3912
Aars2 -4687 -565 4335 -883 5522
Aimp1 -2821 5719 3587 6197 -3383
Aimp2 -6494 1723 1316 5025 -1429
Apeh 4336 2118 2648 3027 1721
Aurkaip1 -3086 3022 42 6936 -4705
Cars 104 -3364 5878 2833 -3220
Cars2 -3833 -5887 -3336 -16 -4348
Chchd1 -4961 1272 -3652 4586 -4442
Dap3 -1253 -4822 1211 3216 -3270
Dars -7892 5922 -3590 920 4739
Dars2 3965 4103 6574 -804 7994
Ddost -3345 -3221 2102 2616 -4771
Ears2 -7724 -8152 -6952 -7156 -5039
Eef1a1 -4411 2294 -379 5219 -1585
Eef1a2 -2588 1169 4877 143 6668
Eef1b2 -4710 2420 473 6170 -4981
Eef1d -3728 5506 -4520 6179 -1242
Eef1e1 -4089 2160 -2652 3568 -2112
Eef1g -4818 -581 -3602 5481 -4562
Eef2 3372 350 -1855 1302 5577
Eif1ax -5050 563 -1955 -625 7369
Eif2b1 2982 1450 -901 6024 5116
Eif2b2 -5516 -4454 2377 5658 8178
Eif2b3 2215 2475 828 -950 -3759
Eif2b4 7283 38 2725 4551 2240
Eif2b5 1288 -5596 2078 3337 6169
Eif2s1 -6701 -39 -1217 5813 2921
Eif2s2 -4538 -2403 -5282 4050 -5700
Eif2s3x 17 -3878 -3881 -646 1396
Eif3a -6953 -3944 1407 -5013 -7267
Eif3b 1168 -6669 317 185 1132
Eif3c 5026 1285 6212 1990 -609
Eif3d -246 5830 31 5012 3393
Eif3e -3996 -271 -1571 3711 -2173
Eif3f -1429 -114 5534 4747 1677
Eif3g -6158 4506 -1026 6812 -3309
Eif3h -5774 4130 -1152 6092 398
Eif3i -5204 989 3667 6588 1783
Eif3j1 -933 -3758 -6113 5970 -3553
Eif3j2 -7756 -7169 -7559 -7227 -640
Eif3k -5937 2750 -2777 5339 -2714
Eif3l 1203 1231 2859 4204 1293
Eif3m -3122 5534 -872 6520 2334
Eif4a1 -5925 -6104 4369 5645 -6174
Eif4a2 -6255 2282 -1778 4032 6477
Eif4b 7049 1455 4759 -676 3264
Eif4e -2868 336 -2621 4261 2119
Eif4ebp1 -884 6714 2834 3590 -216
Eif4g1 3439 953 4989 -4135 2939
Eif4h 3731 704 3643 3900 5149
Eif5 1858 2090 1643 4507 7317
Eif5b -1320 -3993 -2163 2055 -7070
Eprs 7535 -3999 5735 731 -722
Eral1 -4952 934 643 4929 3792
Etf1 -4514 -1719 -5831 2237 745
Fars2 -1891 66 2600 4980 1813
Farsa 5058 -2253 396 3116 3726
Farsb -4071 1254 -3756 447 6473
Fau -5907 1583 1608 7212 -5383
Gadd45gip1 -5657 6927 -2559 7248 -6665
Gars -1783 -3875 2936 533 2555
Gfm1 -2018 -937 1527 1626 6987
Gfm2 1062 -7473 -3525 -6490 -3291
Gspt1 1609 -582 -4047 -5342 6563
Gspt2 -5177 6055 689 -4954 -1529
Hars -4231 -4776 -1446 -151 4778
Hars2 -4336 -7754 6189 1841 1391
Iars 3479 -5780 -3489 -6464 6023
Iars2 -1282 4470 1856 130 -57
Kars -3919 -5643 -4095 4476 3554
Lars 7141 5295 6692 2736 1842
Lars2 3961 3386 -7671 2923 -2072
Mars1 1094 -4538 4234 181 -4294
Mars2 -1357 -1637 -3125 -5587 -805
Mrpl1 992 5947 -2443 6649 5258
Mrpl10 1879 1361 -2761 4599 -1740
Mrpl11 -5254 5334 1665 6839 -3134
Mrpl12 -5882 4072 -2217 6609 -276
Mrpl13 -6207 2695 -1459 6553 -5019
Mrpl14 -7286 -119 1512 6661 -4211
Mrpl15 -2305 1549 863 6178 4693
Mrpl16 -1284 5083 2305 5753 -2518
Mrpl17 -1714 3409 3223 5890 1456
Mrpl18 -5890 -1549 -1994 5860 -3037
Mrpl19 596 -6654 -4785 4294 663
Mrpl2 1870 1052 3513 7315 -2532
Mrpl20 -6519 2377 2323 7258 -3749
Mrpl21 -2110 5249 -981 6671 -4232
Mrpl22 -2060 2064 -5366 5105 -5899
Mrpl23 4859 6608 7517 6345 5644
Mrpl24 -3031 -2024 -898 3526 -4571
Mrpl27 -4208 5727 2391 6774 -4936
Mrpl28 -5222 -318 115 6773 -3335
Mrpl3 1174 5406 2209 4493 5245
Mrpl30 -4723 -7449 -4961 7085 -4843
Mrpl32 -744 1078 -2106 5355 -5809
Mrpl33 -6497 1202 -4073 6503 -5647
Mrpl34 -4227 4066 1161 6463 664
Mrpl35 -4084 -7926 -2449 6136 -3332
Mrpl36 1669 -4014 -3043 5490 899
Mrpl37 -4200 -2415 6182 3310 -2662
Mrpl38 -5630 -1707 -140 5052 5520
Mrpl39 -2052 -2049 -2448 6571 4690
Mrpl4 2848 -3719 587 4090 4241
Mrpl40 -1688 -635 2112 6926 -149
Mrpl41 -1196 4119 -114 7186 -2810
Mrpl42 -4711 1149 -1566 6210 -5136
Mrpl43 2128 6123 3105 6914 -1411
Mrpl44 -330 1775 -2714 6957 -236
Mrpl46 -7085 4523 2912 6237 715
Mrpl47 -5944 2207 -1391 4451 -6722
Mrpl48 -6124 -2533 -1624 6942 -1540
Mrpl49 -2365 5073 -1722 6491 4270
Mrpl50 -1198 1058 -5051 4751 -72
Mrpl51 -4570 404 -5422 7040 -4837
Mrpl52 -5954 1977 -1130 7390 -7235
Mrpl53 -6639 1342 2774 7284 1770
Mrpl54 -2430 6666 1091 7299 -113
Mrpl55 -1268 4941 3529 6330 -3406
Mrpl57 -6419 3753 294 6037 -1433
Mrpl58 -644 7271 -505 7526 -1114
Mrpl9 4967 -648 5546 6962 8185
Mrps10 -1298 2599 1556 6347 -6188
Mrps11 -3356 4316 -4616 4464 -2541
Mrps12 -4618 -969 -2510 7009 -1687
Mrps14 -4998 3422 -1075 6290 -4505
Mrps15 3255 4779 5761 6181 -7028
Mrps16 -3689 -728 3672 7136 -2981
Mrps17 -3198 -4205 721 6176 -2111
Mrps18a -5153 773 375 5147 -4985
Mrps18b 1882 4699 6568 5615 3311
Mrps18c -7065 5718 1280 7176 -4449
Mrps2 -5187 3643 -3063 3194 -1712
Mrps21 -1319 -1469 -1393 7411 -6422
Mrps22 -7948 2226 -3386 5476 27
Mrps23 -1105 2061 446 6563 1203
Mrps24 -3065 4540 -715 6986 -5226
Mrps25 -2151 -2197 1641 4566 -4358
Mrps26 -2660 6707 1526 7237 -2044
Mrps27 -2279 2536 5187 6772 2400
Mrps28 -6811 5250 -284 7418 4481
Mrps30 -1493 -76 -340 2793 7545
Mrps31 -2956 5290 -6391 1471 -6530
Mrps33 -3032 2817 2967 7164 -5463
Mrps34 -1524 5391 4883 7215 -2980
Mrps35 -4109 -2386 -4247 5154 -5105
Mrps36 -528 1971 -5580 6482 -2136
Mrps5 -3252 4678 -5618 1452 -3187
Mrps6 -6365 -347 -3933 5125 -5302
Mrps7 -7344 2502 -1725 6239 -3589
Mrps9 -2595 4672 -159 6221 -6523
Mrrf -7772 1183 -3588 5073 2464
Mtfmt 1689 -5402 6027 5724 -7073
Mtif2 4688 4640 -1816 4425 -3488
Mtif3 -1214 -341 2008 4991 -1724
Mtrf1l -1708 -2289 -7824 -4404 -4230
N6amt1 -2858 7114 5278 7000 -1276
Nars -4966 -971 -6979 2552 5196
Nars2 4863 606 -441 1143 1622
Oxa1l 2952 3978 5784 2108 7131
Pabpc1 -4196 -1362 4329 -2356 -620
Pars2 36 5386 4577 -5659 -4308
Ppa1 -6926 1357 -4181 4045 -2994
Ppa2 -2490 5091 -382 6994 -2196
Ptcd3 -2581 -4130 -1696 1339 1168
Qars -1177 -2125 1998 -1044 5216
Rars -1491 -2819 -3228 5096 3454
Rars2 4918 5836 -3068 5662 -3739
Rpl10 7552 2305 -6483 1980 1798
Rpl10a -4754 5887 -3904 6315 -6264
Rpl11 -7040 -1610 -1752 7106 -5100
Rpl12 -1293 111 -1276 5593 -4815
Rpl13 -5435 705 -309 7111 -4751
Rpl13a -6127 -800 -4926 6137 -3678
Rpl14 -4973 3377 -3827 6231 -6184
Rpl15 -1081 4664 -97 5670 -5225
Rpl17 -6154 1812 -4356 5972 -3587
Rpl18 -3623 1407 1250 6814 -5632
Rpl18a -1090 3984 -5189 6777 -4423
Rpl19 -6145 1844 1393 7139 -5256
Rpl21 -5242 1494 -2632 6613 -7105
Rpl22 2309 1493 135 7361 -5393
Rpl22l1 -6274 -4977 -2367 6270 -5683
Rpl23 -4886 -1314 -5284 6983 -7403
Rpl23a -5685 181 -4668 5986 -6814
Rpl24 -6576 1391 -3886 6934 -6380
Rpl26 -6659 1690 -587 7025 -6436
Rpl27 -6845 1737 -3419 6972 -3911
Rpl27a -5517 3660 -2513 5849 -4735
Rpl28 -1279 5641 -1248 5705 -5460
Rpl29 -1125 4140 -4187 6593 -5922
Rpl3 -4393 97 1158 6008 -4443
Rpl30 -3489 -1769 -4305 6489 -7269
Rpl31 -6836 -3203 -1412 7055 -6596
Rpl32 -4734 -2231 1048 7325 -5634
Rpl34 -5472 -4039 -1304 7052 -5665
Rpl35 -5746 -5044 -3769 7203 -6944
Rpl35a -5482 -3840 570 7450 -6779
Rpl36 -4150 -526 -925 7394 -6244
Rpl36a -5737 966 -3217 6846 -6933
Rpl36al -5513 1911 -471 7142 -7041
Rpl37 -4803 -2009 -157 7169 -7308
Rpl37a -5196 -2693 70 7353 -7233
Rpl38 -4285 -3890 857 7427 -7458
Rpl39 -6226 -2451 1477 7435 -7398
Rpl4 -4925 1852 -4074 6135 -4712
Rpl5 5744 -2476 -3141 5665 42
Rpl6 -5411 5527 -1164 5021 -4217
Rpl7 -5113 1762 151 6242 -4040
Rpl7a -3564 4076 1931 6938 -2667
Rpl8 -3703 3543 -3664 6481 -4491
Rpl9 -5504 344 903 6756 -2526
Rplp0 -3763 4412 -942 6357 956
Rplp1 -3659 -3603 -814 6990 -6512
Rplp2 -1405 721 5081 7200 -5799
Rpn1 -4337 -7680 -5653 954 -6688
Rpn2 567 2281 -341 -1514 -2629
Rps10 -5436 1596 -1596 7118 -2524
Rps11 -6088 -966 -1330 6240 -6425
Rps12 -6536 2445 -4827 7047 -5574
Rps13 -2674 -235 -1978 6430 -3919
Rps14 -3675 1734 3410 7146 -3493
Rps15 -5634 2477 239 7130 -5513
Rps15a 369 608 -3369 6779 -5204
Rps16 -4792 2799 -1537 6267 -5455
Rps17 -5260 -1557 1246 7182 -6746
Rps18 -4838 1158 194 6830 -4753
Rps19 -6105 -2857 -5576 6611 -5782
Rps2 -2017 387 -812 6266 -3726
Rps20 -4819 -1197 -4402 5625 -7090
Rps21 -4549 -3950 -722 7488 -7191
Rps23 -6959 2961 -3533 6890 -7067
Rps24 -6377 -301 -5394 5997 -5015
Rps25 -6573 -1150 -1883 6238 -5538
Rps26 -5325 3572 -3697 5769 -6007
Rps27 -5449 -2098 2068 7449 -7364
Rps27a -6372 -7132 -2043 6853 -6401
Rps27l -4990 -3246 -4325 6048 -3758
Rps28 -2854 -2799 2837 7397 -7470
Rps29 -234 -4717 -446 7482 -7465
Rps3 -5535 1738 -2705 6117 -1500
Rps3a1 -6001 295 -2164 5731 -4251
Rps4x -3555 -300 -4680 5409 -4453
Rps5 -4284 1344 -1916 5993 -4583
Rps6 -4272 4707 1599 6014 -5295
Rps7 -5696 1849 -3387 6808 -5804
Rps8 -6704 -566 -5243 7004 -6741
Rps9 -5004 1757 -844 6794 -4576
Rpsa -5034 -2245 -4844 5145 -2970
Sars -523 3642 2351 4931 712
Sars2 2073 3945 7679 4920 6199
Sec11a -7127 -6550 -5434 6199 -3396
Sec11c -6474 -2330 -1390 7039 -5441
Sec61a1 -1747 -8379 -6972 893 -2327
Sec61a2 2624 -7285 696 1163 -1570
Sec61b -3658 2229 2906 7337 -6763
Sec61g -2940 -4761 -6122 6367 3468
Spcs1 -4369 1863 -1685 6189 -4700
Spcs2 -5799 -5164 -4098 4006 -4171
Spcs3 -5662 -7747 582 5 7366
Srp14 -6588 1875 1614 6416 -5439
Srp19 -5268 6274 -2237 5258 -5856
Srp54a 1906 -2837 -5232 1541 -2688
Srp68 1016 -7311 1841 -1098 6797
Srp72 3704 4824 509 -5882 1592
Srp9 -4785 4091 702 6767 -1805
Srpr 2424 -3797 -3773 -5219 6962
Srprb -4307 -4558 -1862 4654 -2825
Ssr1 1409 -340 -3512 -2483 1323
Ssr2 -3113 4494 3015 5354 -290
Ssr3 -5658 1122 -2992 2453 3971
Ssr4 -4733 232 2302 5827 -2902
Tars -7623 4920 -4975 330 3508
Tars2 -6945 -3067 4884 2562 -6209
Tram1 -5082 -1901 -2689 -6019 -2866
Trmt112 -2542 6716 -5903 5218 -6826
Tsfm -6083 -3471 -166 6095 -696
Tufm 2 -3435 -3801 3887 -1319
Uba52 -2504 5042 585 6605 -5655
Vars -1428 -5694 1092 508 2665
Vars2 -3160 -3631 751 -8173 797
Wars 2666 -1822 6309 1691 6504
Wars2 340 4354 3320 -8073 3832
Yars -2235 4838 -849 292 5851
Yars2 -444 474 -1756 5487 3562





REGULATION OF RUNX1 EXPRESSION AND ACTIVITY

REGULATION OF RUNX1 EXPRESSION AND ACTIVITY
metric value
setSize 17
pMANOVA 0.000183
p.adjustMANOVA 0.000997
s.dist 0.779
s.hyp 0.119
s.hip -0.429
s.amy -0.163
s.pag -0.578
s.ni -0.221
p.hyp 0.396
p.hip 0.00222
p.amy 0.244
p.pag 3.72e-05
p.ni 0.115



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag hip
Ago3 -8080 -8133
Cdk6 -7574 -7830
Ago2 -7908 -7293
Ccnd2 -8194 -6065
Tnrc6b -5911 -7367
Ccnd1 -4894 -8575
Mov10 -8318 -4851
Cbfb -4395 -8324
Ago4 -4625 -6580
Pml -3743 -5951
Src -3308 -2471

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Ago1 2610 2030 -502 -7431 1967
Ago2 1116 -7293 -3963 -7908 -2195
Ago3 3091 -8133 -6894 -8080 2569
Ago4 -4764 -6580 -7719 -4625 1055
Cbfb -7736 -8324 -6517 -4395 -2457
Ccnd1 -7749 -8575 -2004 -4894 -7027
Ccnd2 1610 -6065 -2292 -8194 -6326
Ccnd3 2906 389 -171 82 1079
Cdk6 -5179 -7830 -4282 -7574 -5178
Mov10 1802 -4851 5394 -8318 -6862
Pml -4085 -5951 2765 -3743 5087
Ptpn11 6553 2873 1961 2579 8298
Runx1 3301 -3005 -3020 443 -5907
Src 1566 -2471 4443 -3308 949
Tnrc6a 6045 21 -2476 -7314 -1813
Tnrc6b 5903 -7367 -3061 -5911 -4397
Tnrc6c 6043 2308 6217 -7044 -427





ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K

ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K
metric value
setSize 11
pMANOVA 0.00554
p.adjustMANOVA 0.0181
s.dist 0.777
s.hyp 0.151
s.hip -0.635
s.amy -0.0855
s.pag -0.402
s.ni 0.0919
p.hyp 0.385
p.hip 0.000264
p.amy 0.624
p.pag 0.0209
p.ni 0.598



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene hip pag
Gab1 -8124 -8153
Pik3cd -7153 -8296
Jak2 -7478 -5348
Pik3ca -7592 -5089
Pik3cg -5565 -6335
Pik3cb -5251 -3920
Irs2 -1332 -4234

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Epor 5719 -5832 6155 636 -1706
Gab1 -8041 -8124 -7710 -8153 -6979
Irs2 1511 -1332 1071 -4234 3315
Jak2 -3055 -7478 -4974 -5348 5153
Lyn -3294 -7194 -7606 2628 1673
Pik3ca -7579 -7592 -7312 -5089 -25
Pik3cb 1265 -5251 2454 -3920 4733
Pik3cd 5623 -7153 6795 -8296 3878
Pik3cg 7511 -5565 4613 -6335 -136
Pik3r1 5354 1098 1928 -4293 543
Pik3r5 6270 -8284 -2895 2392 3044





INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION

INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION
metric value
setSize 12
pMANOVA 0.000169
p.adjustMANOVA 0.000928
s.dist 0.775
s.hyp 0.0314
s.hip 0.599
s.amy -0.429
s.pag 0.165
s.ni 0.169
p.hyp 0.851
p.hip 0.000325
p.amy 0.01
p.pag 0.322
p.ni 0.312



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene hip amy
Pros1 6697 -6566
F8 6657 -5904
Vwf 5512 -6247
Serpine2 4514 -7197
Serping1 7036 -3977
Serpind1 3258 -5931
Gp5 6378 -3029
C1qbp 6114 -1786
Serpinc1 2102 -3199
A2m 7332 -134

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
A2m 7498 7332 -134 4005 7093
C1qbp -3397 6114 -1786 6818 -2779
F8 1136 6657 -5904 -4104 3109
Gp1ba -5216 2836 7902 -1184 -6285
Gp5 512 6378 -3029 1645 7244
Prcp 1683 -8538 -5058 15 3328
Pros1 7448 6697 -6566 1068 4927
Serpinc1 -7866 2102 -3199 295 399
Serpind1 -531 3258 -5931 4959 -2730
Serpine2 -6505 4514 -7197 1992 2502
Serping1 6485 7036 -3977 3323 4054
Vwf -443 5512 -6247 -8107 1199





UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION

UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION
metric value
setSize 21
pMANOVA 1.63e-05
p.adjustMANOVA 0.000114
s.dist 0.769
s.hyp 0.437
s.hip -0.278
s.amy 0.406
s.pag -0.293
s.ni 0.269
p.hyp 0.000523
p.hip 0.0277
p.amy 0.00128
p.pag 0.0203
p.ni 0.0329



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene hyp amy
Camk2b 7405 7585
Grin2c 7709 6726
Camk2a 7207 6629
Grin2b 7286 5901
Gria3 6971 5958
Grin2a 7735 4374
Dlg4 5080 6564
Gria1 6152 4999
Actn2 5000 5279
Grin1 2829 7216
Dlg3 2275 7074
Camk2d 3624 4117
Gria2 2286 3762
Lrrc7 1877 2148

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Actn2 5000 -6366 5279 4139 -6863
Calm1 -3210 -5777 -2383 480 4856
Camk2a 7207 -4146 6629 -5758 2594
Camk2b 7405 -663 7585 1811 -336
Camk2d 3624 5724 4117 -6480 3253
Camk2g -2481 -772 2753 2961 7086
Dlg1 -2526 -6201 60 -478 6813
Dlg2 5792 -4706 -3560 -6197 5701
Dlg3 2275 -6061 7074 -4165 2207
Dlg4 5080 -6512 6564 -2292 -5284
Gria1 6152 -1363 4999 -5220 2242
Gria2 2286 -4974 3762 -6757 -1698
Gria3 6971 -1023 5958 -1351 3445
Gria4 -801 1234 113 -548 6440
Grin1 2829 -3464 7216 -4005 6253
Grin2a 7735 -7350 4374 -4196 4463
Grin2b 7286 -6440 5901 -6614 -2727
Grin2c 7709 2447 6726 1345 8363
Grin2d -620 4842 -1980 -8301 495
Lrrc7 1877 -6764 2148 -6931 997
Nefl -153 -1355 -5259 568 7113





REDUCTION OF CYTOSOLIC CA LEVELS

REDUCTION OF CYTOSOLIC CA LEVELS
metric value
setSize 11
pMANOVA 0.0131
p.adjustMANOVA 0.0362
s.dist 0.763
s.hyp 0.446
s.hip -0.173
s.amy 0.272
s.pag -0.319
s.ni 0.422
p.hyp 0.0105
p.hip 0.319
p.amy 0.119
p.pag 0.0674
p.ni 0.0153



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene hyp ni
Slc8a2 6569 5983
Atp2b3 5390 5646
Atp2b2 6264 4247
Atp2b4 6885 3657
Slc8a3 5482 3119
Atp2a3 6753 2080
Slc8a1 1563 1725

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Atp2a2 -1976 -6303 -224 -5935 6375
Atp2a3 6753 1343 -1279 3840 2080
Atp2b1 6975 -6442 3895 -6483 -365
Atp2b2 6264 -5874 5748 -3152 4247
Atp2b3 5390 3211 4921 -3744 5646
Atp2b4 6885 1283 6673 -6398 3657
Calm1 -3210 -5777 -2383 480 4856
Slc8a1 1563 -7287 -993 -7888 1725
Slc8a2 6569 -2683 7930 -1871 5983
Slc8a3 5482 6557 3827 -3110 3119
Sri -3545 -168 -4218 1597 5179





TRAF6 MEDIATED IRF7 ACTIVATION

TRAF6 MEDIATED IRF7 ACTIVATION
metric value
setSize 15
pMANOVA 0.00331
p.adjustMANOVA 0.0118
s.dist 0.756
s.hyp -0.176
s.hip -0.448
s.amy -0.385
s.pag -0.435
s.ni 0.0476
p.hyp 0.238
p.hip 0.00264
p.amy 0.00989
p.pag 0.00354
p.ni 0.75



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene hip pag
Traf6 -7975 -6680
Tank -5853 -7580
Ddx58 -8007 -5179
Crebbp -6540 -5698
Sike1 -6022 -5176
Ifih1 -2770 -8045
Ikbke -4995 -3261
Ep300 -3349 -4410
Trim25 -4288 -3104
Irf3 -5376 -1185
Mavs -1071 -4923
Traf2 -6830 -546

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Crebbp 5856 -6540 2739 -5698 -6903
Ddx58 -4298 -8007 -2124 -5179 -3533
Ep300 1346 -3349 -2137 -4410 4066
Ifih1 890 -2770 -7809 -8045 -1905
Ikbke -657 -4995 4371 -3261 1491
Irf3 -5768 -5376 -1103 -1185 -7110
Irf7 1101 -8554 -7597 2262 -3028
Mavs -3159 -1071 -1657 -4923 6917
Rnf135 -1744 5488 -4242 -1281 5257
Sike1 -7550 -6022 -3240 -5176 3017
Tank 4790 -5853 -5596 -7580 2567
Tbk1 -6450 3020 -5564 -3672 2664
Traf2 -4243 -6830 -2475 -546 3234
Traf6 -5007 -7975 -7299 -6680 1626
Trim25 1053 -4288 -2307 -3104 4725





TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS

TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS
metric value
setSize 17
pMANOVA 0.000481
p.adjustMANOVA 0.00238
s.dist 0.747
s.hyp 0.441
s.hip -0.1
s.amy 0.554
s.pag -0.112
s.ni 0.185
p.hyp 0.00166
p.hip 0.475
p.amy 7.59e-05
p.pag 0.422
p.ni 0.186



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene amy hyp
Prkca 7641 7016
Prkcb 6373 7139
Ap2b1 6698 6226
Gria3 5958 6971
Prkcg 7502 5151
Gria1 4999 6152
Grip1 4296 7154
Nsf 6748 4475
Ap2a1 6991 3934
Gria2 3762 2286
Pick1 5438 1459
Ap2m1 5424 518
Tspan7 1366 746

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Ap2a1 3934 1830 6991 -1974 5077
Ap2a2 -1706 -4789 6011 -5001 -641
Ap2b1 6226 -5242 6698 -7093 5463
Ap2m1 518 2917 5424 3094 -1755
Ap2s1 -3830 2556 2408 7263 -4706
Gria1 6152 -1363 4999 -5220 2242
Gria2 2286 -4974 3762 -6757 -1698
Gria3 6971 -1023 5958 -1351 3445
Gria4 -801 1234 113 -548 6440
Grip1 7154 2620 4296 -5290 6586
Grip2 3797 2974 -6456 -2101 107
Nsf 4475 2098 6748 -3951 5358
Pick1 1459 -947 5438 4655 -883
Prkca 7016 -4785 7641 -3036 791
Prkcb 7139 -8077 6373 -1079 3865
Prkcg 5151 -4630 7502 2894 3849
Tspan7 746 -4643 1366 2999 -39





LONG TERM POTENTIATION

LONG TERM POTENTIATION
metric value
setSize 23
pMANOVA 1.26e-05
p.adjustMANOVA 8.91e-05
s.dist 0.743
s.hyp 0.442
s.hip -0.289
s.amy 0.325
s.pag -0.328
s.ni 0.246
p.hyp 0.000244
p.hip 0.0165
p.amy 0.007
p.pag 0.0065
p.ni 0.041



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene hyp pag
Grin2b 7286 -6614
Camk2a 7207 -5758
Erbb4 4764 -7731
Dlg2 5792 -6197
Grin2a 7735 -4196
Gria1 6152 -5220
Camk2d 3624 -6480
Gria2 2286 -6757
Lrrc7 1877 -6931
Dlg4 5080 -2292
Grin1 2829 -4005
Dlg3 2275 -4165
Src 1566 -3308

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Actn2 5000 -6366 5279 4139 -6863
Calm1 -3210 -5777 -2383 480 4856
Camk2a 7207 -4146 6629 -5758 2594
Camk2b 7405 -663 7585 1811 -336
Camk2d 3624 5724 4117 -6480 3253
Camk2g -2481 -772 2753 2961 7086
Dlg1 -2526 -6201 60 -478 6813
Dlg2 5792 -4706 -3560 -6197 5701
Dlg3 2275 -6061 7074 -4165 2207
Dlg4 5080 -6512 6564 -2292 -5284
Erbb4 4764 -3200 -5392 -7731 4128
Gria1 6152 -1363 4999 -5220 2242
Gria2 2286 -4974 3762 -6757 -1698
Grin1 2829 -3464 7216 -4005 6253
Grin2a 7735 -7350 4374 -4196 4463
Grin2b 7286 -6440 5901 -6614 -2727
Grin2c 7709 2447 6726 1345 8363
Grin2d -620 4842 -1980 -8301 495
Lrrc7 1877 -6764 2148 -6931 997
Nefl -153 -1355 -5259 568 7113
Nrg1 -383 1943 -4617 -3849 4042
Nrgn 7671 -3823 3249 1016 1864
Src 1566 -2471 4443 -3308 949





INFLUENZA INFECTION

INFLUENZA INFECTION
metric value
setSize 145
pMANOVA 1.16e-41
p.adjustMANOVA 8.32e-40
s.dist 0.742
s.hyp -0.358
s.hip -0.0182
s.amy -0.108
s.pag 0.481
s.ni -0.423
p.hyp 9.47e-14
p.hip 0.705
p.amy 0.0255
p.pag 1.38e-23
p.ni 1.44e-18



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag ni
Rps29 7482 -7465
Rpl38 7427 -7458
Rps28 7397 -7470
Rpl39 7435 -7398
Rps27 7449 -7364
Rps21 7488 -7191
Rpl37a 7353 -7233
Rpl37 7169 -7308
Rpl23 6983 -7403
Polr2l 7528 -6805
Rpl35a 7450 -6779
Rpl36al 7142 -7041
Rpl35 7203 -6944
Rps23 6890 -7067
Rps17 7182 -6746
Rpl36a 6846 -6933
Rps8 7004 -6741
Rpl30 6489 -7269
Rpl21 6613 -7105
Rpl31 7055 -6596

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Aaas 4363 -8487 7277 5048 -92
Calr -7354 -8556 -7756 -5638 -7238
Canx -7011 -5031 -5978 -6732 1684
Clta -4595 6103 2764 5503 1820
Cltc 2826 -3860 1130 -5854 7423
Cpsf4 -4191 2318 7522 485 -4897
Dnajc3 -7880 -8438 -7715 -7017 -6300
Eif2ak2 1083 -8497 -5760 -5156 -2252
Fau -5907 1583 1608 7212 -5383
Grsf1 -2021 5790 -3781 5932 8315
Gtf2f1 -3167 -2326 -184 2998 -5874
Gtf2f2 -3094 6028 -3706 5835 -4944
Hsp90aa1 -7973 -8277 -7326 -4822 -6162
Hspa1a -8073 -7910 -7847 -7813 -6471
Ipo5 -1721 -4846 5723 -1504 3815
Isg15 -7974 -8027 -7403 -6299 -7037
Kpna1 299 -5696 -5744 -4704 4121
Kpna2 -1424 -416 7080 3403 -2875
Kpna3 -8004 -2762 -3870 -7295 8410
Kpna4 -7561 -6154 1200 -3862 8252
Kpnb1 480 -3912 -2013 -6343 3235
Ndc1 2868 -5533 229 -2020 7825
Nup107 538 3895 6063 3867 -402
Nup133 2288 -893 4438 -5990 3285
Nup153 4933 -1425 -3469 -2437 4524
Nup155 5907 -5530 -478 -8029 4440
Nup160 3120 -1981 -4176 -3256 185
Nup188 6629 233 7890 -2605 7217
Nup205 1772 -6620 -358 -7752 3623
Nup210 5309 -6242 5471 -7252 5831
Nup214 1828 355 1352 -4033 -2669
Nup35 -8019 -2953 573 2525 -1663
Nup37 -1215 1701 -195 -3269 -5321
Nup43 -5256 -638 -2168 1237 -1850
Nup50 -4592 -6667 -3076 -6415 5209
Nup54 3600 -668 -5336 7194 -852
Nup62 -1948 -3440 -1398 1316 2609
Nup85 -148 -3865 -105 4250 3474
Nup88 -2564 -2100 5085 760 -1667
Nup93 2223 -3501 6729 -3143 -1784
Nup98 5204 -1666 -5694 -5558 1832
Nupl2 -1949 -1195 -2640 -1238 -2834
Pabpn1 -2254 -2042 5228 1735 -4058
Parp1 5167 3458 7133 -622 5612
Polr2a 3817 3195 7005 -6110 2386
Polr2b 1859 -3814 2977 -2350 6139
Polr2c -3665 -1067 -351 4861 -1046
Polr2d 3856 4361 -1374 3601 -3607
Polr2e -3033 3580 5937 6359 -3867
Polr2f -5573 -562 -4059 7274 -5382
Polr2g -3741 1232 1513 6731 -4181
Polr2h -1953 -4743 88 6981 -1618
Polr2i -6096 -5148 -579 7432 -3750
Polr2j -2039 778 3581 7384 -1213
Polr2k -3217 -284 1604 6714 -6154
Polr2l -2702 -1272 3622 7528 -6805
Pom121 -950 -2392 4175 -7006 5568
Rae1 1118 1246 7492 6151 -298
Ran -6118 -248 2932 4916 -2388
Ranbp2 1731 -6073 -5964 -6211 7830
Rpl10 7552 2305 -6483 1980 1798
Rpl10a -4754 5887 -3904 6315 -6264
Rpl11 -7040 -1610 -1752 7106 -5100
Rpl12 -1293 111 -1276 5593 -4815
Rpl13 -5435 705 -309 7111 -4751
Rpl13a -6127 -800 -4926 6137 -3678
Rpl14 -4973 3377 -3827 6231 -6184
Rpl15 -1081 4664 -97 5670 -5225
Rpl17 -6154 1812 -4356 5972 -3587
Rpl18 -3623 1407 1250 6814 -5632
Rpl18a -1090 3984 -5189 6777 -4423
Rpl19 -6145 1844 1393 7139 -5256
Rpl21 -5242 1494 -2632 6613 -7105
Rpl22 2309 1493 135 7361 -5393
Rpl22l1 -6274 -4977 -2367 6270 -5683
Rpl23 -4886 -1314 -5284 6983 -7403
Rpl23a -5685 181 -4668 5986 -6814
Rpl24 -6576 1391 -3886 6934 -6380
Rpl26 -6659 1690 -587 7025 -6436
Rpl27 -6845 1737 -3419 6972 -3911
Rpl27a -5517 3660 -2513 5849 -4735
Rpl28 -1279 5641 -1248 5705 -5460
Rpl29 -1125 4140 -4187 6593 -5922
Rpl3 -4393 97 1158 6008 -4443
Rpl30 -3489 -1769 -4305 6489 -7269
Rpl31 -6836 -3203 -1412 7055 -6596
Rpl32 -4734 -2231 1048 7325 -5634
Rpl34 -5472 -4039 -1304 7052 -5665
Rpl35 -5746 -5044 -3769 7203 -6944
Rpl35a -5482 -3840 570 7450 -6779
Rpl36 -4150 -526 -925 7394 -6244
Rpl36a -5737 966 -3217 6846 -6933
Rpl36al -5513 1911 -471 7142 -7041
Rpl37 -4803 -2009 -157 7169 -7308
Rpl37a -5196 -2693 70 7353 -7233
Rpl38 -4285 -3890 857 7427 -7458
Rpl39 -6226 -2451 1477 7435 -7398
Rpl4 -4925 1852 -4074 6135 -4712
Rpl5 5744 -2476 -3141 5665 42
Rpl6 -5411 5527 -1164 5021 -4217
Rpl7 -5113 1762 151 6242 -4040
Rpl7a -3564 4076 1931 6938 -2667
Rpl8 -3703 3543 -3664 6481 -4491
Rpl9 -5504 344 903 6756 -2526
Rplp0 -3763 4412 -942 6357 956
Rplp1 -3659 -3603 -814 6990 -6512
Rplp2 -1405 721 5081 7200 -5799
Rps10 -5436 1596 -1596 7118 -2524
Rps11 -6088 -966 -1330 6240 -6425
Rps12 -6536 2445 -4827 7047 -5574
Rps13 -2674 -235 -1978 6430 -3919
Rps14 -3675 1734 3410 7146 -3493
Rps15 -5634 2477 239 7130 -5513
Rps15a 369 608 -3369 6779 -5204
Rps16 -4792 2799 -1537 6267 -5455
Rps17 -5260 -1557 1246 7182 -6746
Rps18 -4838 1158 194 6830 -4753
Rps19 -6105 -2857 -5576 6611 -5782
Rps2 -2017 387 -812 6266 -3726
Rps20 -4819 -1197 -4402 5625 -7090
Rps21 -4549 -3950 -722 7488 -7191
Rps23 -6959 2961 -3533 6890 -7067
Rps24 -6377 -301 -5394 5997 -5015
Rps25 -6573 -1150 -1883 6238 -5538
Rps26 -5325 3572 -3697 5769 -6007
Rps27 -5449 -2098 2068 7449 -7364
Rps27a -6372 -7132 -2043 6853 -6401
Rps27l -4990 -3246 -4325 6048 -3758
Rps28 -2854 -2799 2837 7397 -7470
Rps29 -234 -4717 -446 7482 -7465
Rps3 -5535 1738 -2705 6117 -1500
Rps3a1 -6001 295 -2164 5731 -4251
Rps4x -3555 -300 -4680 5409 -4453
Rps5 -4284 1344 -1916 5993 -4583
Rps6 -4272 4707 1599 6014 -5295
Rps7 -5696 1849 -3387 6808 -5804
Rps8 -6704 -566 -5243 7004 -6741
Rps9 -5004 1757 -844 6794 -4576
Rpsa -5034 -2245 -4844 5145 -2970
Sec13 -6671 26 2130 5485 2317
Seh1l 5956 -2758 6640 -1124 7315
Tgfb1 -6806 -4580 -5587 -452 -787
Tpr 5291 4009 3004 -6130 -2851
Uba52 -2504 5042 585 6605 -5655
Xpo1 -6754 -6101 -6977 -7724 -1601





SYNAPTIC ADHESION LIKE MOLECULES

SYNAPTIC ADHESION LIKE MOLECULES
metric value
setSize 21
pMANOVA 7.75e-06
p.adjustMANOVA 5.95e-05
s.dist 0.742
s.hyp 0.328
s.hip -0.123
s.amy 0.52
s.pag -0.371
s.ni 0.143
p.hyp 0.0092
p.hip 0.33
p.amy 3.74e-05
p.pag 0.00326
p.ni 0.255



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene amy pag
Lrfn4 7556 -6403
Lrfn2 5941 -7845
Grin2b 5901 -6614
Ptprs 7372 -4961
Dlg3 7074 -4165
Grin1 7216 -4005
Gria1 4999 -5220
Lrfn1 5193 -3950
Grin2a 4374 -4196
Ptprf 2682 -6156
Dlg4 6564 -2292
Lrfn3 3009 -3870
Gria3 5958 -1351
Ptprd 260 -6909
Rtn3 2018 -737
Gria4 113 -548
Dlg1 60 -478

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Dlg1 -2526 -6201 60 -478 6813
Dlg3 2275 -6061 7074 -4165 2207
Dlg4 5080 -6512 6564 -2292 -5284
Flot1 -3466 4632 3600 4649 -5860
Flot2 1883 2462 2524 904 6272
Gria1 6152 -1363 4999 -5220 2242
Gria3 6971 -1023 5958 -1351 3445
Gria4 -801 1234 113 -548 6440
Grin1 2829 -3464 7216 -4005 6253
Grin2a 7735 -7350 4374 -4196 4463
Grin2b 7286 -6440 5901 -6614 -2727
Grin2c 7709 2447 6726 1345 8363
Grin2d -620 4842 -1980 -8301 495
Lrfn1 4194 3315 5193 -3950 -1794
Lrfn2 469 3139 5941 -7845 -5676
Lrfn3 -2668 2205 3009 -3870 4730
Lrfn4 -945 -7112 7556 -6403 -2997
Ptprd 2934 -5616 260 -6909 -2463
Ptprf 143 -103 2682 -6156 7921
Ptprs 5976 -4907 7372 -4961 -1833
Rtn3 568 -1898 2018 -737 3370





CELLULAR RESPONSE TO STARVATION

CELLULAR RESPONSE TO STARVATION
metric value
setSize 145
pMANOVA 3.07e-43
p.adjustMANOVA 2.35e-41
s.dist 0.741
s.hyp -0.304
s.hip 0.0548
s.amy -0.0622
s.pag 0.571
s.ni -0.351
p.hyp 2.59e-10
p.hip 0.256
p.amy 0.197
p.pag 1.47e-32
p.ni 3.19e-13



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag ni
Rps29 7482 -7465
Rpl38 7427 -7458
Rps28 7397 -7470
Rpl39 7435 -7398
Rps27 7449 -7364
Rps21 7488 -7191
Rpl37a 7353 -7233
Rpl37 7169 -7308
Rpl23 6983 -7403
Rpl35a 7450 -6779
Rpl36al 7142 -7041
Rpl35 7203 -6944
Rps23 6890 -7067
Rps17 7182 -6746
Rpl36a 6846 -6933
Rps8 7004 -6741
Rpl30 6489 -7269
Rpl21 6613 -7105
Rpl31 7055 -6596
Rpl36 7394 -6244

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Asns 3882 -6268 3921 -1608 3670
Atf2 -2259 -2053 -1225 -6889 4100
Atf3 -7700 -7800 -7270 402 -7377
Atf4 -5109 -7556 -3593 7029 -2762
Atp6v0b -3000 -1762 1490 6318 -2278
Atp6v0c 145 -1137 3074 3296 219
Atp6v0d1 -39 -4833 3798 4934 6676
Atp6v0e 5140 6072 -6401 2015 2433
Atp6v0e2 477 -2581 5428 3773 3497
Atp6v1a -1185 -812 5469 -1248 7878
Atp6v1b2 1049 12 6325 869 6938
Atp6v1c1 -898 -691 2911 4143 3126
Atp6v1c2 -1034 -4211 2675 521 -1897
Atp6v1d -1791 495 1290 3907 -1481
Atp6v1e1 -3768 565 3013 6219 3572
Atp6v1f -2563 3657 273 6975 -1012
Atp6v1g1 -3855 680 -2093 6727 -4612
Atp6v1g2 3736 4687 1585 4719 3383
Atp6v1h -6205 -3480 -831 3446 4328
BC048403 151 -2703 2234 2083 -2305
Bmt2 -5593 -8361 -5925 -6337 2224
Castor1 7102 5723 7838 7343 8364
Castor2 2568 -7866 -4860 -7009 -4853
Cebpb 1867 5859 3905 1566 1301
Cebpg -5947 -3335 -491 -484 -5918
Ddit3 -8087 -8557 -6904 5070 -7401
Depdc5 5572 -3737 3429 -4667 5957
Eif2ak4 6067 4810 662 -4836 -2491
Eif2s1 -6701 -39 -1217 5813 2921
Eif2s2 -4538 -2403 -5282 4050 -5700
Eif2s3x 17 -3878 -3881 -646 1396
Fau -5907 1583 1608 7212 -5383
Flcn 5743 -2266 -346 -5501 53
Fnip1 -4412 -6859 -3479 -6049 6825
Fnip2 6803 3397 4956 -1206 3774
Gcn1 6541 -4336 5274 -6548 2059
Impact -6033 2687 -5811 -5272 -4307
Itfg2 -3020 4730 4745 308 -3783
Kptn 6575 2041 5484 6206 1212
Lamtor1 1167 3839 3216 7498 187
Lamtor2 -4743 6658 -1673 6639 -5059
Lamtor3 -6726 3633 -1958 7249 -1126
Lamtor4 671 -3520 2812 7375 -5951
Lamtor5 -2974 3932 -2210 6552 3766
Mios 2095 3953 2878 2720 4268
Mlst8 6287 5034 7514 4181 5809
Mtor 2415 -2947 6400 -6261 5180
Nprl2 -6150 -6539 1184 4710 -3949
Nprl3 4963 1718 7334 -400 5490
Rheb -7406 -3251 -1847 3154 -1179
Rpl10 7552 2305 -6483 1980 1798
Rpl10a -4754 5887 -3904 6315 -6264
Rpl11 -7040 -1610 -1752 7106 -5100
Rpl12 -1293 111 -1276 5593 -4815
Rpl13 -5435 705 -309 7111 -4751
Rpl13a -6127 -800 -4926 6137 -3678
Rpl14 -4973 3377 -3827 6231 -6184
Rpl15 -1081 4664 -97 5670 -5225
Rpl17 -6154 1812 -4356 5972 -3587
Rpl18 -3623 1407 1250 6814 -5632
Rpl18a -1090 3984 -5189 6777 -4423
Rpl19 -6145 1844 1393 7139 -5256
Rpl21 -5242 1494 -2632 6613 -7105
Rpl22 2309 1493 135 7361 -5393
Rpl22l1 -6274 -4977 -2367 6270 -5683
Rpl23 -4886 -1314 -5284 6983 -7403
Rpl23a -5685 181 -4668 5986 -6814
Rpl24 -6576 1391 -3886 6934 -6380
Rpl26 -6659 1690 -587 7025 -6436
Rpl27 -6845 1737 -3419 6972 -3911
Rpl27a -5517 3660 -2513 5849 -4735
Rpl28 -1279 5641 -1248 5705 -5460
Rpl29 -1125 4140 -4187 6593 -5922
Rpl3 -4393 97 1158 6008 -4443
Rpl30 -3489 -1769 -4305 6489 -7269
Rpl31 -6836 -3203 -1412 7055 -6596
Rpl32 -4734 -2231 1048 7325 -5634
Rpl34 -5472 -4039 -1304 7052 -5665
Rpl35 -5746 -5044 -3769 7203 -6944
Rpl35a -5482 -3840 570 7450 -6779
Rpl36 -4150 -526 -925 7394 -6244
Rpl36a -5737 966 -3217 6846 -6933
Rpl36al -5513 1911 -471 7142 -7041
Rpl37 -4803 -2009 -157 7169 -7308
Rpl37a -5196 -2693 70 7353 -7233
Rpl38 -4285 -3890 857 7427 -7458
Rpl39 -6226 -2451 1477 7435 -7398
Rpl4 -4925 1852 -4074 6135 -4712
Rpl5 5744 -2476 -3141 5665 42
Rpl6 -5411 5527 -1164 5021 -4217
Rpl7 -5113 1762 151 6242 -4040
Rpl7a -3564 4076 1931 6938 -2667
Rpl8 -3703 3543 -3664 6481 -4491
Rpl9 -5504 344 903 6756 -2526
Rplp0 -3763 4412 -942 6357 956
Rplp1 -3659 -3603 -814 6990 -6512
Rplp2 -1405 721 5081 7200 -5799
Rps10 -5436 1596 -1596 7118 -2524
Rps11 -6088 -966 -1330 6240 -6425
Rps12 -6536 2445 -4827 7047 -5574
Rps13 -2674 -235 -1978 6430 -3919
Rps14 -3675 1734 3410 7146 -3493
Rps15 -5634 2477 239 7130 -5513
Rps15a 369 608 -3369 6779 -5204
Rps16 -4792 2799 -1537 6267 -5455
Rps17 -5260 -1557 1246 7182 -6746
Rps18 -4838 1158 194 6830 -4753
Rps19 -6105 -2857 -5576 6611 -5782
Rps2 -2017 387 -812 6266 -3726
Rps20 -4819 -1197 -4402 5625 -7090
Rps21 -4549 -3950 -722 7488 -7191
Rps23 -6959 2961 -3533 6890 -7067
Rps24 -6377 -301 -5394 5997 -5015
Rps25 -6573 -1150 -1883 6238 -5538
Rps26 -5325 3572 -3697 5769 -6007
Rps27 -5449 -2098 2068 7449 -7364
Rps27a -6372 -7132 -2043 6853 -6401
Rps27l -4990 -3246 -4325 6048 -3758
Rps28 -2854 -2799 2837 7397 -7470
Rps29 -234 -4717 -446 7482 -7465
Rps3 -5535 1738 -2705 6117 -1500
Rps3a1 -6001 295 -2164 5731 -4251
Rps4x -3555 -300 -4680 5409 -4453
Rps5 -4284 1344 -1916 5993 -4583
Rps6 -4272 4707 1599 6014 -5295
Rps7 -5696 1849 -3387 6808 -5804
Rps8 -6704 -566 -5243 7004 -6741
Rps9 -5004 1757 -844 6794 -4576
Rpsa -5034 -2245 -4844 5145 -2970
Rptor 6686 -4137 1965 -2648 4861
Rraga -1623 5834 5023 3891 7496
Rragb -6612 4331 -3303 -820 8005
Rragc -1332 2540 741 3185 6898
Rragd 3025 -2221 2462 -7705 2210
Sec13 -6671 26 2130 5485 2317
Seh1l 5956 -2758 6640 -1124 7315
Sesn1 7194 6134 5956 6550 8078
Sesn2 -4224 3362 1036 -1356 7789
Sh3bp4 -2801 -1511 1806 -5155 5210
Slc38a9 7303 -8458 -6912 -6778 1819
Szt2 4344 -7338 5210 -6771 1067
Tcirg1 -4684 -8053 -6719 -5195 -6414
Uba52 -2504 5042 585 6605 -5655
Wdr24 -3303 -907 5934 1687 5
Wdr59 4373 -4347 -1108 -3400 2856





PKA MEDIATED PHOSPHORYLATION OF CREB

PKA MEDIATED PHOSPHORYLATION OF CREB
metric value
setSize 19
pMANOVA 5.46e-05
p.adjustMANOVA 0.000333
s.dist 0.74
s.hyp -0.0309
s.hip -0.386
s.amy 0.0516
s.pag -0.612
s.ni 0.145
p.hyp 0.816
p.hip 0.00358
p.amy 0.697
p.pag 3.84e-06
p.ni 0.274



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag hip
Creb1 -8066 -8363
Adcy4 -8405 -7008
Adcy3 -7195 -8015
Adcy2 -5988 -6343
Prkacb -6658 -5615
Prkar2a -8197 -4370
Prkx -7019 -4528
Nbea -6073 -4254
Adcy6 -8137 -2399
Prkar2b -3385 -5589
Adcy9 -4061 -3268
Prkar1b -1693 -3433
Prkar1a -2814 -1823
Adcy1 -569 -5883

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Adcy1 6550 -5883 1481 -569 7791
Adcy2 5238 -6343 5164 -5988 4022
Adcy3 2809 -8015 5837 -7195 2370
Adcy4 -7925 -7008 -6394 -8405 -6896
Adcy5 5698 1302 4984 -7109 2333
Adcy6 3415 -2399 428 -8137 -2772
Adcy7 2896 1967 -689 -8304 5066
Adcy8 -7137 349 -3569 -6760 -2592
Adcy9 4621 -3268 6495 -4061 4438
Calm1 -3210 -5777 -2383 480 4856
Creb1 -6520 -8363 -6284 -8066 984
Nbea 5096 -4254 5245 -6073 5393
Prkaca 536 2584 4026 -974 -911
Prkacb -5780 -5615 -705 -6658 2764
Prkar1a -1344 -1823 1101 -2814 7059
Prkar1b -1456 -3433 5947 -1693 4760
Prkar2a -6880 -4370 -4761 -8197 4398
Prkar2b -3250 -5589 -1825 -3385 -6274
Prkx -1534 -4528 -6228 -7019 -5454





RRNA PROCESSING

RRNA PROCESSING
metric value
setSize 194
pMANOVA 2.68e-56
p.adjustMANOVA 3.08e-54
s.dist 0.731
s.hyp -0.29
s.hip 0.062
s.amy -0.00171
s.pag 0.544
s.ni -0.388
p.hyp 3.49e-12
p.hip 0.137
p.amy 0.967
p.pag 4.44e-39
p.ni 1.21e-20



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag ni
Rps29 7482 -7465
Rpl38 7427 -7458
Rps28 7397 -7470
Rpl39 7435 -7398
Rps27 7449 -7364
Rps21 7488 -7191
Rpl37a 7353 -7233
Rpl37 7169 -7308
Rpl23 6983 -7403
Rpl35a 7450 -6779
Rpl36al 7142 -7041
Rpl35 7203 -6944
Rps23 6890 -7067
Rps17 7182 -6746
Rpl36a 6846 -6933
Rps8 7004 -6741
Rpl30 6489 -7269
Rpl21 6613 -7105
Gar1 6495 -7230
Rpl31 7055 -6596

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Bms1 1791 -3928 -3344 -1231 -6854
Bop1 1767 -5308 7703 4711 6961
Bud23 -4496 -3746 0 3962 -3803
Bysl -1930 3341 6110 -3041 -4039
C1d -5706 1498 -958 2362 -3062
Csnk1d 901 2905 3451 -1127 4706
Csnk1e -1640 -3459 5499 -4321 -4513
Dcaf13 2760 -8035 4061 4301 -6677
Ddx21 2752 391 601 -2375 -5811
Ddx47 -939 -846 638 4210 3735
Ddx49 2567 6698 5373 6835 4754
Ddx52 -3248 -7088 1207 4814 591
Dhx37 -954 -187 6139 -2322 208
Dimt1 -4370 -5082 -4189 -7954 -1832
Dis3 -4989 -4638 -977 -3561 -2313
Dkc1 -2076 -5632 1032 3311 -6857
Ebna1bp2 -6060 -4105 -6260 3066 -4828
Elac2 7202 -7852 7628 1467 5130
Emg1 -1800 -2369 1018 4295 -67
Eri1 -4276 -7850 -5838 4226 4492
Exosc1 -3066 2621 6782 3973 2395
Exosc10 2714 4634 5384 -1183 -6170
Exosc2 -4473 -7846 865 5584 4321
Exosc3 -6840 5875 2597 43 -4699
Exosc4 -5315 6546 1007 4053 -5408
Exosc5 2688 -832 5816 5713 -486
Exosc7 -1129 -5209 5349 5230 -5128
Exosc8 -1139 -398 -2872 5029 3322
Exosc9 -3486 -2238 2869 6215 2270
Fau -5907 1583 1608 7212 -5383
Fbl -4809 -6182 6839 5535 -7325
Fcf1 -3663 -262 5087 4986 -3558
Ftsj3 1413 -5292 3049 2547 -5416
Gar1 -190 1349 2723 6495 -7230
Gnl3 -6916 2819 -1866 4900 -4803
Heatr1 4085 -7606 598 -7088 373
Hsd17b10 -5240 7146 -1105 6610 5512
Imp3 1159 2252 -555 6532 -3061
Imp4 -2958 -6670 2917 522 -2043
Isg20l2 5692 -5285 -1788 -191 -7146
Krr1 -2892 -7617 -1957 5088 -7178
Las1l -2231 -6747 -3861 -2578 -5994
Ltv1 -1335 -5573 3751 6420 98
Mphosph10 -6153 -31 -5929 1327 -6957
Mphosph6 4508 -2853 5886 1294 -6652
Mrm1 6061 3681 3070 4474 8264
Mrm2 -4539 -5644 640 4545 3078
Mrm3 2116 4564 -3660 4537 486
Mterf4 -4923 -5525 3979 -1483 -5006
Mtrex -702 -2867 -5489 1739 4805
Nat10 6017 -3447 6716 -4062 -2094
Ncl -2374 3952 911 2596 -6917
Nhp2 51 2937 1786 6760 -1956
Nip7 -7469 4466 5520 6455 5106
Nob1 -836 -1530 2951 4840 -311
Noc4l 5041 4363 6409 2214 6809
Nol11 1182 4194 2640 1482 6318
Nol12 430 -770 378 6557 -5603
Nol6 6109 -1544 6597 -4969 4557
Nol9 5988 994 5703 -2813 7025
Nop10 -7622 2474 -2144 6281 -3956
Nop14 3186 6039 -2470 -673 -5975
Nop2 -5966 4336 -4966 -4569 -3564
Nop56 -6236 -2946 -1521 4690 -924
Nop58 3953 816 301 35 -7381
Nsun4 4572 -160 3568 265 7197
Pdcd11 -4668 -6931 1484 1144 -3025
Pelp1 613 1295 5640 999 -3071
Pes1 5773 3817 4130 6027 2925
Pno1 -3813 4096 1057 5874 2146
Prorp -4573 2206 6244 994 6256
Pwp2 -5734 -3735 3192 -2574 -716
Rbm28 -1288 -3441 -1306 -5207 -2290
Rcl1 -3247 1705 2035 5749 2272
Riok1 6591 -3846 3023 1270 -18
Riok2 -4183 -1482 4514 1782 5935
Riok3 6010 -1592 3191 2328 4820
Rpl10 7552 2305 -6483 1980 1798
Rpl10a -4754 5887 -3904 6315 -6264
Rpl11 -7040 -1610 -1752 7106 -5100
Rpl12 -1293 111 -1276 5593 -4815
Rpl13 -5435 705 -309 7111 -4751
Rpl13a -6127 -800 -4926 6137 -3678
Rpl14 -4973 3377 -3827 6231 -6184
Rpl15 -1081 4664 -97 5670 -5225
Rpl17 -6154 1812 -4356 5972 -3587
Rpl18 -3623 1407 1250 6814 -5632
Rpl18a -1090 3984 -5189 6777 -4423
Rpl19 -6145 1844 1393 7139 -5256
Rpl21 -5242 1494 -2632 6613 -7105
Rpl22 2309 1493 135 7361 -5393
Rpl22l1 -6274 -4977 -2367 6270 -5683
Rpl23 -4886 -1314 -5284 6983 -7403
Rpl23a -5685 181 -4668 5986 -6814
Rpl24 -6576 1391 -3886 6934 -6380
Rpl26 -6659 1690 -587 7025 -6436
Rpl27 -6845 1737 -3419 6972 -3911
Rpl27a -5517 3660 -2513 5849 -4735
Rpl28 -1279 5641 -1248 5705 -5460
Rpl29 -1125 4140 -4187 6593 -5922
Rpl3 -4393 97 1158 6008 -4443
Rpl30 -3489 -1769 -4305 6489 -7269
Rpl31 -6836 -3203 -1412 7055 -6596
Rpl32 -4734 -2231 1048 7325 -5634
Rpl34 -5472 -4039 -1304 7052 -5665
Rpl35 -5746 -5044 -3769 7203 -6944
Rpl35a -5482 -3840 570 7450 -6779
Rpl36 -4150 -526 -925 7394 -6244
Rpl36a -5737 966 -3217 6846 -6933
Rpl36al -5513 1911 -471 7142 -7041
Rpl37 -4803 -2009 -157 7169 -7308
Rpl37a -5196 -2693 70 7353 -7233
Rpl38 -4285 -3890 857 7427 -7458
Rpl39 -6226 -2451 1477 7435 -7398
Rpl4 -4925 1852 -4074 6135 -4712
Rpl5 5744 -2476 -3141 5665 42
Rpl6 -5411 5527 -1164 5021 -4217
Rpl7 -5113 1762 151 6242 -4040
Rpl7a -3564 4076 1931 6938 -2667
Rpl8 -3703 3543 -3664 6481 -4491
Rpl9 -5504 344 903 6756 -2526
Rplp0 -3763 4412 -942 6357 956
Rplp1 -3659 -3603 -814 6990 -6512
Rplp2 -1405 721 5081 7200 -5799
Rpp14 -7709 -32 -3262 2652 3658
Rpp21 -3012 2025 6220 5886 -6379
Rpp25 5272 4802 6352 6637 -3213
Rpp30 -3138 4151 -4983 2569 -1250
Rpp38 -6179 -4212 -858 4196 -4504
Rpp40 720 -779 -2883 3767 -3076
Rps10 -5436 1596 -1596 7118 -2524
Rps11 -6088 -966 -1330 6240 -6425
Rps12 -6536 2445 -4827 7047 -5574
Rps13 -2674 -235 -1978 6430 -3919
Rps14 -3675 1734 3410 7146 -3493
Rps15 -5634 2477 239 7130 -5513
Rps15a 369 608 -3369 6779 -5204
Rps16 -4792 2799 -1537 6267 -5455
Rps17 -5260 -1557 1246 7182 -6746
Rps18 -4838 1158 194 6830 -4753
Rps19 -6105 -2857 -5576 6611 -5782
Rps2 -2017 387 -812 6266 -3726
Rps20 -4819 -1197 -4402 5625 -7090
Rps21 -4549 -3950 -722 7488 -7191
Rps23 -6959 2961 -3533 6890 -7067
Rps24 -6377 -301 -5394 5997 -5015
Rps25 -6573 -1150 -1883 6238 -5538
Rps26 -5325 3572 -3697 5769 -6007
Rps27 -5449 -2098 2068 7449 -7364
Rps27a -6372 -7132 -2043 6853 -6401
Rps27l -4990 -3246 -4325 6048 -3758
Rps28 -2854 -2799 2837 7397 -7470
Rps29 -234 -4717 -446 7482 -7465
Rps3 -5535 1738 -2705 6117 -1500
Rps3a1 -6001 295 -2164 5731 -4251
Rps4x -3555 -300 -4680 5409 -4453
Rps5 -4284 1344 -1916 5993 -4583
Rps6 -4272 4707 1599 6014 -5295
Rps7 -5696 1849 -3387 6808 -5804
Rps8 -6704 -566 -5243 7004 -6741
Rps9 -5004 1757 -844 6794 -4576
Rpsa -5034 -2245 -4844 5145 -2970
Rrp1 -3910 2645 4697 4743 -6070
Rrp36 -7983 -1185 -3670 7049 -637
Rrp7a -4480 -2447 354 3344 -2507
Rrp9 -7661 -2345 1812 3545 -2992
Senp3 1531 436 733 544 4006
Snu13 -5832 716 -529 6149 180
Tbl3 4625 1978 7571 4316 8173
Tex10 5310 -7707 -7792 -2884 -6681
Tfb1m -1292 2810 4843 -240 -6059
Thumpd1 5996 3691 5765 3992 3857
Trmt10c 661 -63 3517 3419 2120
Trmt112 -2542 6716 -5903 5218 -6826
Tsr1 7396 342 2689 -113 6708
Tsr3 -4365 144 1402 6775 906
Uba52 -2504 5042 585 6605 -5655
Utp11 -8076 2036 -6772 2935 -4409
Utp14a 3014 2003 -5246 -1434 -3086
Utp15 1888 -4341 -3103 -5808 -1428
Utp18 -871 2960 -1270 -1026 -2520
Utp20 1410 8 6331 -7145 841
Utp25 7655 4715 -4041 1704 2593
Utp3 -6029 -5208 -1932 4749 -7434
Utp4 938 -56 -3453 -6067 3587
Utp6 -6502 -2482 -6822 -3163 4455
Wdr12 -7705 4 -2688 -745 -988
Wdr18 -3116 1929 3849 6766 4692
Wdr3 -6829 691 7286 -8019 4395
Wdr36 -3917 4002 -1976 -615 -279
Wdr43 -7417 5907 3174 1794 4465
Wdr46 1737 -1683 5043 4374 2551
Wdr75 -6168 -1662 -5453 -3903 -1018
Xrn2 6705 5960 -21 7311 7224





BIOTIN TRANSPORT AND METABOLISM

BIOTIN TRANSPORT AND METABOLISM
metric value
setSize 11
pMANOVA 0.00731
p.adjustMANOVA 0.0226
s.dist 0.73
s.hyp 0.111
s.hip 0.55
s.amy 0.338
s.pag -0.00956
s.ni 0.323
p.hyp 0.524
p.hip 0.00157
p.amy 0.0525
p.pag 0.956
p.ni 0.064



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene hip amy
Pccb 6774 7335
Hlcs 6687 6690
Mccc2 7056 3324
Acacb 6228 2952
Btd 4575 3637
Pdzd11 1505 6079
Pcx 5280 496
Mccc1 1579 1173

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Acaca -127 -5798 -842 -7383 1886
Acacb 6376 6228 2952 -4760 8286
Btd -7199 4575 3637 -2445 289
Hlcs 6930 6687 6690 -63 6000
Mccc1 2041 1579 1173 -5482 3035
Mccc2 7172 7056 3324 3356 -3100
Pcca -1767 2233 -562 7527 6754
Pccb -3903 6774 7335 6081 -1278
Pcx -2192 5280 496 -2092 7847
Pdzd11 -65 1505 6079 4903 -114
Slc5a6 462 5338 -585 -5162 4146





CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE

CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE
metric value
setSize 11
pMANOVA 0.0113
p.adjustMANOVA 0.0321
s.dist 0.724
s.hyp -0.319
s.hip -0.405
s.amy -0.151
s.pag -0.466
s.ni 0.136
p.hyp 0.0672
p.hip 0.0202
p.amy 0.387
p.pag 0.0074
p.ni 0.434



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag hip
Creb1 -8066 -8363
Prkacb -6658 -5615
Prkar2a -8197 -4370
Prkx -7019 -4528
Prkar2b -3385 -5589
Prkar1b -1693 -3433
Prkar1a -2814 -1823
Adcy1 -569 -5883

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Adcy1 6550 -5883 1481 -569 7791
Adcy8 -7137 349 -3569 -6760 -2592
Calm1 -3210 -5777 -2383 480 4856
Creb1 -6520 -8363 -6284 -8066 984
Prkaca 536 2584 4026 -974 -911
Prkacb -5780 -5615 -705 -6658 2764
Prkar1a -1344 -1823 1101 -2814 7059
Prkar1b -1456 -3433 5947 -1693 4760
Prkar2a -6880 -4370 -4761 -8197 4398
Prkar2b -3250 -5589 -1825 -3385 -6274
Prkx -1534 -4528 -6228 -7019 -5454





NEGATIVE REGULATION OF NOTCH4 SIGNALING

NEGATIVE REGULATION OF NOTCH4 SIGNALING
metric value
setSize 54
pMANOVA 4.6e-16
p.adjustMANOVA 1.89e-14
s.dist 0.724
s.hyp -0.382
s.hip 0.05
s.amy 0.0849
s.pag 0.582
s.ni -0.17
p.hyp 1.18e-06
p.hip 0.525
p.amy 0.281
p.pag 1.31e-13
p.ni 0.0305



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag hyp
Psma4 6831 -7504
Psmb3 7151 -6332
Rps27a 6853 -6372
Psma3 7155 -6066
Psma7 6865 -6285
Sem1 6969 -6006
Psmb6 6933 -5672
Psma6 6511 -5994
Tacc3 5725 -6674
Psma1 4832 -7420
Psma2 6209 -5644
Psmc2 5333 -6518
Psmb1 5823 -5858
Psmd14 5163 -6510
Skp1 4373 -7030
Psme1 6188 -4847
Psmb4 6715 -4320
Ubb 6541 -4378
Psme2 4745 -5948
Psmb5 7354 -3602

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Akt1 -725 267 1944 3433 7591
Cul1 5439 4556 -3455 -2303 3314
Fbxw7 -474 -7149 4798 -790 3165
Notch4 7638 3639 6478 5522 7513
Psma1 -7420 -4010 -2108 4832 1858
Psma2 -5644 3865 -2900 6209 1865
Psma3 -6066 979 -2046 7155 -4041
Psma4 -7504 977 368 6831 -5642
Psma5 -2124 -1232 2483 4725 2300
Psma6 -5994 3421 -370 6511 835
Psma7 -6285 2069 2339 6865 571
Psmb1 -5858 -1406 -2701 5823 -2062
Psmb10 -3492 4071 526 5974 -4727
Psmb2 -634 4648 5325 7007 830
Psmb3 -6332 -4121 2181 7151 -84
Psmb4 -4320 1432 -1045 6715 -3833
Psmb5 -3602 1198 3279 7354 -522
Psmb6 -5672 -1356 -959 6933 -4272
Psmb7 -1170 1445 2791 7138 -1108
Psmb8 -4080 -6385 -7753 1678 -7164
Psmb9 -4395 2842 -6017 -1361 -6203
Psmc1 -3306 -2805 3510 5660 -2811
Psmc2 -6518 3638 311 5333 14
Psmc3 -2810 -6533 330 5063 -1709
Psmc4 -1805 -523 3727 6567 -1984
Psmc5 -3339 1551 -4032 5126 -3280
Psmc6 -6889 -1882 -5077 3383 2777
Psmd1 -6211 -4112 2043 1517 1743
Psmd10 -5057 5662 -811 3277 1494
Psmd11 -3954 -7414 -6745 -3634 -2989
Psmd12 -7136 -641 -4440 3580 -1003
Psmd13 -420 3420 1880 6754 -3079
Psmd14 -6510 -4665 1516 5163 1500
Psmd2 5901 -1504 6553 -254 4336
Psmd3 6 -1368 4418 6572 -1820
Psmd4 -3476 -556 3530 4997 -899
Psmd5 -7412 -4455 -6171 -4153 7500
Psmd6 -5055 -1678 -1384 2086 1811
Psmd7 88 -5762 6557 6395 -2888
Psmd8 -1002 758 5775 5963 -933
Psmd9 -869 -4765 -1399 6885 -2353
Psme1 -4847 4903 2140 6188 -6113
Psme2 -5948 -131 -860 4745 -6182
Psme3 2209 -3777 5865 -3604 6598
Psmf1 2377 3789 7161 2699 6535
Rbx1 234 -1186 -2007 6309 -3980
Rps27a -6372 -7132 -2043 6853 -6401
Sem1 -6006 529 -1985 6969 -6676
Skp1 -7030 -655 -398 4373 1142
Tacc3 -6674 4929 6296 5725 -2186
Uba52 -2504 5042 585 6605 -5655
Ubb -4378 3667 1287 6541 -5290
Ubc -1247 3415 2683 -2012 -1479
Ywhaz 336 -1873 4676 -3566 -2575





PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING

PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING
metric value
setSize 11
pMANOVA 0.00916
p.adjustMANOVA 0.0275
s.dist 0.721
s.hyp 0.395
s.hip -0.232
s.amy 0.402
s.pag -0.386
s.ni 0.0224
p.hyp 0.0234
p.hip 0.183
p.amy 0.0211
p.pag 0.0267
p.ni 0.898



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene amy hyp
Cacna1e 6936 6197
Cacnb3 6511 6311
Cacna1b 7298 4997
Cacna2d3 4129 5831
Cacna1a 5610 3802
Cacnb1 6234 1524
Cacnb2 1406 4802
Cacna2d2 1192 4313

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Cacna1a 3802 -5311 5610 -3347 3475
Cacna1b 4997 -1552 7298 -6236 440
Cacna1e 6197 -7845 6936 -7992 -3711
Cacna2d2 4313 4362 1192 -2579 2557
Cacna2d3 5831 744 4129 -3448 7281
Cacnb1 1524 -8297 6234 -7272 -1478
Cacnb2 4802 234 1406 -5481 3692
Cacnb3 6311 -7576 6511 -5054 -2668
Cacnb4 4051 -5803 -438 -3739 7573
Cacng2 -4441 1887 -3216 3644 -2985
Cacng4 -4738 1861 -353 2914 -6794





COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING

COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING
metric value
setSize 26
pMANOVA 1.69e-06
p.adjustMANOVA 1.53e-05
s.dist 0.719
s.hyp -0.488
s.hip -0.134
s.amy -0.0583
s.pag 0.37
s.ni -0.348
p.hyp 1.65e-05
p.hip 0.237
p.amy 0.607
p.pag 0.0011
p.ni 0.00211



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene hyp pag
Pfdn5 -5586 6325
Pfdn1 -4880 6680
Pfdn6 -4423 7177
Cct5 -7287 3825
Pfdn2 -3890 5967
Cct3 -7734 2831
Tuba1a -5422 3572
Cct2 -6976 2670
Tubb4b -5695 3097
Pfdn4 -7842 2216
Cct7 -7381 2117
Vbp1 -7942 1328
Tubb3 -2697 3566
Tubb2a -4425 1810
Tcp1 -6241 1082
Tubb4a -1886 3342
Tuba1b -3026 1706
Cct8 -4413 648
Tuba4a -464 2676

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Actb 172 -2786 6540 1236 -4618
Cct2 -6976 -6216 -4431 2670 -2928
Cct3 -7734 -7399 -1737 2831 -4158
Cct4 -7846 -7519 -6415 -2536 -6802
Cct5 -7287 -3378 -1743 3825 -3457
Cct6a -7949 -4985 -4197 -717 -3098
Cct7 -7381 -8123 -2899 2117 -5938
Cct8 -4413 -6328 -4084 648 -4316
Pfdn1 -4880 2985 -1140 6680 -4865
Pfdn2 -3890 2147 -325 5967 -7085
Pfdn4 -7842 -1286 -1495 2216 -5421
Pfdn5 -5586 -592 -3078 6325 -4013
Pfdn6 -4423 3532 883 7177 -5876
Tcp1 -6241 -6345 -3761 1082 -4000
Tuba1a -5422 -8 3860 3572 -1571
Tuba1b -3026 -1501 -2474 1706 1084
Tuba1c 7751 4601 -4435 1956 3635
Tuba4a -464 -6482 6752 2676 4991
Tuba8 7361 -6707 7647 6804 -200
Tubb2a -4425 6203 3896 1810 -4403
Tubb2b -7631 -525 -7115 -2860 -5116
Tubb3 -2697 4372 2624 3566 931
Tubb4a -1886 3082 5443 3342 3352
Tubb4b -5695 2166 3550 3097 1598
Tubb6 345 545 -3085 -885 352
Vbp1 -7942 -3561 -807 1328 2473





TRAF3 DEPENDENT IRF ACTIVATION PATHWAY

TRAF3 DEPENDENT IRF ACTIVATION PATHWAY
metric value
setSize 13
pMANOVA 0.0196
p.adjustMANOVA 0.0496
s.dist 0.716
s.hyp -0.211
s.hip -0.401
s.amy -0.347
s.pag -0.433
s.ni 0.00433
p.hyp 0.189
p.hip 0.0123
p.amy 0.0304
p.pag 0.00684
p.ni 0.978



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag hip
Traf3 -6833 -7345
Ddx58 -5179 -8007
Crebbp -5698 -6540
Sike1 -5176 -6022
Ifih1 -8045 -2770
Ikbke -3261 -4995
Ep300 -4410 -3349
Trim25 -3104 -4288
Irf3 -1185 -5376
Mavs -4923 -1071

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Crebbp 5856 -6540 2739 -5698 -6903
Ddx58 -4298 -8007 -2124 -5179 -3533
Ep300 1346 -3349 -2137 -4410 4066
Ifih1 890 -2770 -7809 -8045 -1905
Ikbke -657 -4995 4371 -3261 1491
Irf3 -5768 -5376 -1103 -1185 -7110
Irf7 1101 -8554 -7597 2262 -3028
Mavs -3159 -1071 -1657 -4923 6917
Rnf135 -1744 5488 -4242 -1281 5257
Sike1 -7550 -6022 -3240 -5176 3017
Tbk1 -6450 3020 -5564 -3672 2664
Traf3 -4865 -7345 -5306 -6833 1194
Trim25 1053 -4288 -2307 -3104 4725





ADENYLATE CYCLASE INHIBITORY PATHWAY

ADENYLATE CYCLASE INHIBITORY PATHWAY
metric value
setSize 13
pMANOVA 0.00299
p.adjustMANOVA 0.0109
s.dist 0.714
s.hyp 0.0959
s.hip -0.221
s.amy 0.02
s.pag -0.662
s.ni 0.113
p.hyp 0.549
p.hip 0.167
p.amy 0.901
p.pag 3.53e-05
p.ni 0.48



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag hip
Adcy4 -8405 -7008
Adcy3 -7195 -8015
Adcy2 -5988 -6343
Gnai3 -4572 -4674
Adcy6 -8137 -2399
Gnai1 -4433 -3365
Adcy9 -4061 -3268
Adcy1 -569 -5883

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Adcy1 6550 -5883 1481 -569 7791
Adcy2 5238 -6343 5164 -5988 4022
Adcy3 2809 -8015 5837 -7195 2370
Adcy4 -7925 -7008 -6394 -8405 -6896
Adcy5 5698 1302 4984 -7109 2333
Adcy6 3415 -2399 428 -8137 -2772
Adcy7 2896 1967 -689 -8304 5066
Adcy8 -7137 349 -3569 -6760 -2592
Adcy9 4621 -3268 6495 -4061 4438
Gnai1 -7586 -3365 -2697 -4433 2266
Gnai2 -4861 4027 -6734 -2244 -4963
Gnai3 -2266 -4674 -2638 -4572 1506
Gnal 6117 2185 443 -6523 5570





MITOCHONDRIAL PROTEIN IMPORT

MITOCHONDRIAL PROTEIN IMPORT
metric value
setSize 63
pMANOVA 2.86e-17
p.adjustMANOVA 1.27e-15
s.dist 0.712
s.hyp -0.239
s.hip 0.176
s.amy 0.0449
s.pag 0.643
s.ni -0.0604
p.hyp 0.00103
p.hip 0.016
p.amy 0.538
p.pag 9.77e-19
p.ni 0.407



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene pag hyp
Timm8b 7295 -7076
Fxn 6236 -7245
Timm9 6366 -6663
Tomm22 7265 -5795
Timm23 7204 -5748
Cox17 7358 -5578
Tomm5 6691 -6134
Ndufb8 7254 -5455
Tomm6 7048 -5389
Pmpcb 5047 -7063
Coa4 5049 -7038
Atp5g1 7378 -4692
Chchd4 6060 -5401
Grpel1 7306 -4461
Timm22 6449 -4971
Cox19 5991 -5148
Coa6 3797 -7380
Timm50 5671 -4930
Chchd2 5387 -5001
Dnajc19 7467 -3357

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Aco2 5025 873 1479 2225 8071
Atp5a1 85 172 1149 1994 5105
Atp5b -231 -1196 -507 6630 4246
Atp5g1 -4692 -4063 -1542 7378 -921
Bcs1l -2096 937 947 -557 4570
Chchd10 659 6662 1537 6809 -3518
Chchd2 -5001 1520 -4065 5387 -3865
Chchd3 -2013 -2411 1394 7175 -2172
Chchd4 -5401 5679 7167 6060 -1818
Chchd5 3509 2188 -2081 5592 -2479
Chchd7 -3177 -1838 973 6069 -3610
Cmc2 -2782 2466 4084 5733 7622
Cmc4 -5595 204 2419 2770 311
Coa4 -7038 5572 -6564 5049 -544
Coa6 -7380 6782 -3275 3797 -2016
Coq2 -3759 -111 2488 6196 6134
Cox17 -5578 -1377 1031 7358 -7400
Cox19 -5148 -5349 3732 5991 873
Cs -997 -1921 -2172 623 5854
Cyc1 -2233 4850 3117 7172 3586
Dnajc19 -3357 5835 -2942 7467 -7297
Fxn -7245 3296 -7061 6236 -4353
Gfer -3757 6771 2354 4728 -4652
Grpel1 -4461 187 1438 7306 3492
Grpel2 -1158 -7485 3965 4836 620
Hscb -1232 -1359 412 5971 3881
Hspa9 -1762 1791 -3119 -402 2721
Hspd1 -7939 -8179 -7333 -6342 -5599
Idh3g 3672 6087 2279 6426 6570
Ldhd 4055 1559 626 5285 1357
Mtx1 2550 1923 6338 6889 -1599
Mtx2 -179 -787 2691 5561 -181
Ndufb8 -5455 591 1725 7254 -333
Pam16 3935 -7652 -7876 7292 -7472
Pitrm1 -3101 4324 21 -6646 7841
Pmpca 6660 5070 199 5571 5414
Pmpcb -7063 5016 -2464 5047 -1924
Samm50 -638 -7884 1078 -1768 -1324
Slc25a12 1244 4301 5027 -5680 6399
Slc25a13 5129 7350 3152 5968 8426
Slc25a4 -2495 4740 -2447 5750 363
Taz 2149 117 6741 1412 -4846
Timm10 -2174 5363 -362 7076 1039
Timm10b 1550 -242 -3363 6921 -1604
Timm13 -2116 3624 2151 7474 -5514
Timm17a -197 -3170 -7267 5005 -589
Timm17b -6430 2395 -2057 3869 383
Timm21 1061 4720 2071 6186 -4474
Timm22 -4971 487 411 6449 3493
Timm23 -5748 -557 1106 7204 3920
Timm44 -4644 -1316 -940 5156 -2643
Timm50 -4930 -445 -774 5671 -3720
Timm8a1 -1869 -3161 753 6173 367
Timm8b -7076 -1727 -1707 7295 -4600
Timm9 -6663 -44 2115 6366 -5061
Tomm20 -1494 -1498 3523 187 4954
Tomm22 -5795 -3247 -938 7265 -2785
Tomm40 1394 3778 5466 6050 973
Tomm5 -6134 -3748 3388 6691 -2848
Tomm6 -5389 -1013 -4449 7048 -4670
Tomm7 -2648 -890 954 7537 -6432
Tomm70a 2500 2431 -12 -1935 6947
Vdac1 4541 1517 6512 4559 -1925





MUCOPOLYSACCHARIDOSES

MUCOPOLYSACCHARIDOSES
metric value
setSize 11
pMANOVA 0.00618
p.adjustMANOVA 0.0195
s.dist 0.711
s.hyp 0.236
s.hip 0.428
s.amy 0.438
s.pag -0.192
s.ni 0.192
p.hyp 0.175
p.hip 0.0139
p.amy 0.0119
p.pag 0.269
p.ni 0.27



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene amy hip
Glb1 7075 6465
Sgsh 4780 6978
Hyal1 4170 6279
Arsb 4615 5126
Galns 5611 3798
Hgsnat 5571 2854
Naglu 7989 827
Gns 1355 4864
Gusb 434 1213

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Arsb 5009 5126 4615 -2007 6732
Galns -6308 3798 5611 2656 713
Glb1 -678 6465 7075 120 3757
Gns 3320 4864 1355 -5963 5608
Gusb 3413 1213 434 4722 -3906
Hgsnat 4937 2854 5571 -2587 6187
Hyal1 4204 6279 4170 -8104 -2157
Ids -3023 -1652 -1291 -6112 5770
Idua 1638 -6036 -1813 -4453 -5212
Naglu 3510 827 7989 2948 7785
Sgsh 2726 6978 4780 -2805 -2982





NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION

NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION
metric value
setSize 21
pMANOVA 6.46e-05
p.adjustMANOVA 0.000387
s.dist 0.707
s.hyp 0.352
s.hip -0.35
s.amy 0.343
s.pag -0.243
s.ni 0.277
p.hyp 0.00526
p.hip 0.00556
p.amy 0.00654
p.pag 0.0537
p.ni 0.0281



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene hyp hip
Grin2a 7735 -7350
Grin2b 7286 -6440
Camk4 6681 -5705
Dlg4 5080 -6512
Actn2 5000 -6366
Camk2a 7207 -4146
Dlg2 5792 -4706
Dlg3 2275 -6061
Lrrc7 1877 -6764
Grin1 2829 -3464
Ppm1e 6624 -1276
Camk2b 7405 -663

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Actn2 5000 -6366 5279 4139 -6863
Calm1 -3210 -5777 -2383 480 4856
Camk1 -7683 -5366 -2266 5537 -6355
Camk2a 7207 -4146 6629 -5758 2594
Camk2b 7405 -663 7585 1811 -336
Camk2d 3624 5724 4117 -6480 3253
Camk2g -2481 -772 2753 2961 7086
Camk4 6681 -5705 4549 -2352 7655
Dlg1 -2526 -6201 60 -478 6813
Dlg2 5792 -4706 -3560 -6197 5701
Dlg3 2275 -6061 7074 -4165 2207
Dlg4 5080 -6512 6564 -2292 -5284
Grin1 2829 -3464 7216 -4005 6253
Grin2a 7735 -7350 4374 -4196 4463
Grin2b 7286 -6440 5901 -6614 -2727
Grin2c 7709 2447 6726 1345 8363
Grin2d -620 4842 -1980 -8301 495
Lrrc7 1877 -6764 2148 -6931 997
Nefl -153 -1355 -5259 568 7113
Ppm1e 6624 -1276 1601 -4038 6088
Ppm1f -5340 -5857 390 -4729 4386





ATF6 ATF6 ALPHA ACTIVATES CHAPERONES

ATF6 ATF6 ALPHA ACTIVATES CHAPERONES
metric value
setSize 12
pMANOVA 0.047
p.adjustMANOVA 0.0994
s.dist 0.704
s.hyp -0.333
s.hip -0.404
s.amy -0.388
s.pag -0.137
s.ni -0.227
p.hyp 0.0458
p.hip 0.0154
p.amy 0.0199
p.pag 0.411
p.ni 0.173



Warning in xtfrm.data.frame(x): cannot xtfrm data frames


Top 20 genes
Gene hip amy
Hspa5 -8614 -7975
Xbp1 -8605 -7945
Hsp90b1 -8424 -7893
Calr -8556 -7756
Ddit3 -8557 -6904
Nfya -6390 -7828
Atf4 -7556 -3593

Click HERE to show all gene set members

All member genes
hyp hip amy pag ni
Atf4 -5109 -7556 -3593 7029 -2762
Atf6 7586 -2375 5449 -3372 8083
Calr -7354 -8556 -7756 -5638 -7238
Ddit3 -8087 -8557 -6904 5070 -7401
Hsp90b1 -7732 -8424 -7893 -4419 -7388
Hspa5 -8142 -8614 -7975 -8202 -7402
Mbtps1 7525 7285 6541 -523 5308
Mbtps2 1436 5622 -3583 152 6970
Nfya -1638 -6390 -7828 -4497 891
Nfyb -6572 -3590 4348 455 -2550
Nfyc 1976 3520 -45 3546 4908
Xbp1 -7999 -8605 -7945 -7851 -7288





Here is the session info with all the versions of packages used.

sessionInfo()
## R version 4.2.1 (2022-06-23)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 22.04.1 LTS
## 
## Matrix products: default
## BLAS:   /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3
## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so
## 
## locale:
##  [1] LC_CTYPE=en_US.UTF-8       LC_NUMERIC=C              
##  [3] LC_TIME=en_US.UTF-8        LC_COLLATE=en_US.UTF-8    
##  [5] LC_MONETARY=en_US.UTF-8    LC_MESSAGES=en_US.UTF-8   
##  [7] LC_PAPER=en_US.UTF-8       LC_NAME=C                 
##  [9] LC_ADDRESS=C               LC_TELEPHONE=C            
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C       
## 
## attached base packages:
## [1] stats4    stats     graphics  grDevices utils     datasets  methods  
## [8] base     
## 
## other attached packages:
##  [1] pkgload_1.3.0               GGally_2.1.2               
##  [3] gtools_3.9.3                echarts4r_0.4.4            
##  [5] beeswarm_0.4.0              vioplot_0.3.7              
##  [7] sm_2.2-5.7.1                kableExtra_1.3.4           
##  [9] topconfects_1.12.0          limma_3.52.4               
## [11] eulerr_6.1.1                mitch_1.8.0                
## [13] MASS_7.3-58.1               fgsea_1.22.0               
## [15] gplots_3.1.3                DESeq2_1.36.0              
## [17] SummarizedExperiment_1.26.1 Biobase_2.56.0             
## [19] MatrixGenerics_1.8.1        matrixStats_0.62.0         
## [21] GenomicRanges_1.48.0        GenomeInfoDb_1.32.4        
## [23] IRanges_2.30.1              S4Vectors_0.34.0           
## [25] BiocGenerics_0.42.0         reshape2_1.4.4             
## [27] forcats_0.5.2               stringr_1.4.1              
## [29] dplyr_1.0.10                purrr_0.3.5                
## [31] readr_2.1.3                 tidyr_1.2.1                
## [33] tibble_3.1.8                ggplot2_3.3.6              
## [35] tidyverse_1.3.2             zoo_1.8-11                 
## 
## loaded via a namespace (and not attached):
##   [1] readxl_1.4.1           backports_1.4.1        fastmatch_1.1-3       
##   [4] systemfonts_1.0.4      plyr_1.8.7             splines_4.2.1         
##   [7] BiocParallel_1.30.3    digest_0.6.29          htmltools_0.5.3       
##  [10] fansi_1.0.3            magrittr_2.0.3         memoise_2.0.1         
##  [13] googlesheets4_1.0.1    tzdb_0.3.0             Biostrings_2.64.1     
##  [16] annotate_1.74.0        modelr_0.1.9           svglite_2.1.0         
##  [19] prettyunits_1.1.1      colorspace_2.0-3       blob_1.2.3            
##  [22] rvest_1.0.3            haven_2.5.1            xfun_0.33             
##  [25] crayon_1.5.2           RCurl_1.98-1.9         jsonlite_1.8.2        
##  [28] genefilter_1.78.0      survival_3.4-0         glue_1.6.2            
##  [31] gtable_0.3.1           gargle_1.2.1           zlibbioc_1.42.0       
##  [34] XVector_0.36.0         webshot_0.5.4          DelayedArray_0.22.0   
##  [37] scales_1.2.1           DBI_1.1.3              Rcpp_1.0.9            
##  [40] viridisLite_0.4.1      xtable_1.8-4           progress_1.2.2        
##  [43] bit_4.0.4              htmlwidgets_1.5.4      httr_1.4.4            
##  [46] RColorBrewer_1.1-3     ellipsis_0.3.2         pkgconfig_2.0.3       
##  [49] reshape_0.8.9          XML_3.99-0.11          farver_2.1.1          
##  [52] sass_0.4.2             dbplyr_2.2.1           locfit_1.5-9.6        
##  [55] utf8_1.2.2             tidyselect_1.2.0       labeling_0.4.2        
##  [58] rlang_1.0.6            later_1.3.0            AnnotationDbi_1.58.0  
##  [61] munsell_0.5.0          cellranger_1.1.0       tools_4.2.1           
##  [64] cachem_1.0.6           cli_3.4.1              generics_0.1.3        
##  [67] RSQLite_2.2.18         broom_1.0.1            evaluate_0.17         
##  [70] fastmap_1.1.0          yaml_2.3.5             knitr_1.40            
##  [73] bit64_4.0.5            fs_1.5.2               caTools_1.18.2        
##  [76] KEGGREST_1.36.3        mime_0.12              xml2_1.3.3            
##  [79] compiler_4.2.1         rstudioapi_0.14        png_0.1-7             
##  [82] reprex_2.0.2           geneplotter_1.74.0     bslib_0.4.0           
##  [85] stringi_1.7.8          highr_0.9              lattice_0.20-45       
##  [88] Matrix_1.5-1           vctrs_0.4.2            pillar_1.8.1          
##  [91] lifecycle_1.0.3        jquerylib_0.1.4        data.table_1.14.2     
##  [94] bitops_1.0-7           httpuv_1.6.6           R6_2.5.1              
##  [97] promises_1.2.0.1       KernSmooth_2.23-20     gridExtra_2.3         
## [100] codetools_0.2-18       assertthat_0.2.1       withr_2.5.0           
## [103] GenomeInfoDbData_1.2.8 parallel_4.2.1         hms_1.1.2             
## [106] grid_4.2.1             rmarkdown_2.17         googledrive_2.0.0     
## [109] shiny_1.7.2            lubridate_1.8.0

END of report